Ophthalmology Breaking News. Read the articles of experts who specialize in ophthalmology and ophthalmic industry news. https://ophthalmologybreakingnews.com/ https://ophthalmologybreakingnews.com/files/favicon.png https://ophthalmologybreakingnews.com/ https://rss.app 2026-04-04T02:00:29+03:00 en https://ophthalmologybreakingnews.com/files/images/blog_aviceda-reports-topline-phase-2b-siglec-data-for-avd-104-in-ga.jpg https://ophthalmologybreakingnews.com/aviceda-reports-topline-phase-2b-siglec-data-for-avd-104-in-ga 2025-12-16T10:56:44+03:00 en https://ophthalmologybreakingnews.com/aviceda-reports-topline-phase-2b-siglec-data-for-avd-104-in-ga https://ophthalmologybreakingnews.com/files/images/blog_alcon-announces-amended-merger-agreement-with-staar-surgical.jpg https://ophthalmologybreakingnews.com/alcon-announces-amended-merger-agreement-with-staar-surgical 2025-12-10T14:30:03+03:00 en https://ophthalmologybreakingnews.com/alcon-announces-amended-merger-agreement-with-staar-surgical https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-ide-approval-for-endoart-synthetic-endothelial-layer-us-clinical-study.jpg https://ophthalmologybreakingnews.com/fda-grants-ide-approval-for-endoart-synthetic-endothelial-layer-us-clinical-study 2025-12-10T10:24:48+03:00 en https://ophthalmologybreakingnews.com/fda-grants-ide-approval-for-endoart-synthetic-endothelial-layer-us-clinical-study https://ophthalmologybreakingnews.com/files/images/blog_vialase-initiates-first-us-ide-trial-patient-treatment-for-incision-free-glaucoma-laser-procedure.jpg https://ophthalmologybreakingnews.com/vialase-initiates-first-us-ide-trial-patient-treatment 2025-12-04T14:08:10+03:00 en https://ophthalmologybreakingnews.com/vialase-initiates-first-us-ide-trial-patient-treatment https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-amneal-pharmaceuticals-cyclosporine-ophthalmic-emulsion-005.jpg https://ophthalmologybreakingnews.com/fda-approves-amneals-cyclosporine-ophthalmic-emulsion-005 2025-12-04T10:43:46+03:00 en https://ophthalmologybreakingnews.com/fda-approves-amneals-cyclosporine-ophthalmic-emulsion-005 https://ophthalmologybreakingnews.com/files/images/blog_european-regulators-approve-pre-filled-syringe-version-of-byooviz-lucentis-biosimilar.jpg https://ophthalmologybreakingnews.com/eu-approves-pre-filled-syringe-version-of-byooviz 2025-12-03T14:01:12+03:00 en https://ophthalmologybreakingnews.com/eu-approves-pre-filled-syringe-version-of-byooviz https://ophthalmologybreakingnews.com/files/images/blog_lotus-submits-nda-for-presbyopia-treatment-vizz-in-south-korea-under-lenz-partnership.jpg https://ophthalmologybreakingnews.com/lotus-submits-nda-for-presbyopia-treatment-vizz-in-south-korea 2025-12-03T10:50:02+03:00 en https://ophthalmologybreakingnews.com/lotus-submits-nda-for-presbyopia-treatment-vizz-in-south-korea https://ophthalmologybreakingnews.com/files/images/blog_kiora-pharmaceuticals-secures-new-us-patent-for-novel-kio-100-formulations.jpg https://ophthalmologybreakingnews.com/kiora-secures-new-us-patent-for-novel-kio-100-formulations 2025-12-02T13:42:07+03:00 en https://ophthalmologybreakingnews.com/kiora-secures-new-us-patent-for-novel-kio-100-formulations https://ophthalmologybreakingnews.com/files/images/blog_belite-bio-reports-phase-3-success-for-tinlarebant-in-stargardt-disease.jpg https://ophthalmologybreakingnews.com/belite-bio-reports-phase-3-success-for-tinlarebant 2025-12-02T10:42:29+03:00 en https://ophthalmologybreakingnews.com/belite-bio-reports-phase-3-success-for-tinlarebant https://ophthalmologybreakingnews.com/files/images/blog_2025-recap-top-10-breakthroughs-in-ophthalmology-research.jpg https://ophthalmologybreakingnews.com/2025-recap-top-10-breakthroughs-in-ophthalmology-research 2025-12-01T15:28:03+03:00 en https://ophthalmologybreakingnews.com/2025-recap-top-10-breakthroughs-in-ophthalmology-research https://ophthalmologybreakingnews.com/files/images/blog_dual-mechanisms-behind-rapid-eye-dominance-plasticity-discovered-in-adult-brain.jpg https://ophthalmologybreakingnews.com/dual-mechanisms-behind-rapid-eye-dominance-plasticity 2025-12-01T13:33:01+03:00 en https://ophthalmologybreakingnews.com/dual-mechanisms-behind-rapid-eye-dominance-plasticity https://ophthalmologybreakingnews.com/files/images/blog_virtual-retina-model-offers-breakthrough-insights-for-vision-loss-treatments.jpg https://ophthalmologybreakingnews.com/virtual-retina-model-offers-breakthrough-insights 2025-12-01T10:46:16+03:00 en https://ophthalmologybreakingnews.com/virtual-retina-model-offers-breakthrough-insights https://ophthalmologybreakingnews.com/files/images/blog_sandoz-launches-afqlir-in-europe-a-new-biosimilar-option-for-retinal-disease-treatment.jpg https://ophthalmologybreakingnews.com/sandoz-launches-afqlir-in-europe 2025-11-28T15:39:58+03:00 en https://ophthalmologybreakingnews.com/sandoz-launches-afqlir-in-europe https://ophthalmologybreakingnews.com/files/images/blog_access-to-ophthalmologists-in-the-us-has-improved-over-the-last-decade-study-finds.jpg https://ophthalmologybreakingnews.com/access-to-ophthalmologists-in-the-us-has-improved 2025-11-28T13:32:03+03:00 en https://ophthalmologybreakingnews.com/access-to-ophthalmologists-in-the-us-has-improved https://ophthalmologybreakingnews.com/files/images/blog_celltrion-receives-health-canada-approval-for-eydenzelt.jpg https://ophthalmologybreakingnews.com/celltrion-receives-health-canada-approval-for-eydenzelt 2025-11-28T10:45:45+03:00 en https://ophthalmologybreakingnews.com/celltrion-receives-health-canada-approval-for-eydenzelt https://ophthalmologybreakingnews.com/files/images/blog_study-finds-rigid-gas-permeable-lenses-improve-vision-after-congenital-glaucoma-surgery-in-children.jpg https://ophthalmologybreakingnews.com/rigid-gas-permeable-lenses-improve-vision 2025-11-27T13:36:15+03:00 en https://ophthalmologybreakingnews.com/rigid-gas-permeable-lenses-improve-vision https://ophthalmologybreakingnews.com/files/images/blog_first-of-its-kind-platform-evaluates-ai-fairness-and-accuracy-in-diabetic-eye-disease-screening.jpg https://ophthalmologybreakingnews.com/platform-evaluates-ai-fairness-and-accuracy-in-ded-screening 2025-11-27T10:40:07+03:00 en https://ophthalmologybreakingnews.com/platform-evaluates-ai-fairness-and-accuracy-in-ded-screening https://ophthalmologybreakingnews.com/files/images/blog_ripple-therapeutics-enters-evaluation-and-licensing-agreement-with-bausch-lomb.jpg https://ophthalmologybreakingnews.com/ripple-enters-evaluation-and-licensing-agreement 2025-11-26T13:45:37+03:00 en https://ophthalmologybreakingnews.com/ripple-enters-evaluation-and-licensing-agreement https://ophthalmologybreakingnews.com/files/images/blog_inflammasome-therapeutics-completes-enrollment-for-phase-2-study-of-k8-in-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/inflammasome-therapeutics-completes-enrollment 2025-11-26T10:43:04+03:00 en https://ophthalmologybreakingnews.com/inflammasome-therapeutics-completes-enrollment https://ophthalmologybreakingnews.com/files/images/blog_2025-recap-top-10-company-acquisitions-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/2025-recap-top-10-company-acquisitions 2025-11-28T16:42:47+03:00 en https://ophthalmologybreakingnews.com/2025-recap-top-10-company-acquisitions https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-randomizes-first-patient-in-helios-3-phase-3-study-for-axpaxli-in-npdr.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-randomizes-first-patient 2025-11-25T10:46:24+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-randomizes-first-patient https://ophthalmologybreakingnews.com/files/images/blog_artiolsr-leading-surgeons-share-real-world-clinical-outcomes-with-full-visual-range-iols.jpg https://ophthalmologybreakingnews.com/artiols-leading-surgeons-share-real-world-clinical-outcomes 2025-11-28T16:42:25+03:00 en https://ophthalmologybreakingnews.com/artiols-leading-surgeons-share-real-world-clinical-outcomes https://ophthalmologybreakingnews.com/files/images/blog_corza-medical-announces-commercial-launch-of-sensortek-rop-kit.jpg https://ophthalmologybreakingnews.com/corza-announces-commercial-launch-of-sensortek-rop-kit 2025-11-24T15:44:29+03:00 en https://ophthalmologybreakingnews.com/corza-announces-commercial-launch-of-sensortek-rop-kit https://ophthalmologybreakingnews.com/files/images/blog_agc-biologics-to-manufacture-aavantgardes-dual-vector-gene-therapies-for-inherited-retinal-disorders.jpg https://ophthalmologybreakingnews.com/agc-to-manufacture-aavantgardes-dual-vector-gene-therapies 2025-11-24T10:51:01+03:00 en https://ophthalmologybreakingnews.com/agc-to-manufacture-aavantgardes-dual-vector-gene-therapies https://ophthalmologybreakingnews.com/files/images/blog_stem-cell-models-offer-new-insight-into-childhood-genetic-blindness.jpg https://ophthalmologybreakingnews.com/stem-cell-models-offer-new-insight-into-childhood-genetic-blindness 2025-11-21T14:04:16+03:00 en https://ophthalmologybreakingnews.com/stem-cell-models-offer-new-insight-into-childhood-genetic-blindness https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-eylea-hd-for-retinal-vein-occlusion-expands-dosing-intervals-across-indications.jpg https://ophthalmologybreakingnews.com/fda-approves-eylea-hd-for-retinal-vein-occlusion 2025-11-21T10:46:05+03:00 en https://ophthalmologybreakingnews.com/fda-approves-eylea-hd-for-retinal-vein-occlusion https://ophthalmologybreakingnews.com/files/images/blog_foundation-fighting-blindness-releases-4-year-rush2a-data-to-public.jpg https://ophthalmologybreakingnews.com/foundation-fighting-blindness-releases-4-year-rush2a-data-to-public 2025-11-20T16:05:25+03:00 en https://ophthalmologybreakingnews.com/foundation-fighting-blindness-releases-4-year-rush2a-data-to-public https://ophthalmologybreakingnews.com/files/images/blog_newton-partners-with-hong-kong-optical-lens-to-expand-distribution-in-asia.jpg https://ophthalmologybreakingnews.com/newton-partners-with-hong-kong-optical-lens 2025-11-20T13:43:51+03:00 en https://ophthalmologybreakingnews.com/newton-partners-with-hong-kong-optical-lens https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-announces-positive-recommendation-for-pivotal-phase-3-trials-of-duravyu.jpg https://ophthalmologybreakingnews.com/eyepoint-announces-positive-recommendation 2025-11-20T10:39:20+03:00 en https://ophthalmologybreakingnews.com/eyepoint-announces-positive-recommendation https://ophthalmologybreakingnews.com/files/images/blog_harrow-finalizes-acquisition-of-melt-pharmaceuticals.jpg https://ophthalmologybreakingnews.com/harrow-finalizes-acquisition-of-melt-pharmaceuticals 2025-11-19T15:50:28+03:00 en https://ophthalmologybreakingnews.com/harrow-finalizes-acquisition-of-melt-pharmaceuticals https://ophthalmologybreakingnews.com/files/images/blog_coave-therapeutics-unveils-lead-gene-therapy-program-cotx-10.jpg https://ophthalmologybreakingnews.com/coave-unveils-lead-gene-therapy-program-cotx-10 2025-11-19T14:02:36+03:00 en https://ophthalmologybreakingnews.com/coave-unveils-lead-gene-therapy-program-cotx-10 https://ophthalmologybreakingnews.com/files/images/blog_topcon-receives-fda-510k-clearance-and-launches-omnia-a-fully-automated-4-in-1-pretesting-system.jpg https://ophthalmologybreakingnews.com/topcon-receives-fda-510k-clearance-and-launches-omnia 2025-11-19T10:56:01+03:00 en https://ophthalmologybreakingnews.com/topcon-receives-fda-510k-clearance-and-launches-omnia https://ophthalmologybreakingnews.com/files/images/blog_non-invasive-brain-stimulation-improves-visual-recovery-after-stroke.jpg https://ophthalmologybreakingnews.com/non-invasive-brain-stimulation-improves-visual-recovery-after-stroke 2025-11-18T13:36:53+03:00 en https://ophthalmologybreakingnews.com/non-invasive-brain-stimulation-improves-visual-recovery-after-stroke https://ophthalmologybreakingnews.com/files/images/blog_enova-maestror-redefining-visual-outcomes-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/enova-maestro-redefining-visual-outcomes-after-cataract-surgery 2025-11-18T10:30:22+03:00 en https://ophthalmologybreakingnews.com/enova-maestro-redefining-visual-outcomes-after-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_ior-partners-introduces-md-od-collaboration-model-in-office-based-surgery.jpg https://ophthalmologybreakingnews.com/ior-partners-introduces-md-od-collaboration-model 2025-11-17T15:52:30+03:00 en https://ophthalmologybreakingnews.com/ior-partners-introduces-md-od-collaboration-model https://ophthalmologybreakingnews.com/files/images/blog_heru-reaches-milestone-with-over-one-million-eyes-tested-using-wearable-platform.jpg https://ophthalmologybreakingnews.com/heru-reaches-milestone-with-over-one-million-eyes-tested 2025-11-17T13:35:45+03:00 en https://ophthalmologybreakingnews.com/heru-reaches-milestone-with-over-one-million-eyes-tested https://ophthalmologybreakingnews.com/files/images/blog_heidelberg-engineering-joins-ccoi-through-essilorluxotticas-vision-architect-membership.jpg https://ophthalmologybreakingnews.com/heidelberg-engineering-joins-ccoi 2025-11-17T10:40:07+03:00 en https://ophthalmologybreakingnews.com/heidelberg-engineering-joins-ccoi https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-joins-global-collaborative-community-to-advance-ophthalmic-innovation.jpg https://ophthalmologybreakingnews.com/essilorluxottica-joins-global-collaborative-community 2025-11-14T15:42:35+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-joins-global-collaborative-community https://ophthalmologybreakingnews.com/files/images/blog_orasis-pharmaceuticals-launches-qlosi-starter-packs-to-expand-patient-access.jpg https://ophthalmologybreakingnews.com/orasis-launches-qlosi-starter-packs 2025-11-14T13:32:53+03:00 en https://ophthalmologybreakingnews.com/orasis-launches-qlosi-starter-packs https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-doses-first-participant-in-opgx-best1-gene-therapy-trial-for-best-disease.jpg https://ophthalmologybreakingnews.com/opus-doses-first-participant-in-opgx-best1 2025-11-14T10:31:59+03:00 en https://ophthalmologybreakingnews.com/opus-doses-first-participant-in-opgx-best1 https://ophthalmologybreakingnews.com/files/images/blog_apellis-reports-5-year-data-showing-syfovre-significantly-delays-geographic-atrophy-progression.jpg https://ophthalmologybreakingnews.com/apellis-reports-5-year-data 2025-11-13T13:26:27+03:00 en https://ophthalmologybreakingnews.com/apellis-reports-5-year-data https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-releases-new-data-supporting-long-term-efficacy-of-the-omnir-surgical-system.jpg https://ophthalmologybreakingnews.com/sight-sciences-releases-new-data 2025-11-13T10:29:53+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-releases-new-data https://ophthalmologybreakingnews.com/files/images/blog_toddler-vision-test-enhances-early-detection-of-eye-disorders.jpg https://ophthalmologybreakingnews.com/toddler-vision-test-enhances-early-detection-of-eye-disorders 2025-11-12T14:32:38+03:00 en https://ophthalmologybreakingnews.com/toddler-vision-test-enhances-early-detection-of-eye-disorders https://ophthalmologybreakingnews.com/files/images/blog_defeye-secures-strategic-investment-from-exsight-ventures-to-advance-ocular-biologics-platform.jpg https://ophthalmologybreakingnews.com/defeye-secures-strategic-investment-from-exsight-ventures 2025-11-24T13:43:16+03:00 en https://ophthalmologybreakingnews.com/defeye-secures-strategic-investment-from-exsight-ventures https://ophthalmologybreakingnews.com/files/images/blog_bausch-lombs-one-by-one-program-diverts-over-691000-pounds-of-eye-care-waste-from-us-landfills.jpg https://ophthalmologybreakingnews.com/bausch-lombs-one-by-one-program 2025-11-11T15:40:26+03:00 en https://ophthalmologybreakingnews.com/bausch-lombs-one-by-one-program https://ophthalmologybreakingnews.com/files/images/blog_eli-lilly-acquires-rights-to-meiragtxs-gene-therapy-program-for-lca4-in-continued-ophthalmology-expansion.jpg https://ophthalmologybreakingnews.com/eli-lilly-acquires-rights-to-meiragtxs-gene-therapy-program 2025-11-24T13:43:37+03:00 en https://ophthalmologybreakingnews.com/eli-lilly-acquires-rights-to-meiragtxs-gene-therapy-program https://ophthalmologybreakingnews.com/files/images/blog_spyglass-pharma-reports-positive-clinical-results-for-bim-iol-system-in-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/spyglass-reports-positive-clinical-results-for-bim-iol-system 2025-11-11T13:38:48+03:00 en https://ophthalmologybreakingnews.com/spyglass-reports-positive-clinical-results-for-bim-iol-system https://ophthalmologybreakingnews.com/files/images/blog_laser-heat-therapy-shows-potential-to-halt-progression-of-dry-macular-degeneration.jpg https://ophthalmologybreakingnews.com/laser-heat-therapy-shows-potential 2025-11-10T15:44:56+03:00 en https://ophthalmologybreakingnews.com/laser-heat-therapy-shows-potential https://ophthalmologybreakingnews.com/files/images/blog_kodiak-sciences-shares-positive-20-week-results-from-apex-study-of-ksi-101-for-mesi.jpg https://ophthalmologybreakingnews.com/kodiak-shares-positive-20-week-results-from-apex-study 2025-11-24T13:43:52+03:00 en https://ophthalmologybreakingnews.com/kodiak-shares-positive-20-week-results-from-apex-study https://ophthalmologybreakingnews.com/files/images/blog_polyactiva-and-raresight-partner-on-pediatric-retinal-disease-therapies.jpg https://ophthalmologybreakingnews.com/polyactiva-and-raresight-partner 2025-11-10T10:49:12+03:00 en https://ophthalmologybreakingnews.com/polyactiva-and-raresight-partner https://ophthalmologybreakingnews.com/files/images/blog_santen-secures-uk-mhra-approval-for-ryjunea-to-slow-myopia-progression-in-children.jpg https://ophthalmologybreakingnews.com/santen-secures-uk-mhra-approval-for-ryjunea 2025-11-07T15:35:47+03:00 en https://ophthalmologybreakingnews.com/santen-secures-uk-mhra-approval-for-ryjunea https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-advances-opgx-lca5-gene-therapy-for-lca-following-fda-guidance.jpg https://ophthalmologybreakingnews.com/opus-advances-opgx-lca5-gene-therapy 2025-11-07T13:26:02+03:00 en https://ophthalmologybreakingnews.com/opus-advances-opgx-lca5-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_4d-molecular-therapeutics-reports-positive-long-term-phase-1-2-prism-data-in-wet-amd.jpg https://ophthalmologybreakingnews.com/4dmt-reports-positive-long-term-phase-1-2-prism-data 2025-11-07T10:26:15+03:00 en https://ophthalmologybreakingnews.com/4dmt-reports-positive-long-term-phase-1-2-prism-data https://ophthalmologybreakingnews.com/files/images/blog_lambdavision-advances-space-manufactured-artificial-retina-with-7-million-in-seed-funding.jpg https://ophthalmologybreakingnews.com/lambdavision-advances-space-manufactured-artificial-retina 2025-11-06T15:37:05+03:00 en https://ophthalmologybreakingnews.com/lambdavision-advances-space-manufactured-artificial-retina https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-therapeutics-presents-5-year-safety-data-for-mco-010-optogenetic-therapy-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/nanoscope-presents-5-year-safety-data-for-mco-010 2025-11-06T13:28:54+03:00 en https://ophthalmologybreakingnews.com/nanoscope-presents-5-year-safety-data-for-mco-010 https://ophthalmologybreakingnews.com/files/images/blog_tenpoint-therapeutics-submits-nda-for-brimochol-pf-in-south-korea.jpg https://ophthalmologybreakingnews.com/tenpoint-submits-nda-for-brimochol-pf-in-south-korea 2025-11-06T10:31:43+03:00 en https://ophthalmologybreakingnews.com/tenpoint-submits-nda-for-brimochol-pf-in-south-korea https://ophthalmologybreakingnews.com/files/images/blog_enova-advancedt-edof-iol-next-generation-vision-with-light-tailoring-technology.jpg https://ophthalmologybreakingnews.com/enova-advanced-edof-iol 2025-11-17T15:59:48+03:00 en https://ophthalmologybreakingnews.com/enova-advanced-edof-iol https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-reaches-randomization-target-in-phase-3-sol-r-trial-of-axpaxli-for-wet-amd.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-reaches-randomization-target 2025-11-05T15:44:29+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-reaches-randomization-target https://ophthalmologybreakingnews.com/files/images/blog_sydnexis-reports-positive-topline-data-from-phase-3-star-trial-of-syd-101-for-pediatric-myopia.jpg https://ophthalmologybreakingnews.com/sydnexis-reports-positive-topline-data 2025-11-05T11:02:11+03:00 en https://ophthalmologybreakingnews.com/sydnexis-reports-positive-topline-data https://ophthalmologybreakingnews.com/files/images/blog_avisi-technologies-reports-positive-12-month-results-for-visiplate-aqueous-shunt-at-aao-2025.jpg https://ophthalmologybreakingnews.com/avisi-reports-positive-12-month-results 2025-11-17T15:59:26+03:00 en https://ophthalmologybreakingnews.com/avisi-reports-positive-12-month-results https://ophthalmologybreakingnews.com/files/images/blog_aavantgarde-bio-secures-141-million-in-series-b-financing-to-advance-gene-therapy-programs-for-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/aavantgarde-bio-secures-141-million-in-series-b-financing 2025-11-04T15:44:11+03:00 en https://ophthalmologybreakingnews.com/aavantgarde-bio-secures-141-million-in-series-b-financing https://ophthalmologybreakingnews.com/files/images/blog_viridian-therapeutics-submits-bla-for-veligrotug-in-thyroid-eye-disease-following-positive-phase-3-results.jpg https://ophthalmologybreakingnews.com/viridian-submits-bla-for-veligrotug-in-ted 2025-11-04T13:27:02+03:00 en https://ophthalmologybreakingnews.com/viridian-submits-bla-for-veligrotug-in-ted https://ophthalmologybreakingnews.com/files/images/blog_everest-medicines-expands-into-ophthalmology-with-licensing-agreement-for-vis-101-in-asia.jpg https://ophthalmologybreakingnews.com/everest-medicines-expands-into-ophthalmology 2025-11-17T15:59:01+03:00 en https://ophthalmologybreakingnews.com/everest-medicines-expands-into-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_celularity-and-defeye-forge-strategic-partnership-to-advance-regenerative-therapies-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/celularity-and-defeye-forge-strategic-partnership 2025-11-03T15:27:35+03:00 en https://ophthalmologybreakingnews.com/celularity-and-defeye-forge-strategic-partnership https://ophthalmologybreakingnews.com/files/images/blog_4dmt-and-otsuka-announce-strategic-partnership-to-advance-4d-150-gene-therapy-across-asia-pacific.jpg https://ophthalmologybreakingnews.com/4dmt-and-otsuka-announce-strategic-partnership 2025-11-03T10:29:57+03:00 en https://ophthalmologybreakingnews.com/4dmt-and-otsuka-announce-strategic-partnership https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-novel-molecular-mechanisms-shaping-retinal-neuron-identity.jpg https://ophthalmologybreakingnews.com/novel-molecular-mechanisms-shaping-retinal-neuron-identity 2025-10-31T15:51:07+03:00 en https://ophthalmologybreakingnews.com/novel-molecular-mechanisms-shaping-retinal-neuron-identity https://ophthalmologybreakingnews.com/files/images/blog_sparingvision-doses-first-patient-in-nyrvana-trial-evaluating-spvn20-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/sparingvision-doses-first-patient-in-nyrvana-trial 2025-10-31T13:29:11+03:00 en https://ophthalmologybreakingnews.com/sparingvision-doses-first-patient-in-nyrvana-trial https://ophthalmologybreakingnews.com/files/images/blog_samsung-bioepis-to-regain-european-commercial-rights-for-ophthalmology-biosimilars-byooviz-and-opuviz-from-biogen.jpg https://ophthalmologybreakingnews.com/samsung-bioepis-to-regain-european-commercial-rights 2025-10-31T10:34:38+03:00 en https://ophthalmologybreakingnews.com/samsung-bioepis-to-regain-european-commercial-rights https://ophthalmologybreakingnews.com/files/images/blog_regeneron-delays-eylea-hd-pre-filled-syringe-submission-following-fda-crl.jpg https://ophthalmologybreakingnews.com/regeneron-delays-eylea-hd-pre-filled-syringe-submission 2025-11-10T15:52:23+03:00 en https://ophthalmologybreakingnews.com/regeneron-delays-eylea-hd-pre-filled-syringe-submission https://ophthalmologybreakingnews.com/files/images/blog_locus-biosciences-and-viatris-partner-to-develop-precision-bacteriophage-therapies-for-ophthalmic-infections.jpg https://ophthalmologybreakingnews.com/locus-biosciences-and-viatris-partner 2025-10-30T15:37:05+03:00 en https://ophthalmologybreakingnews.com/locus-biosciences-and-viatris-partner https://ophthalmologybreakingnews.com/files/images/blog_onl-therapeutics-randomizes-first-patient-in-phase-2-galaxy-trial-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/onl-therapeutics-randomizes-first-patient 2025-10-30T13:35:50+03:00 en https://ophthalmologybreakingnews.com/onl-therapeutics-randomizes-first-patient https://ophthalmologybreakingnews.com/files/images/blog_early-protein-trigger-of-diabetic-retinopathy-identified-by-ucl-scientists.jpg https://ophthalmologybreakingnews.com/early-protein-trigger-of-dr-identified 2025-11-10T15:52:06+03:00 en https://ophthalmologybreakingnews.com/early-protein-trigger-of-dr-identified https://ophthalmologybreakingnews.com/files/images/blog_eli-lilly-expands-into-ophthalmology-with-acquisition-of-adverum-biotechnologies.jpg https://ophthalmologybreakingnews.com/eli-lilly-acquires-adverum-biotechnologies 2025-11-10T15:51:49+03:00 en https://ophthalmologybreakingnews.com/eli-lilly-acquires-adverum-biotechnologies https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-complete-response-letter-for-sydnexis-syd-101-pediatric-myopia-drug-application.jpg https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-for-syd-101 2025-10-24T13:39:13+03:00 en https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-for-syd-101 https://ophthalmologybreakingnews.com/files/images/blog_topcon-invests-in-sanro-health-to-drive-ophthalmic-data-integration-and-ai-based-care.jpg https://ophthalmologybreakingnews.com/topcon-invests-in-sanro-health 2025-10-24T10:48:09+03:00 en https://ophthalmologybreakingnews.com/topcon-invests-in-sanro-health https://ophthalmologybreakingnews.com/files/images/blog_new-ppib-gene-variant-identified-as-cause-of-hereditary-optic-atrophy.jpg https://ophthalmologybreakingnews.com/ppib-gene-variant-identified-as-cause-of-hereditary-optic-atrophy 2025-10-23T15:48:17+03:00 en https://ophthalmologybreakingnews.com/ppib-gene-variant-identified-as-cause-of-hereditary-optic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_fyb201-ranivisio-launches-in-europe-as-first-lucentis-biosimilar-in-pre-filled-syringe.jpg https://ophthalmologybreakingnews.com/fyb201-ranivisio-launches-in-europe 2025-10-23T13:33:46+03:00 en https://ophthalmologybreakingnews.com/fyb201-ranivisio-launches-in-europe https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-therapeutics-reports-3-year-vision-improvements-from-remain-study-of-mco-010-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/nanoscope-reports-3-year-vision-improvements 2025-10-23T10:32:26+03:00 en https://ophthalmologybreakingnews.com/nanoscope-reports-3-year-vision-improvements https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-introduces-idhea-to-support-digital-eye-care-and-oculomics-research.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-introduces-idhea 2025-10-22T13:32:17+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-introduces-idhea https://ophthalmologybreakingnews.com/files/images/blog_veo-ophthalmics-partners-with-perivision-to-launch-ai-powered-visionone-vr-visual-field-platform-in-the-us.jpg https://ophthalmologybreakingnews.com/veo-ophthalmics-partners-with-perivision 2025-10-22T10:48:34+03:00 en https://ophthalmologybreakingnews.com/veo-ophthalmics-partners-with-perivision https://ophthalmologybreakingnews.com/files/images/blog_retinal-implant-restores-central-vision-in-patients-with-advanced-amd-primavera-trial-shows.jpg https://ophthalmologybreakingnews.com/retinal-implant-restores-central-vision 2025-11-03T10:47:53+03:00 en https://ophthalmologybreakingnews.com/retinal-implant-restores-central-vision https://ophthalmologybreakingnews.com/files/images/blog_stoke-therapeutics-releases-2-year-data-from-falcon-natural-history-study-in-autosomal-dominant-optic-atrophy.jpg https://ophthalmologybreakingnews.com/stoke-releases-2-year-data-from-falcon 2025-10-21T16:15:21+03:00 en https://ophthalmologybreakingnews.com/stoke-releases-2-year-data-from-falcon https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-glaukos-epioxa-first-incision-free-corneal-cross-linking-therapy-for-keratoconus.jpg https://ophthalmologybreakingnews.com/fda-approves-glaukos-epioxa 2025-10-21T10:34:21+03:00 en https://ophthalmologybreakingnews.com/fda-approves-glaukos-epioxa https://ophthalmologybreakingnews.com/files/images/blog_astellas-presents-long-term-data-supporting-sustained-efficacy-and-safety-of-izervay-in-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/astellas-presents-long-term-data 2025-11-03T10:47:37+03:00 en https://ophthalmologybreakingnews.com/astellas-presents-long-term-data https://ophthalmologybreakingnews.com/files/images/blog_fda-selects-dompe-for-national-priority-voucher-program-to-advance-intranasal-ngf-therapy-for-naion.jpg https://ophthalmologybreakingnews.com/fda-selects-dompé-for-national-priority-voucher-program 2025-10-20T15:55:27+03:00 en https://ophthalmologybreakingnews.com/fda-selects-dompé-for-national-priority-voucher-program https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-to-acquire-toku-inc-expanding-ai-driven-preventive-health-solutions.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-to-acquire-toku-inc 2025-10-20T10:33:01+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-to-acquire-toku-inc https://ophthalmologybreakingnews.com/files/images/blog_aurion-biotech-reports-positive-12-month-results-from-phase-1-2-clara-trial-of-aurn001-corneal-endothelial-cell-therapy.jpg https://ophthalmologybreakingnews.com/aurion-biotech-reports-positive-12-month-results 2025-11-03T10:47:18+03:00 en https://ophthalmologybreakingnews.com/aurion-biotech-reports-positive-12-month-results https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-pharmaceuticals-unveils-phase-3-program-for-duravyu-in-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/eyepoint-unveils-phase-3-program-for-duravyu 2025-10-17T15:46:53+03:00 en https://ophthalmologybreakingnews.com/eyepoint-unveils-phase-3-program-for-duravyu https://ophthalmologybreakingnews.com/files/images/blog_optos-launches-silverstone-rgb-retinal-imaging-system-with-nine-integrated-modalities.jpg https://ophthalmologybreakingnews.com/optos-launches-silverstone-rgb-retinal-imaging-system 2025-10-17T13:31:09+03:00 en https://ophthalmologybreakingnews.com/optos-launches-silverstone-rgb-retinal-imaging-system https://ophthalmologybreakingnews.com/files/images/blog_formycon-expands-global-access-to-eylear-biosimilar-fyb203-through-licensing-agreements-in-australia-and-latin-america.jpg https://ophthalmologybreakingnews.com/formycon-expands-global-access-to-fyb203 2025-10-17T10:39:37+03:00 en https://ophthalmologybreakingnews.com/formycon-expands-global-access-to-fyb203 https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-acquires-retinai-to-expand-ai-and-data-capabilities-in-vision-care.jpg https://ophthalmologybreakingnews.com/essilorluxottica-acquires-retinai 2025-10-16T15:37:34+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-acquires-retinai https://ophthalmologybreakingnews.com/files/images/blog_ocusciences-secures-ce-mark-for-ocumet-beacon-accelerating-european-expansion.jpg https://ophthalmologybreakingnews.com/ocusciences-secures-ce-mark-for-ocumet-beacon 2025-10-16T13:38:16+03:00 en https://ophthalmologybreakingnews.com/ocusciences-secures-ce-mark-for-ocumet-beacon https://ophthalmologybreakingnews.com/files/images/blog_avisi-technologies-receives-fda-ide-approval-to-initiate-us-clinical-trial-for-visiplate-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/avisi-technologies-receives-fda-ide-approval 2025-10-16T10:35:55+03:00 en https://ophthalmologybreakingnews.com/avisi-technologies-receives-fda-ide-approval https://ophthalmologybreakingnews.com/files/images/blog_pulsesight-therapeutics-publishes-data-supporting-transferrin-therapy-for-dry-amd-and-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/pulsesight-therapeutics-publishes-data 2025-10-15T13:49:54+03:00 en https://ophthalmologybreakingnews.com/pulsesight-therapeutics-publishes-data https://ophthalmologybreakingnews.com/files/images/blog_iantrek-launches-alloflo-uveo-in-the-us-introducing-first-surgical-treatment-for-uveoscleral-pathway-in-glaucoma.jpg https://ophthalmologybreakingnews.com/iantrek-launches-alloflo-uveo-in-the-us 2025-10-15T10:46:56+03:00 en https://ophthalmologybreakingnews.com/iantrek-launches-alloflo-uveo-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_diversified-segmental-defocus-optimization-dsdo-spectacles-shown-to-delay-myopia-onset-in-children.jpg https://ophthalmologybreakingnews.com/dsdo-spectacles-shown-to-delay-myopia-onset-in-children 2025-10-14T15:50:22+03:00 en https://ophthalmologybreakingnews.com/dsdo-spectacles-shown-to-delay-myopia-onset-in-children https://ophthalmologybreakingnews.com/files/images/blog_epion-therapeutics-epismart-cross-linking-system-granted-fda-fast-track-designation.jpg https://ophthalmologybreakingnews.com/epismart-granted-fda-fast-track-designation 2025-10-14T13:35:02+03:00 en https://ophthalmologybreakingnews.com/epismart-granted-fda-fast-track-designation https://ophthalmologybreakingnews.com/files/images/blog_abeona-therapeutics-abo-503-selected-for-fdas-rare-disease-endpoint-advancement-pilot-program.jpg https://ophthalmologybreakingnews.com/abo-503-selected-for-fdas-rare-disease-endpoint-advancement-pilot-program 2025-10-14T10:35:40+03:00 en https://ophthalmologybreakingnews.com/abo-503-selected-for-fdas-rare-disease-endpoint-advancement-pilot-program https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-celltrions-eylea-biosimilar-eydenzelt-for-retinal-diseases.jpg https://ophthalmologybreakingnews.com/fda-approves-celltrions-eydenzelt-for-retinal-diseases 2025-10-30T13:22:44+03:00 en https://ophthalmologybreakingnews.com/fda-approves-celltrions-eydenzelt-for-retinal-diseases https://ophthalmologybreakingnews.com/files/images/blog_tilak-healthcare-receives-positive-opinion-in-france-for-early-reimbursement-of-odysight-telemonitoring-device.jpg https://ophthalmologybreakingnews.com/tilak-healthcare-receives-positive-opinion-in-france 2025-10-30T13:22:27+03:00 en https://ophthalmologybreakingnews.com/tilak-healthcare-receives-positive-opinion-in-france https://ophthalmologybreakingnews.com/files/images/blog_vision-saving-procedure-may-extend-survival-in-uveal-melanoma-ucla-study-suggests.jpg https://ophthalmologybreakingnews.com/vision-saving-procedure-may-extend-survival-in-uveal-melanoma 2025-10-10T14:37:06+03:00 en https://ophthalmologybreakingnews.com/vision-saving-procedure-may-extend-survival-in-uveal-melanoma https://ophthalmologybreakingnews.com/files/images/blog_aviadobio-and-ugenex-therapeutics-collaborate-to-advance-optogenetic-gene-therapy-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/aviadobio-and-ugenex-therapeutics-collaborate 2025-10-10T10:14:24+03:00 en https://ophthalmologybreakingnews.com/aviadobio-and-ugenex-therapeutics-collaborate https://ophthalmologybreakingnews.com/files/images/blog_samsara-vision-initiates-perspective-trial-for-sing-imt-in-pseudophakic-patients.jpg https://ophthalmologybreakingnews.com/samsara-initiates-perspective-trial-for-sing-imt 2025-10-09T15:36:23+03:00 en https://ophthalmologybreakingnews.com/samsara-initiates-perspective-trial-for-sing-imt https://ophthalmologybreakingnews.com/files/images/blog_study-finds-patient-wealth-strongly-linked-to-quality-of-glaucoma-care.jpg https://ophthalmologybreakingnews.com/patient-wealth-strongly-linked-to-quality-of-glaucoma-care 2025-10-09T13:51:12+03:00 en https://ophthalmologybreakingnews.com/patient-wealth-strongly-linked-to-quality-of-glaucoma-care https://ophthalmologybreakingnews.com/files/images/blog_horizon-surgical-systems-completes-first-robotic-cataract-surgery-using-polaris-platform.jpg https://ophthalmologybreakingnews.com/horizon-completes-first-robotic-cataract-surgery 2025-10-09T10:32:23+03:00 en https://ophthalmologybreakingnews.com/horizon-completes-first-robotic-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_eyedura-therapeutics-collaborates-with-seri-to-advance-insulin-based-therapy-for-neurotrophic-keratitis.jpg https://ophthalmologybreakingnews.com/eyedura-therapeutics-collaborates-with-seri 2025-10-08T13:43:57+03:00 en https://ophthalmologybreakingnews.com/eyedura-therapeutics-collaborates-with-seri https://ophthalmologybreakingnews.com/files/images/blog_complement-therapeutics-receives-fda-clearance-to-initiate-clinical-trial-of-ctx001-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/complement-therapeutics-receives-fda-clearance 2025-10-30T13:21:50+03:00 en https://ophthalmologybreakingnews.com/complement-therapeutics-receives-fda-clearance https://ophthalmologybreakingnews.com/files/images/blog_jj-to-present-new-data-highlighting-acuvue-oasys-max-1-day-for-astigmatism-at-aaopt-2025.jpg https://ophthalmologybreakingnews.com/jj-to-present-new-data 2025-10-08T10:49:54+03:00 en https://ophthalmologybreakingnews.com/jj-to-present-new-data https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-breakthrough-therapy-designation-to-nacuitys-npi-001-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/fda-grants-breakthrough-therapy-designation-to-npi-001 2025-10-07T13:51:12+03:00 en https://ophthalmologybreakingnews.com/fda-grants-breakthrough-therapy-designation-to-npi-001 https://ophthalmologybreakingnews.com/files/images/blog_regenxbio-completes-enrollment-in-pivotal-phase-3-trials-of-sura-vec-gene-therapy-for-wet-amd.jpg https://ophthalmologybreakingnews.com/regenxbio-completes-enrollment-in-pivotal-phase-3-trials-of-sura-vec 2025-10-20T11:17:10+03:00 en https://ophthalmologybreakingnews.com/regenxbio-completes-enrollment-in-pivotal-phase-3-trials-of-sura-vec https://ophthalmologybreakingnews.com/files/images/blog_oculis-to-launch-registrational-program-for-privosegtor-in-neuro-ophthalmology-following-fda-feedback.jpg https://ophthalmologybreakingnews.com/oculis-to-launch-registrational-program-for-privosegtor 2025-10-07T10:31:35+03:00 en https://ophthalmologybreakingnews.com/oculis-to-launch-registrational-program-for-privosegtor https://ophthalmologybreakingnews.com/files/images/blog_cirrus-therapeutics-raises-11-million-to-advance-first-in-class-gene-therapy-for-dry-amd.jpg https://ophthalmologybreakingnews.com/cirrus-raises-11-million 2025-10-06T13:51:29+03:00 en https://ophthalmologybreakingnews.com/cirrus-raises-11-million https://ophthalmologybreakingnews.com/files/images/blog_aavantgardes-aavb-039-gene-therapy-for-stargardt-disease-receives-orphan-drug-designation-from-fda.jpg https://ophthalmologybreakingnews.com/aavb-039-gene-therapy-for-stargardt-disease 2025-10-20T11:16:27+03:00 en https://ophthalmologybreakingnews.com/aavb-039-gene-therapy-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_cleaner-air-linked-to-better-eyesight-in-children-study-finds.jpg https://ophthalmologybreakingnews.com/cleaner-air-linked-to-better-eyesight-in-children 2025-10-03T15:57:32+03:00 en https://ophthalmologybreakingnews.com/cleaner-air-linked-to-better-eyesight-in-children https://ophthalmologybreakingnews.com/files/images/blog_new-dual-modality-imaging-system-offers-high-resolution-retinal-oxygen-mapping.jpg https://ophthalmologybreakingnews.com/new-dual-modality-imaging-system 2025-10-03T13:44:50+03:00 en https://ophthalmologybreakingnews.com/new-dual-modality-imaging-system https://ophthalmologybreakingnews.com/files/images/blog_nicoxs-ncx-470-maintains-long-term-efficacy-in-phase-3-denali-trial-for-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/ncx-470-maintains-long-term-efficacy-in-phase-3-denali-trial 2025-10-03T10:32:35+03:00 en https://ophthalmologybreakingnews.com/ncx-470-maintains-long-term-efficacy-in-phase-3-denali-trial https://ophthalmologybreakingnews.com/files/images/blog_polyunsaturated-fatty-acid-therapy-reverses-age-related-vision-decline-in-mice-uc-irvine-study-finds.jpg https://ophthalmologybreakingnews.com/polyunsaturated-fatty-acid-therapy 2025-10-02T13:33:41+03:00 en https://ophthalmologybreakingnews.com/polyunsaturated-fatty-acid-therapy https://ophthalmologybreakingnews.com/files/images/blog_zeiss-vision-care-acquires-stake-in-ocumeda-to-advance-tele-ophthalmology-innovation.jpg https://ophthalmologybreakingnews.com/zeiss-vision-care-acquires-stake-in-ocumeda 2025-10-02T10:29:51+03:00 en https://ophthalmologybreakingnews.com/zeiss-vision-care-acquires-stake-in-ocumeda https://ophthalmologybreakingnews.com/files/images/blog_lenz-therapeutics-launches-vizzt-in-the-us-for-the-treatment-of-presbyopia.jpg https://ophthalmologybreakingnews.com/lenz-therapeutics-launches-vizz-in-the-us 2025-10-01T15:57:02+03:00 en https://ophthalmologybreakingnews.com/lenz-therapeutics-launches-vizz-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-reports-positive-3-month-pediatric-data-from-opgx-lca5-phase-1-2-trial-in-lca5.jpg https://ophthalmologybreakingnews.com/opus-reports-positive-3-month-pediatric-data-from-opgx-lca5 2025-10-01T13:47:44+03:00 en https://ophthalmologybreakingnews.com/opus-reports-positive-3-month-pediatric-data-from-opgx-lca5 https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-gmbh-showcases-premium-iol-innovations-at-escrs-2025.jpg https://ophthalmologybreakingnews.com/vsy-showcases-premium-iol-innovations-at-escrs-2025 2025-10-14T10:37:41+03:00 en https://ophthalmologybreakingnews.com/vsy-showcases-premium-iol-innovations-at-escrs-2025 https://ophthalmologybreakingnews.com/files/images/blog_lupin-acquires-visufarma-to-strengthen-european-ophthalmology-presence.jpg https://ophthalmologybreakingnews.com/lupin-acquires-visufarma 2025-09-30T15:41:46+03:00 en https://ophthalmologybreakingnews.com/lupin-acquires-visufarma https://ophthalmologybreakingnews.com/files/images/blog_kala-bio-discontinues-development-of-kpi-012-following-chase-trial-failure.jpg https://ophthalmologybreakingnews.com/kala-bio-discontinues-development-of-kpi-012 2025-09-30T13:26:51+03:00 en https://ophthalmologybreakingnews.com/kala-bio-discontinues-development-of-kpi-012 https://ophthalmologybreakingnews.com/files/images/blog_enceltor-granted-permanent-j-code-enhancing-access-for-patients-with-macular-telangiectasia-type-2.jpg https://ophthalmologybreakingnews.com/encelto-granted-permanent-j-code 2025-09-30T11:05:28+03:00 en https://ophthalmologybreakingnews.com/encelto-granted-permanent-j-code https://ophthalmologybreakingnews.com/files/images/blog_mrna-vaccine-demonstrates-potential-to-treat-age-related-macular-degeneration-in-preclinical-study.jpg https://ophthalmologybreakingnews.com/mrna-vaccine-demonstrates-potential 2025-09-29T15:43:37+03:00 en https://ophthalmologybreakingnews.com/mrna-vaccine-demonstrates-potential https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-marketing-authorization-for-essilor-stellest-lenses-to-slow-myopia-progression-in-children.jpg https://ophthalmologybreakingnews.com/fda-grants-marketing-authorization-for-essilor-stellest-lenses 2025-09-29T13:33:26+03:00 en https://ophthalmologybreakingnews.com/fda-grants-marketing-authorization-for-essilor-stellest-lenses https://ophthalmologybreakingnews.com/files/images/blog_lumibird-unveils-absolunicl-guru-integration-at-escrs.jpg https://ophthalmologybreakingnews.com/lumibird-unveils-absolu–icl-guru-integration 2025-09-29T10:55:58+03:00 en https://ophthalmologybreakingnews.com/lumibird-unveils-absolu–icl-guru-integration https://ophthalmologybreakingnews.com/files/images/blog_after-ophthalmology-star-awards-osa-2025-n-winners-reflect-on-recognition-and-the-future-of-ophthalmology.jpg https://ophthalmologybreakingnews.com/after-ophthalmology-star-awards-2025 2025-09-26T14:20:37+03:00 en https://ophthalmologybreakingnews.com/after-ophthalmology-star-awards-2025 https://ophthalmologybreakingnews.com/files/images/blog_harrow-launches-harrow-access-for-all-to-broaden-affordable-eye-care-access-nationwide.jpg https://ophthalmologybreakingnews.com/harrow-launches-harrow-access-for-all 2025-09-26T10:31:18+03:00 en https://ophthalmologybreakingnews.com/harrow-launches-harrow-access-for-all https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-launches-tera-dry-eye-imager-to-advance-ded-diagnosis-and-management.jpg https://ophthalmologybreakingnews.com/topcon-launches-tera-dry-eye-imager 2025-09-25T15:36:20+03:00 en https://ophthalmologybreakingnews.com/topcon-launches-tera-dry-eye-imager https://ophthalmologybreakingnews.com/files/images/blog_adult-stem-cell-therapy-shows-early-promise-for-treating-advanced-dry-amd.jpg https://ophthalmologybreakingnews.com/adult-stem-cell-therapy-shows-early-promise 2025-09-25T13:29:29+03:00 en https://ophthalmologybreakingnews.com/adult-stem-cell-therapy-shows-early-promise https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-amneal-pharmaceuticals-generic-bimatoprost-001-for-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/fda-approves-amneals-generic-bimatoprost-001 2025-09-25T10:25:25+03:00 en https://ophthalmologybreakingnews.com/fda-approves-amneals-generic-bimatoprost-001 https://ophthalmologybreakingnews.com/files/images/blog_landmark-genetic-study-reveals-how-the-fovea-develops-to-enable-sharp-central-vision.jpg https://ophthalmologybreakingnews.com/genetic-study-reveals-how-the-fovea-develops 2025-09-24T15:35:23+03:00 en https://ophthalmologybreakingnews.com/genetic-study-reveals-how-the-fovea-develops https://ophthalmologybreakingnews.com/files/images/blog_european-commission-grants-marketing-authorization-for-eyluxvi-alteogens-aflibercept-biosimilar.jpg https://ophthalmologybreakingnews.com/ec-grants-marketing-authorization-for-eyluxvi 2025-09-24T13:33:08+03:00 en https://ophthalmologybreakingnews.com/ec-grants-marketing-authorization-for-eyluxvi https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-completes-adult-dosing-in-lighthouse-trial-for-xlrs-gene-therapy.jpg https://ophthalmologybreakingnews.com/atsena-completes-adult-dosing-in-lighthouse-trial 2025-09-24T10:32:13+03:00 en https://ophthalmologybreakingnews.com/atsena-completes-adult-dosing-in-lighthouse-trial https://ophthalmologybreakingnews.com/files/images/blog_luxa-biotechnology-reports-promising-phase-1-2a-results-for-regenerative-therapy-in-dry-amd.jpg https://ophthalmologybreakingnews.com/luxa-reports-promising-phase-1-2a-results 2025-09-23T15:51:09+03:00 en https://ophthalmologybreakingnews.com/luxa-reports-promising-phase-1-2a-results https://ophthalmologybreakingnews.com/files/images/blog_palatin-technologies-receives-65-million-milestone-payment-through-boehringer-ingelheim-partnership.jpg https://ophthalmologybreakingnews.com/palatin-receives-65-million-milestone-payment 2025-09-23T13:26:32+03:00 en https://ophthalmologybreakingnews.com/palatin-receives-65-million-milestone-payment https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-idebenone-for-priority-review-as-first-potential-treatment-for-lhon.jpg https://ophthalmologybreakingnews.com/fda-accepts-idebenone-for-priority-review 2025-09-23T10:34:03+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-idebenone-for-priority-review https://ophthalmologybreakingnews.com/files/images/blog_exsight-ventures-invests-in-revopsis-therapeutics-to-advance-wet-amd-and-ded-treatment-candidate.jpg https://ophthalmologybreakingnews.com/exsight-ventures-invests-in-revopsis-therapeutics 2025-09-22T15:28:14+03:00 en https://ophthalmologybreakingnews.com/exsight-ventures-invests-in-revopsis-therapeutics https://ophthalmologybreakingnews.com/files/images/blog_character-biosciences-expands-leadership-team-and-secures-additional-series-b-financing-to-advance-amd-pipeline.jpg https://ophthalmologybreakingnews.com/character-biosciences-expands-leadership-team 2025-10-14T10:37:28+03:00 en https://ophthalmologybreakingnews.com/character-biosciences-expands-leadership-team https://ophthalmologybreakingnews.com/files/images/blog_iveena-delivery-systems-secures-2-million-nei-grant-to-advance-pediatric-myopia-therapy.jpg https://ophthalmologybreakingnews.com/iveena-secures-2-million-nei-grant 2025-09-22T10:35:22+03:00 en https://ophthalmologybreakingnews.com/iveena-secures-2-million-nei-grant https://ophthalmologybreakingnews.com/files/images/blog_study-highlights-semaglutides-protective-potential-against-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/semaglutides-protective-potential-against-dr 2025-09-19T15:34:57+03:00 en https://ophthalmologybreakingnews.com/semaglutides-protective-potential-against-dr https://ophthalmologybreakingnews.com/files/images/blog_optos-and-toku-collaborate-to-integrate-ai-powered-bioage-into-us-eye-care-practices.jpg https://ophthalmologybreakingnews.com/optos-and-toku-collaborate 2025-09-19T13:31:08+03:00 en https://ophthalmologybreakingnews.com/optos-and-toku-collaborate https://ophthalmologybreakingnews.com/files/images/blog_vyome-announces-promising-preclinical-data-for-topical-mycophenolate-eye-drop-in-uveitis.jpg https://ophthalmologybreakingnews.com/vyome-announces-promising-preclinical-data-for-topical-mycophenolate 2025-09-19T10:44:50+03:00 en https://ophthalmologybreakingnews.com/vyome-announces-promising-preclinical-data-for-topical-mycophenolate https://ophthalmologybreakingnews.com/files/images/blog_formycon-expands-fyb203-access-in-europe-through-horus-pharma-deal.jpg https://ophthalmologybreakingnews.com/formycon-expands-fyb203-access-in-europe 2025-09-18T10:36:40+03:00 en https://ophthalmologybreakingnews.com/formycon-expands-fyb203-access-in-europe https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-gmbh-announces-ophthalmology-star-awards-2025-winners-at-escrs-congress.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-announces-osa-2025-winners 2025-10-07T10:33:05+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-announces-osa-2025-winners https://ophthalmologybreakingnews.com/files/images/blog_sagent-pharmaceuticals-enters-ophthalmic-market-with-launch-of-travoprost-ophthalmic-solution-0004.jpg https://ophthalmologybreakingnews.com/sagent-enters-ophthalmic-market 2025-09-17T15:39:32+03:00 en https://ophthalmologybreakingnews.com/sagent-enters-ophthalmic-market https://ophthalmologybreakingnews.com/files/images/blog_kodiak-sciences-shares-new-apex-study-data-on-ksi-101-for-inflammatory-macular-edema.jpg https://ophthalmologybreakingnews.com/kodiak-sciences-shares-new-apex-study-data 2025-09-17T13:46:05+03:00 en https://ophthalmologybreakingnews.com/kodiak-sciences-shares-new-apex-study-data https://ophthalmologybreakingnews.com/files/images/blog_belite-bio-completes-phase-3-dragon-study-evaluating-tinlarebant-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/belite-bio-completes-phase-3-dragon-study 2025-09-17T10:29:54+03:00 en https://ophthalmologybreakingnews.com/belite-bio-completes-phase-3-dragon-study https://ophthalmologybreakingnews.com/files/images/blog_ocugen-and-kwangdong-finalize-licensing-agreement-for-ocu400-gene-therapy-in-south-korea.jpg https://ophthalmologybreakingnews.com/ocugen-and-kwangdong-finalize-licensing-agreement-for-ocu400 2025-09-16T15:48:40+03:00 en https://ophthalmologybreakingnews.com/ocugen-and-kwangdong-finalize-licensing-agreement-for-ocu400 https://ophthalmologybreakingnews.com/files/images/blog_kalaris-therapeutics-launches-phase-1b-2-dose-finding-trial-of-th103-for-wet-amd.jpg https://ophthalmologybreakingnews.com/kalaris-launches-phase-1b-2-dose-finding-trial-of-th103 2025-09-16T13:24:02+03:00 en https://ophthalmologybreakingnews.com/kalaris-launches-phase-1b-2-dose-finding-trial-of-th103 https://ophthalmologybreakingnews.com/files/images/blog_viridian-therapeutics-completes-enrollment-in-reveal-1-and-reveal-2-phase-3-trials-for-vrdn-003-in-ted.jpg https://ophthalmologybreakingnews.com/viridian-completes-enrollment 2025-09-16T10:27:35+03:00 en https://ophthalmologybreakingnews.com/viridian-completes-enrollment https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-launches-elara-900-and-refractor-900-ahead-of-escrs-and-aao-2025.jpg https://ophthalmologybreakingnews.com/haag-streit-launches-elara-900-and-refractor-900 2025-09-15T13:28:06+03:00 en https://ophthalmologybreakingnews.com/haag-streit-launches-elara-900-and-refractor-900 https://ophthalmologybreakingnews.com/files/images/blog_optain-health-secures-26-million-in-series-a-funding-to-advance-ai-powered-retinal-screening.jpg https://ophthalmologybreakingnews.com/optain-health-secures-26-million-in-series-a-funding 2025-09-15T10:32:16+03:00 en https://ophthalmologybreakingnews.com/optain-health-secures-26-million-in-series-a-funding https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-invests-in-senseye-to-advance-mental-health-diagnostics-through-the-eye.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-invests-in-senseye 2025-09-12T15:41:14+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-invests-in-senseye https://ophthalmologybreakingnews.com/files/images/blog_inflammasome-therapeutics-reports-promising-early-data-for-k8-in-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/inflammasome-reports-promising-early-data-for-k8-in-ga 2025-09-12T13:27:03+03:00 en https://ophthalmologybreakingnews.com/inflammasome-reports-promising-early-data-for-k8-in-ga https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-fast-track-status-to-sanofis-gene-therapy-candidate-for-wet-amd.jpg https://ophthalmologybreakingnews.com/fda-grants-fast-track-status-to-sanofis-gene-therapy-candidate 2025-10-06T10:55:00+03:00 en https://ophthalmologybreakingnews.com/fda-grants-fast-track-status-to-sanofis-gene-therapy-candidate https://ophthalmologybreakingnews.com/files/images/blog_new-digital-refocusing-method-could-simplify-and-expand-access-to-retinal-imaging.jpg https://ophthalmologybreakingnews.com/new-imaging-tech-enhances-retina-exams 2025-09-11T15:33:41+03:00 en https://ophthalmologybreakingnews.com/new-imaging-tech-enhances-retina-exams https://ophthalmologybreakingnews.com/files/images/blog_university-of-houston-researchers-receive-36m-grant-to-study-vision-critical-gene-linked-to-retinal-disease.jpg https://ophthalmologybreakingnews.com/uh-researchers-receive-36m-grant 2025-09-11T13:22:10+03:00 en https://ophthalmologybreakingnews.com/uh-researchers-receive-36m-grant https://ophthalmologybreakingnews.com/files/images/blog_sandoz-and-regeneron-settle-us-patent-disputes-over-aflibercept-biosimilar-enzeevu.jpg https://ophthalmologybreakingnews.com/sandoz-and-regeneron-settle-us-patent-disputes 2025-09-11T10:18:46+03:00 en https://ophthalmologybreakingnews.com/sandoz-and-regeneron-settle-us-patent-disputes https://ophthalmologybreakingnews.com/files/images/blog_roche-reports-positive-topline-data-from-avonelle-x-and-salween-trials-of-vabysmo.jpg https://ophthalmologybreakingnews.com/roche-reports-positive-topline-data-from-avonelle-x-and-salween 2025-09-29T15:52:53+03:00 en https://ophthalmologybreakingnews.com/roche-reports-positive-topline-data-from-avonelle-x-and-salween https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-reports-positive-phase-2-data-for-gene-therapy-in-x-linked-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/beacon-reports-positive-phase-2-data-for-gene-therapy 2025-09-10T13:24:54+03:00 en https://ophthalmologybreakingnews.com/beacon-reports-positive-phase-2-data-for-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-wavelight-plus-first-fully-personalized-lasik-treatment-in-the-us-and-canada.jpg https://ophthalmologybreakingnews.com/alcon-launches-wavelight-plus 2025-09-10T10:31:44+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-wavelight-plus https://ophthalmologybreakingnews.com/files/images/blog_ai-powered-eye-scans-show-over-93-accuracy-in-detecting-diabetic-eye-disease-in-australian-trial.jpg https://ophthalmologybreakingnews.com/ai-powered-eye-scans-show-over-93-accuracy 2025-09-22T13:27:57+03:00 en https://ophthalmologybreakingnews.com/ai-powered-eye-scans-show-over-93-accuracy https://ophthalmologybreakingnews.com/files/images/blog_aavantgarde-bio-presents-new-clinical-data-from-luce-1-gene-therapy-trial-in-usher-syndrome-type-1b.jpg https://ophthalmologybreakingnews.com/aavantgarde-presents-new-clinical-data-from-luce-1 2025-09-09T13:23:18+03:00 en https://ophthalmologybreakingnews.com/aavantgarde-presents-new-clinical-data-from-luce-1 https://ophthalmologybreakingnews.com/files/images/blog_what-not-to-miss-at-the-escrs-2025-congress-in-copenhagen.jpg https://ophthalmologybreakingnews.com/what-not-to-miss-at-the-escrs-2025 2025-09-17T10:16:02+03:00 en https://ophthalmologybreakingnews.com/what-not-to-miss-at-the-escrs-2025 https://ophthalmologybreakingnews.com/files/images/blog_valitor-presents-preclinical-safety-data-for-long-acting-anti-vegf-vltr-559-in-wet-amd.jpg https://ophthalmologybreakingnews.com/valitor-presents-preclinical-safety-data 2025-09-08T15:31:16+03:00 en https://ophthalmologybreakingnews.com/valitor-presents-preclinical-safety-data https://ophthalmologybreakingnews.com/files/images/blog_celltrion-reports-positive-phase-3-trial-results-for-eydenzelt-in-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/celltrion-reports-positive-phase-3-trial-results-for-eydenzelt-in-dme 2025-09-08T13:32:49+03:00 en https://ophthalmologybreakingnews.com/celltrion-reports-positive-phase-3-trial-results-for-eydenzelt-in-dme https://ophthalmologybreakingnews.com/files/images/blog_ashvattha-therapeutics-announces-positive-phase-2-results-for-migaldendranib-in-dme-and-wet-amd.jpg https://ophthalmologybreakingnews.com/ashvattha-announces-positive-phase-2-results-for-migaldendranib 2025-09-08T10:34:23+03:00 en https://ophthalmologybreakingnews.com/ashvattha-announces-positive-phase-2-results-for-migaldendranib https://ophthalmologybreakingnews.com/files/images/blog_virtualens-introduces-virtual-reality-iol-simulator-for-cataract-patient-education.jpg https://ophthalmologybreakingnews.com/virtualens-introduces-virtual-reality-iol-simulator 2025-09-05T15:27:42+03:00 en https://ophthalmologybreakingnews.com/virtualens-introduces-virtual-reality-iol-simulator https://ophthalmologybreakingnews.com/files/images/blog_contivue-port-delivery-system-receives-ce-mark-for-neovascular-amd.jpg https://ophthalmologybreakingnews.com/contivue-receives-ce-mark-for-neovascular-amd 2025-09-05T13:27:10+03:00 en https://ophthalmologybreakingnews.com/contivue-receives-ce-mark-for-neovascular-amd https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-begins-dosing-in-phase-3-trial-for-night-driving-impairment-after-refractive-surgery.jpg https://ophthalmologybreakingnews.com/opus-begins-dosing-in-phase-3-trial 2025-09-05T10:29:15+03:00 en https://ophthalmologybreakingnews.com/opus-begins-dosing-in-phase-3-trial https://ophthalmologybreakingnews.com/files/images/blog_alcon-completes-lumithera-acquisition-to-expand-dry-amd-portfolio.jpg https://ophthalmologybreakingnews.com/alcon-completes-lumithera-acquisition 2025-09-04T13:23:56+03:00 en https://ophthalmologybreakingnews.com/alcon-completes-lumithera-acquisition https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-seeks-fda-meeting-after-second-crl-for-ons-5010.jpg https://ophthalmologybreakingnews.com/outlook-seeks-fda-meeting-after-second-crl-for-ons-5010 2025-09-04T10:29:51+03:00 en https://ophthalmologybreakingnews.com/outlook-seeks-fda-meeting-after-second-crl-for-ons-5010 https://ophthalmologybreakingnews.com/files/images/blog_enovar-iol-family-advancing-safety-and-efficiency-in-daily-ophthalmic-practice.jpg https://ophthalmologybreakingnews.com/enova-iol-family-vsy 2025-09-17T10:16:46+03:00 en https://ophthalmologybreakingnews.com/enova-iol-family-vsy https://ophthalmologybreakingnews.com/files/images/blog_iantrek-expands-clinical-evidence-for-alloflo-uveo-with-two-new-peer-reviewed-publications.jpg https://ophthalmologybreakingnews.com/iantrek-expands-clinical-evidence-for-alloflo-uveo 2025-09-03T16:03:08+03:00 en https://ophthalmologybreakingnews.com/iantrek-expands-clinical-evidence-for-alloflo-uveo https://ophthalmologybreakingnews.com/files/images/blog_new-world-medical-introduces-ahmed-clearpath-st-for-glaucoma-management.jpg https://ophthalmologybreakingnews.com/new-world-medical-introduces-ahmed-clearpath-st 2025-09-03T13:26:08+03:00 en https://ophthalmologybreakingnews.com/new-world-medical-introduces-ahmed-clearpath-st https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-therapeutics-secures-ema-orphan-designations-and-fda-rmat-status-for-retinal-gene-therapy-candidate-mco-010.jpg https://ophthalmologybreakingnews.com/nanoscope-secures-ema-orphan-designations-and-fda-rmat-status-for-mco-010 2025-09-10T13:25:53+03:00 en https://ophthalmologybreakingnews.com/nanoscope-secures-ema-orphan-designations-and-fda-rmat-status-for-mco-010 https://ophthalmologybreakingnews.com/files/images/blog_smart-fluorescent-eye-patch-enables-noninvasive-monitoring-of-eye-health.jpg https://ophthalmologybreakingnews.com/smart-fluorescent-eye-patch-enables-noninvasive-monitoring-of-eye-health 2025-09-02T13:29:32+03:00 en https://ophthalmologybreakingnews.com/smart-fluorescent-eye-patch-enables-noninvasive-monitoring-of-eye-health https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-names-thomas-lenzen-as-ceo.jpg https://ophthalmologybreakingnews.com/haag-streit-names-thomas-lenzen-as-ceo 2025-09-02T10:37:29+03:00 en https://ophthalmologybreakingnews.com/haag-streit-names-thomas-lenzen-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_retinitis-pigmentosa-mouse-models-accurately-reflect-pathobiology-of-human-rp59.jpg https://ophthalmologybreakingnews.com/rp-mouse-models-accurately-reflect-pathobiology-of-human-rp59 2025-09-01T13:40:48+03:00 en https://ophthalmologybreakingnews.com/rp-mouse-models-accurately-reflect-pathobiology-of-human-rp59 https://ophthalmologybreakingnews.com/files/images/blog_barti-software-secures-12m-series-a-to-advance-ai-powered-ehr-solutions-in-eye-care.jpg https://ophthalmologybreakingnews.com/barti-software-secures-12m-series 2025-09-01T10:47:38+03:00 en https://ophthalmologybreakingnews.com/barti-software-secures-12m-series https://ophthalmologybreakingnews.com/files/images/blog_glp-1-receptor-agonists-linked-to-reduced-risk-of-non-infectious-uveitis.jpg https://ophthalmologybreakingnews.com/glp-1-receptor-agonists-linked-to-reduced-risk-of-non-infectious-uveitis 2025-08-29T15:30:58+03:00 en https://ophthalmologybreakingnews.com/glp-1-receptor-agonists-linked-to-reduced-risk-of-non-infectious-uveitis https://ophthalmologybreakingnews.com/files/images/blog_altris-ai-unveils-flagging-system-to-streamline-oct-data-search-and-biomarker-detection.jpg https://ophthalmologybreakingnews.com/altris-ai-unveils-flagging-system-to-streamline-oct-data-search 2025-08-29T13:26:48+03:00 en https://ophthalmologybreakingnews.com/altris-ai-unveils-flagging-system-to-streamline-oct-data-search https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-second-complete-response-letter-for-outlook-therapeutics-wet-amd-candidate.jpg https://ophthalmologybreakingnews.com/fda-issues-second-crl-for-outlooks-wet-amd-candidate 2025-08-29T10:29:28+03:00 en https://ophthalmologybreakingnews.com/fda-issues-second-crl-for-outlooks-wet-amd-candidate https://ophthalmologybreakingnews.com/files/images/blog_cornells-eye-on-a-chip-sheds-light-on-mechanism-behind-steroid-induced-glaucoma.jpg https://ophthalmologybreakingnews.com/eye-on-a-chip-sheds-light-on-mechanism 2025-08-28T13:36:15+03:00 en https://ophthalmologybreakingnews.com/eye-on-a-chip-sheds-light-on-mechanism https://ophthalmologybreakingnews.com/files/images/blog_ciliatech-receives-ce-mark-for-intercil-uveal-spacer-implant.jpg https://ophthalmologybreakingnews.com/ciliatech-receives-ce-mark-for-intercil-uveal-spacer-implant 2025-08-28T10:26:38+03:00 en https://ophthalmologybreakingnews.com/ciliatech-receives-ce-mark-for-intercil-uveal-spacer-implant https://ophthalmologybreakingnews.com/files/images/blog_glp-1-ras-tied-to-higher-dr-risk-lower-severe-complications.jpg https://ophthalmologybreakingnews.com/glp-1-ras-tied-to-higher-dr-risk-lower-severe-complications 2025-08-27T15:26:30+03:00 en https://ophthalmologybreakingnews.com/glp-1-ras-tied-to-higher-dr-risk-lower-severe-complications https://ophthalmologybreakingnews.com/files/images/blog_eye-exams-may-offer-early-detection-pathway-for-alzheimers-disease.jpg https://ophthalmologybreakingnews.com/eye-exams-may-offer-early-detection-pathway-for-alzheimers-disease 2025-08-27T13:29:16+03:00 en https://ophthalmologybreakingnews.com/eye-exams-may-offer-early-detection-pathway-for-alzheimers-disease https://ophthalmologybreakingnews.com/files/images/blog_qlaris-bio-doses-first-patient-in-phase-2-nightingale-trial-for-normal-tension-glaucoma.jpg https://ophthalmologybreakingnews.com/qlaris-bio-doses-first-patient-in-phase-2-nightingale-trial 2025-08-27T10:30:15+03:00 en https://ophthalmologybreakingnews.com/qlaris-bio-doses-first-patient-in-phase-2-nightingale-trial https://ophthalmologybreakingnews.com/files/images/blog_discovery-of-natural-molecules-offers-promise-for-early-glaucoma-detection-and-neuroprotection.jpg https://ophthalmologybreakingnews.com/discovery-of-natural-molecules-offers-promise 2025-08-26T15:43:22+03:00 en https://ophthalmologybreakingnews.com/discovery-of-natural-molecules-offers-promise https://ophthalmologybreakingnews.com/files/images/blog_elevating-outcomes-through-precision-the-enova-iol-family.jpg https://ophthalmologybreakingnews.com/the-enova-iol-family 2025-09-08T10:39:08+03:00 en https://ophthalmologybreakingnews.com/the-enova-iol-family https://ophthalmologybreakingnews.com/files/images/blog_zeiss-cirrus-pathfinder-receives-ce-mark-for-ai-powered-oct-assessment-and-workflow-optimization.jpg https://ophthalmologybreakingnews.com/zeiss-cirrus-pathfinder-receives-ce-mark 2025-08-26T10:25:19+03:00 en https://ophthalmologybreakingnews.com/zeiss-cirrus-pathfinder-receives-ce-mark https://ophthalmologybreakingnews.com/files/images/blog_glaucoma-research-foundation-launches-treatment-accelerator-initiative-backed-by-5-million-gift.jpg https://ophthalmologybreakingnews.com/glaucoma-research-foundation-launches-treatment-accelerator-initiative 2025-08-25T15:26:53+03:00 en https://ophthalmologybreakingnews.com/glaucoma-research-foundation-launches-treatment-accelerator-initiative https://ophthalmologybreakingnews.com/files/images/blog_european-commission-grants-marketing-authorization-for-aflibercept-biosimilar-mynzepli.jpg https://ophthalmologybreakingnews.com/ec-grants-marketing-authorization-for-mynzepli 2025-08-25T13:43:57+03:00 en https://ophthalmologybreakingnews.com/ec-grants-marketing-authorization-for-mynzepli https://ophthalmologybreakingnews.com/files/images/blog_nicoxs-ncx-470-meets-phase-3-goals-supports-nda-filings-in-us-and-china.jpg https://ophthalmologybreakingnews.com/nicoxs-ncx-470-meets-phase-3-goals 2025-08-25T10:30:20+03:00 en https://ophthalmologybreakingnews.com/nicoxs-ncx-470-meets-phase-3-goals https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-rmat-designation-to-veongens-gene-therapy-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-veongens-gene-therapy 2025-08-22T15:26:32+03:00 en https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-veongens-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-fast-track-designation-to-aldeyras-adx-2191-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-aldeyras-adx-2191-for-rp 2025-08-22T10:18:42+03:00 en https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-aldeyras-adx-2191-for-rp https://ophthalmologybreakingnews.com/files/images/blog_fda-delays-target-action-dates-for-two-eylea-hd-submissions-to-q4-2025-following-manufacturing-inspection.jpg https://ophthalmologybreakingnews.com/fda-delays-target-action-dates-for-two-eylea-hd-submissions 2025-09-17T10:17:38+03:00 en https://ophthalmologybreakingnews.com/fda-delays-target-action-dates-for-two-eylea-hd-submissions https://ophthalmologybreakingnews.com/files/images/blog_higher-omega-3-intake-linked-to-lower-risk-of-myopia-in-children-study-suggests.jpg https://ophthalmologybreakingnews.com/higher-omega-3-intake-linked-to-lower-risk-of-myopia-in-children 2025-08-21T15:32:21+03:00 en https://ophthalmologybreakingnews.com/higher-omega-3-intake-linked-to-lower-risk-of-myopia-in-children https://ophthalmologybreakingnews.com/files/images/blog_oxford-researchers-develop-novel-microstent-to-advance-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/oxford-researchers-develop-novel-microstent 2025-08-21T13:30:47+03:00 en https://ophthalmologybreakingnews.com/oxford-researchers-develop-novel-microstent https://ophthalmologybreakingnews.com/files/images/blog_iantrek-secures-42-million-series-c-financing-to-launch-alloflo-uveo-and-advance-interventional-glaucoma-portfolio.jpg https://ophthalmologybreakingnews.com/iantrek-secures-42-million-series-c-financing 2025-08-21T10:28:01+03:00 en https://ophthalmologybreakingnews.com/iantrek-secures-42-million-series-c-financing https://ophthalmologybreakingnews.com/files/images/blog_bvi-launches-us-surgical-leadership-council-to-drive-innovation-in-ophthalmic-surgery.jpg https://ophthalmologybreakingnews.com/bvi-launches-us-surgical-leadership-council 2025-08-20T15:26:37+03:00 en https://ophthalmologybreakingnews.com/bvi-launches-us-surgical-leadership-council https://ophthalmologybreakingnews.com/files/images/blog_mhra-approves-phase-2a-study-of-anxv-for-diabetic-retinopathy-and-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/mhra-approves-phase-2a-study-of-anxv 2025-08-20T13:24:33+03:00 en https://ophthalmologybreakingnews.com/mhra-approves-phase-2a-study-of-anxv https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-ind-for-opus-genetics-opgx-best1-gene-therapy.jpg https://ophthalmologybreakingnews.com/fda-clears-ind-for-opus-genetics-opgx-best1-gene-therapy 2025-08-20T10:25:46+03:00 en https://ophthalmologybreakingnews.com/fda-clears-ind-for-opus-genetics-opgx-best1-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_roche-canada-announces-public-funding-of-vabysmo-for-macular-edema-secondary-to-rvo-on-ramq.jpg https://ophthalmologybreakingnews.com/roche-canada-announces-public-funding-of-vabysmo-for-macular-edema 2025-08-19T15:31:55+03:00 en https://ophthalmologybreakingnews.com/roche-canada-announces-public-funding-of-vabysmo-for-macular-edema https://ophthalmologybreakingnews.com/files/images/blog_boehringer-ingelheim-and-palatin-technologies-establish-global-collaboration-for-melanocortin-receptor-targeted-retinal-therapy.jpg https://ophthalmologybreakingnews.com/boehringer-ingelheim-and-palatin-establish-global-collaboration 2025-08-19T13:42:09+03:00 en https://ophthalmologybreakingnews.com/boehringer-ingelheim-and-palatin-establish-global-collaboration https://ophthalmologybreakingnews.com/files/images/blog_first-patients-dosed-in-jc02-88-trial-evaluating-famzeretcel-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/first-patients-dosed-in-jc02-88-trial 2025-08-19T10:41:43+03:00 en https://ophthalmologybreakingnews.com/first-patients-dosed-in-jc02-88-trial https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-visual-thalamus-plays-a-larger-role-in-visual-processing-than-previously-believed.jpg https://ophthalmologybreakingnews.com/study-reveals-visual-thalamus-plays-a-larger-role-in-visual-processing 2025-08-18T15:31:37+03:00 en https://ophthalmologybreakingnews.com/study-reveals-visual-thalamus-plays-a-larger-role-in-visual-processing https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-establishes-diabetes-the-eyes-advisory-committee-to-tackle-diabetes-related-eye-diseases.jpg https://ophthalmologybreakingnews.com/prevent-blindness-establishes-diabetes-eyes-advisory-committee 2025-08-18T13:29:33+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-establishes-diabetes-eyes-advisory-committee https://ophthalmologybreakingnews.com/files/images/blog_eyestem-secures-10-million-in-funding-to-advance-rpe-cell-therapy-program.jpg https://ophthalmologybreakingnews.com/eyestem-secures-10-million-in-funding 2025-08-18T10:27:56+03:00 en https://ophthalmologybreakingnews.com/eyestem-secures-10-million-in-funding https://ophthalmologybreakingnews.com/files/images/blog_first-fda-approved-treatment-for-mactel-now-performed-in-the-united-states.jpg https://ophthalmologybreakingnews.com/first-fda-approved-treatment-for-mactel-now-performed-in-us 2025-08-15T15:52:55+03:00 en https://ophthalmologybreakingnews.com/first-fda-approved-treatment-for-mactel-now-performed-in-us https://ophthalmologybreakingnews.com/files/images/blog_painreform-acquires-majority-equity-interest-in-layerbio-to-advance-ocuring-k-technology.jpg https://ophthalmologybreakingnews.com/painreform-acquires-majority-equity-interest-in-layerbio 2025-08-15T13:35:52+03:00 en https://ophthalmologybreakingnews.com/painreform-acquires-majority-equity-interest-in-layerbio https://ophthalmologybreakingnews.com/files/images/blog_avista-therapeutics-and-forge-biologics-partner-to-advance-gene-therapy-for-x-linked-retinoschisis.jpg https://ophthalmologybreakingnews.com/avista-and-forge-partner-to-advance-gene-therapy 2025-08-15T10:30:04+03:00 en https://ophthalmologybreakingnews.com/avista-and-forge-partner-to-advance-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_lupin-and-sandoz-sign-licensing-deal-for-biosimilar-ranibizumab-across-multiple-regions.jpg https://ophthalmologybreakingnews.com/lupin-and-sandoz-sign-licensing-deal 2025-08-14T13:30:51+03:00 en https://ophthalmologybreakingnews.com/lupin-and-sandoz-sign-licensing-deal https://ophthalmologybreakingnews.com/files/images/blog_regenxbio-launches-phase-2b-3-trial-of-sura-vec-for-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/regenxbio-launches-phase-2b-3-trial-of-sura-vec-for-dr 2025-08-14T10:29:10+03:00 en https://ophthalmologybreakingnews.com/regenxbio-launches-phase-2b-3-trial-of-sura-vec-for-dr https://ophthalmologybreakingnews.com/files/images/blog_myra-vision-receives-fda-conditional-approval-to-begin-ide-study-in-glaucoma.jpg https://ophthalmologybreakingnews.com/myra-vision-receives-fda-conditional-approval-to-begin-ide-study 2025-08-13T15:38:43+03:00 en https://ophthalmologybreakingnews.com/myra-vision-receives-fda-conditional-approval-to-begin-ide-study https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-secures-fda-special-protocol-assessment-for-npdr-trial-of-axpaxli.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-secures-fda-special-protocol-assessment 2025-08-13T13:25:00+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-secures-fda-special-protocol-assessment https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-fast-track-designation-to-aavantgarde-bio-for-stargardt-disease-gene-therapy-aavb-039.jpg https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-aavb-039 2025-08-13T10:25:28+03:00 en https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-aavb-039 https://ophthalmologybreakingnews.com/files/images/blog_eye-scan-can-predict-heart-attack-or-stroke-risk-with-70-accuracy.jpg https://ophthalmologybreakingnews.com/eye-scan-can-predict-heart-attack-or-stroke-risk-with-70-accuracy 2025-08-12T13:46:59+03:00 en https://ophthalmologybreakingnews.com/eye-scan-can-predict-heart-attack-or-stroke-risk-with-70-accuracy https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-complex-muscle-patterns-behind-blinking-and-eyelid-movement.jpg https://ophthalmologybreakingnews.com/study-reveals-complex-muscle-patterns-behind-blinking 2025-08-12T10:25:26+03:00 en https://ophthalmologybreakingnews.com/study-reveals-complex-muscle-patterns-behind-blinking https://ophthalmologybreakingnews.com/files/images/blog_nordic-pharmas-lacrifill-canalicular-gel-recognized-in-tfos-dews-iii-report.jpg https://ophthalmologybreakingnews.com/lacrifill-canalicular-gel-recognized-in-tfos-dews-iii-report 2025-08-11T13:33:22+03:00 en https://ophthalmologybreakingnews.com/lacrifill-canalicular-gel-recognized-in-tfos-dews-iii-report https://ophthalmologybreakingnews.com/files/images/blog_study-confirms-long-term-benefit-of-encelto-implant-for-macular-telangiectasia-type-2.jpg https://ophthalmologybreakingnews.com/study-confirms-long-term-benefit-of-encelto-implant-for-mactel 2025-08-29T13:31:39+03:00 en https://ophthalmologybreakingnews.com/study-confirms-long-term-benefit-of-encelto-implant-for-mactel https://ophthalmologybreakingnews.com/files/images/blog_nice-approves-idebenone-for-lhon-patients-in-the-uk.jpg https://ophthalmologybreakingnews.com/nice-approves-idebenone-for-lhon-patients-in-uk 2025-08-11T10:34:06+03:00 en https://ophthalmologybreakingnews.com/nice-approves-idebenone-for-lhon-patients-in-uk https://ophthalmologybreakingnews.com/files/images/blog_glp-1-receptor-agonist-use-associated-with-increased-risk-of-naion-in-older-adults-with-type-2-diabetes.jpg https://ophthalmologybreakingnews.com/glp-1-receptor-agonist-use-associated-with-increased-risk-of-naion 2025-08-08T15:42:13+03:00 en https://ophthalmologybreakingnews.com/glp-1-receptor-agonist-use-associated-with-increased-risk-of-naion https://ophthalmologybreakingnews.com/files/images/blog_snails-offer-new-model-for-eye-regeneration-research-opening-doors-for-vision-restoration-therapies.jpg https://ophthalmologybreakingnews.com/snails-offer-new-model-for-eye-regeneration-research 2025-08-20T13:25:15+03:00 en https://ophthalmologybreakingnews.com/snails-offer-new-model-for-eye-regeneration-research https://ophthalmologybreakingnews.com/files/images/blog_polyactiva-begins-us-phase-2b-trial-of-pa5108-biodegradable-ocular-implant-for-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/polyactiva-starts-us-phase-2b-trial-of-pa5108 2025-08-08T10:40:22+03:00 en https://ophthalmologybreakingnews.com/polyactiva-starts-us-phase-2b-trial-of-pa5108 https://ophthalmologybreakingnews.com/files/images/blog_glutamine-metabolism-plays-a-crucial-role-in-photoreceptor-health-study-finds.jpg https://ophthalmologybreakingnews.com/glutamine-metabolism-plays-crucial-role-in-photoreceptor-health 2025-08-07T15:41:44+03:00 en https://ophthalmologybreakingnews.com/glutamine-metabolism-plays-crucial-role-in-photoreceptor-health https://ophthalmologybreakingnews.com/files/images/blog_study-identifies-metabolic-stress-as-a-major-barrier-to-retinal-cell-transplant-survival.jpg https://ophthalmologybreakingnews.com/study-identifies-metabolic-stress-as-a-major-barrier 2025-08-07T13:38:47+03:00 en https://ophthalmologybreakingnews.com/study-identifies-metabolic-stress-as-a-major-barrier https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-launches-enova-hydrophobic-iols-featuring-patented-rotaryjett-technology.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-launches-enova-hydrophobic-iols 2025-08-29T13:30:48+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-launches-enova-hydrophobic-iols https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-publishes-cost-utility-analysis-comparing-tearcare-and-cyclosporine-005-for-mgd-associated-dry-eye.jpg https://ophthalmologybreakingnews.com/sight-sciences-publishes-cost-utility-analysis-comparing-tearcare-and-cyclosporine-005-for-mgd-associated-dry-eye 2025-08-07T10:34:39+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-publishes-cost-utility-analysis-comparing-tearcare-and-cyclosporine-005-for-mgd-associated-dry-eye https://ophthalmologybreakingnews.com/files/images/blog_kowa-initiates-phase-3-safety-trial-for-ncx-470-in-japan.jpg https://ophthalmologybreakingnews.com/kowa-initiates-phase-3-safety-trial-for-ncx-470-in-japan 2025-08-06T13:37:41+03:00 en https://ophthalmologybreakingnews.com/kowa-initiates-phase-3-safety-trial-for-ncx-470-in-japan https://ophthalmologybreakingnews.com/files/images/blog_alcon-to-acquire-staar-surgical-in-15-billion-deal-to-expand-refractive-portfolio.jpg https://ophthalmologybreakingnews.com/alcon-to-acquire-staar-surgical 2025-08-06T10:26:58+03:00 en https://ophthalmologybreakingnews.com/alcon-to-acquire-staar-surgical https://ophthalmologybreakingnews.com/files/images/blog_raytone-biotech-doses-first-patient-in-clinical-trial-of-rtp-008-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/raytone-doses-first-patient-in-clinical-trial-of-rtp-008-for-ded 2025-08-05T15:28:14+03:00 en https://ophthalmologybreakingnews.com/raytone-doses-first-patient-in-clinical-trial-of-rtp-008-for-ded https://ophthalmologybreakingnews.com/files/images/blog_4d-molecular-therapeutics-announces-positive-60-week-data-from-spectra-trial-evaluating-4d-150-in-dme.jpg https://ophthalmologybreakingnews.com/4dmt-announces-positive-60-week-data-from-spectra-trial 2025-08-05T13:29:41+03:00 en https://ophthalmologybreakingnews.com/4dmt-announces-positive-60-week-data-from-spectra-trial https://ophthalmologybreakingnews.com/files/images/blog_genentech-presents-five-year-data-on-susvimo-highlighting-long-term-outcomes-in-wet-amd.jpg https://ophthalmologybreakingnews.com/genentech-presents-five-year-data-on-susvimo 2025-08-05T10:25:49+03:00 en https://ophthalmologybreakingnews.com/genentech-presents-five-year-data-on-susvimo https://ophthalmologybreakingnews.com/files/images/blog_study-finds-no-added-benefit-of-corticosteroids-or-corneal-cross-linking-in-bacterial-keratitis-treatment.jpg https://ophthalmologybreakingnews.com/no-added-benefit-of-corticosteroids-or-corneal-cross-linking 2025-08-04T15:36:25+03:00 en https://ophthalmologybreakingnews.com/no-added-benefit-of-corticosteroids-or-corneal-cross-linking https://ophthalmologybreakingnews.com/files/images/blog_optomed-launches-lumo-handheld-fundus-camera-to-expand-access-to-retinal-imaging.jpg https://ophthalmologybreakingnews.com/optomed-launches-lumo-handheld-fundus-camera 2025-08-04T13:27:55+03:00 en https://ophthalmologybreakingnews.com/optomed-launches-lumo-handheld-fundus-camera https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-tryptyr-in-the-us-for-rapid-relief-of-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/alcon-launches-tryptyr-in-the-us 2025-08-04T10:46:47+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-tryptyr-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_exonate-to-launch-phase-2b-clear-de-trial-for-exn407-eye-drop-in-npdr-and-dme.jpg https://ophthalmologybreakingnews.com/exonate-to-launch-phase-2b-clear-de-trial-for-exn407 2025-08-01T15:33:17+03:00 en https://ophthalmologybreakingnews.com/exonate-to-launch-phase-2b-clear-de-trial-for-exn407 https://ophthalmologybreakingnews.com/files/images/blog_viridian-therapeutics-partners-with-kissei-pharmaceutical-to-advance-thyroid-eye-disease-therapies-in-japan.jpg https://ophthalmologybreakingnews.com/viridian-partners-with-kissei-pharmaceutical 2025-08-01T13:42:51+03:00 en https://ophthalmologybreakingnews.com/viridian-partners-with-kissei-pharmaceutical https://ophthalmologybreakingnews.com/files/images/blog_lenz-therapeutics-secures-fda-approval-for-vizz-for-presbyopia-treatment.jpg https://ophthalmologybreakingnews.com/lenz-therapeutics-secures-fda-approval-for-vizz 2025-08-01T10:36:11+03:00 en https://ophthalmologybreakingnews.com/lenz-therapeutics-secures-fda-approval-for-vizz https://ophthalmologybreakingnews.com/files/images/blog_eye-tracking-metrics-show-promise-in-identifying-concussion-related-vision-disorders-in-adolescents.jpg https://ophthalmologybreakingnews.com/eye-tracking-metrics-show-promise 2025-07-31T15:31:01+03:00 en https://ophthalmologybreakingnews.com/eye-tracking-metrics-show-promise https://ophthalmologybreakingnews.com/files/images/blog_corxel-submits-nda-for-lnz100-in-china-for-presbyopia-treatment.jpg https://ophthalmologybreakingnews.com/corxel-submits-nda-for-lnz100-in-china-for-presbyopia-treatment 2025-07-31T13:33:30+03:00 en https://ophthalmologybreakingnews.com/corxel-submits-nda-for-lnz100-in-china-for-presbyopia-treatment https://ophthalmologybreakingnews.com/files/images/blog_topcon-acquires-iris-to-advance-ai-powered-retinal-screenings-and-connected-eye-care.jpg https://ophthalmologybreakingnews.com/topcon-acquires-iris 2025-07-31T10:31:52+03:00 en https://ophthalmologybreakingnews.com/topcon-acquires-iris https://ophthalmologybreakingnews.com/files/images/blog_bausch-lombs-lumify-preservative-free-meets-primary-endpoint-in-phase-3-trial.jpg https://ophthalmologybreakingnews.com/lumify-preservative-free-meets-phase3-goal 2025-07-30T15:39:38+03:00 en https://ophthalmologybreakingnews.com/lumify-preservative-free-meets-phase3-goal https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-pharmaceuticals-completes-enrollment-of-phase-3-trials-for-duravyu-in-wet-amd.jpg https://ophthalmologybreakingnews.com/eyepoint-completes-enrollment-of-phase-3-trials-for-duravyu 2025-07-30T13:26:21+03:00 en https://ophthalmologybreakingnews.com/eyepoint-completes-enrollment-of-phase-3-trials-for-duravyu https://ophthalmologybreakingnews.com/files/images/blog_alteogen-receives-positive-chmp-opinion-for-aflibercept-biosimilar-eyluxvi.jpg https://ophthalmologybreakingnews.com/alteogen-receives-positive-chmp-opinion-for-eyluxvi 2025-07-30T10:32:10+03:00 en https://ophthalmologybreakingnews.com/alteogen-receives-positive-chmp-opinion-for-eyluxvi https://ophthalmologybreakingnews.com/files/images/blog_boehringer-ingelheim-and-re-vana-therapeutics-partner-to-develop-long-acting-ophthalmic-therapies.jpg https://ophthalmologybreakingnews.com/boehringer-ingelheim-and-re-vana-therapeutics-partner 2025-07-29T15:38:47+03:00 en https://ophthalmologybreakingnews.com/boehringer-ingelheim-and-re-vana-therapeutics-partner https://ophthalmologybreakingnews.com/files/images/blog_researchers-identify-microglia-as-key-responders-in-retinal-injury.jpg https://ophthalmologybreakingnews.com/researchers-identify-microglia-as-key-responders-in-retinal-injury 2025-07-28T15:34:42+03:00 en https://ophthalmologybreakingnews.com/researchers-identify-microglia-as-key-responders-in-retinal-injury https://ophthalmologybreakingnews.com/files/images/blog_enovation-in-iol-material-vsy-biotechnologys-enovar-premium-iols-set-new-standard-with-100-glistening-free-technology.jpg https://ophthalmologybreakingnews.com/vsy-biotechnologys-enova-premium-iols-set-new-standard 2025-08-12T13:25:57+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnologys-enova-premium-iols-set-new-standard https://ophthalmologybreakingnews.com/files/images/blog_aldeyra-therapeutics-receives-ema-orphan-drug-designation-for-adx-2191-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/aldeyra-receives-ema-orphan-drug-designation-for-adx-2191-in-rp 2025-07-28T10:25:50+03:00 en https://ophthalmologybreakingnews.com/aldeyra-receives-ema-orphan-drug-designation-for-adx-2191-in-rp https://ophthalmologybreakingnews.com/files/images/blog_annexon-completes-enrollment-in-phase-3-archer-ii-trial-of-vonaprument-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/annexon-completes-enrollment-in-phase-3-archer-ii-trial 2025-07-25T15:26:33+03:00 en https://ophthalmologybreakingnews.com/annexon-completes-enrollment-in-phase-3-archer-ii-trial https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-and-global-rdh12-alliance-join-forces-to-accelerate-gene-therapy-for-inherited-childhood-blindness.jpg https://ophthalmologybreakingnews.com/opus-global-rdh12-alliance-join-forces 2025-07-25T13:37:33+03:00 en https://ophthalmologybreakingnews.com/opus-global-rdh12-alliance-join-forces https://ophthalmologybreakingnews.com/files/images/blog_kiora-pharmaceuticals-secures-us-patent-for-kio-104-in-ocular-inflammatory-diseases.jpg https://ophthalmologybreakingnews.com/kiora-pharmaceuticals-secures-us-patent-for-kio-104 2025-07-25T10:21:07+03:00 en https://ophthalmologybreakingnews.com/kiora-pharmaceuticals-secures-us-patent-for-kio-104 https://ophthalmologybreakingnews.com/files/images/blog_technician-led-virtual-eye-clinics-could-improve-nhs-ophthalmology-access-ucl-study-finds.jpg https://ophthalmologybreakingnews.com/virtual-clinics-cut-nhs-eye-care-delays 2025-07-24T16:01:40+03:00 en https://ophthalmologybreakingnews.com/virtual-clinics-cut-nhs-eye-care-delays https://ophthalmologybreakingnews.com/files/images/blog_ocugen-expands-retina-scientific-advisory-board-and-executive-team-for-gene-therapy-development.jpg https://ophthalmologybreakingnews.com/ocugen-expands-retina-scientific-advisory-board 2025-07-24T13:33:15+03:00 en https://ophthalmologybreakingnews.com/ocugen-expands-retina-scientific-advisory-board https://ophthalmologybreakingnews.com/files/images/blog_topcon-partners-with-okko-health-to-expand-home-vision-monitoring.jpg https://ophthalmologybreakingnews.com/topcon-partners-with-okko-health-to-expand-home-vision-monitoring 2025-07-24T10:32:20+03:00 en https://ophthalmologybreakingnews.com/topcon-partners-with-okko-health-to-expand-home-vision-monitoring https://ophthalmologybreakingnews.com/files/images/blog_key-indicators-of-neuropathic-ocular-pain-identified-in-post-lasik-patients.jpg https://ophthalmologybreakingnews.com/key-indicators-of-neuropathic-ocular-pain-identified-in-post-lasik-patients 2025-07-23T15:37:53+03:00 en https://ophthalmologybreakingnews.com/key-indicators-of-neuropathic-ocular-pain-identified-in-post-lasik-patients https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharma-secures-19-million-in-non-dilutive-funding-to-advance-urcosimod-for-neuropathic-corneal-pain.jpg https://ophthalmologybreakingnews.com/okyo-pharma-secures-non-dilutive-funding 2025-07-23T13:23:24+03:00 en https://ophthalmologybreakingnews.com/okyo-pharma-secures-non-dilutive-funding https://ophthalmologybreakingnews.com/files/images/blog_cloudbreak-pharma-reports-positive-phase-2-results-for-cbt-004-in-vascularized-pinguecula.jpg https://ophthalmologybreakingnews.com/cloudbreak-pharma-reports-positive-phase-2-results-for-cbt-004 2025-07-22T15:28:49+03:00 en https://ophthalmologybreakingnews.com/cloudbreak-pharma-reports-positive-phase-2-results-for-cbt-004 https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-to-acquire-pucores-ophthalmic-lens-materials-division.jpg https://ophthalmologybreakingnews.com/essilorluxottica-to-acquire-pucores-ophthalmic-lens-materials-division 2025-07-22T13:23:36+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-to-acquire-pucores-ophthalmic-lens-materials-division https://ophthalmologybreakingnews.com/files/images/blog_viatris-phase-3-study-of-mr-139-for-blepharitis-fails-to-meet-primary-endpoint.jpg https://ophthalmologybreakingnews.com/viatris-phase-3-study-of-mr-139-for-blepharitis-fails 2025-07-22T10:26:06+03:00 en https://ophthalmologybreakingnews.com/viatris-phase-3-study-of-mr-139-for-blepharitis-fails https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedical-launches-strategic-review-to-advance-suprachoroidal-space-delivery-platform.jpg https://ophthalmologybreakingnews.com/clearside-launches-strategic-review-to-advance-scs-delivery-platform 2025-07-21T15:32:44+03:00 en https://ophthalmologybreakingnews.com/clearside-launches-strategic-review-to-advance-scs-delivery-platform https://ophthalmologybreakingnews.com/files/images/blog_lupin-launches-loteprednol-etabonate-ophthalmic-suspension-05-in-the-us-market.jpg https://ophthalmologybreakingnews.com/lupin-launches-loteprednol-etabonate-ophthalmic-suspension-05-in-us 2025-07-21T13:28:00+03:00 en https://ophthalmologybreakingnews.com/lupin-launches-loteprednol-etabonate-ophthalmic-suspension-05-in-us https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharma-reports-positive-phase-2-trial-results-of-urcosimod-for-neuropathic-corneal-pain.jpg https://ophthalmologybreakingnews.com/okyo-pharma-reports-positive-phase-2-trial-results-of-urcosimod-for-ncp 2025-07-21T10:31:16+03:00 en https://ophthalmologybreakingnews.com/okyo-pharma-reports-positive-phase-2-trial-results-of-urcosimod-for-ncp https://ophthalmologybreakingnews.com/files/images/blog_nicox-grants-kowa-exclusive-rights-to-glaucoma-candidate-ncx-470-in-us-and-global-markets.jpg https://ophthalmologybreakingnews.com/nicox-grants-kowa-exclusive-rights-to-ncx-470-in-us-and-global-markets 2025-07-18T15:30:37+03:00 en https://ophthalmologybreakingnews.com/nicox-grants-kowa-exclusive-rights-to-ncx-470-in-us-and-global-markets https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-aldeyras-resubmitted-nda-for-reproxalap-in-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/fda-accepts-aldeyras-resubmitted-nda-for-reproxalap-in-ded 2025-07-18T13:24:45+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-aldeyras-resubmitted-nda-for-reproxalap-in-ded https://ophthalmologybreakingnews.com/files/images/blog_harrow-secures-exclusive-us-rights-to-samsung-bioepis-ophthalmology-biosimilars-portfolio.jpg https://ophthalmologybreakingnews.com/harrow-secures-exclusive-us-rights-to-samsung-bioepis 2025-07-18T10:29:50+03:00 en https://ophthalmologybreakingnews.com/harrow-secures-exclusive-us-rights-to-samsung-bioepis https://ophthalmologybreakingnews.com/files/images/blog_krystal-biotech-initiates-emerald-1-trial-first-patient-dosed-in-study-of-gene-therapy-for-neurotrophic-keratitis.jpg https://ophthalmologybreakingnews.com/krystal-biotech-initiates-emerald-1-trial 2025-07-17T15:25:31+03:00 en https://ophthalmologybreakingnews.com/krystal-biotech-initiates-emerald-1-trial https://ophthalmologybreakingnews.com/files/images/blog_cancer-drug-prl3-zumab-shows-promise-as-novel-treatment-for-blinding-eye-diseases.jpg https://ophthalmologybreakingnews.com/cancer-drug-prl3-zumab-shows-promise-as-novel-treatment-for-blinding-eye-diseases 2025-07-17T13:36:45+03:00 en https://ophthalmologybreakingnews.com/cancer-drug-prl3-zumab-shows-promise-as-novel-treatment-for-blinding-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_sanofis-intravitreal-gene-therapy-receives-fda-fast-track-designation-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/sanofis-intravitreal-gene-therapy-receives-fda-fast-track-designation 2025-07-17T10:35:08+03:00 en https://ophthalmologybreakingnews.com/sanofis-intravitreal-gene-therapy-receives-fda-fast-track-designation https://ophthalmologybreakingnews.com/files/images/blog_kala-bio-completes-enrollment-in-chase-phase-2b-trial-for-persistent-corneal-epithelial-defect.jpg https://ophthalmologybreakingnews.com/kala-bio-completes-enrollment-in-chase-phase-2b-trial 2025-07-16T15:53:49+03:00 en https://ophthalmologybreakingnews.com/kala-bio-completes-enrollment-in-chase-phase-2b-trial https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-initiates-rolling-bla-submission-to-fda-for-mco-010-the-first-gene-agnostic-therapy-for-rp.jpg https://ophthalmologybreakingnews.com/nanoscope-initiates-rolling-bla-submission-to-fda-for-mco-010 2025-07-16T13:25:01+03:00 en https://ophthalmologybreakingnews.com/nanoscope-initiates-rolling-bla-submission-to-fda-for-mco-010 https://ophthalmologybreakingnews.com/files/images/blog_aavantgarde-receives-fda-clearance-to-advance-aavb-039-for-stargardt-disease-into-phase-1-2-trial.jpg https://ophthalmologybreakingnews.com/aavantgarde-receives-fda-clearance-to-advance-aavb-039 2025-07-16T10:25:48+03:00 en https://ophthalmologybreakingnews.com/aavantgarde-receives-fda-clearance-to-advance-aavb-039 https://ophthalmologybreakingnews.com/files/images/blog_belite-bio-completes-enrollment-in-global-phase-3-phoenix-trial-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/belite-completes-enrollment-in-global-phase-3-phoenix-trial-for-ga 2025-07-11T15:26:04+03:00 en https://ophthalmologybreakingnews.com/belite-completes-enrollment-in-global-phase-3-phoenix-trial-for-ga https://ophthalmologybreakingnews.com/files/images/blog_lenz-therapeutics-and-laboratoires-thea-partner-to-commercialize-lnz100-for-presbyopia-in-canada.jpg https://ophthalmologybreakingnews.com/lenz-and-laboratoires-théa-partner-to-commercialize-lnz100-in-canada 2025-07-11T13:31:13+03:00 en https://ophthalmologybreakingnews.com/lenz-and-laboratoires-théa-partner-to-commercialize-lnz100-in-canada https://ophthalmologybreakingnews.com/files/images/blog_boehringer-ingelheim-launches-phase-2-study-of-oral-therapy-for-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/boehringer-ingelheim-launches-phase-2-study-of-oral-therapy 2025-07-11T10:23:07+03:00 en https://ophthalmologybreakingnews.com/boehringer-ingelheim-launches-phase-2-study-of-oral-therapy https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-completes-enrollment-in-registrational-phase-2-3-vista-trial-of-laru-zova-for-xlrp.jpg https://ophthalmologybreakingnews.com/beacon-completes-enrollment-in-registrational-phase-2-3-vista-trial 2025-07-10T15:38:39+03:00 en https://ophthalmologybreakingnews.com/beacon-completes-enrollment-in-registrational-phase-2-3-vista-trial https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-enters-the-japanese-market.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-enters-the-japanese-market 2025-08-04T11:39:31+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-enters-the-japanese-market https://ophthalmologybreakingnews.com/files/images/blog_atsena-aligns-with-fda-on-regulatory-pathway-for-atsn-201-in-xlrs.jpg https://ophthalmologybreakingnews.com/atsena-aligns-with-fda-on-regulatory-pathway-for-atsn-201-in-xlrs 2025-07-10T10:26:01+03:00 en https://ophthalmologybreakingnews.com/atsena-aligns-with-fda-on-regulatory-pathway-for-atsn-201-in-xlrs https://ophthalmologybreakingnews.com/files/images/blog_bluerock-therapeutics-treats-first-patient-in-phase-1-2a-trial-of-opct-001-for-primary-photoreceptor-diseases.jpg https://ophthalmologybreakingnews.com/bluerock-therapeutics-treats-first-patient-in-phase-1-2a-trial-of-opct-001 2025-07-09T15:30:09+03:00 en https://ophthalmologybreakingnews.com/bluerock-therapeutics-treats-first-patient-in-phase-1-2a-trial-of-opct-001 https://ophthalmologybreakingnews.com/files/images/blog_health-canada-approves-aflivu-an-aflibercept-biosimilar-for-retinal-diseases.jpg https://ophthalmologybreakingnews.com/health-canada-approves-aflivu 2025-07-09T13:25:05+03:00 en https://ophthalmologybreakingnews.com/health-canada-approves-aflivu https://ophthalmologybreakingnews.com/files/images/blog_precautionary-recall-announced-for-specific-batch-of-zaditen-eye-drops-in-the-uk.jpg https://ophthalmologybreakingnews.com/precautionary-recall-announced-for-specific-batch-of-zaditen-eye-drops-in-the-uk 2025-07-09T10:44:28+03:00 en https://ophthalmologybreakingnews.com/precautionary-recall-announced-for-specific-batch-of-zaditen-eye-drops-in-the-uk https://ophthalmologybreakingnews.com/files/images/blog_first-patient-dosed-in-phase-1-trial-of-pulsesight-therapeutics-pst-611-for-dry-amd-ga.jpg https://ophthalmologybreakingnews.com/pulsesight-doses-first-patient-in-pst-611-trial 2025-07-08T15:51:04+03:00 en https://ophthalmologybreakingnews.com/pulsesight-doses-first-patient-in-pst-611-trial https://ophthalmologybreakingnews.com/files/images/blog_4dmt-accelerates-4front-phase-3-program-for-wet-amd-implements-workforce-reduction.jpg https://ophthalmologybreakingnews.com/4dmt-accelerates-4front-phase-3-program-for-wet-amd 2025-07-08T13:23:41+03:00 en https://ophthalmologybreakingnews.com/4dmt-accelerates-4front-phase-3-program-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_alcon-to-acquire-lumithera-maker-of-photobiomodulation-device-for-dry-amd.jpg https://ophthalmologybreakingnews.com/alcon-to-acquire-lumithera-maker-of-photobiomodulation-device 2025-07-08T10:28:00+03:00 en https://ophthalmologybreakingnews.com/alcon-to-acquire-lumithera-maker-of-photobiomodulation-device https://ophthalmologybreakingnews.com/files/images/blog_36-month-results-from-phase-1-2a-clinical-study-of-rg6501-released.jpg https://ophthalmologybreakingnews.com/36-month-results-from-phase-1-2a-clinical-study-of-rg6501-released 2025-07-07T13:58:49+03:00 en https://ophthalmologybreakingnews.com/36-month-results-from-phase-1-2a-clinical-study-of-rg6501-released https://ophthalmologybreakingnews.com/files/images/blog_pyc-to-finalize-registrational-study-for-rp11-after-positive-fda-feedback.jpg https://ophthalmologybreakingnews.com/pyc-to-finalize-registrational-study-for-rp11 2025-07-07T10:33:19+03:00 en https://ophthalmologybreakingnews.com/pyc-to-finalize-registrational-study-for-rp11 https://ophthalmologybreakingnews.com/files/images/blog_relative-peripheral-refraction-found-to-predict-myopia-progression-in-children.jpg https://ophthalmologybreakingnews.com/relative-peripheral-refraction-found-to-predict-myopia-progression-in-children 2025-07-04T15:24:34+03:00 en https://ophthalmologybreakingnews.com/relative-peripheral-refraction-found-to-predict-myopia-progression-in-children https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-exercises-option-to-license-abeonas-aav204-for-retinal-gene-therapy.jpg https://ophthalmologybreakingnews.com/beacon-exercises-option-to-license-abeonas-aav204 2025-07-04T13:30:40+03:00 en https://ophthalmologybreakingnews.com/beacon-exercises-option-to-license-abeonas-aav204 https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-new-campaign-to-raise-dry-eye-awareness-backed-by-fresh-survey-data.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-new-campaign-to-raise-dry-eye-awareness 2025-07-04T10:19:09+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-new-campaign-to-raise-dry-eye-awareness https://ophthalmologybreakingnews.com/files/images/blog_health-canada-approves-biocons-yesafili-a-biosimilar-to-eylea.jpg https://ophthalmologybreakingnews.com/health-canada-approves-biocons-yesafili-a-biosimilar-to-eylea 2025-07-03T15:33:26+03:00 en https://ophthalmologybreakingnews.com/health-canada-approves-biocons-yesafili-a-biosimilar-to-eylea https://ophthalmologybreakingnews.com/files/images/blog_retinalgenix-technologies-and-labcorp-partner-on-dna-rna-gps-pharmaco-genetic-mapping-platform.jpg https://ophthalmologybreakingnews.com/retinalgenix-and-labcorp-partner-on-dna-rna-gps-mapping-platform 2025-07-03T13:20:45+03:00 en https://ophthalmologybreakingnews.com/retinalgenix-and-labcorp-partner-on-dna-rna-gps-mapping-platform https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-marks-july-as-dry-eye-month-to-raise-awareness-and-educate-the-public.jpg https://ophthalmologybreakingnews.com/prevent-blindness-marks-july-as-dry-eye-month 2025-07-03T10:53:12+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-marks-july-as-dry-eye-month https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-key-role-of-adam10-in-retinal-disease-development.jpg https://ophthalmologybreakingnews.com/study-reveals-key-role-of-adam10-in-retinal-disease-development 2025-07-02T15:34:58+03:00 en https://ophthalmologybreakingnews.com/study-reveals-key-role-of-adam10-in-retinal-disease-development https://ophthalmologybreakingnews.com/files/images/blog_feliqs-raises-9-million-series-a-to-advance-flq-101-clinical-trial-for-retinopathy-of-prematurity.jpg https://ophthalmologybreakingnews.com/feliqs-raises-9-million-series-a-to-advance-flq-101-clinical-trial 2025-07-02T13:25:52+03:00 en https://ophthalmologybreakingnews.com/feliqs-raises-9-million-series-a-to-advance-flq-101-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_formycon-and-bio-usawa-partner-to-bring-fyb201-bioucenta-to-sub-saharan-africa.jpg https://ophthalmologybreakingnews.com/formycon-and-bio-usawa-partner-to-bring-fyb201-to-sub-saharan-africa 2025-07-02T10:27:31+03:00 en https://ophthalmologybreakingnews.com/formycon-and-bio-usawa-partner-to-bring-fyb201-to-sub-saharan-africa https://ophthalmologybreakingnews.com/files/images/blog_nicox-completes-phase-3-denali-trial-of-ncx-470-in-open-angle-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/nicox-completes-phase-3-denali-trial-of-ncx-470 2025-07-01T15:26:54+03:00 en https://ophthalmologybreakingnews.com/nicox-completes-phase-3-denali-trial-of-ncx-470 https://ophthalmologybreakingnews.com/files/images/blog_glaukos-secures-eu-mdr-certification-for-istent-infinite-and-istent-inject-w.jpg https://ophthalmologybreakingnews.com/glaukos-secures-eu-mdr-certification-for-istent-infinite-and-istent-inject-w 2025-07-01T13:30:26+03:00 en https://ophthalmologybreakingnews.com/glaukos-secures-eu-mdr-certification-for-istent-infinite-and-istent-inject-w https://ophthalmologybreakingnews.com/files/images/blog_european-commission-grants-label-extension-for-eylea-8-mg-allowing-6-month-treatment-intervals.jpg https://ophthalmologybreakingnews.com/ec-grants-label-extension-for-eylea-8-mg 2025-07-01T10:31:02+03:00 en https://ophthalmologybreakingnews.com/ec-grants-label-extension-for-eylea-8-mg https://ophthalmologybreakingnews.com/files/images/blog_krystal-biotech-doses-first-patient-in-phase-iii-iolite-trial-for-kb803.jpg https://ophthalmologybreakingnews.com/krystal-biotech-doses-first-patient-in-phase-iii-iolite-trial-for-kb803 2025-06-30T15:54:21+03:00 en https://ophthalmologybreakingnews.com/krystal-biotech-doses-first-patient-in-phase-iii-iolite-trial-for-kb803 https://ophthalmologybreakingnews.com/files/images/blog_retinal-degeneration-fund-to-support-opus-genetics-opgx-mertk-gene-therapy-program.jpg https://ophthalmologybreakingnews.com/rd-fund-to-support-opus-genetics-opgx-mertk-gene-therapy-program 2025-06-30T13:24:09+03:00 en https://ophthalmologybreakingnews.com/rd-fund-to-support-opus-genetics-opgx-mertk-gene-therapy-program https://ophthalmologybreakingnews.com/files/images/blog_iridex-enrolls-first-patient-in-dame-trial-evaluating-micropulse-as-adjunct-to-anti-vegf-for-dme.jpg https://ophthalmologybreakingnews.com/iridex-enrolls-first-patient-in-dame-trial 2025-06-30T10:25:00+03:00 en https://ophthalmologybreakingnews.com/iridex-enrolls-first-patient-in-dame-trial https://ophthalmologybreakingnews.com/files/images/blog_perfuse-therapeutics-reports-positive-phase-ii-results-for-per-001-in-glaucoma-and-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/perfuse-therapeutics-reports-positive-phase-ii-results-for-per-001 2025-06-27T15:27:56+03:00 en https://ophthalmologybreakingnews.com/perfuse-therapeutics-reports-positive-phase-ii-results-for-per-001 https://ophthalmologybreakingnews.com/files/images/blog_aldeyra-therapeutics-secures-fda-agreement-for-adx-2191-clinical-trial-protocol.jpg https://ophthalmologybreakingnews.com/aldeyra-secures-fda-agreement-for-adx-2191-clinical-trial-protocol 2025-06-27T13:24:41+03:00 en https://ophthalmologybreakingnews.com/aldeyra-secures-fda-agreement-for-adx-2191-clinical-trial-protocol https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-announces-positive-phase-iii-results-for-phentolamine-075-in-presbyopia.jpg https://ophthalmologybreakingnews.com/opus-announces-positive-phase-iii-results-for-phentolamine-075 2025-06-27T10:32:33+03:00 en https://ophthalmologybreakingnews.com/opus-announces-positive-phase-iii-results-for-phentolamine-075 https://ophthalmologybreakingnews.com/files/images/blog_valorum-biologics-to-commercialize-formycons-eylea-biosimilar-fyb203-ahzantive-in-us-and-canada.jpg https://ophthalmologybreakingnews.com/valorum-to-commercialize-formycons-fyb203-ahzantive-in-us-and-canada 2025-06-26T10:30:18+03:00 en https://ophthalmologybreakingnews.com/valorum-to-commercialize-formycons-fyb203-ahzantive-in-us-and-canada https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-announces-groundbreaking-innovation-in-intraocular-lens-technology.jpg https://ophthalmologybreakingnews.com/vsy-announces-groundbreaking-innovation-in-intraocular-lens-technology 2025-07-28T09:35:33+03:00 en https://ophthalmologybreakingnews.com/vsy-announces-groundbreaking-innovation-in-intraocular-lens-technology https://ophthalmologybreakingnews.com/files/images/blog_become-the-next-ophthalmology-star-at-osa 2025.jpg https://ophthalmologybreakingnews.com/become-the-next-ophthalmology-star-at-osa-2025 2025-06-25T15:32:59+03:00 en https://ophthalmologybreakingnews.com/become-the-next-ophthalmology-star-at-osa-2025 https://ophthalmologybreakingnews.com/files/images/blog_targeting-cholesterol-metabolism-may-offer-new-strategy-to-prevent-vision-loss-in-amd.jpg https://ophthalmologybreakingnews.com/apom-linked-to-amd-and-heart-disease-treatment 2025-06-25T13:25:17+03:00 en https://ophthalmologybreakingnews.com/apom-linked-to-amd-and-heart-disease-treatment https://ophthalmologybreakingnews.com/files/images/blog_stuart-therapeutics-reports-initial-phase-iii-results-for-st-100-in-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/stuart-therapeutics-reports-initial-phase-iii-results-for-st-100-in-ded 2025-06-25T10:53:28+03:00 en https://ophthalmologybreakingnews.com/stuart-therapeutics-reports-initial-phase-iii-results-for-st-100-in-ded https://ophthalmologybreakingnews.com/files/images/blog_tfos-dews-iii-digest-report-highlights-latest-research-advancements-in-dry-eye-disease-management.jpg https://ophthalmologybreakingnews.com/tfos-dews-iii-digest-report-new-advancements-in-ded-management 2025-06-24T13:42:13+03:00 en https://ophthalmologybreakingnews.com/tfos-dews-iii-digest-report-new-advancements-in-ded-management https://ophthalmologybreakingnews.com/files/images/blog_glaucoma-foundation-receives-25m-endowment-from-herbert-simon-family-foundation.jpg https://ophthalmologybreakingnews.com/glaucoma-foundation-receives-2.5m-endowment 2025-06-24T10:25:57+03:00 en https://ophthalmologybreakingnews.com/glaucoma-foundation-receives-2.5m-endowment https://ophthalmologybreakingnews.com/files/images/blog_france-leads-eu-in-reimbursing-miyosmart-lenses-for-childhood-myopia.jpg https://ophthalmologybreakingnews.com/france-leads-eu-in-reimbursing-miyosmart-lenses-for-childhood-myopia 2025-06-23T15:37:52+03:00 en https://ophthalmologybreakingnews.com/france-leads-eu-in-reimbursing-miyosmart-lenses-for-childhood-myopia https://ophthalmologybreakingnews.com/files/images/blog_new-study-links-mmr-germline-variants-to-uveal-melanoma-risk.jpg https://ophthalmologybreakingnews.com/new-study-links-mmr-germline-variants-to-uveal-melanoma-risk 2025-06-23T13:28:15+03:00 en https://ophthalmologybreakingnews.com/new-study-links-mmr-germline-variants-to-uveal-melanoma-risk https://ophthalmologybreakingnews.com/files/images/blog_ontario-health-coalition-files-complaints-over-illegal-cataract-surgery-fees.jpg https://ophthalmologybreakingnews.com/ontario-health-coalition-files-complaints-over-illegal-cataract-surgery-fees 2025-06-23T10:39:07+03:00 en https://ophthalmologybreakingnews.com/ontario-health-coalition-files-complaints-over-illegal-cataract-surgery-fees https://ophthalmologybreakingnews.com/files/images/blog_eyecare4kids-names-maggie-cline-as-new-ceo-founder-joseph-carbone-to-lead-international-expansion.jpg https://ophthalmologybreakingnews.com/eyecare4kids-names-maggie-cline-as-new-ceo 2025-06-20T15:24:43+03:00 en https://ophthalmologybreakingnews.com/eyecare4kids-names-maggie-cline-as-new-ceo https://ophthalmologybreakingnews.com/files/images/blog_amaros-closes-series-a-financing-and-forms-advisory-board-to-advance-ophthalmic-ai-platform.jpg https://ophthalmologybreakingnews.com/amaros-closes-series-a-financing 2025-06-20T13:33:44+03:00 en https://ophthalmologybreakingnews.com/amaros-closes-series-a-financing https://ophthalmologybreakingnews.com/files/images/blog_new-app-offers-clinically-proven-blinking-exercises-to-relieve-dry-eye-symptoms.jpg https://ophthalmologybreakingnews.com/new-app-offers-clinically-proven-blinking-exercises 2025-06-20T10:34:43+03:00 en https://ophthalmologybreakingnews.com/new-app-offers-clinically-proven-blinking-exercises https://ophthalmologybreakingnews.com/files/images/blog_retinal-thinning-linked-to-genetic-risk-for-schizophrenia-study-finds.jpg https://ophthalmologybreakingnews.com/retinal-thinning-linked-to-genetic-risk-for-schizophrenia 2025-06-19T15:29:59+03:00 en https://ophthalmologybreakingnews.com/retinal-thinning-linked-to-genetic-risk-for-schizophrenia https://ophthalmologybreakingnews.com/files/images/blog_hadley-launches-donahoe-center-to-enhance-emotional-support-for-vision-loss.jpg https://ophthalmologybreakingnews.com/hadley-launches-donahoe-center 2025-06-19T13:26:29+03:00 en https://ophthalmologybreakingnews.com/hadley-launches-donahoe-center https://ophthalmologybreakingnews.com/files/images/blog_eyestem-completes-phase-1-study-of-eyecyte-rpe-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/eyestem-completes-phase-1-study-of-eyecyte-rpe-for-ga 2025-06-19T10:24:10+03:00 en https://ophthalmologybreakingnews.com/eyestem-completes-phase-1-study-of-eyecyte-rpe-for-ga https://ophthalmologybreakingnews.com/files/images/blog_mount-sinais-nyee-launches-center-for-refractive-solutions-in-new-york.jpg https://ophthalmologybreakingnews.com/nyee-launches-center-for-refractive-solutions-in-new-york 2025-06-18T15:29:15+03:00 en https://ophthalmologybreakingnews.com/nyee-launches-center-for-refractive-solutions-in-new-york https://ophthalmologybreakingnews.com/files/images/blog_gene-therapy-reduces-eye-pressure-in-mice-offers-potential-alternative-to-glaucoma-drops.jpg https://ophthalmologybreakingnews.com/gene-therapy-reduces-eye-pressure-in-mice 2025-06-18T13:38:43+03:00 en https://ophthalmologybreakingnews.com/gene-therapy-reduces-eye-pressure-in-mice https://ophthalmologybreakingnews.com/files/images/blog_aldeyra-resubmits-nda-for-reproxalap-in-dry-eye-disease-treatment.jpg https://ophthalmologybreakingnews.com/aldeyra-resubmits-nda-for-reproxalap-in-ded-treatment 2025-06-18T10:57:53+03:00 en https://ophthalmologybreakingnews.com/aldeyra-resubmits-nda-for-reproxalap-in-ded-treatment https://ophthalmologybreakingnews.com/files/images/blog_new-handheld-device-enhances-early-detection-and-treatment-of-amblyopia.jpg https://ophthalmologybreakingnews.com/new-handheld-device-enhances-early-detection-and-treatment-of-amblyopia 2025-06-17T15:32:08+03:00 en https://ophthalmologybreakingnews.com/new-handheld-device-enhances-early-detection-and-treatment-of-amblyopia https://ophthalmologybreakingnews.com/files/images/blog_heidelberg-engineering-launches-zinserlab-to-drive-innovation-in-ophthalmic-imaging.jpg https://ophthalmologybreakingnews.com/heidelberg-engineering-launches-zinserlab 2025-06-17T13:39:56+03:00 en https://ophthalmologybreakingnews.com/heidelberg-engineering-launches-zinserlab https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-ocugen-to-launch-phase-2-3-confirmatory-trial-of-ocu410st-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/fda-clears-ocugen-to-launch-phase-2-3-confirmatory-trial 2025-06-17T10:25:41+03:00 en https://ophthalmologybreakingnews.com/fda-clears-ocugen-to-launch-phase-2-3-confirmatory-trial https://ophthalmologybreakingnews.com/files/images/blog_vigeneron-rebrands-as-veongen-earns-fda-rpdd-for-gene-therapy.jpg https://ophthalmologybreakingnews.com/vigeneron-rebrands-as-veongen-earns-fda-rpdd-for-gene-therapy 2025-06-16T15:36:52+03:00 en https://ophthalmologybreakingnews.com/vigeneron-rebrands-as-veongen-earns-fda-rpdd-for-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_ema-identifies-rare-risk-of-vision-loss-with-semaglutide-based-therapies.jpg https://ophthalmologybreakingnews.com/ema-identifies-rare-risk-of-vision-loss-with-semaglutide-based-therapies 2025-07-10T14:15:34+03:00 en https://ophthalmologybreakingnews.com/ema-identifies-rare-risk-of-vision-loss-with-semaglutide-based-therapies https://ophthalmologybreakingnews.com/files/images/blog_polyactiva-secures-aud-40-million-in-series-c-funding-to-advance-pa5108-and-prezia-drug-delivery-platform.jpg https://ophthalmologybreakingnews.com/polyactiva-secures-aud-40-million-in-series-c-funding 2025-06-16T10:49:59+03:00 en https://ophthalmologybreakingnews.com/polyactiva-secures-aud-40-million-in-series-c-funding https://ophthalmologybreakingnews.com/files/images/blog_zeteo-biomedical-secures-us-and-eu-patents-for-next-generation-drug-delivery-technologies.jpg https://ophthalmologybreakingnews.com/zeteo-biomedical-secures-us-and-eu-patents 2025-06-13T15:49:03+03:00 en https://ophthalmologybreakingnews.com/zeteo-biomedical-secures-us-and-eu-patents https://ophthalmologybreakingnews.com/files/images/blog_splicebio-raises-135-million-in-series-b-to-advance-gene-therapy-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/splicebio-raises-135-million-in-series-b 2025-06-13T13:27:03+03:00 en https://ophthalmologybreakingnews.com/splicebio-raises-135-million-in-series-b https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-amneals-prednisolone-acetate-ophthalmic-suspension-for-steroid-responsive-ocular-inflammation.jpg https://ophthalmologybreakingnews.com/fda-approves-amneals-prednisolone-acetate-ophthalmic-suspension 2025-06-13T10:26:32+03:00 en https://ophthalmologybreakingnews.com/fda-approves-amneals-prednisolone-acetate-ophthalmic-suspension https://ophthalmologybreakingnews.com/files/images/blog_university-of-colorado-anschutz-medical-campus-receives-40-million-gift-to-advance-ophthalmic-research-and-innovation.jpg https://ophthalmologybreakingnews.com/university-of-colorado-anschutz-medical-campus-receives-40-million-gift 2025-06-12T15:28:29+03:00 en https://ophthalmologybreakingnews.com/university-of-colorado-anschutz-medical-campus-receives-40-million-gift https://ophthalmologybreakingnews.com/files/images/blog_study-links-primary-open-angle-glaucoma-diagnosis-to-decline-in-mental-health-scores.jpg https://ophthalmologybreakingnews.com/study-links-primary-open-angle-glaucoma-diagnosis-to-decline-in-mental-health-scores 2025-06-12T13:25:15+03:00 en https://ophthalmologybreakingnews.com/study-links-primary-open-angle-glaucoma-diagnosis-to-decline-in-mental-health-scores https://ophthalmologybreakingnews.com/files/images/blog_qlaris-bio-advances-development-of-fixed-dose-combination-therapy-for-glaucoma.jpg https://ophthalmologybreakingnews.com/qlaris-bio-advances-development-of-fixed-dose-combination-therapy 2025-06-12T10:27:38+03:00 en https://ophthalmologybreakingnews.com/qlaris-bio-advances-development-of-fixed-dose-combination-therapy https://ophthalmologybreakingnews.com/files/images/blog_geneditbio-doses-first-patient-in-investigator-initiated-trial-of-geb-101-for-tgfbi-corneal-dystrophy.jpg https://ophthalmologybreakingnews.com/geneditbio-doses-first-patient-in-investigator-initiated-trial-of-geb-101 2025-06-11T15:28:19+03:00 en https://ophthalmologybreakingnews.com/geneditbio-doses-first-patient-in-investigator-initiated-trial-of-geb-101 https://ophthalmologybreakingnews.com/files/images/blog_gore-launches-silicone-free-05-ml-improject-plunger-for-ophthalmic-drug-delivery.jpg https://ophthalmologybreakingnews.com/gore-launches-silicone-free-05-ml-improject-plunger 2025-06-11T13:25:54+03:00 en https://ophthalmologybreakingnews.com/gore-launches-silicone-free-05-ml-improject-plunger https://ophthalmologybreakingnews.com/files/images/blog_vivavision-biotech-receives-positive-fda-feedback-on-vvn461ld-development-for-postoperative-inflammation.jpg https://ophthalmologybreakingnews.com/vivavision-receives-positive-fda-feedback-on-vvn461ld-development 2025-06-11T10:26:40+03:00 en https://ophthalmologybreakingnews.com/vivavision-receives-positive-fda-feedback-on-vvn461ld-development https://ophthalmologybreakingnews.com/files/images/blog_zeiss-clarus-700-receives-nmpa-approval-in-china-for-advanced-retinal-imaging.jpg https://ophthalmologybreakingnews.com/zeiss-clarus-700-receives-nmpa-approval-in-china 2025-06-10T13:28:03+03:00 en https://ophthalmologybreakingnews.com/zeiss-clarus-700-receives-nmpa-approval-in-china https://ophthalmologybreakingnews.com/files/images/blog_european-commission-approves-ryjunea-for-slowing-progression-of-pediatric-myopia.jpg https://ophthalmologybreakingnews.com/european-commission-approves-ryjunea 2025-06-10T10:28:46+03:00 en https://ophthalmologybreakingnews.com/european-commission-approves-ryjunea https://ophthalmologybreakingnews.com/files/images/blog_harrow-acquires-us-commercial-rights-to-byqlovi-for-treating-postoperative-inflammation-and-pain.jpg https://ophthalmologybreakingnews.com/harrow-acquires-us-commercial-rights-to-byqlovi 2025-06-30T10:25:27+03:00 en https://ophthalmologybreakingnews.com/harrow-acquires-us-commercial-rights-to-byqlovi https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-blink-nourish-and-blink-boost-lubricating-eye-drops-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-blink-nourish-and-blink-boost 2025-06-05T10:28:24+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-blink-nourish-and-blink-boost https://ophthalmologybreakingnews.com/files/images/blog_iveena-submits-ind-application-for-phase-2-trial-of-ivmed-85-in-pediatric-myopia.jpg https://ophthalmologybreakingnews.com/iveena-submits-ind-application-for-phase-2-trial-of-ivmed-85 2025-06-04T15:24:26+03:00 en https://ophthalmologybreakingnews.com/iveena-submits-ind-application-for-phase-2-trial-of-ivmed-85 https://ophthalmologybreakingnews.com/files/images/blog_telomir-reports-promising-preclinical-results-for-oral-amd-therapy-telomir-1.jpg https://ophthalmologybreakingnews.com/telomir-reports-promising-preclinical-results-for-telomir-1 2025-06-04T13:20:52+03:00 en https://ophthalmologybreakingnews.com/telomir-reports-promising-preclinical-results-for-telomir-1 https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-nda-for-brimochol-pf-to-treat-presbyopia.jpg https://ophthalmologybreakingnews.com/fda-accepts-nda-for-brimochol-pf-to-treat-presbyopia 2025-06-04T10:27:30+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-nda-for-brimochol-pf-to-treat-presbyopia https://ophthalmologybreakingnews.com/files/images/blog_european-stroke-organization-issues-first-international-guideline-for-visual-impairment-post-stroke.jpg https://ophthalmologybreakingnews.com/eso-issues-first-international-guideline-for-visual-impairment-post-stroke 2025-06-03T15:16:48+03:00 en https://ophthalmologybreakingnews.com/eso-issues-first-international-guideline-for-visual-impairment-post-stroke https://ophthalmologybreakingnews.com/files/images/blog_spyglass-pharma-secures-75-million-series-d-financing-to-advance-long-term-glaucoma-drug-delivery-platform.jpg https://ophthalmologybreakingnews.com/spyglass-pharma-secures-75-million-series-d-financing 2025-06-03T13:34:28+03:00 en https://ophthalmologybreakingnews.com/spyglass-pharma-secures-75-million-series-d-financing https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-phase-3-lynx-2-trial-meets-primary-endpoint-for-night-vision-impairment-in-keratorefractive-patients.jpg https://ophthalmologybreakingnews.com/opus-genetics-phase-3-lynx-2-trial-meets-primary-endpoint 2025-06-03T10:27:46+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-phase-3-lynx-2-trial-meets-primary-endpoint https://ophthalmologybreakingnews.com/files/images/blog_genetic-research-offers-new-hope-for-patients-with-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/genetic-research-offers-new-hope 2025-06-02T15:30:25+03:00 en https://ophthalmologybreakingnews.com/genetic-research-offers-new-hope https://ophthalmologybreakingnews.com/files/images/blog_swept-source-as-oct-shows-diagnostic-potential-in-early-onset-childhood-glaucoma.jpg https://ophthalmologybreakingnews.com/swept-source-as-oct-shows-diagnostic-potential 2025-06-02T13:40:42+03:00 en https://ophthalmologybreakingnews.com/swept-source-as-oct-shows-diagnostic-potential https://ophthalmologybreakingnews.com/files/images/blog_cirm-awards-47-million-to-advance-gene-therapy-for-vision-loss-in-blue-cone-monochromacy.jpg https://ophthalmologybreakingnews.com/cirm-awards-47-million-to-advance-gene-therapy 2025-06-02T10:24:13+03:00 en https://ophthalmologybreakingnews.com/cirm-awards-47-million-to-advance-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-to-acquire-optegra-expanding-presence-in-european-ophthalmology-market.jpg https://ophthalmologybreakingnews.com/essilorluxottica-to-acquire-optegra 2025-05-30T15:36:29+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-to-acquire-optegra https://ophthalmologybreakingnews.com/files/images/blog_alcon-receives-fda-approval-for-tryptyr-to-treat-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/alcon-receives-fda-approval-for-tryptyr-to-treat-ded 2025-06-17T13:44:01+03:00 en https://ophthalmologybreakingnews.com/alcon-receives-fda-approval-for-tryptyr-to-treat-ded https://ophthalmologybreakingnews.com/files/images/blog_nicox-to-receive-milestone-payments-from-kowa-as-ncx-470-advances-toward-phase-3-trials-in-japan.jpg https://ophthalmologybreakingnews.com/nicox-to-receive-milestone-payments-from-kowa 2025-05-30T13:25:59+03:00 en https://ophthalmologybreakingnews.com/nicox-to-receive-milestone-payments-from-kowa https://ophthalmologybreakingnews.com/files/images/blog_oral-hiv-drug-lamivudine-shows-vision-improvement-in-dme-patients-early-trial-suggests.jpg https://ophthalmologybreakingnews.com/hiv-drug-lamivudine-shows-vision-improvement-in-dme-patients 2025-05-29T15:32:56+03:00 en https://ophthalmologybreakingnews.com/hiv-drug-lamivudine-shows-vision-improvement-in-dme-patients https://ophthalmologybreakingnews.com/files/images/blog_pangaea-data-receives-investment-from-topcon-healthcare-to-advance-ai-in-eye-care.jpg https://ophthalmologybreakingnews.com/pangaea-data-receives-investment-from-topcon 2025-05-29T13:28:41+03:00 en https://ophthalmologybreakingnews.com/pangaea-data-receives-investment-from-topcon https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-to-complete-enrollment-in-sol-r-trial-for-axpaxli-in-wet-amd.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-to-complete-enrollment-in-sol-r-trial 2025-05-29T10:44:57+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-to-complete-enrollment-in-sol-r-trial https://ophthalmologybreakingnews.com/files/images/blog_ocugens-ocu410st-granted-rare-pediatric-disease-designation-for-abca4-associated-retinopathies.jpg https://ophthalmologybreakingnews.com/ocugens-ocu410st-granted-rpdd-for-abca4 2025-05-28T15:31:42+03:00 en https://ophthalmologybreakingnews.com/ocugens-ocu410st-granted-rpdd-for-abca4 https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-completes-enrollment-in-phase-3-lugano-trial-of-duravyu-for-wet-amd.jpg https://ophthalmologybreakingnews.com/eyepoint-completes-enrollment-in-phase-3-lugano-trial-of-duravyu 2025-05-28T13:29:05+03:00 en https://ophthalmologybreakingnews.com/eyepoint-completes-enrollment-in-phase-3-lugano-trial-of-duravyu https://ophthalmologybreakingnews.com/files/images/blog_iolyx-therapeutics-reports-promising-phase-2-results-for-ilyx-002-in-autoimmune-associated-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/iolyx-reports-promising-phase-2-results-for-ilyx-002 2025-05-28T10:26:59+03:00 en https://ophthalmologybreakingnews.com/iolyx-reports-promising-phase-2-results-for-ilyx-002 https://ophthalmologybreakingnews.com/files/images/blog_nasa-astronauts-to-headline-heidelberg-engineerings-2025-international-spectralis-symposium.jpg https://ophthalmologybreakingnews.com/nasa-astronauts-to-headline-2025-international-spectralis-symposium 2025-05-27T15:30:26+03:00 en https://ophthalmologybreakingnews.com/nasa-astronauts-to-headline-2025-international-spectralis-symposium https://ophthalmologybreakingnews.com/files/images/blog_kriya-therapeutics-presents-preclinical-data-for-kriya-825-gene-therapy-in-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/kriya-presents-preclinical-data-for-kriya-825 2025-05-27T13:33:11+03:00 en https://ophthalmologybreakingnews.com/kriya-presents-preclinical-data-for-kriya-825 https://ophthalmologybreakingnews.com/files/images/blog_who-will-be-the-next-ophthalmology-star-at-osa-2025.jpg https://ophthalmologybreakingnews.com/who-will-be-the-next-ophthalmology-star-at-osa-2025 2025-05-27T10:25:32+03:00 en https://ophthalmologybreakingnews.com/who-will-be-the-next-ophthalmology-star-at-osa-2025 https://ophthalmologybreakingnews.com/files/images/blog_millions-still-lack-access-to-glasses-as-global-vision-correction-progress-stalls.jpg https://ophthalmologybreakingnews.com/millions-still-lack-access-to-glasses 2025-05-26T15:39:26+03:00 en https://ophthalmologybreakingnews.com/millions-still-lack-access-to-glasses https://ophthalmologybreakingnews.com/files/images/blog_nih-scientists-test-surgical-technique-to-enhance-cell-therapy-for-dry-amd-in-animal-models.jpg https://ophthalmologybreakingnews.com/nih-scientists-test-surgical-technique 2025-05-26T13:28:05+03:00 en https://ophthalmologybreakingnews.com/nih-scientists-test-surgical-technique https://ophthalmologybreakingnews.com/files/images/blog_eylea-8-mg-receives-approval-in-china-for-wet-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/eylea-8-mg-receives-approval-in-china-for-wet-amd 2025-05-26T10:33:48+03:00 en https://ophthalmologybreakingnews.com/eylea-8-mg-receives-approval-in-china-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_new-gene-therapy-tools-show-promise-for-treating-inherited-retinal-degenerations-in-advanced-stages.jpg https://ophthalmologybreakingnews.com/gene-therapy-tools-show-promise-for-treating-inherited-retinal-degenerations 2025-05-23T15:36:01+03:00 en https://ophthalmologybreakingnews.com/gene-therapy-tools-show-promise-for-treating-inherited-retinal-degenerations https://ophthalmologybreakingnews.com/files/images/blog_deepeye-medical-secures-ce-mark-for-ai-based-retinal-therapy-planning-tool.jpg https://ophthalmologybreakingnews.com/deepeye-medical-secures-ce-mark-for-ai-based-retinal-therapy-planning-tool 2025-05-23T13:39:27+03:00 en https://ophthalmologybreakingnews.com/deepeye-medical-secures-ce-mark-for-ai-based-retinal-therapy-planning-tool https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-genentechs-susvimo-for-the-treatment-of-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/fda-approves-genentechs-susvimo-for-diabetic-retinopathy 2025-05-23T10:22:36+03:00 en https://ophthalmologybreakingnews.com/fda-approves-genentechs-susvimo-for-diabetic-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-lumify-preservative-free-redness-reliever-eye-drops-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-lumify-preservative-free-in-the-us 2025-05-22T15:30:19+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-lumify-preservative-free-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_grifols-receives-fda-clearance-to-begin-phase-2-trial-of-immunoglobulin-eye-drops-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/grifols-receives-fda-clearance-to-begin-phase-2-trial 2025-05-22T13:50:55+03:00 en https://ophthalmologybreakingnews.com/grifols-receives-fda-clearance-to-begin-phase-2-trial https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-breakthrough-therapy-designation-to-tinlarebant-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/fda-grants-breakthrough-therapy-designation-to-tinlarebant-for-stargardt-disease 2025-05-22T10:29:04+03:00 en https://ophthalmologybreakingnews.com/fda-grants-breakthrough-therapy-designation-to-tinlarebant-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_ashvattha-therapeutics-reports-positive-phase-2-data-for-subcutaneous-migaldendranib-in-retinal-diseases.jpg https://ophthalmologybreakingnews.com/ashvattha-reports-positive-phase-2-data-for-subcutaneous-migaldendranib 2025-05-21T15:30:54+03:00 en https://ophthalmologybreakingnews.com/ashvattha-reports-positive-phase-2-data-for-subcutaneous-migaldendranib https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-atia-vision-to-initiate-us-clinical-trial-for-omnivu-lens-system-in-cataract-patients.jpg https://ophthalmologybreakingnews.com/fda-approves-atia-vision-to-initiate-us-clinical-trial-for-omnivu-lens-system 2025-05-21T13:31:57+03:00 en https://ophthalmologybreakingnews.com/fda-approves-atia-vision-to-initiate-us-clinical-trial-for-omnivu-lens-system https://ophthalmologybreakingnews.com/files/images/blog_viridian-therapeutics-reports-positive-long-term-data-for-veligrotug-in-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/viridian-reports-positive-long-term-data-for-veligrotug-in-ted 2025-05-21T10:30:16+03:00 en https://ophthalmologybreakingnews.com/viridian-reports-positive-long-term-data-for-veligrotug-in-ted https://ophthalmologybreakingnews.com/files/images/blog_experimental-drug-blocks-protein-linking-hypoglycemia-to-diabetic-vision-loss.jpg https://ophthalmologybreakingnews.com/experimental-drug-blocks-protein-linking-hypoglycemia-to-diabetic-vision-loss 2025-05-20T15:33:52+03:00 en https://ophthalmologybreakingnews.com/experimental-drug-blocks-protein-linking-hypoglycemia-to-diabetic-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_sylentis-announces-positive-phase-2a-results-for-eye-drop-sirna-therapy-syl1801-in-namd.jpg https://ophthalmologybreakingnews.com/sylentis-announces-positive-phase-2a-results 2025-05-20T13:25:41+03:00 en https://ophthalmologybreakingnews.com/sylentis-announces-positive-phase-2a-results https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-reports-promising-interim-results-for-gene-therapy-targeting-x-linked-retinoschisis-xlrs.jpg https://ophthalmologybreakingnews.com/atsena-reports-promising-interim-results-for-gene-therapy 2025-05-20T10:39:53+03:00 en https://ophthalmologybreakingnews.com/atsena-reports-promising-interim-results-for-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_mild-intraocular-inflammation-more-frequent-with-aflibercept-8-mg-in-real-world-use-study-finds.jpg https://ophthalmologybreakingnews.com/mild-intraocular-inflammation-more-frequent-with-aflibercept-8-mg 2025-05-16T15:17:19+03:00 en https://ophthalmologybreakingnews.com/mild-intraocular-inflammation-more-frequent-with-aflibercept-8-mg https://ophthalmologybreakingnews.com/files/images/blog_nicox-reports-positive-results-from-whistler-phase-3b-trial-of-ncx-470-in-iop-reduction.jpg https://ophthalmologybreakingnews.com/nicox-reports-positive-results-from-whistler-phase-3b-trial 2025-05-16T13:20:28+03:00 en https://ophthalmologybreakingnews.com/nicox-reports-positive-results-from-whistler-phase-3b-trial https://ophthalmologybreakingnews.com/files/images/blog_intalight-secures-ce-mark-for-dream-oct-platform-clears-path-for-commercialization-in-europe.jpg https://ophthalmologybreakingnews.com/intalight-secures-ce-mark-for-dream-oct-platform 2025-05-16T10:15:27+03:00 en https://ophthalmologybreakingnews.com/intalight-secures-ce-mark-for-dream-oct-platform https://ophthalmologybreakingnews.com/files/images/blog_aqueous-humor-liquid-biopsy-proven-safe-in-pediatric-retinoblastoma-patients.jpg https://ophthalmologybreakingnews.com/aqueous-humor-liquid-biopsy-proven-safe-in-pediatric-retinoblastoma-patients 2025-05-15T15:17:52+03:00 en https://ophthalmologybreakingnews.com/aqueous-humor-liquid-biopsy-proven-safe-in-pediatric-retinoblastoma-patients https://ophthalmologybreakingnews.com/files/images/blog_elevated-intraocular-pressure-linked-to-vision-loss-and-optic-nerve-damage-study-finds.jpg https://ophthalmologybreakingnews.com/elevated-intraocular-pressure-linked-to-vision-loss 2025-05-15T13:43:28+03:00 en https://ophthalmologybreakingnews.com/elevated-intraocular-pressure-linked-to-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-zenlens-chroma-hoa-scleral-lens-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-zenlens-chroma-hoa-in-the-us 2025-05-15T10:21:26+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-zenlens-chroma-hoa-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_vision-care-and-fall-prevention-linked-to-longer-lifespan-in-older-adults.jpg https://ophthalmologybreakingnews.com/vision-care-and-fall-prevention-linked-to-longer-lifespan-in-older-adults 2025-05-14T15:31:27+03:00 en https://ophthalmologybreakingnews.com/vision-care-and-fall-prevention-linked-to-longer-lifespan-in-older-adults https://ophthalmologybreakingnews.com/files/images/blog_oral-zervimesine-slows-geographic-atrophy-progression-in-phase-2-dry-amd-trial.jpg https://ophthalmologybreakingnews.com/oral-zervimesine-slows-ga-progression-in-phase-2-dry-amd-trial 2025-05-14T13:27:57+03:00 en https://ophthalmologybreakingnews.com/oral-zervimesine-slows-ga-progression-in-phase-2-dry-amd-trial https://ophthalmologybreakingnews.com/files/images/blog_alliance-for-healthcare-from-the-eye-launches-to-advance-ai-powered-disease-detection.jpg https://ophthalmologybreakingnews.com/alliance-for-healthcare-from-the-eye-launches 2025-05-14T10:40:38+03:00 en https://ophthalmologybreakingnews.com/alliance-for-healthcare-from-the-eye-launches https://ophthalmologybreakingnews.com/files/images/blog_ai-enhanced-imaging-system-from-duke-university-offers-faster-clearer-retinal-cell-visualization.jpg https://ophthalmologybreakingnews.com/ai-enhanced-imaging-system-offers-faster-retinal-cell-visualization 2025-05-13T15:45:38+03:00 en https://ophthalmologybreakingnews.com/ai-enhanced-imaging-system-offers-faster-retinal-cell-visualization https://ophthalmologybreakingnews.com/files/images/blog_isarna-therapeutics-presents-final-phase-2-results-for-isth0036-in-wet-amd-and-dme-at-arvo-2025.jpg https://ophthalmologybreakingnews.com/isarna-therapeutics-presents-final-phase-2-results-for-isth0036 2025-05-13T13:27:32+03:00 en https://ophthalmologybreakingnews.com/isarna-therapeutics-presents-final-phase-2-results-for-isth0036 https://ophthalmologybreakingnews.com/files/images/blog_nationwide-recall-issued-for-over-70000-eye-care-products-due-to-safety-risks.jpg https://ophthalmologybreakingnews.com/nationwide-recall-issued-for-over-70000-eye-care-products 2025-06-10T10:27:29+03:00 en https://ophthalmologybreakingnews.com/nationwide-recall-issued-for-over-70000-eye-care-products https://ophthalmologybreakingnews.com/files/images/blog_eyecool-therapeutics-reports-positive-pilot-study-results-for-etx-4143-in-chronic-ocular-surface-pain-cosp.jpg https://ophthalmologybreakingnews.com/eyecool-therapeutics-reports-positive-pilot-study-results 2025-05-12T15:35:15+03:00 en https://ophthalmologybreakingnews.com/eyecool-therapeutics-reports-positive-pilot-study-results https://ophthalmologybreakingnews.com/files/images/blog_perfuse-therapeutics-reports-positive-phase-1-2a-results-for-per-001-intravitreal-implant-in-glaucoma.jpg https://ophthalmologybreakingnews.com/perfuse-therapeutics-reports-positive-phase-1-2a-results 2025-05-12T13:28:23+03:00 en https://ophthalmologybreakingnews.com/perfuse-therapeutics-reports-positive-phase-1-2a-results https://ophthalmologybreakingnews.com/files/images/blog_lumitheras-lightsite-phase-3b-extension-trial-demonstrates-long-term-vision-improvement-in-dry-amd.jpg https://ophthalmologybreakingnews.com/lumitheras-lightsite-phase-3b-extension-trial 2025-05-12T10:30:48+03:00 en https://ophthalmologybreakingnews.com/lumitheras-lightsite-phase-3b-extension-trial https://ophthalmologybreakingnews.com/files/images/blog_vitamin-supplementation-may-slow-glaucoma-progression-new-study-suggests.jpg https://ophthalmologybreakingnews.com/vitamin-supplementation-may-slow-glaucoma-progression 2025-05-09T15:12:44+03:00 en https://ophthalmologybreakingnews.com/vitamin-supplementation-may-slow-glaucoma-progression https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-launches-idhea-to-advance-ai-and-digital-health-innovation-from-ocular-data.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-launches-idhea 2025-05-09T13:25:47+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-launches-idhea https://ophthalmologybreakingnews.com/files/images/blog_alkeus-pharmaceuticals-presents-positive-24-month-phase-2-data-for-gildeuretinol-in-ga-at-arvo-2025.jpg https://ophthalmologybreakingnews.com/alkeus-presents-positive-24-month-phase-2-data 2025-05-09T10:16:50+03:00 en https://ophthalmologybreakingnews.com/alkeus-presents-positive-24-month-phase-2-data https://ophthalmologybreakingnews.com/files/images/blog_aldeyra-to-resubmit-nda-for-reproxalap-following-positive-phase-3-dry-eye-chamber-results.jpg https://ophthalmologybreakingnews.com/aldeyra-to-resubmit-nda-for-reproxalap 2025-05-08T15:30:18+03:00 en https://ophthalmologybreakingnews.com/aldeyra-to-resubmit-nda-for-reproxalap https://ophthalmologybreakingnews.com/files/images/blog_innovent-biologics-presents-1-year-phase-2-data-on-ibi302-for-namd-at-arvo-2025.jpg https://ophthalmologybreakingnews.com/innovent-biologics-presents-1-year-phase-2-data-on-ibi302 2025-05-08T13:43:29+03:00 en https://ophthalmologybreakingnews.com/innovent-biologics-presents-1-year-phase-2-data-on-ibi302 https://ophthalmologybreakingnews.com/files/images/blog_carl-zeiss-meditec-ag-announces-leadership-change.jpg https://ophthalmologybreakingnews.com/carl-zeiss-meditec-ag-announces-leadership-change 2025-05-08T10:28:20+03:00 en https://ophthalmologybreakingnews.com/carl-zeiss-meditec-ag-announces-leadership-change https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-presents-12-month-opgx-lca5-gene-therapy-data-at-arvo-2025.jpg https://ophthalmologybreakingnews.com/opus-genetics-presents-12-month-opgx-lca5-data 2025-05-07T15:33:17+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-presents-12-month-opgx-lca5-data https://ophthalmologybreakingnews.com/files/images/blog_unity-biotechnology-reports-36-week-results-from-phase-2b-aspire-trial-of-ubx1325-in-dme.jpg https://ophthalmologybreakingnews.com/unity-biotechnology-reports-36-week-results 2025-05-07T13:54:23+03:00 en https://ophthalmologybreakingnews.com/unity-biotechnology-reports-36-week-results https://ophthalmologybreakingnews.com/files/images/blog_revolutionizing-cataract-surgery-alsee-boost-preloaded-and-alsee-boost-toric-preloaded.jpg https://ophthalmologybreakingnews.com/revolutionizing-cataract-surgery-alsee-boost-preloaded 2025-05-07T10:31:13+03:00 en https://ophthalmologybreakingnews.com/revolutionizing-cataract-surgery-alsee-boost-preloaded https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-clearance-for-ocumet-beacon-retinal-imaging-device.jpg https://ophthalmologybreakingnews.com/fda-grants-clearance-for-ocumet-beacon 2025-05-06T15:49:17+03:00 en https://ophthalmologybreakingnews.com/fda-grants-clearance-for-ocumet-beacon https://ophthalmologybreakingnews.com/files/images/blog_ema-chmp-issues-positive-opinion-for-teprotumumab-tepezza-in-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/ema-chmp-issues-positive-opinion-for-teprotumumab-tepezza-in-ted 2025-05-06T13:34:36+03:00 en https://ophthalmologybreakingnews.com/ema-chmp-issues-positive-opinion-for-teprotumumab-tepezza-in-ted https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-acquires-retinsight-to-expand-ai-driven-retinal-imaging-capabilities.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-acquires-retinsight 2025-05-06T10:50:34+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-acquires-retinsight https://ophthalmologybreakingnews.com/files/images/blog_zeiss-unveils-ai-powered-research-data-platform-for-ophthalmology.jpg https://ophthalmologybreakingnews.com/zeiss-unveils-ai-powered-research-data-platform-for-ophthalmology 2025-05-05T15:23:29+03:00 en https://ophthalmologybreakingnews.com/zeiss-unveils-ai-powered-research-data-platform-for-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-rmat-designation-to-4d-molecular-therapeutics-4d-150-for-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-4dmts-4d-150-for-dme 2025-05-05T13:24:20+03:00 en https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-4dmts-4d-150-for-dme https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-fast-track-designation-to-okyo-pharmas-urcosimod-for-neuropathic-corneal-pain.jpg https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-okyo-pharmas-urcosimod 2025-05-05T10:28:31+03:00 en https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-okyo-pharmas-urcosimod https://ophthalmologybreakingnews.com/files/images/blog_palatin-releases-updated-responder-analysis-results-from-phase-3-melody-1-trial-in-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/palatin-releases-updated-responder-analysis-results 2025-04-30T15:18:50+03:00 en https://ophthalmologybreakingnews.com/palatin-releases-updated-responder-analysis-results https://ophthalmologybreakingnews.com/files/images/blog_ace-vision-group-closes-294-million-series-b-financing-to-advance-presbyopia-laser-technology.jpg https://ophthalmologybreakingnews.com/ace-vision-group-closes-294-million-series-b-financing 2025-04-30T13:35:09+03:00 en https://ophthalmologybreakingnews.com/ace-vision-group-closes-294-million-series-b-financing https://ophthalmologybreakingnews.com/files/images/blog_fda-expands-luminopias-label-to-include-amblyopia-patients-aged-8-to-12.jpg https://ophthalmologybreakingnews.com/fda-expands-luminopias-label 2025-04-30T10:42:35+03:00 en https://ophthalmologybreakingnews.com/fda-expands-luminopias-label https://ophthalmologybreakingnews.com/files/images/blog_study-highlights-need-for-early-advice-to-young-adults-amid-rising-dry-eye-disease-cases.jpg https://ophthalmologybreakingnews.com/study-highlights-need-for-early-advice-to-young-adults 2025-04-29T15:28:15+03:00 en https://ophthalmologybreakingnews.com/study-highlights-need-for-early-advice-to-young-adults https://ophthalmologybreakingnews.com/files/images/blog_researchers-identify-molecular-link-between-hpv-and-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/researchers-identify-molecular-link-between-hpv-and-ted 2025-04-29T13:43:25+03:00 en https://ophthalmologybreakingnews.com/researchers-identify-molecular-link-between-hpv-and-ted https://ophthalmologybreakingnews.com/files/images/blog_unity-biotechnology-announces-nejm-evidence-publication-of-phase-2-ubx1325-data-in-dme.jpg https://ophthalmologybreakingnews.com/nejm-evidence-publication-of-phase-2-ubx1325-data-in-dme 2025-04-29T10:33:55+03:00 en https://ophthalmologybreakingnews.com/nejm-evidence-publication-of-phase-2-ubx1325-data-in-dme https://ophthalmologybreakingnews.com/files/images/blog_istar-medical-announces-positive-5-year-results-of-miniject-in-glaucoma-patients.jpg https://ophthalmologybreakingnews.com/istar-medical-announces-positive-5-year-results-of-miniject 2025-05-05T16:14:37+03:00 en https://ophthalmologybreakingnews.com/istar-medical-announces-positive-5-year-results-of-miniject https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-resolves-envista-iol-recall-issue-and-begins-product-relaunch.jpg https://ophthalmologybreakingnews.com/bausch-lomb-resolves-envista-iol-recall-issue 2025-04-28T13:25:23+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-resolves-envista-iol-recall-issue https://ophthalmologybreakingnews.com/files/images/blog_positive-topline-results-from-phase-2-vvn461-trial-for-non-infectious-anterior-uveitis.jpg https://ophthalmologybreakingnews.com/positive-topline-results-from-phase-2-vvn461-trial 2025-04-28T10:26:54+03:00 en https://ophthalmologybreakingnews.com/positive-topline-results-from-phase-2-vvn461-trial https://ophthalmologybreakingnews.com/files/images/blog_study-fear-of-vision-loss-may-deter-some-patients-from-undergoing-cataract-surgery.jpg https://ophthalmologybreakingnews.com/fear-of-vision-loss-may-delay-cataract-surgery 2025-04-25T13:47:43+03:00 en https://ophthalmologybreakingnews.com/fear-of-vision-loss-may-delay-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_early-onset-atopic-dermatitis-linked-to-increased-risk-of-pediatric-uveitis.jpg https://ophthalmologybreakingnews.com/early-onset-atopic-dermatitis-linked-to-increased-risk-of-pediatric-uveitis 2025-04-25T10:36:09+03:00 en https://ophthalmologybreakingnews.com/early-onset-atopic-dermatitis-linked-to-increased-risk-of-pediatric-uveitis https://ophthalmologybreakingnews.com/files/images/blog_nih-researchers-use-ai-to-sharpen-standard-ophthalmoscopes-for-high-resolution-retinal-imaging.jpg https://ophthalmologybreakingnews.com/nih-researchers-use-ai-to-sharpen-standard-ophthalmoscopes 2025-04-24T15:44:20+03:00 en https://ophthalmologybreakingnews.com/nih-researchers-use-ai-to-sharpen-standard-ophthalmoscopes https://ophthalmologybreakingnews.com/files/images/blog_augmented-reality-based-visual-training-improves-vision-in-adults-with-amblyopia.jpg https://ophthalmologybreakingnews.com/augmented-reality-based-visual-training-improves-vision 2025-04-24T13:29:17+03:00 en https://ophthalmologybreakingnews.com/augmented-reality-based-visual-training-improves-vision https://ophthalmologybreakingnews.com/files/images/blog_india-approves-first-005-atropine-eye-drop-for-myopia-control-in-children.jpg https://ophthalmologybreakingnews.com/india-approves-first-005-atropine-eye-drop 2025-04-24T10:21:45+03:00 en https://ophthalmologybreakingnews.com/india-approves-first-005-atropine-eye-drop https://ophthalmologybreakingnews.com/files/images/blog_researchers-stimulate-retina-to-reveal-never-before-seen-color-named-olo.jpg https://ophthalmologybreakingnews.com/retinal-stimulation-reveals-new-color 2025-04-22T15:17:21+03:00 en https://ophthalmologybreakingnews.com/retinal-stimulation-reveals-new-color https://ophthalmologybreakingnews.com/files/images/blog_postoperative-pilocarpine-use-after-kdb-goniotomy-may-reduce-long-term-glaucoma-medication-needs.jpg https://ophthalmologybreakingnews.com/postoperative-pilocarpine-use-after-kdb-goniotomy 2025-04-22T13:29:56+03:00 en https://ophthalmologybreakingnews.com/postoperative-pilocarpine-use-after-kdb-goniotomy https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-complete-response-letter-to-regeneron-for-eylea-hd-sbla-on-extended-dosing-intervals.jpg https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-to-regeneron 2025-04-22T10:39:29+03:00 en https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-to-regeneron https://ophthalmologybreakingnews.com/files/images/blog_scientists-uncover-structural-insights-into-rbp3-a-key-protein-in-visual-function-and-retinal-health.jpg https://ophthalmologybreakingnews.com/scientists-uncover-structural-insights-into-rbp3 2025-04-21T13:26:13+03:00 en https://ophthalmologybreakingnews.com/scientists-uncover-structural-insights-into-rbp3 https://ophthalmologybreakingnews.com/files/images/blog_zhaoke-ophthalmology-enrolls-first-patient-in-phase-3-trial-of-cyclosporine-ophthalmic-gel-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/zhaoke-enrolls-first-patient-in-phase-3-trial-of-cyclosporine 2025-04-21T10:46:40+03:00 en https://ophthalmologybreakingnews.com/zhaoke-enrolls-first-patient-in-phase-3-trial-of-cyclosporine https://ophthalmologybreakingnews.com/files/images/blog_mst-forms-strategic-distribution-partnership-with-mani-to-expand-ophthalmic-surgical-blade-access-in-the-us.jpg https://ophthalmologybreakingnews.com/mst-forms-strategic-distribution-partnership-with-mani 2025-04-18T15:24:58+03:00 en https://ophthalmologybreakingnews.com/mst-forms-strategic-distribution-partnership-with-mani https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-regenerons-sbla-for-eylea-hd-for-priority-review.jpg https://ophthalmologybreakingnews.com/fda-accepts-regenerons-sbla-for-eylea-hd-for-priority-review 2025-04-18T13:26:31+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-regenerons-sbla-for-eylea-hd-for-priority-review https://ophthalmologybreakingnews.com/files/images/blog_bvi-medical-receives-fda-510k-clearance-for-leos-glaucoma-surgical-system.jpg https://ophthalmologybreakingnews.com/bvi-receives-fda-510k-clearance-for-leos 2025-04-18T10:14:44+03:00 en https://ophthalmologybreakingnews.com/bvi-receives-fda-510k-clearance-for-leos https://ophthalmologybreakingnews.com/files/images/blog_study-finds-continued-patching-after-age-4-offers-limited-visual-benefit-in-children-with-unilateral-congenital-cataract.jpg https://ophthalmologybreakingnews.com/continued-patching-after-age-4-offers-limited-visual-benefit 2025-04-17T13:33:01+03:00 en https://ophthalmologybreakingnews.com/continued-patching-after-age-4-offers-limited-visual-benefit https://ophthalmologybreakingnews.com/files/images/blog_repurposed-blood-pressure-drug-shows-promise-in-preventing-vision-loss-from-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/repurposed-blood-pressure-drug-shows-promise 2025-04-17T10:34:44+03:00 en https://ophthalmologybreakingnews.com/repurposed-blood-pressure-drug-shows-promise https://ophthalmologybreakingnews.com/files/images/blog_scientists-map-retinal-inhibitory-signaling-system-for-the-first-time.jpg https://ophthalmologybreakingnews.com/scientists-map-retinal-inhibitory-signaling-system 2025-04-16T15:16:11+03:00 en https://ophthalmologybreakingnews.com/scientists-map-retinal-inhibitory-signaling-system https://ophthalmologybreakingnews.com/files/images/blog_biocon-biologics-secures-us-market-entry-timeline-for-yesafili-interchangeable-biosimilar-to-eylea.jpg https://ophthalmologybreakingnews.com/biocon-secures-us-market-entry-timeline 2025-04-16T13:26:18+03:00 en https://ophthalmologybreakingnews.com/biocon-secures-us-market-entry-timeline https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-receives-fda-rmat-designation-for-gene-therapy-targeting-x-linked-retinoschisis.jpg https://ophthalmologybreakingnews.com/atsena-therapeutics-receives-fda-rmat-designation 2025-04-16T10:23:51+03:00 en https://ophthalmologybreakingnews.com/atsena-therapeutics-receives-fda-rmat-designation https://ophthalmologybreakingnews.com/files/images/blog_ai-powered-eye-scans-show-promise-in-cardiovascular-risk-screening-in-primary-care.jpg https://ophthalmologybreakingnews.com/ai-powered-eye-scans-show-promise 2025-04-15T15:45:15+03:00 en https://ophthalmologybreakingnews.com/ai-powered-eye-scans-show-promise https://ophthalmologybreakingnews.com/files/images/blog_study-finds-post-pandemic-rise-in-prevalence-and-severity-of-pediatric-astigmatism.jpg https://ophthalmologybreakingnews.com/study-finds-post-pandemic-rise 2025-04-15T13:27:14+03:00 en https://ophthalmologybreakingnews.com/study-finds-post-pandemic-rise https://ophthalmologybreakingnews.com/files/images/blog_eyestem-reports-positive-phase-1-results-for-eyecyte-rpe-in-geographic-atrophy-patients.jpg https://ophthalmologybreakingnews.com/eyestem-reports-positive-phase-1-results 2025-04-15T10:55:20+03:00 en https://ophthalmologybreakingnews.com/eyestem-reports-positive-phase-1-results https://ophthalmologybreakingnews.com/files/images/blog_nextech-and-ocuco-announce-strategic-partnership-to-create-integrated-end-to-end-eyecare-platform.jpg https://ophthalmologybreakingnews.com/nextech-and-ocuco-announce-strategic-partnership 2025-04-14T15:25:41+03:00 en https://ophthalmologybreakingnews.com/nextech-and-ocuco-announce-strategic-partnership https://ophthalmologybreakingnews.com/files/images/blog_pykus-therapeutics-completes-enrollment-in-pilot-trial-of-pyk-2101-retinal-sealant-for-retinal-detachment-surgery.jpg https://ophthalmologybreakingnews.com/pykus-completes-enrollment-in-pilot-trial 2025-04-14T13:16:41+03:00 en https://ophthalmologybreakingnews.com/pykus-completes-enrollment-in-pilot-trial https://ophthalmologybreakingnews.com/files/images/blog_vantage-biosciences-doses-first-patient-in-phase-2-trial-of-vx-01-an-oral-therapy-for-non-proliferative-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/vantage-biosciences-doses-first-patient 2025-04-14T09:47:45+03:00 en https://ophthalmologybreakingnews.com/vantage-biosciences-doses-first-patient https://ophthalmologybreakingnews.com/files/images/blog_eye-health-may-serve-as-early-indicator-of-dementia-risk-otago-study-finds.jpg https://ophthalmologybreakingnews.com/eye-health-linked-to-dementia-risk 2025-04-11T15:37:56+03:00 en https://ophthalmologybreakingnews.com/eye-health-linked-to-dementia-risk https://ophthalmologybreakingnews.com/files/images/blog_oculis-completes-enrollment-in-phase-3-diamond-trials-for-ocs-01-in-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/oculis-completes-enrollment-in-phase-3-diamond-trials 2025-04-11T13:15:41+03:00 en https://ophthalmologybreakingnews.com/oculis-completes-enrollment-in-phase-3-diamond-trials https://ophthalmologybreakingnews.com/files/images/blog_harrow-expands-vevye-access-for-all-program-to-klarity-c-patients.jpg https://ophthalmologybreakingnews.com/harrow-expands-vevye-access-for-all-program 2025-04-11T10:25:46+03:00 en https://ophthalmologybreakingnews.com/harrow-expands-vevye-access-for-all-program https://ophthalmologybreakingnews.com/files/images/blog_study-links-semaglutide-use-to-increased-risk-of-naion-in-patients-with-diabetes.jpg https://ophthalmologybreakingnews.com/study-links-semaglutide-use-to-increased-risk-of-naion 2025-04-10T15:18:20+03:00 en https://ophthalmologybreakingnews.com/study-links-semaglutide-use-to-increased-risk-of-naion https://ophthalmologybreakingnews.com/files/images/blog_bayer-submits-ema-application-to-expand-aflibercept-8mg-indication-to-include-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/bayer-submits-ema-application 2025-04-10T13:33:30+03:00 en https://ophthalmologybreakingnews.com/bayer-submits-ema-application https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-outlook-therapeutics-biologics-license-application-for-ons-5010-in-wet-amd.jpg https://ophthalmologybreakingnews.com/fda-accepts-outlook-therapeutics-bla-for-ons-5010 2025-04-10T10:18:53+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-outlook-therapeutics-bla-for-ons-5010 https://ophthalmologybreakingnews.com/files/images/blog_cellular-response-in-eye-drainage-system-may-inform-glaucoma-treatments.jpg https://ophthalmologybreakingnews.com/cellular-response-in-eye-drainage-system 2025-04-09T15:37:23+03:00 en https://ophthalmologybreakingnews.com/cellular-response-in-eye-drainage-system https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-reports-1-month-pediatric-results-for-opgx-lca5-gene-therapy-in-inherited-retinal-disease.jpg https://ophthalmologybreakingnews.com/opus-reports-1-month-pediatric-results-for-opgx-lca5 2025-04-09T13:28:41+03:00 en https://ophthalmologybreakingnews.com/opus-reports-1-month-pediatric-results-for-opgx-lca5 https://ophthalmologybreakingnews.com/files/images/blog_tenpoint-therapeutics-submits-nda-to-fda-for-brimochol-pf-in-presbyopia-treatment.jpg https://ophthalmologybreakingnews.com/tenpoint-submits-nda-for-brimocholpf 2025-04-09T10:28:37+03:00 en https://ophthalmologybreakingnews.com/tenpoint-submits-nda-for-brimocholpf https://ophthalmologybreakingnews.com/files/images/blog_santens-tapcom-receives-nmpa-approval-in-china-for-open-angle-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/santens-tapcom-receives-nmpa-approval-in-china 2025-04-08T15:20:26+03:00 en https://ophthalmologybreakingnews.com/santens-tapcom-receives-nmpa-approval-in-china https://ophthalmologybreakingnews.com/files/images/blog_orasis-pharmaceuticals-launches-qlosi-eye-drops-for-presbyopia-in-the-us.jpg https://ophthalmologybreakingnews.com/orasis-pharmaceuticals-launches-qlosi 2025-04-08T13:38:30+03:00 en https://ophthalmologybreakingnews.com/orasis-pharmaceuticals-launches-qlosi https://ophthalmologybreakingnews.com/files/images/blog_nordic-pharmas-lacrifill-canalicular-gel-receives-ce-mark-approval-in-the-eu.jpg https://ophthalmologybreakingnews.com/nordic-pharmas-lacrifill-receives-ce-mark 2025-04-08T10:23:46+03:00 en https://ophthalmologybreakingnews.com/nordic-pharmas-lacrifill-receives-ce-mark https://ophthalmologybreakingnews.com/files/images/blog_cocoa-extract-fails-to-prevent-age-related-macular-degeneration-clinical-trial-finds.jpg https://ophthalmologybreakingnews.com/cocoa-extract-fails-to-prevent-amd 2025-04-07T15:27:32+03:00 en https://ophthalmologybreakingnews.com/cocoa-extract-fails-to-prevent-amd https://ophthalmologybreakingnews.com/files/images/blog_vision-restoration-breakthrough-retinal-therapy-achieves-first-long-term-neural-regeneration.jpg https://ophthalmologybreakingnews.com/retinal-therapy-achieves-vision-restoration 2025-06-17T13:44:48+03:00 en https://ophthalmologybreakingnews.com/retinal-therapy-achieves-vision-restoration https://ophthalmologybreakingnews.com/files/images/blog_avisi-technologies-reports-promising-6-month-interim-results-from-vita-trial-on-visiplate-device.jpg https://ophthalmologybreakingnews.com/avisi-reports-promising-interim-results 2025-04-07T10:50:39+03:00 en https://ophthalmologybreakingnews.com/avisi-reports-promising-interim-results https://ophthalmologybreakingnews.com/files/images/blog_five-year-data-confirms-efficacy-of-highly-aspherical-lenslets-in-controlling-myopia-progression-in-children.jpg https://ophthalmologybreakingnews.com/five-year-data-confirms-efficacy-of-highly-aspherical-lenslets 2025-04-04T15:29:15+03:00 en https://ophthalmologybreakingnews.com/five-year-data-confirms-efficacy-of-highly-aspherical-lenslets https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-secures-150-million-series-c-funding-to-advance-ocular-gene-therapy-pipeline.jpg https://ophthalmologybreakingnews.com/atsena-therapeutics-secures-150-million 2025-04-04T13:23:07+03:00 en https://ophthalmologybreakingnews.com/atsena-therapeutics-secures-150-million https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-complete-response-letter-to-aldeyra-therapeutics-for-reproxalap-nda-resubmission.jpg https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-to-aldeyra 2025-04-04T10:19:03+03:00 en https://ophthalmologybreakingnews.com/fda-issues-complete-response-letter-to-aldeyra https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-declares-april-as-womens-eye-health-and-safety-month.jpg https://ophthalmologybreakingnews.com/prevent-blindness-declares-april-as-womens-eye-health 2025-04-03T15:55:59+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-declares-april-as-womens-eye-health https://ophthalmologybreakingnews.com/files/images/blog_human-retinal-stem-like-cells-discovered-with-potential-to-repair-vision-loss.jpg https://ophthalmologybreakingnews.com/human-retinal-stem-like-cells-discovered 2025-04-03T13:25:22+03:00 en https://ophthalmologybreakingnews.com/human-retinal-stem-like-cells-discovered https://ophthalmologybreakingnews.com/files/images/blog_labtician-ophthalmics-launches-lab-triactiv-artificial-tears.jpg https://ophthalmologybreakingnews.com/labtician-ophthalmics-launches-lab-triactiv 2025-04-03T10:25:54+03:00 en https://ophthalmologybreakingnews.com/labtician-ophthalmics-launches-lab-triactiv https://ophthalmologybreakingnews.com/files/images/blog_zeiss-medical-technology-receives-nmpa-approval-for-ilm-blue-in-china.jpg https://ophthalmologybreakingnews.com/zeiss-medical-technology-receives-nmpa-approval 2025-04-02T15:25:57+03:00 en https://ophthalmologybreakingnews.com/zeiss-medical-technology-receives-nmpa-approval https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharma-reports-positive-long-term-stability-data-for-urcosimod-in-neuropathic-corneal-pain.jpg https://ophthalmologybreakingnews.com/okyo-reports-positive-long-term-stability-data 2025-04-02T13:26:49+03:00 en https://ophthalmologybreakingnews.com/okyo-reports-positive-long-term-stability-data https://ophthalmologybreakingnews.com/files/images/blog_sydnexis-receives-positive-chmp-opinion-for-syd-101-to-treat-pediatric-myopia-in-europe.jpg https://ophthalmologybreakingnews.com/sydnexis-receives-positive-chmp-opinion 2025-04-02T10:22:59+03:00 en https://ophthalmologybreakingnews.com/sydnexis-receives-positive-chmp-opinion https://ophthalmologybreakingnews.com/files/images/blog_alcon-acquires-majority-stake-in-aurion-biotech-to-advance-cell-therapy-for-corneal-disease.jpg https://ophthalmologybreakingnews.com/alcon-acquires-majority-stake-in-aurion-biotech 2025-03-28T13:29:51+03:00 en https://ophthalmologybreakingnews.com/alcon-acquires-majority-stake-in-aurion-biotech https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-issues-voluntary-recall-of-select-envista-intraocular-lenses.jpg https://ophthalmologybreakingnews.com/bausch-lomb-issues-voluntary-recall 2025-03-28T10:25:48+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-issues-voluntary-recall https://ophthalmologybreakingnews.com/files/images/blog_pantheon-vision-and-eyedeal-medical-partner-to-develop-bioengineered-corneal-implant.jpg https://ophthalmologybreakingnews.com/pantheon-vision-partners-with-eyedeal-medical 2025-04-03T08:21:52+03:00 en https://ophthalmologybreakingnews.com/pantheon-vision-partners-with-eyedeal-medical https://ophthalmologybreakingnews.com/files/images/blog_alsanza-highlights-presbyopia-correction-with-fourier-iols.jpg https://ophthalmologybreakingnews.com/alsanza-highlights-presbyopia-correction-with-fourier-iols 2025-03-27T15:09:46+03:00 en https://ophthalmologybreakingnews.com/alsanza-highlights-presbyopia-correction-with-fourier-iols https://ophthalmologybreakingnews.com/files/images/blog_character-biosciences-secures-93-million-to-advance-genetics-based-therapeutics-for-amd.jpg https://ophthalmologybreakingnews.com/character-biosciences-secures-93-million 2025-03-27T13:20:16+03:00 en https://ophthalmologybreakingnews.com/character-biosciences-secures-93-million https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-therapeutics-publishes-clinical-data-demonstrating-vision-restoration-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/nanoscope-therapeutics-publishes-clinical-data 2025-03-27T10:57:26+03:00 en https://ophthalmologybreakingnews.com/nanoscope-therapeutics-publishes-clinical-data https://ophthalmologybreakingnews.com/files/images/blog_surrozen-shifts-strategic-focus-to-ophthalmology-discontinues-liver-program.jpg https://ophthalmologybreakingnews.com/surrozen-shifts-strategic-focus-to-ophthalmology 2025-03-26T15:20:44+03:00 en https://ophthalmologybreakingnews.com/surrozen-shifts-strategic-focus-to-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_unity-biotechnology-reports-promising-topline-results-from-phase-2b-aspire-study-in-dme.jpg https://ophthalmologybreakingnews.com/unity-biotechnology-reports-promising-topline-results 2025-03-26T13:29:44+03:00 en https://ophthalmologybreakingnews.com/unity-biotechnology-reports-promising-topline-results https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-publishes-phase-4-study-results-on-early-patient-reported-outcomes-with-miebo-in-ded.jpg https://ophthalmologybreakingnews.com/bausch-lomb-publishes-phase-4-study-results 2025-03-26T10:23:09+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-publishes-phase-4-study-results https://ophthalmologybreakingnews.com/files/images/blog_zeiss-expands-availability-of-visulas-combi-laser-workstation-to-canada.jpg https://ophthalmologybreakingnews.com/zeiss-expands-availability-of-visulas-to-canada 2025-09-09T15:40:08+03:00 en https://ophthalmologybreakingnews.com/zeiss-expands-availability-of-visulas-to-canada https://ophthalmologybreakingnews.com/files/images/blog_optheas-phase-3-coast-trial-for-wet-amd-fails-to-meet-primary-endpoint.jpg https://ophthalmologybreakingnews.com/optheas-phase-3-coast-trial-falls-short 2025-03-25T15:23:56+03:00 en https://ophthalmologybreakingnews.com/optheas-phase-3-coast-trial-falls-short https://ophthalmologybreakingnews.com/files/images/blog_alcon-boosts-femtosecond-laser-portfolio-with-acquisition-of-lensar.jpg https://ophthalmologybreakingnews.com/alcon-boosts-femtosecond-laser-portfolio 2025-03-25T10:22:56+03:00 en https://ophthalmologybreakingnews.com/alcon-boosts-femtosecond-laser-portfolio https://ophthalmologybreakingnews.com/files/images/blog_glaucoma-research-foundation-awards-2025-shaffer-research-grants-to-advance-vision-saving-discoveries.jpg https://ophthalmologybreakingnews.com/glaucoma-research-foundation-awards-2025-shaffer-research-grants 2025-03-24T15:18:03+03:00 en https://ophthalmologybreakingnews.com/glaucoma-research-foundation-awards-2025-shaffer-research-grants https://ophthalmologybreakingnews.com/files/images/blog_nih-researchers-demonstrate-promise-of-pedf-based-eye-drops-for-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/nih-researchers-demonstrate-promise-of-pedf-based-eye-drops 2025-03-24T13:18:21+03:00 en https://ophthalmologybreakingnews.com/nih-researchers-demonstrate-promise-of-pedf-based-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_kalaris-therapeutics-and-allovir-complete-merger-to-advance-retinal-disease-pipeline.jpg https://ophthalmologybreakingnews.com/kalaris-and-allovir-complete-merger 2025-03-24T13:05:58+03:00 en https://ophthalmologybreakingnews.com/kalaris-and-allovir-complete-merger https://ophthalmologybreakingnews.com/files/images/blog_formosa-pharmaceuticals-partners-with-cipla-to-launch-app13007-in-11-countries.jpg https://ophthalmologybreakingnews.com/formosa-pharmaceuticals-partners-with-cipla 2025-03-24T13:07:56+03:00 en https://ophthalmologybreakingnews.com/formosa-pharmaceuticals-partners-with-cipla https://ophthalmologybreakingnews.com/files/images/blog_ocugen-advances-to-second-dosing-cohort-in-phase-1-trial-of-ocu200-for-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/ocugen-advances-to-second-dosing-cohort 2025-03-24T13:07:28+03:00 en https://ophthalmologybreakingnews.com/ocugen-advances-to-second-dosing-cohort https://ophthalmologybreakingnews.com/files/images/blog_veterans-study-uncovers-new-genetic-risk-factors-for-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/veterans-study-uncovers-new-genetic-risk-factors 2025-03-24T13:06:55+03:00 en https://ophthalmologybreakingnews.com/veterans-study-uncovers-new-genetic-risk-factors https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-arise-an-intelligent-cloud-based-orthokeratology-lens-fitting-system.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-arise 2025-03-20T16:52:39+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-arise https://ophthalmologybreakingnews.com/files/images/blog_eye-care-in-local-clinics-can-reduce-nhs-patient-wait-times-and-optimize-resources.jpg https://ophthalmologybreakingnews.com/eye-care-in-local-clinics 2025-03-20T15:46:57+03:00 en https://ophthalmologybreakingnews.com/eye-care-in-local-clinics https://ophthalmologybreakingnews.com/files/images/blog_osrx-expands-medication-sizes-and-introduces-direct-to-patient-post-op-kits.jpg https://ophthalmologybreakingnews.com/osrx-expands-medication-sizes 2025-03-20T13:25:43+03:00 en https://ophthalmologybreakingnews.com/osrx-expands-medication-sizes https://ophthalmologybreakingnews.com/files/images/blog_nicox-completes-data-collection-for-ncx-470-phase-3b-whistler-glaucoma-trial.jpg https://ophthalmologybreakingnews.com/nicox-completes-data-collection-for-ncx-470 2025-03-20T09:45:06+03:00 en https://ophthalmologybreakingnews.com/nicox-completes-data-collection-for-ncx-470 https://ophthalmologybreakingnews.com/files/images/blog_new-study-highlights-racial-and-economic-barriers-in-glaucoma-care-access.jpg https://ophthalmologybreakingnews.com/study-highlights-racial-and-economic-barriers 2025-03-19T15:27:14+03:00 en https://ophthalmologybreakingnews.com/study-highlights-racial-and-economic-barriers https://ophthalmologybreakingnews.com/files/images/blog_hanall-biopharma-secures-orphan-drug-designation-in-japan-for-batoclimab-to-treat-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/hanall-secures-orphan-drug-designation-in-japan 2025-03-19T13:26:36+03:00 en https://ophthalmologybreakingnews.com/hanall-secures-orphan-drug-designation-in-japan https://ophthalmologybreakingnews.com/files/images/blog_iantreks-bio-interventional-technology-shows-positive-glaucoma-surgery-results.jpg https://ophthalmologybreakingnews.com/iantreks-bio-interventional-technology-shows-positive-results 2025-03-19T10:30:44+03:00 en https://ophthalmologybreakingnews.com/iantreks-bio-interventional-technology-shows-positive-results https://ophthalmologybreakingnews.com/files/images/blog_china-approves-first-igf-1r-monoclonal-antibody-for-thyroid-eye-disease-innovent-biologics-announces.jpg https://ophthalmologybreakingnews.com/china-approves-first-igf-1r-monoclonal-antibody 2025-03-18T15:23:03+03:00 en https://ophthalmologybreakingnews.com/china-approves-first-igf-1r-monoclonal-antibody https://ophthalmologybreakingnews.com/files/images/blog_stealth-biotherapeutics-reaches-50-enrollment-in-phase-3-renew-study-for-dry-amd.jpg https://ophthalmologybreakingnews.com/stealth-biotherapeutics-reaches-50-enrollment 2025-03-18T13:18:38+03:00 en https://ophthalmologybreakingnews.com/stealth-biotherapeutics-reaches-50-enrollment https://ophthalmologybreakingnews.com/files/images/blog_harrow-launches-vevye-access-for-all-reducing-patient-barriers-for-dry-eye-disease-treatment.jpg https://ophthalmologybreakingnews.com/harrow-launches-vevye-access-for-all 2025-03-18T10:17:56+03:00 en https://ophthalmologybreakingnews.com/harrow-launches-vevye-access-for-all https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-pig-retinal-cells-to-advance-eye-treatments.jpg https://ophthalmologybreakingnews.com/researchers-develop-pig-retinal-cells 2025-03-17T15:29:43+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-pig-retinal-cells https://ophthalmologybreakingnews.com/files/images/blog_f-org-technique-revolutionizes-early-detection-of-retinal-diseases.jpg https://ophthalmologybreakingnews.com/f-org-technique-revolutionizes-early-detection-of-retinal-diseases 2025-03-17T13:34:19+03:00 en https://ophthalmologybreakingnews.com/f-org-technique-revolutionizes-early-detection-of-retinal-diseases https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-expanded-label-for-iluvien-to-include-chronic-noninfectious-uveitis.jpg https://ophthalmologybreakingnews.com/fda-approves-expanded-label-for-iluvien 2025-03-17T10:16:34+03:00 en https://ophthalmologybreakingnews.com/fda-approves-expanded-label-for-iluvien https://ophthalmologybreakingnews.com/files/images/blog_cyclosporine-a-eye-drops-reduce-ocular-discomfort-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/cyclosporine-a-eye-drops-reduce-ocular-discomfort 2025-03-14T15:50:24+03:00 en https://ophthalmologybreakingnews.com/cyclosporine-a-eye-drops-reduce-ocular-discomfort https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-most-glaucoma-patients-unaware-of-preservative-free-treatment-options.jpg https://ophthalmologybreakingnews.com/most-glaucoma-patients-unaware-of-preservative-free-treatment-options 2025-03-14T13:34:37+03:00 en https://ophthalmologybreakingnews.com/most-glaucoma-patients-unaware-of-preservative-free-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-interview-with-jeff-todd-president-ceo-of-prevent-blindness.jpg https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-jeff-todd-president-ceo-of-prevent-blindness 2025-05-15T10:21:54+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-jeff-todd-president-ceo-of-prevent-blindness https://ophthalmologybreakingnews.com/files/images/blog_radiusxr-and-glaukos-collaborate-with-topcon-to-inspire-visual-field-solution-launch.jpg https://ophthalmologybreakingnews.com/radiusxr-and-glaukos-collaborate-with-topcon 2025-03-14T10:28:54+03:00 en https://ophthalmologybreakingnews.com/radiusxr-and-glaukos-collaborate-with-topcon https://ophthalmologybreakingnews.com/files/images/blog_ai-maps-blood-vessels-in-the-retina-for-better-diagnostics.jpg https://ophthalmologybreakingnews.com/ai-maps-blood-vessels-in-the-retina 2025-03-13T15:28:30+03:00 en https://ophthalmologybreakingnews.com/ai-maps-blood-vessels-in-the-retina https://ophthalmologybreakingnews.com/files/images/blog_harrow-secures-5-year-strategic-agreement-for-triesence-and-announces-next-generation-development.jpg https://ophthalmologybreakingnews.com/harrow-secures-5-year-strategic-agreement-for-triesence 2025-03-13T13:35:17+03:00 en https://ophthalmologybreakingnews.com/harrow-secures-5-year-strategic-agreement-for-triesence https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-receives-fda-fast-track-designation-for-atsn-201-gene-therapy-in-x-linked-retinoschisis.jpg https://ophthalmologybreakingnews.com/atsena-receives-fda-fast-track-designation-for-atsn-201 2025-03-13T10:19:58+03:00 en https://ophthalmologybreakingnews.com/atsena-receives-fda-fast-track-designation-for-atsn-201 https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-blood-metabolites-may-reduce-genetic-risk-of-glaucoma.jpg https://ophthalmologybreakingnews.com/blood-metabolites-may-reduce-genetic-risk-of-glaucoma 2025-03-12T15:33:52+03:00 en https://ophthalmologybreakingnews.com/blood-metabolites-may-reduce-genetic-risk-of-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_kodiak-sciences-completes-enrollment-in-phase-3-glow2-trial-of-tarcocimab-tedromer-for-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/kodiak-completes-enrollment-in-phase-3-glow2-trial 2025-03-12T13:17:32+03:00 en https://ophthalmologybreakingnews.com/kodiak-completes-enrollment-in-phase-3-glow2-trial https://ophthalmologybreakingnews.com/files/images/blog_sydnexis-announces-fda-acceptance-of-nda-for-syd-101-in-pediatric-myopia-treatment.jpg https://ophthalmologybreakingnews.com/sydnexis-announces-fda-acceptance-of-nda-for-syd-101 2025-03-12T10:28:44+03:00 en https://ophthalmologybreakingnews.com/sydnexis-announces-fda-acceptance-of-nda-for-syd-101 https://ophthalmologybreakingnews.com/files/images/blog_per-launches-retina-resource-a-comprehensive-anti-vegf-education-platform.jpg https://ophthalmologybreakingnews.com/per-launches-retina-resource 2025-03-11T15:20:54+03:00 en https://ophthalmologybreakingnews.com/per-launches-retina-resource https://ophthalmologybreakingnews.com/files/images/blog_4dmt-enrolls-first-patients-in-phase-3-clinical-trial-of-4d-150-for-wet-amd.jpg https://ophthalmologybreakingnews.com/4dmt-enrolls-first-patients-in-phase-3-clinical-trial 2025-03-11T13:35:25+03:00 en https://ophthalmologybreakingnews.com/4dmt-enrolls-first-patients-in-phase-3-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharma-seeks-fda-fast-track-designation-for-urcosimod-in-neuropathic-corneal-pain-treatment.jpg https://ophthalmologybreakingnews.com/okyo-pharma-seeks-fda-fast-track-designation 2025-03-11T10:27:41+03:00 en https://ophthalmologybreakingnews.com/okyo-pharma-seeks-fda-fast-track-designation https://ophthalmologybreakingnews.com/files/images/blog_the-pupil-as-a-window-to-the-sleeping-brain-new-research-reveals-unexpected-brain-activity-during-sleep.jpg https://ophthalmologybreakingnews.com/pupil-as-a-window-to-the-sleeping-brain 2025-03-10T15:25:58+03:00 en https://ophthalmologybreakingnews.com/pupil-as-a-window-to-the-sleeping-brain https://ophthalmologybreakingnews.com/files/images/blog_luxa-biotechnology-presents-promising-phase-1-2a-trial-data-for-rpesc-rpe-4w-in-dry-amd.jpg https://ophthalmologybreakingnews.com/luxa-biotechnology-presents-promising-phase-1-2a-trial-data 2025-03-10T13:31:48+03:00 en https://ophthalmologybreakingnews.com/luxa-biotechnology-presents-promising-phase-1-2a-trial-data https://ophthalmologybreakingnews.com/files/images/blog_lumata-health-secures-23-million-series-b-funding-to-expand-vision-saving-technology.jpg https://ophthalmologybreakingnews.com/lumata-health-secures-23-million 2025-03-10T10:20:00+03:00 en https://ophthalmologybreakingnews.com/lumata-health-secures-23-million https://ophthalmologybreakingnews.com/files/images/blog_diabetic-eye-disease-on-the-rise-but-most-severe-forms-declining-since-2014.jpg https://ophthalmologybreakingnews.com/diabetic-eye-disease-on-the-rise 2025-03-07T15:29:55+03:00 en https://ophthalmologybreakingnews.com/diabetic-eye-disease-on-the-rise https://ophthalmologybreakingnews.com/files/images/blog_ai-in-ophthalmology-top-artificial-intelligence-tools-transforming-eye-health.jpg https://ophthalmologybreakingnews.com/top-artificial-intelligence-tools-transforming-eye-health 2025-05-15T10:22:22+03:00 en https://ophthalmologybreakingnews.com/top-artificial-intelligence-tools-transforming-eye-health https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-revakinagene-taroretcel-lwey-encelto-for-macular-telangiectasia-type-2.jpg https://ophthalmologybreakingnews.com/fda-approves-revakinagene-taroretcel-lwey-encelto 2025-03-07T10:28:31+03:00 en https://ophthalmologybreakingnews.com/fda-approves-revakinagene-taroretcel-lwey-encelto https://ophthalmologybreakingnews.com/files/images/blog_association-between-triglyceride-glucose-index-and-central-retinal-artery-occlusion.jpg https://ophthalmologybreakingnews.com/association-between-tyg-index-and-crao 2025-03-06T15:28:09+03:00 en https://ophthalmologybreakingnews.com/association-between-tyg-index-and-crao https://ophthalmologybreakingnews.com/files/images/blog_optos-unveils-monacopro-ultra-widefield-and-oct-retinal-imaging-technology.jpg https://ophthalmologybreakingnews.com/optos-unveils-monacopro-ultra-widefield 2025-03-06T13:37:37+03:00 en https://ophthalmologybreakingnews.com/optos-unveils-monacopro-ultra-widefield https://ophthalmologybreakingnews.com/files/images/blog_avirmax-biopharma-prepares-for-ind-enabling-study-of-abi-201.jpg https://ophthalmologybreakingnews.com/avirmax-prepares-for-ind-enabling-study-of-abi-201 2025-03-06T10:15:57+03:00 en https://ophthalmologybreakingnews.com/avirmax-prepares-for-ind-enabling-study-of-abi-201 https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-launches-metis-900-a-next-generation-ophthalmic-surgical-microscope.jpg https://ophthalmologybreakingnews.com/haag-streit-launches-metis-900 2025-09-09T15:39:47+03:00 en https://ophthalmologybreakingnews.com/haag-streit-launches-metis-900 https://ophthalmologybreakingnews.com/files/images/blog_novel-stem-cell-therapy-repairs-irreversible-corneal-damage-in-clinical-trial.jpg https://ophthalmologybreakingnews.com/stem-cell-therapy-repairs-irreversible-corneal-damage 2025-03-05T15:40:51+03:00 en https://ophthalmologybreakingnews.com/stem-cell-therapy-repairs-irreversible-corneal-damage https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-purified-cortrophin-gel-prefilled-syringe-from-ani-pharmaceuticals.jpg https://ophthalmologybreakingnews.com/fda-approves-purified-cortrophin-gel-prefilled-syringe 2025-03-05T10:30:00+03:00 en https://ophthalmologybreakingnews.com/fda-approves-purified-cortrophin-gel-prefilled-syringe https://ophthalmologybreakingnews.com/files/images/blog_adverum-biotechnologies-initiates-artemis-phase-3-trial-for-ixo-vec-gene-therapy-in-wet-amd.jpg https://ophthalmologybreakingnews.com/adverum-biotechnologies-initiates-artemis-phase-3-trial 2025-03-04T15:30:01+03:00 en https://ophthalmologybreakingnews.com/adverum-biotechnologies-initiates-artemis-phase-3-trial https://ophthalmologybreakingnews.com/files/images/blog_nicox-announces-new-data-from-ncx-470-mont-blanc-trial-provides-development-updates.jpg https://ophthalmologybreakingnews.com/nicox-announces-new-data-from-ncx-470-mont-blanc-trial 2025-03-04T13:15:34+03:00 en https://ophthalmologybreakingnews.com/nicox-announces-new-data-from-ncx-470-mont-blanc-trial https://ophthalmologybreakingnews.com/files/images/blog_opthea-publishes-phase-2b-trial-data-for-wet-amd.jpg https://ophthalmologybreakingnews.com/opthea-publishes-phase-2b-trial-data-for-wet-amd 2025-03-04T10:28:49+03:00 en https://ophthalmologybreakingnews.com/opthea-publishes-phase-2b-trial-data-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_altris-ai-launches-advanced-optic-disc-analysis-for-glaucoma-detection.jpg https://ophthalmologybreakingnews.com/altris-ai-launches-advanced-optic-disc-analysis 2025-03-03T15:41:45+03:00 en https://ophthalmologybreakingnews.com/altris-ai-launches-advanced-optic-disc-analysis https://ophthalmologybreakingnews.com/files/images/blog_advances-in-corneal-healing-research-drive-new-treatments-for-rare-eye-diseases.jpg https://ophthalmologybreakingnews.com/advances-in-corneal-healing-research 2025-03-03T13:26:54+03:00 en https://ophthalmologybreakingnews.com/advances-in-corneal-healing-research https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-resubmits-bla-for-ons-5010-for-treatment-of-wet-amd.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-resubmits-bla-for-ons-5010 2025-03-03T10:43:11+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-resubmits-bla-for-ons-5010 https://ophthalmologybreakingnews.com/files/images/blog_stem-cell-transplant-shows-safety-promise-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/stem-cell-transplant-shows-safety-promise-for-wet-amd-treatment 2025-02-28T15:51:51+03:00 en https://ophthalmologybreakingnews.com/stem-cell-transplant-shows-safety-promise-for-wet-amd-treatment https://ophthalmologybreakingnews.com/files/images/blog_professor-michael-belkin-honored-with-lifetime-achievement-award-at-mixiii-2025.jpg https://ophthalmologybreakingnews.com/professor-michael-belkin-honored-with-lifetime-achievement 2025-02-28T14:00:45+03:00 en https://ophthalmologybreakingnews.com/professor-michael-belkin-honored-with-lifetime-achievement https://ophthalmologybreakingnews.com/files/images/blog_retinalgenix-technologies-begins-testing-remote-ocular-monitoring-system.jpg https://ophthalmologybreakingnews.com/retinalgenix-technologies-begins-testing-remote-ocular-monitoring-system 2025-02-28T10:40:48+03:00 en https://ophthalmologybreakingnews.com/retinalgenix-technologies-begins-testing-remote-ocular-monitoring-system https://ophthalmologybreakingnews.com/files/images/blog_perceive-pharma-secures-15m-series-a-funding-to-advance-neuroprotective-therapies-for-glaucoma.jpg https://ophthalmologybreakingnews.com/perceive-pharma-secures-15m-series-a-funding 2025-02-27T15:48:24+03:00 en https://ophthalmologybreakingnews.com/perceive-pharma-secures-15m-series-a-funding https://ophthalmologybreakingnews.com/files/images/blog_china-approves-zeiss-visumax-800-with-smile-pro-software.jpg https://ophthalmologybreakingnews.com/china-approves-zeiss-visumax-800 2025-02-27T13:34:09+03:00 en https://ophthalmologybreakingnews.com/china-approves-zeiss-visumax-800 https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-announces-fda-fast-track-designation-and-enrollment-updates-for-phentolamine-ophthalmic-solution.jpg https://ophthalmologybreakingnews.com/opus-genetics-announces-fda-fast-track-designation 2025-02-27T10:24:32+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-announces-fda-fast-track-designation https://ophthalmologybreakingnews.com/files/images/blog_new-research-links-breathing-to-pupil-size-and-vision-regulation.jpg https://ophthalmologybreakingnews.com/new-research-links-breathing-to-pupil-size-and-vision-regulation 2025-02-26T15:49:46+03:00 en https://ophthalmologybreakingnews.com/new-research-links-breathing-to-pupil-size-and-vision-regulation https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-rmat-designation-to-rpesc-rpe-4w-transplantation-for-dry-amd.jpg https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-rpesc-rpe-4w 2025-02-26T13:25:28+03:00 en https://ophthalmologybreakingnews.com/fda-grants-rmat-designation-to-rpesc-rpe-4w https://ophthalmologybreakingnews.com/files/images/blog_uk-mhra-approves-aflibercept-biosimilar-fyb203-ahzantive-from-formycon.jpg https://ophthalmologybreakingnews.com/uk-mhra-approves-aflibercept-biosimilar-fyb203-ahzantive 2025-02-26T10:24:40+03:00 en https://ophthalmologybreakingnews.com/uk-mhra-approves-aflibercept-biosimilar-fyb203-ahzantive https://ophthalmologybreakingnews.com/files/images/blog_mount-sinai-researchers-identify-key-mechanisms-behind-age-related-meibomian-gland-dysfunction.jpg https://ophthalmologybreakingnews.com/mount-sinai-researchers-identify-key-mechanisms 2025-02-25T15:58:17+03:00 en https://ophthalmologybreakingnews.com/mount-sinai-researchers-identify-key-mechanisms https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-systane-pro-pf-in-the-us-for-long-lasting-dry-eye-relief.jpg https://ophthalmologybreakingnews.com/alcon-launches-systane-pro-pf-in-the-us 2025-02-25T13:23:57+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-systane-pro-pf-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_glaukos-announces-fda-acceptance-of-nda-submission-for-epioxa.jpg https://ophthalmologybreakingnews.com/glaukos-announces-fda-acceptance-of-nda-submission-for-epioxa 2025-02-25T10:22:07+03:00 en https://ophthalmologybreakingnews.com/glaukos-announces-fda-acceptance-of-nda-submission-for-epioxa https://ophthalmologybreakingnews.com/files/images/blog_genetic-therapy-brings-life-changing-vision-improvements-for-infants.jpg https://ophthalmologybreakingnews.com/genetic-therapy-brings-life-changing-vision-improvements-for-infants 2025-02-24T15:32:36+03:00 en https://ophthalmologybreakingnews.com/genetic-therapy-brings-life-changing-vision-improvements-for-infants https://ophthalmologybreakingnews.com/files/images/blog_retinal-detachment-risk-after-boston-type-1-keratoprosthesis-b1kpro-implantation.jpg https://ophthalmologybreakingnews.com/retinal-detachment-risk-after-b1kpro 2025-02-24T13:32:46+03:00 en https://ophthalmologybreakingnews.com/retinal-detachment-risk-after-b1kpro https://ophthalmologybreakingnews.com/files/images/blog_telomir-1-demonstrates-strong-ros-reduction-properties-showing-potential-for-amd-treatment.jpg https://ophthalmologybreakingnews.com/telomir-1-demonstrates-strong-ros-reduction-properties 2025-02-24T10:22:45+03:00 en https://ophthalmologybreakingnews.com/telomir-1-demonstrates-strong-ros-reduction-properties https://ophthalmologybreakingnews.com/files/images/blog_heart-eye-unveils-ai-driven-retinal-imaging-system-for-cardiovascular-risk-detection.jpg https://ophthalmologybreakingnews.com/heart-eye-unveils-ai-driven-retinal-imaging-system 2025-02-21T15:19:00+03:00 en https://ophthalmologybreakingnews.com/heart-eye-unveils-ai-driven-retinal-imaging-system https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-doses-first-pediatric-patient-in-phase-1-2-trial-for-opgx-lca5-gene-therapy.jpg https://ophthalmologybreakingnews.com/opus-genetics-doses-first-pediatric-patient 2025-02-21T13:38:57+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-doses-first-pediatric-patient https://ophthalmologybreakingnews.com/files/images/blog_seonix-bio-introduces-sightscore-the-first-clinical-polygenic-risk-score-test-for-glaucoma-in-the-us.jpg https://ophthalmologybreakingnews.com/seonix-bio-introduces-sightscore-in-the-us 2025-02-21T10:25:59+03:00 en https://ophthalmologybreakingnews.com/seonix-bio-introduces-sightscore-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_genetically-diverse-mouse-models-uncover-eye-aging-patterns-and-links-to-brain-health.jpg https://ophthalmologybreakingnews.com/genetically-diverse-mouse-models-uncover-eye-aging-patterns 2025-02-20T15:41:45+03:00 en https://ophthalmologybreakingnews.com/genetically-diverse-mouse-models-uncover-eye-aging-patterns https://ophthalmologybreakingnews.com/files/images/blog_opthea-completes-week-52-patient-visits-in-coast-phase-3-trial-for-wet-amd.jpg https://ophthalmologybreakingnews.com/opthea-completes-week-52-patient-visits 2025-02-20T13:35:26+03:00 en https://ophthalmologybreakingnews.com/opthea-completes-week-52-patient-visits https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-voyager-dslt-in-the-us-for-first-line-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/alcon-launches-voyager-dslt-in-the-us 2025-02-20T10:45:38+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-voyager-dslt-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_study-identifies-novel-retinal-disorder-linked-to-sudden-vision-loss-in-children.jpg https://ophthalmologybreakingnews.com/study-identifies-novel-retinal-disorder 2025-02-19T15:41:33+03:00 en https://ophthalmologybreakingnews.com/study-identifies-novel-retinal-disorder https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-new-world-medicals-via360-surgical-system-for-ophthalmic-procedures.jpg https://ophthalmologybreakingnews.com/fda-clears-new-world-medicals-via360 2025-02-19T13:27:23+03:00 en https://ophthalmologybreakingnews.com/fda-clears-new-world-medicals-via360 https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-biologics-license-application-for-avt06-alvotechs-biosimilar-to-eylea.jpg https://ophthalmologybreakingnews.com/fda-accepts-bla-for-avt06 2025-02-19T10:38:32+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-bla-for-avt06 https://ophthalmologybreakingnews.com/files/images/blog_study-links-lgood-cholesterol-to-increased-glaucoma-risk-in-adults-over-55.jpg https://ophthalmologybreakingnews.com/study-links-good-cholesterol-to-increased-glaucoma 2025-02-18T15:38:49+03:00 en https://ophthalmologybreakingnews.com/study-links-good-cholesterol-to-increased-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_telefonica-integrates-5g-and-ai-to-advance-ophthalmic-diagnostics-with-cateye.jpg https://ophthalmologybreakingnews.com/telefónica-integrates-5g-and-ai 2025-02-18T13:48:31+03:00 en https://ophthalmologybreakingnews.com/telefónica-integrates-5g-and-ai https://ophthalmologybreakingnews.com/files/images/blog_lumevoq-gene-therapy-shows-sustained-visual-acuity-improvements-in-lhon-after-5-years.jpg https://ophthalmologybreakingnews.com/lumevoq-gene-therapy-shows-sustained-visual-acuity-improvements 2025-02-18T10:56:54+03:00 en https://ophthalmologybreakingnews.com/lumevoq-gene-therapy-shows-sustained-visual-acuity-improvements https://ophthalmologybreakingnews.com/files/images/blog_stanford-study-identifies-new-method-for-measuring-choroidal-tumor-thickness.jpg https://ophthalmologybreakingnews.com/stanford-study-identifies-new-method 2025-02-17T15:32:32+03:00 en https://ophthalmologybreakingnews.com/stanford-study-identifies-new-method https://ophthalmologybreakingnews.com/files/images/blog_new-drug-delivery-method-shows-promise-for-long-lasting-glaucoma-relief.jpg https://ophthalmologybreakingnews.com/new-drug-delivery-method-shows-promise 2025-02-17T13:32:04+03:00 en https://ophthalmologybreakingnews.com/new-drug-delivery-method-shows-promise https://ophthalmologybreakingnews.com/files/images/blog_mediprint-ophthalmics-advances-ll-bmt1-a-sustained-drug-delivery-contact-lens-for-glaucoma.jpg https://ophthalmologybreakingnews.com/mediprint-ophthalmics-advances-ll-bmt1 2025-02-17T10:28:45+03:00 en https://ophthalmologybreakingnews.com/mediprint-ophthalmics-advances-ll-bmt1 https://ophthalmologybreakingnews.com/files/images/blog_new-research-reveals-how-tiny-eye-movements-enhance-visual-acuity.jpg https://ophthalmologybreakingnews.com/research-reveals-how-tiny-eye-movements-enhance-visual-acuity 2025-02-14T15:40:50+03:00 en https://ophthalmologybreakingnews.com/research-reveals-how-tiny-eye-movements-enhance-visual-acuity https://ophthalmologybreakingnews.com/files/images/blog_study-finds-human-breast-milk-may-aid-in-corneal-wound-healing.jpg https://ophthalmologybreakingnews.com/human-breast-milk-may-aid-in-corneal-wound-healing 2025-02-14T13:32:00+03:00 en https://ophthalmologybreakingnews.com/human-breast-milk-may-aid-in-corneal-wound-healing https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-amended-label-for-izervay-in-the-treatment-of-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/fda-approves-amended-label-for-izervay 2025-02-14T11:12:20+03:00 en https://ophthalmologybreakingnews.com/fda-approves-amended-label-for-izervay https://ophthalmologybreakingnews.com/files/images/blog_virtual-vision-health-launches-visual-acuity-testing-on-virtual-eye-vr-platform.jpg https://ophthalmologybreakingnews.com/virtual-vision-launches-visual-acuity-testing 2025-02-13T15:30:06+03:00 en https://ophthalmologybreakingnews.com/virtual-vision-launches-visual-acuity-testing https://ophthalmologybreakingnews.com/files/images/blog_study-finds-older-women-at-higher-risk-of-inflammation-from-gene-therapies-for-eye-diseases.jpg https://ophthalmologybreakingnews.com/older-women-at-higher-risk-of-inflammation 2025-02-13T13:36:49+03:00 en https://ophthalmologybreakingnews.com/older-women-at-higher-risk-of-inflammation https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharmas-lead-asset-ok-101-receives-us-adopted-name-urcosimod.jpg https://ophthalmologybreakingnews.com/okyo-pharmas-lead-asset-ok-101-receives-us-adopted-name 2025-02-13T10:17:45+03:00 en https://ophthalmologybreakingnews.com/okyo-pharmas-lead-asset-ok-101-receives-us-adopted-name https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-acquires-cellview-imaging-to-strengthen-retinal-diagnostic-capabilities.jpg https://ophthalmologybreakingnews.com/essilorluxottica-acquires-cellview-imaging-for-retinal-diagnostic 2025-02-12T15:22:30+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-acquires-cellview-imaging-for-retinal-diagnostic https://ophthalmologybreakingnews.com/files/images/blog_teclens-secures-93-million-in-series-a-funding-to-advance-noninvasive-refractive-technology.jpg https://ophthalmologybreakingnews.com/teclens-secures-93-million-in-series-a-funding 2025-02-12T13:38:45+03:00 en https://ophthalmologybreakingnews.com/teclens-secures-93-million-in-series-a-funding https://ophthalmologybreakingnews.com/files/images/blog_aeye-health-and-topcon-healthcare-announce-results-of-autonomous-diabetic-retinopathy-screening-study.jpg https://ophthalmologybreakingnews.com/aeye-health-and-topcon-healthcare-announce-results 2025-02-12T10:17:46+03:00 en https://ophthalmologybreakingnews.com/aeye-health-and-topcon-healthcare-announce-results https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedical-presents-new-data-from-odyssey-phase-2b-trial-on-cls-ax.jpg https://ophthalmologybreakingnews.com/clearside-biomedical-presents-new-data-from-odyssey-phase-2b-trial 2025-02-11T15:21:02+03:00 en https://ophthalmologybreakingnews.com/clearside-biomedical-presents-new-data-from-odyssey-phase-2b-trial https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-provides-update-on-potential-sale-and-future-plans.jpg https://ophthalmologybreakingnews.com/bausch-lomb-provides-update-on-potential-sale 2025-02-11T13:28:16+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-provides-update-on-potential-sale https://ophthalmologybreakingnews.com/files/images/blog_regeneron-reports-positive-phase-3-trial-results-for-eylea-hd-aflibercept-8-mg.jpg https://ophthalmologybreakingnews.com/regeneron-reports-positive-phase-3-trial-results 2025-02-11T10:23:23+03:00 en https://ophthalmologybreakingnews.com/regeneron-reports-positive-phase-3-trial-results https://ophthalmologybreakingnews.com/files/images/blog_experimental-study-links-covid-19-infection-to-age-related-blindness-risk.jpg https://ophthalmologybreakingnews.com/experimental-study-links-covid-19-infection-to-age-related-blindness-risk 2025-02-10T15:25:01+03:00 en https://ophthalmologybreakingnews.com/experimental-study-links-covid-19-infection-to-age-related-blindness-risk https://ophthalmologybreakingnews.com/files/images/blog_sleep-apnea-linked-to-increased-risk-of-wet-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/sleep-apnea-linked-to-increased-risk-of-wet-amd 2025-02-10T13:33:32+03:00 en https://ophthalmologybreakingnews.com/sleep-apnea-linked-to-increased-risk-of-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_reprogramming-stem-cells-to-create-retinal-sheets-a-promising-approach-to-restoring-vision.jpg https://ophthalmologybreakingnews.com/reprogramming-stem-cells-to-create-retinal-sheets 2025-02-10T10:25:23+03:00 en https://ophthalmologybreakingnews.com/reprogramming-stem-cells-to-create-retinal-sheets https://ophthalmologybreakingnews.com/files/images/blog_high-resolution-retinal-maps-advance-disease-diagnosis.jpg https://ophthalmologybreakingnews.com/high-resolution-retinal-maps-advance-disease-diagnosis 2025-02-07T15:25:44+03:00 en https://ophthalmologybreakingnews.com/high-resolution-retinal-maps-advance-disease-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_pykus-therapeutics-to-present-initial-clinical-data-on-novel-retinal-sealant-pyk-2101.jpg https://ophthalmologybreakingnews.com/pykus-therapeutics-to-present-initial-clinical-data 2025-02-07T13:27:23+03:00 en https://ophthalmologybreakingnews.com/pykus-therapeutics-to-present-initial-clinical-data https://ophthalmologybreakingnews.com/files/images/blog_lumenis-launches-optilift-to-address-lower-lid-laxity-and-impaired-blinking.jpg https://ophthalmologybreakingnews.com/lumenis-launches-optilift-to-address-lower-lid-laxity-and-impaired-blinking 2025-02-07T10:30:38+03:00 en https://ophthalmologybreakingnews.com/lumenis-launches-optilift-to-address-lower-lid-laxity-and-impaired-blinking https://ophthalmologybreakingnews.com/files/images/blog_essilorluxotticas-nuance-audio-glasses-a-vision-and-hearing-innovation-approved-by-fda.jpg https://ophthalmologybreakingnews.com/essilorluxotticas-nuance-audio-glasses-approved-by-fda 2025-02-06T15:39:02+03:00 en https://ophthalmologybreakingnews.com/essilorluxotticas-nuance-audio-glasses-approved-by-fda https://ophthalmologybreakingnews.com/files/images/blog_qlaris-bio-reports-positive-phase-2-results-for-qls-111-in-glaucoma-and-ocular-hypertension.jpg https://ophthalmologybreakingnews.com/qlaris-bio-reports-positive-phase-2-results-for-qls-111 2025-02-06T13:49:17+03:00 en https://ophthalmologybreakingnews.com/qlaris-bio-reports-positive-phase-2-results-for-qls-111 https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-reports-positive-6-month-results-for-phase-2-verona-trial-of-duravyu-in-dme.jpg https://ophthalmologybreakingnews.com/eyepoint-reports-positive-6-month-results-for-phase-2-verona-trial 2025-02-06T10:21:34+03:00 en https://ophthalmologybreakingnews.com/eyepoint-reports-positive-6-month-results-for-phase-2-verona-trial https://ophthalmologybreakingnews.com/files/images/blog_mayo-clinic-researchers-develop-3d-uveal-melanoma-models-to-advance-treatment-research.jpg https://ophthalmologybreakingnews.com/mayo-clinic-researchers-develop-3d-uveal-melanoma-models 2025-02-05T15:40:54+03:00 en https://ophthalmologybreakingnews.com/mayo-clinic-researchers-develop-3d-uveal-melanoma-models https://ophthalmologybreakingnews.com/files/images/blog_mckesson-acquires-controlling-interest-in-prism-vision-holdings.jpg https://ophthalmologybreakingnews.com/mckesson-acquires-controlling-interest-in-prism-vision-holdings 2025-02-05T13:21:39+03:00 en https://ophthalmologybreakingnews.com/mckesson-acquires-controlling-interest-in-prism-vision-holdings https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-continuous-delivery-ranibizumab-injection-susvimo-for-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/fda-approves-continuous-delivery-ranibizumab-injection-susvimo 2025-02-05T10:22:57+03:00 en https://ophthalmologybreakingnews.com/fda-approves-continuous-delivery-ranibizumab-injection-susvimo https://ophthalmologybreakingnews.com/files/images/blog_ophthalmic-complications-observed-in-patients-using-semaglutide-and-tirzepatide.jpg https://ophthalmologybreakingnews.com/ophthalmic-complications-observed-in-patients-using-semaglutide-and-tirzepatide 2025-02-04T15:31:04+03:00 en https://ophthalmologybreakingnews.com/ophthalmic-complications-observed-in-patients-using-semaglutide-and-tirzepatide https://ophthalmologybreakingnews.com/files/images/blog_virtual-screening-identifies-potential-treatments-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/virtual-screening-identifies-potential-treatments-for-retinitis-pigmentosa 2025-02-04T13:23:27+03:00 en https://ophthalmologybreakingnews.com/virtual-screening-identifies-potential-treatments-for-retinitis-pigmentosa https://ophthalmologybreakingnews.com/files/images/blog_notal-vision-publishes-positive-results-from-pivotal-study-on-ai-algorithm-in-home-based-oct-system.jpg https://ophthalmologybreakingnews.com/notal-vision-publishes-positive-results-from-pivotal-study 2025-02-04T10:20:09+03:00 en https://ophthalmologybreakingnews.com/notal-vision-publishes-positive-results-from-pivotal-study https://ophthalmologybreakingnews.com/files/images/blog_retrospective-study-reveals-geographic-atrophy-can-cause-significant-vision-loss-within-36-months.jpg https://ophthalmologybreakingnews.com/study-reveals-geographic-atrophy-can-cause-significant-vision-loss 2025-02-03T15:52:14+03:00 en https://ophthalmologybreakingnews.com/study-reveals-geographic-atrophy-can-cause-significant-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-secures-rmat-designation-for-laru-zova-gene-therapy-in-xlrp-treatment.jpg https://ophthalmologybreakingnews.com/beacon-therapeutics-secures-rmat-designation-for-laru-zova 2025-02-03T13:27:06+03:00 en https://ophthalmologybreakingnews.com/beacon-therapeutics-secures-rmat-designation-for-laru-zova https://ophthalmologybreakingnews.com/files/images/blog_iantrek-announces-first-commercial-cases-of-crex-micro-interventional-system-for-trabecular-outflow-enhancement.jpg https://ophthalmologybreakingnews.com/iantrek-announces-first-commercial-cases-of-crex 2025-02-03T10:14:21+03:00 en https://ophthalmologybreakingnews.com/iantrek-announces-first-commercial-cases-of-crex https://ophthalmologybreakingnews.com/files/images/blog_new-genetic-regions-linked-to-anterior-uveitis-identified-in-international-study.jpg https://ophthalmologybreakingnews.com/new-genetic-regions-linked-to-anterior-uveitis-identified 2025-01-31T15:24:08+03:00 en https://ophthalmologybreakingnews.com/new-genetic-regions-linked-to-anterior-uveitis-identified https://ophthalmologybreakingnews.com/files/images/blog_vyluma-announces-nmpa-acceptance-of-nvk002-for-pediatric-myopia-in-china.jpg https://ophthalmologybreakingnews.com/vyluma-announces-nmpa-acceptance-of-nvk002 2025-01-31T13:25:35+03:00 en https://ophthalmologybreakingnews.com/vyluma-announces-nmpa-acceptance-of-nvk002 https://ophthalmologybreakingnews.com/files/images/blog_ai-optics-sentinel-camera-receives-fda-510k-clearance-for-portable-retinal-imaging.jpg https://ophthalmologybreakingnews.com/ai-optics-sentinel-camera-receives-fda-510k-clearance 2025-01-31T10:21:20+03:00 en https://ophthalmologybreakingnews.com/ai-optics-sentinel-camera-receives-fda-510k-clearance https://ophthalmologybreakingnews.com/files/images/blog_ema-endorses-macustars-research-on-early-amd-clinical-trials.jpg https://ophthalmologybreakingnews.com/ema-endorses-macustars-research-on-early-amd-clinical-trials 2025-01-30T15:21:19+03:00 en https://ophthalmologybreakingnews.com/ema-endorses-macustars-research-on-early-amd-clinical-trials https://ophthalmologybreakingnews.com/files/images/blog_harrow-launches.jpg https://ophthalmologybreakingnews.com/harrow-launches-harrow-cares-program-with-cencora 2025-01-30T13:34:31+03:00 en https://ophthalmologybreakingnews.com/harrow-launches-harrow-cares-program-with-cencora https://ophthalmologybreakingnews.com/files/images/blog_seabelife-reports-promising-in-vivo-results-for-sbl03-ophthalmic-gel-in-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/seabelife-reports-promising-in-vivo-results-for-sbl03-ophthalmic-gel 2025-01-30T10:23:08+03:00 en https://ophthalmologybreakingnews.com/seabelife-reports-promising-in-vivo-results-for-sbl03-ophthalmic-gel https://ophthalmologybreakingnews.com/files/images/blog_new-research-links-retinal-imaging-and-deep-learning-to-improved-schizophrenia-detection.jpg https://ophthalmologybreakingnews.com/research-links-retinal-imaging-to-improved-schizophrenia-detection 2025-01-29T15:33:21+03:00 en https://ophthalmologybreakingnews.com/research-links-retinal-imaging-to-improved-schizophrenia-detection https://ophthalmologybreakingnews.com/files/images/blog_viralgen-and-axovia-therapeutics-partner-to-develop-gene-therapy-for-bardet-biedl-syndrome.jpg https://ophthalmologybreakingnews.com/viralgen-and-axovia-therapeutics-partner-to-develop-gene-therapy 2025-01-29T13:26:40+03:00 en https://ophthalmologybreakingnews.com/viralgen-and-axovia-therapeutics-partner-to-develop-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_apellis-pharmaceuticals-secures-australian-approval-for-syfovre-pegcetacoplan-in-geographic-atrophy-treatment.jpg https://ophthalmologybreakingnews.com/apellis-pharmaceuticals-secures-australian-approval-for-syfovre 2025-01-29T09:48:32+03:00 en https://ophthalmologybreakingnews.com/apellis-pharmaceuticals-secures-australian-approval-for-syfovre https://ophthalmologybreakingnews.com/files/images/blog_precision-gene-editing-offers-hope-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/precision-gene-editing-offers-hope-for-stargardt-disease 2025-01-28T13:32:59+03:00 en https://ophthalmologybreakingnews.com/precision-gene-editing-offers-hope-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_norlase-secures-fda-510k-clearance-and-ce-mark-for-lynx-pattern-scanning-laser-indirect-ophthalmoscope.jpg https://ophthalmologybreakingnews.com/norlase-secures-fda-510k-clearance-and-ce-mark-for-lynx 2025-01-28T10:23:53+03:00 en https://ophthalmologybreakingnews.com/norlase-secures-fda-510k-clearance-and-ce-mark-for-lynx https://ophthalmologybreakingnews.com/files/images/blog_neureye-research-team-leads-ai-innovation-in-detecting-dementia-via-retinal-imaging.jpg https://ophthalmologybreakingnews.com/neureye-research-team-leads-ai-innovation 2025-01-27T15:46:53+03:00 en https://ophthalmologybreakingnews.com/neureye-research-team-leads-ai-innovation https://ophthalmologybreakingnews.com/files/images/blog_merit-acquires-osod-to-strengthen-early-stage-ophthalmic-drug-development.jpg https://ophthalmologybreakingnews.com/merit-acquires-osod-to-strengthen-early-stage-ophthalmic-drug-development 2025-01-27T13:41:31+03:00 en https://ophthalmologybreakingnews.com/merit-acquires-osod-to-strengthen-early-stage-ophthalmic-drug-development https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-presents-results-from-norse-eight-trial-evaluating-ons-5010-for-the-treatment-of-wet-amd.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-presents-results-from-norse-eight-trial 2025-01-27T10:29:03+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-presents-results-from-norse-eight-trial https://ophthalmologybreakingnews.com/files/images/blog_semaglutide-use-linked-to-increased-risk-of-nonarteritic-anterior-ischemic-optic-neuropathy.jpg https://ophthalmologybreakingnews.com/semaglutide-use-linked-to-increased-risk-of-naion 2025-01-24T15:21:30+03:00 en https://ophthalmologybreakingnews.com/semaglutide-use-linked-to-increased-risk-of-naion https://ophthalmologybreakingnews.com/files/images/blog_study-highlights-risks-of-home-temperature-fluctuations-on-anti-vegf-drug-safety.jpg https://ophthalmologybreakingnews.com/study-highlights-risks-of-home-temperature-fluctuations-on-anti-vegf-drug-safety 2025-01-24T13:27:50+03:00 en https://ophthalmologybreakingnews.com/study-highlights-risks-of-home-temperature-fluctuations-on-anti-vegf-drug-safety https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedical-and-arctic-vision-secure-approvals-for-suprachoroidal-treatment-in-australia-and-singapore.jpg https://ophthalmologybreakingnews.com/arctic-vision-secures-approval-for-suprachoroidal-treatment 2025-01-24T10:35:54+03:00 en https://ophthalmologybreakingnews.com/arctic-vision-secures-approval-for-suprachoroidal-treatment https://ophthalmologybreakingnews.com/files/images/blog_ziapin2-restores-retinal-function-in-preclinical-models-of-retinitis-pigmentosa-and-macular-degeneration.jpg https://ophthalmologybreakingnews.com/ziapin2-restores-retinal-function-in-preclinical-models-of-rp-and-amd 2025-01-23T15:47:44+03:00 en https://ophthalmologybreakingnews.com/ziapin2-restores-retinal-function-in-preclinical-models-of-rp-and-amd https://ophthalmologybreakingnews.com/files/images/blog_stuart-therapeutics-completes-phase-3-trial-of-vezocolmitide-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/stuart-therapeutics-completes-phase-3-trial-of-vezocolmitide 2025-01-23T13:24:52+03:00 en https://ophthalmologybreakingnews.com/stuart-therapeutics-completes-phase-3-trial-of-vezocolmitide https://ophthalmologybreakingnews.com/files/images/blog_pantheon-vision-advances-development-of-bioengineered-corneal-implants.jpg https://ophthalmologybreakingnews.com/pantheon-vision-advances-development-of-bioengineered-corneal-implants 2025-01-23T10:19:25+03:00 en https://ophthalmologybreakingnews.com/pantheon-vision-advances-development-of-bioengineered-corneal-implants https://ophthalmologybreakingnews.com/files/images/blog_follow-up-study-confirms-lasting-benefits-of-bifocal-contact-lenses-for-myopia-in-kids.jpg https://ophthalmologybreakingnews.com/study-confirms-lasting-benefits-of-bifocal-contact-lenses 2025-01-22T15:39:12+03:00 en https://ophthalmologybreakingnews.com/study-confirms-lasting-benefits-of-bifocal-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_both-high-and-low-hdl-levels-linked-to-age-related-macular-degeneration-risk.jpg https://ophthalmologybreakingnews.com/both-high-and-low-hdl-levels-linked-to-amd-risk 2025-01-22T13:30:42+03:00 en https://ophthalmologybreakingnews.com/both-high-and-low-hdl-levels-linked-to-amd-risk https://ophthalmologybreakingnews.com/files/images/blog_nacuity-pharmaceuticals-receives-fda-fast-track-designation-for-npi-001-tablets-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/nacuity-pharmaceuticals-receives-fda-fast-track-designation-for-npi-001 2025-01-22T10:20:05+03:00 en https://ophthalmologybreakingnews.com/nacuity-pharmaceuticals-receives-fda-fast-track-designation-for-npi-001 https://ophthalmologybreakingnews.com/files/images/blog_helpmesee-expands-simulation-based-cataract-surgery-training-with-new-partnerships.jpg https://ophthalmologybreakingnews.com/helpmesee-expands-simulation-based-cataract-surgery-training 2025-01-21T15:30:08+03:00 en https://ophthalmologybreakingnews.com/helpmesee-expands-simulation-based-cataract-surgery-training https://ophthalmologybreakingnews.com/files/images/blog_glaukos-announces-positive-clinical-updates-for-idose-platform.jpg https://ophthalmologybreakingnews.com/glaukos-announces-positive-clinical-updates-for-idose-platform 2025-01-21T13:19:24+03:00 en https://ophthalmologybreakingnews.com/glaukos-announces-positive-clinical-updates-for-idose-platform https://ophthalmologybreakingnews.com/files/images/blog_formycon-receives-eu-approval-for-eylea-biosimilar-fyb203-under-the-brand-names-ahzantive-and-baiama.jpg https://ophthalmologybreakingnews.com/formycon-receives-eu-approval-for-fyb203 2025-01-21T10:21:51+03:00 en https://ophthalmologybreakingnews.com/formycon-receives-eu-approval-for-fyb203 https://ophthalmologybreakingnews.com/files/images/blog_rhygaze-secures-86-million-series-a-financing-to-advance-gene-therapy-for-vision-restoration.jpg https://ophthalmologybreakingnews.com/rhygaze-secures-86-million-series-a-financing 2025-01-20T15:19:54+03:00 en https://ophthalmologybreakingnews.com/rhygaze-secures-86-million-series-a-financing https://ophthalmologybreakingnews.com/files/images/blog_inflammx-therapeutics-enters-option-agreement-with-bausch-lomb.jpg https://ophthalmologybreakingnews.com/inflammx-therapeutics-enters-option-agreement-with-bausch-lomb 2025-01-20T13:33:14+03:00 en https://ophthalmologybreakingnews.com/inflammx-therapeutics-enters-option-agreement-with-bausch-lomb https://ophthalmologybreakingnews.com/files/images/blog_ocugen-doses-first-patient-in-phase-1-trial-of-ocu200-for-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/ocugen-doses-first-patient-in-phase-1-trial-of-ocu200 2025-01-20T10:26:37+03:00 en https://ophthalmologybreakingnews.com/ocugen-doses-first-patient-in-phase-1-trial-of-ocu200 https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-completes-12-week-analysis-of-norse-eight-trial-for-ons-5010-in-wet-amd.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-completes-12-week-analysis-of-norse-eight-trial 2025-01-17T15:28:55+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-completes-12-week-analysis-of-norse-eight-trial https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-receives-historic-97-million-legacy-donation.jpg https://ophthalmologybreakingnews.com/prevent-blindness-receives-historic-97-million-legacy-donation 2025-01-17T13:21:22+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-receives-historic-97-million-legacy-donation https://ophthalmologybreakingnews.com/files/images/blog_inflammasome-therapeutics-reports-promising-results-from-k8-implant-trial-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/inflammasome-therapeutics-reports-promising-results-from-k8-implant-trial 2025-01-17T10:20:06+03:00 en https://ophthalmologybreakingnews.com/inflammasome-therapeutics-reports-promising-results-from-k8-implant-trial https://ophthalmologybreakingnews.com/files/images/blog_4dmt-announces-positive-interim-results-from-spectra-clinical-trial-for-4d-150-in-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/4dmt-announces-positive-interim-results-from-spectra-clinical-trial-for-4d-150 2025-01-16T15:22:44+03:00 en https://ophthalmologybreakingnews.com/4dmt-announces-positive-interim-results-from-spectra-clinical-trial-for-4d-150 https://ophthalmologybreakingnews.com/files/images/blog_ocugen-reports-positive-2-year-results-for-ocu400-gene-therapy-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/ocugen-reports-positive-2-year-results-for-ocu400 2025-01-16T13:27:00+03:00 en https://ophthalmologybreakingnews.com/ocugen-reports-positive-2-year-results-for-ocu400 https://ophthalmologybreakingnews.com/files/images/blog_abbvie-and-regenxbio-share-updates-on-abbv-rgx-314-gene-therapy-for-wet-amd-and-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/abbvie-and-regenxbio-share-updates-on-abbv-rgx-314 2025-01-16T10:24:51+03:00 en https://ophthalmologybreakingnews.com/abbvie-and-regenxbio-share-updates-on-abbv-rgx-314 https://ophthalmologybreakingnews.com/files/images/blog_pulsesight-therapeutics-advances-pst-611-for-dry-amd-ga-with-phase-1-clinical-plan.jpg https://ophthalmologybreakingnews.com/pulsesight-therapeutics-advances-pst-611 2025-01-15T15:17:55+03:00 en https://ophthalmologybreakingnews.com/pulsesight-therapeutics-advances-pst-611 https://ophthalmologybreakingnews.com/files/images/blog_sling-therapeutics-announces-positive-results-from-phase-2b-3-lids-trial-of-linsitinib-for-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/sling-therapeutics-announces-positive-results 2025-01-15T13:25:40+03:00 en https://ophthalmologybreakingnews.com/sling-therapeutics-announces-positive-results https://ophthalmologybreakingnews.com/files/images/blog_samsara-vision-announces-positive-6-month-outcomes-of-sing-imt-surgery.jpg https://ophthalmologybreakingnews.com/samsara-announces-positive-6-month-outcomes-of-sing-imt-surgery 2025-01-15T10:16:20+03:00 en https://ophthalmologybreakingnews.com/samsara-announces-positive-6-month-outcomes-of-sing-imt-surgery https://ophthalmologybreakingnews.com/files/images/blog_formycon-partners-with-teva-and-klinge-biopharma-for-commercialization-of-aflibercept-biosimilar-fyb203-ahzantive.jpg https://ophthalmologybreakingnews.com/formycon-partners-with-teva-and-klinge-biopharma 2025-01-14T15:19:23+03:00 en https://ophthalmologybreakingnews.com/formycon-partners-with-teva-and-klinge-biopharma https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-zeiss-mel-90-excimer-laser-for-refractive-surgery.jpg https://ophthalmologybreakingnews.com/fda-approves-zeiss-mel-90-excimer 2025-01-31T14:48:15+03:00 en https://ophthalmologybreakingnews.com/fda-approves-zeiss-mel-90-excimer https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-acquires-whitecap-biosciences.jpg https://ophthalmologybreakingnews.com/bausch-lomb-acquires-whitecap-biosciences 2025-01-14T13:24:27+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-acquires-whitecap-biosciences https://ophthalmologybreakingnews.com/files/images/blog_acelyrin-unveils-phase-3-program-design-for-lonigutamab-in-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/acelyrin-unveils-phase-3-program-design-for-lonigutamab 2025-01-13T15:21:18+03:00 en https://ophthalmologybreakingnews.com/acelyrin-unveils-phase-3-program-design-for-lonigutamab https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-publishes-36-month-analysis-of-omni-surgical-system-for-primary-open-angle-glaucoma.jpg https://ophthalmologybreakingnews.com/sight-sciences-publishes-36-month-analysis-of-omni 2025-01-13T13:29:50+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-publishes-36-month-analysis-of-omni https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-revised-supplemental-new-drug-application-for-izervay.jpg https://ophthalmologybreakingnews.com/fda-accepts-revised-supplemental-new-drug-application-for-izervay 2025-01-13T11:17:13+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-revised-supplemental-new-drug-application-for-izervay https://ophthalmologybreakingnews.com/files/images/blog_alkeus-pharmaceuticals-reports-positive-interim-results-for-tease-3-study-of-gildeuretinol-in-stargardt-disease.jpg https://ophthalmologybreakingnews.com/alkeus-reports-positive-interim-results-for-tease-3-study-of-gildeuretinol 2025-01-10T15:26:14+03:00 en https://ophthalmologybreakingnews.com/alkeus-reports-positive-interim-results-for-tease-3-study-of-gildeuretinol https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-epithelial-thickness-module-for-heidelberg-engineerings-anterion-imaging-platform.jpg https://ophthalmologybreakingnews.com/fda-clears-epithelial-thickness-module-for-heidelberg 2025-01-10T13:25:43+03:00 en https://ophthalmologybreakingnews.com/fda-clears-epithelial-thickness-module-for-heidelberg https://ophthalmologybreakingnews.com/files/images/blog_tenpoint-therapeutics-reports-positive-phase-3-data-for-brimochol-pf-in-presbyopia-treatment.jpg https://ophthalmologybreakingnews.com/tenpoint-reports-positive-phase-3-data-for-brimochol-pf 2025-01-10T10:17:14+03:00 en https://ophthalmologybreakingnews.com/tenpoint-reports-positive-phase-3-data-for-brimochol-pf https://ophthalmologybreakingnews.com/files/images/blog_vigeneron-achieves-key-milestones-for-vg901-gene-therapy-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/vigeneron-achieves-key-milestones-for-vg901-gene-therapy 2025-01-09T15:23:21+03:00 en https://ophthalmologybreakingnews.com/vigeneron-achieves-key-milestones-for-vg901-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_aviceda-therapeutics-secures-2075-million-to-advance-avd-104-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/aviceda-secures-2075-million-to-advance-avd-104 2025-01-09T13:27:16+03:00 en https://ophthalmologybreakingnews.com/aviceda-secures-2075-million-to-advance-avd-104 https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-advances-lighthouse-study-for-gene-therapy-atsn-201-in-x-linked-retinoschisis.jpg https://ophthalmologybreakingnews.com/atsena-advances-lighthouse-study-for-gene-therapy-atsn-201 2025-01-09T10:15:58+03:00 en https://ophthalmologybreakingnews.com/atsena-advances-lighthouse-study-for-gene-therapy-atsn-201 https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-and-glaucoma-research-foundation-launch-second-annual-faces-of-glaucoma-campaign.jpg https://ophthalmologybreakingnews.com/bausch-lomb-and-glaucoma-research-foundation-launch-second-campaign 2025-01-08T15:24:04+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-and-glaucoma-research-foundation-launch-second-campaign https://ophthalmologybreakingnews.com/files/images/blog_microdrops-show-potential-for-safer-retinopathy-of-prematurity-screening-in-preterm-infants.jpg https://ophthalmologybreakingnews.com/microdrops-show-potential-for-safer-rop-screening 2025-01-08T13:22:59+03:00 en https://ophthalmologybreakingnews.com/microdrops-show-potential-for-safer-rop-screening https://ophthalmologybreakingnews.com/files/images/blog_canyon-labs-acquires-iuvo-biosciences-lab-services-and-consulting-divisions.jpg https://ophthalmologybreakingnews.com/canyon-labs-acquires-iuvo-biosciences-lab-services 2025-01-08T10:24:11+03:00 en https://ophthalmologybreakingnews.com/canyon-labs-acquires-iuvo-biosciences-lab-services https://ophthalmologybreakingnews.com/files/images/blog_oct-octa-findings-reveal-neuroretinal-alterations-in-fibromyalgia-patients.jpg https://ophthalmologybreakingnews.com/oct-octa-findings-reveal-neuroretinal-alterations-in-fibromyalgia-patients 2025-01-07T15:23:38+03:00 en https://ophthalmologybreakingnews.com/oct-octa-findings-reveal-neuroretinal-alterations-in-fibromyalgia-patients https://ophthalmologybreakingnews.com/files/images/blog_lumibird-medical-rebrands-its-japanese-subsidiary.jpg https://ophthalmologybreakingnews.com/lumibird-medical-rebrands-its-japanese-subsidiary 2025-01-07T13:23:49+03:00 en https://ophthalmologybreakingnews.com/lumibird-medical-rebrands-its-japanese-subsidiary https://ophthalmologybreakingnews.com/files/images/blog_oculis-announces-positive-phase-2-results-for-ocs-05-in-acute-optic-neuritis.jpg https://ophthalmologybreakingnews.com/oculis-announces-positive-phase-2-results-for-ocs-05 2025-01-07T10:18:39+03:00 en https://ophthalmologybreakingnews.com/oculis-announces-positive-phase-2-results-for-ocs-05 https://ophthalmologybreakingnews.com/files/images/blog_cencora-completes-acquisition-of-retina-consultants-of-america.jpg https://ophthalmologybreakingnews.com/cencora-completes-acquisition-of-rca 2025-01-06T15:30:50+03:00 en https://ophthalmologybreakingnews.com/cencora-completes-acquisition-of-rca https://ophthalmologybreakingnews.com/files/images/blog_ocugen-advances-phase-2-of-ocu410-armada-clinical-trial.jpg https://ophthalmologybreakingnews.com/ocugen-advances-phase-2-of-ocu410 2025-01-06T13:17:06+03:00 en https://ophthalmologybreakingnews.com/ocugen-advances-phase-2-of-ocu410 https://ophthalmologybreakingnews.com/files/images/blog_regeneron-acquires-uk-based-biotech-oxular.jpg https://ophthalmologybreakingnews.com/regeneron-acquires-uk-based-biotech-oxular 2025-01-06T10:21:09+03:00 en https://ophthalmologybreakingnews.com/regeneron-acquires-uk-based-biotech-oxular https://ophthalmologybreakingnews.com/files/images/blog_valo-health-suspends-development-of-opl-0401-for-diabetic-retinopathy-after-phase-2-study.jpg https://ophthalmologybreakingnews.com/valo-suspends-opl-0401-for-diabetic-retinopathy 2025-02-04T14:56:07+03:00 en https://ophthalmologybreakingnews.com/valo-suspends-opl-0401-for-diabetic-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_ai-driven-discovery-uncovers-potential-treatment-for-acute-glaucoma.jpg https://ophthalmologybreakingnews.com/ai-identifies-potential-treatment-for-acute-glaucoma 2025-01-03T13:50:13+03:00 en https://ophthalmologybreakingnews.com/ai-identifies-potential-treatment-for-acute-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_study-links-lower-socioeconomic-status-to-increased-risk-of-open-globe-injury-and-poorer-outcomes.jpg https://ophthalmologybreakingnews.com/study-links-lower-socioeconomic-status-to-increased-risk-of-ogi 2025-02-04T10:52:29+03:00 en https://ophthalmologybreakingnews.com/study-links-lower-socioeconomic-status-to-increased-risk-of-ogi https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-offers-free-glaucoma-resources-for-patients-care-partners-and-professionals.jpg https://ophthalmologybreakingnews.com/prevent-blindness-offers-free-glaucoma-resources 2025-01-02T10:21:53+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-offers-free-glaucoma-resources https://ophthalmologybreakingnews.com/files/images/blog_sustained-visual-improvements-in-lhon-patients-treated-with-aav-gene-therapy.jpg https://ophthalmologybreakingnews.com/sustained-visual-improvements-in-lhon-patients 2025-02-04T15:10:16+03:00 en https://ophthalmologybreakingnews.com/sustained-visual-improvements-in-lhon-patients https://ophthalmologybreakingnews.com/files/images/blog_cyclodialysis-procedure-with-scleral-reinforcement-effectively-lowers-iop-in-open-angle-glaucoma.jpg https://ophthalmologybreakingnews.com/cyclodialysis-lowers-iop-in-glaucoma-patients 2025-02-04T10:51:40+03:00 en https://ophthalmologybreakingnews.com/cyclodialysis-lowers-iop-in-glaucoma-patients https://ophthalmologybreakingnews.com/files/images/blog_alcon-recalls-systane-ultra-pf-lot-over-potential-fungal-contamination.jpg https://ophthalmologybreakingnews.com/alcon-recalls-systane-ultra-pf-lot 2024-12-30T13:49:26+03:00 en https://ophthalmologybreakingnews.com/alcon-recalls-systane-ultra-pf-lot https://ophthalmologybreakingnews.com/files/images/blog_brolucizumab-shows-promise-over-aflibercept-for-diabetic-macular-edema-insights-from-a-meta-analysis.jpg https://ophthalmologybreakingnews.com/brolucizumab-shows-promise-over-aflibercept-for-dme 2025-02-04T10:40:12+03:00 en https://ophthalmologybreakingnews.com/brolucizumab-shows-promise-over-aflibercept-for-dme https://ophthalmologybreakingnews.com/files/images/blog_diabetes-does-not-significantly-affect-outcomes-of-epiretinal-membrane-surgery.jpg https://ophthalmologybreakingnews.com/diabetes-does-not-significantly-affect-outcomes-of-epiretinal-membrane-surgery 2025-02-04T15:00:24+03:00 en https://ophthalmologybreakingnews.com/diabetes-does-not-significantly-affect-outcomes-of-epiretinal-membrane-surgery https://ophthalmologybreakingnews.com/files/images/blog_visual-resistance-training-enhances-reaction-times-in-athletes.jpg https://ophthalmologybreakingnews.com/visual-resistance-training-enhances-reaction-times-in-athletes 2024-12-27T13:51:55+03:00 en https://ophthalmologybreakingnews.com/visual-resistance-training-enhances-reaction-times-in-athletes https://ophthalmologybreakingnews.com/files/images/blog_study-highlights-growing-treatment-burden-of-retinal-diseases-in-finland.jpg https://ophthalmologybreakingnews.com/growing-treatment-burden-of-retinal-diseases-in-finland 2025-02-04T15:05:29+03:00 en https://ophthalmologybreakingnews.com/growing-treatment-burden-of-retinal-diseases-in-finland https://ophthalmologybreakingnews.com/files/images/blog_mental-health-and-awareness-barriers-hinder-diabetic-eye-screenings.jpg https://ophthalmologybreakingnews.com/mental-health-and-awareness-barriers-hinder-diabetic-eye-screenings 2024-12-26T10:11:09+03:00 en https://ophthalmologybreakingnews.com/mental-health-and-awareness-barriers-hinder-diabetic-eye-screenings https://ophthalmologybreakingnews.com/files/images/blog_long-term-efficacy-of-micropulse-tlt-validated-for-glaucoma-management.jpg https://ophthalmologybreakingnews.com/long-term-efficacy-of-micropulse-tlt-validated 2024-12-25T13:52:28+03:00 en https://ophthalmologybreakingnews.com/long-term-efficacy-of-micropulse-tlt-validated https://ophthalmologybreakingnews.com/files/images/blog_peptide-based-eye-drops-offer-new-hope-for-treating-dry-amd.jpg https://ophthalmologybreakingnews.com/peptide-based-eye-drops-offer-new-hope-for-treating-dry-amd 2024-12-27T10:10:47+03:00 en https://ophthalmologybreakingnews.com/peptide-based-eye-drops-offer-new-hope-for-treating-dry-amd https://ophthalmologybreakingnews.com/files/images/blog_galimedix-therapeutics-initiates-phase-2-study-of-gal-101-eye-drops-for-dry-amd.jpg https://ophthalmologybreakingnews.com/galimedix-initiates-phase-2-study-of-gal-101 2024-12-24T15:14:24+03:00 en https://ophthalmologybreakingnews.com/galimedix-initiates-phase-2-study-of-gal-101 https://ophthalmologybreakingnews.com/files/images/blog_glaukos-submits-nda-for-epioxa-a-next-generation-corneal-cross-linking-therapy.jpg https://ophthalmologybreakingnews.com/glaukos-submits-nda-for-epioxa 2024-12-24T13:12:12+03:00 en https://ophthalmologybreakingnews.com/glaukos-submits-nda-for-epioxa https://ophthalmologybreakingnews.com/files/images/blog_national-eye-institute-study-highlights-new-role-of-annexin-v-biomarker-in-retinal-cell-degeneration.jpg https://ophthalmologybreakingnews.com/nei-study-highlights-new-role-of-annexin-v-biomarker 2024-12-24T10:21:44+03:00 en https://ophthalmologybreakingnews.com/nei-study-highlights-new-role-of-annexin-v-biomarker https://ophthalmologybreakingnews.com/files/images/blog_2024-recap-top-8-groundbreaking-innovations-in-eye-disease-therapies-and-technologies.jpg https://ophthalmologybreakingnews.com/2024-recap-top-8-groundbreaking-innovations 2025-03-14T15:39:32+03:00 en https://ophthalmologybreakingnews.com/2024-recap-top-8-groundbreaking-innovations https://ophthalmologybreakingnews.com/files/images/blog_4dmt-publishes-preclinical-data-highlighting-the-potential-of-the-therapeutic-vector-evolution-tve-platform.jpg https://ophthalmologybreakingnews.com/4dmt-publishes-preclinical-data-of-tve-platform 2024-12-23T10:21:17+03:00 en https://ophthalmologybreakingnews.com/4dmt-publishes-preclinical-data-of-tve-platform https://ophthalmologybreakingnews.com/files/images/blog_sepul-bio-doses-first-patient-in-phase-2b-trial-of-ultevursen-for-ush2a-associated-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/sepul-bio-doses-first-patient-in-phase-2b-trial-of-ultevursen-for-ush2a 2024-12-20T13:31:15+03:00 en https://ophthalmologybreakingnews.com/sepul-bio-doses-first-patient-in-phase-2b-trial-of-ultevursen-for-ush2a https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-receives-fda-spa-agreement-for-phase-3-trial-of-apx3330-in-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/opus-genetics-receives-fda-spa-agreement 2024-12-20T10:17:16+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-receives-fda-spa-agreement https://ophthalmologybreakingnews.com/files/images/blog_regenerons-aflibercept-8mg-injection-meets-primary-endpoint-in-phase-3-quasar-trial-for-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/regenerons-aflibercept-8mg-injection-meets-primary-endpoint-in-phase-3 2024-12-19T15:17:21+03:00 en https://ophthalmologybreakingnews.com/regenerons-aflibercept-8mg-injection-meets-primary-endpoint-in-phase-3 https://ophthalmologybreakingnews.com/files/images/blog_aurion-biotech-announces-positive-phase-1-2-results-for-aurn001-in-corneal-edema-treatment.jpg https://ophthalmologybreakingnews.com/aurion-announces-positive-phase-1-2-results-for-aurn001 2024-12-19T13:40:50+03:00 en https://ophthalmologybreakingnews.com/aurion-announces-positive-phase-1-2-results-for-aurn001 https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-vigenerons-ind-for-vg801-gene-therapy-to-treat-stargardt-disease-and-abca4-linked-retinal-dystrophies.jpg https://ophthalmologybreakingnews.com/fda-clears-vigenerons-ind-for-vg801-gene-therapy 2024-12-19T10:21:05+03:00 en https://ophthalmologybreakingnews.com/fda-clears-vigenerons-ind-for-vg801-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_viridian-announces-positive-topline-results-from-phase-3-veligrotug-trial-for-chronic-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/viridian-announces-positive-topline-results-from-phase-3-veligrotug-trial 2024-12-18T15:21:10+03:00 en https://ophthalmologybreakingnews.com/viridian-announces-positive-topline-results-from-phase-3-veligrotug-trial https://ophthalmologybreakingnews.com/files/images/blog_ema-chmp-issues-positive-opinion-for-aflibercept-biosimilar-from-celltrion.jpg https://ophthalmologybreakingnews.com/ema-chmp-issues-positive-opinion-for-aflibercept-biosimilar 2024-12-18T13:32:19+03:00 en https://ophthalmologybreakingnews.com/ema-chmp-issues-positive-opinion-for-aflibercept-biosimilar https://ophthalmologybreakingnews.com/files/images/blog_eyedna-therapeutics-receives-fda-rare-pediatric-disease-designation-for-hora-pde6b.jpg https://ophthalmologybreakingnews.com/eyedna-therapeutics-receives-fda-rare-pediatric-disease-designation-for-hora-pde6b 2024-12-18T10:30:27+03:00 en https://ophthalmologybreakingnews.com/eyedna-therapeutics-receives-fda-rare-pediatric-disease-designation-for-hora-pde6b https://ophthalmologybreakingnews.com/files/images/blog_researchers-awarded-27-million-nih-grant-to-study-retinal-connections-in-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/researchers-awarded-27-million-nih-grant 2024-12-17T15:32:05+03:00 en https://ophthalmologybreakingnews.com/researchers-awarded-27-million-nih-grant https://ophthalmologybreakingnews.com/files/images/blog_vabysmo-prefilled-syringe-approved-in-the-eu-for-retinal-conditions.jpg https://ophthalmologybreakingnews.com/vabysmo-prefilled-syringe-approved-in-the-eu 2024-12-17T13:32:51+03:00 en https://ophthalmologybreakingnews.com/vabysmo-prefilled-syringe-approved-in-the-eu https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-completes-part-a-dosing-in-phase-i-ii-clinical-trial-of-atsn-201-for-x-linked-retinoschisis.jpg https://ophthalmologybreakingnews.com/atsena-completes-part-a-dosing-in-phase-i-ii-clinical-trial 2024-12-17T10:35:59+03:00 en https://ophthalmologybreakingnews.com/atsena-completes-part-a-dosing-in-phase-i-ii-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_phenocell-and-amarna-therapeutics-secure-eurostars-grant-for-dry-amd-gene-therapy-platform.jpg https://ophthalmologybreakingnews.com/phenocell-and-amarna-secure-eurostars-grant 2024-12-16T15:25:30+03:00 en https://ophthalmologybreakingnews.com/phenocell-and-amarna-secure-eurostars-grant https://ophthalmologybreakingnews.com/files/images/blog_acelyrin-announces-phase-2b-3-trial-of-izokibep-did-not-meet-primary-endpoint.jpg https://ophthalmologybreakingnews.com/phase-2b-3-trial-of-izokibep-did-not-meet-primary-endpoint 2024-12-16T13:33:41+03:00 en https://ophthalmologybreakingnews.com/phase-2b-3-trial-of-izokibep-did-not-meet-primary-endpoint https://ophthalmologybreakingnews.com/files/images/blog_2024-recap-top-8-fda-approvals-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/2024-recap-top-8-fda-approvals-in-ophthalmology 2025-01-10T13:31:01+03:00 en https://ophthalmologybreakingnews.com/2024-recap-top-8-fda-approvals-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_tenpoint-therapeutics-and-visus-therapeutics-merge-strengthening-ophthalmic-therapeutics-pipeline.jpg https://ophthalmologybreakingnews.com/tenpoint-visus-merge-strengthening-ophthalmic-therapeutics-pipeline 2024-12-13T13:22:14+03:00 en https://ophthalmologybreakingnews.com/tenpoint-visus-merge-strengthening-ophthalmic-therapeutics-pipeline https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-gmbh-appoints-christian-bach-as-managing-director.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-appoints-christian-bach 2024-12-13T11:35:39+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-appoints-christian-bach https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-sb-007-gene-therapy-ind-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/fda-clears-sb-007-for-stargardt-disease 2024-12-18T09:39:15+03:00 en https://ophthalmologybreakingnews.com/fda-clears-sb-007-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_visirose-introduces-investigational-non-invasive-therapy-for-infectious-keratitis.jpg https://ophthalmologybreakingnews.com/visirose-introduces-investigational-non-invasive-therapy 2024-12-12T15:35:37+03:00 en https://ophthalmologybreakingnews.com/visirose-introduces-investigational-non-invasive-therapy https://ophthalmologybreakingnews.com/files/images/blog_study-fluoxetine-enhances-visual-acuity-in-adults-with-amblyopia.jpg https://ophthalmologybreakingnews.com/fluoxetine-enhances-va-in-adults-with-amblyopia 2024-12-12T13:29:28+03:00 en https://ophthalmologybreakingnews.com/fluoxetine-enhances-va-in-adults-with-amblyopia https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-acquires-elios-system-expanding-glaucoma-treatment-options.jpg https://ophthalmologybreakingnews.com/bausch-lomb-acquires-elios-system 2025-01-23T08:30:40+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-acquires-elios-system https://ophthalmologybreakingnews.com/files/images/blog_nona-biosciences-and-kodiak-sciences-collaborate-to-develop-novel-antibodies-for-ophthalmic-diseases.jpg https://ophthalmologybreakingnews.com/nona-kodiak-collaborate-to-develop-novel-antibodies-for-ophthalmic-diseases 2024-12-11T13:27:15+03:00 en https://ophthalmologybreakingnews.com/nona-kodiak-collaborate-to-develop-novel-antibodies-for-ophthalmic-diseases https://ophthalmologybreakingnews.com/files/images/blog_vialase-and-moran-eye-center-partner-to-advance-glaucoma-research-and-innovation.jpg https://ophthalmologybreakingnews.com/vialase-moran-eye-center-partner-to-advance-glaucoma-research 2024-12-11T10:20:51+03:00 en https://ophthalmologybreakingnews.com/vialase-moran-eye-center-partner-to-advance-glaucoma-research https://ophthalmologybreakingnews.com/files/images/blog_empagliflozin-linked-to-reduced-progression-of-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/empagliflozin-linked-to-reduced-progression-of-dr 2025-02-04T15:07:48+03:00 en https://ophthalmologybreakingnews.com/empagliflozin-linked-to-reduced-progression-of-dr https://ophthalmologybreakingnews.com/files/images/blog_nonsteroidal-immunomodulator-vvn461-meets-endpoints-in-post-cataract-surgery-inflammation-trial.jpg https://ophthalmologybreakingnews.com/vvn461-meets-endpoints-in-post-cataract-surgery-inflammation-trial 2025-02-04T15:03:50+03:00 en https://ophthalmologybreakingnews.com/vvn461-meets-endpoints-in-post-cataract-surgery-inflammation-trial https://ophthalmologybreakingnews.com/files/images/blog_uc-irvine-scientists-identify-dna-damage-as-a-key-factor-in-amd.jpg https://ophthalmologybreakingnews.com/uc-irvine-scientists-identify-dna-damage-as-a-key-factor-in-amd 2024-12-09T15:36:56+03:00 en https://ophthalmologybreakingnews.com/uc-irvine-scientists-identify-dna-damage-as-a-key-factor-in-amd https://ophthalmologybreakingnews.com/files/images/blog_2024-recap-top-10-breakthroughs-in-ophthalmology-research.jpg https://ophthalmologybreakingnews.com/2024-recap-top-10-breakthroughs-in-ophthalmology-research 2025-01-10T13:31:17+03:00 en https://ophthalmologybreakingnews.com/2024-recap-top-10-breakthroughs-in-ophthalmology-research https://ophthalmologybreakingnews.com/files/images/blog_onesight-essilorluxottica-foundation-partners-with-who-on-specs-2030-initiative.jpg https://ophthalmologybreakingnews.com/onesight-essilorluxottica-foundation-partners-with-who 2024-12-09T10:10:51+03:00 en https://ophthalmologybreakingnews.com/onesight-essilorluxottica-foundation-partners-with-who https://ophthalmologybreakingnews.com/files/images/blog_cambium-bio-secures-funding-to-advance-dry-eye-disease-treatment.jpg https://ophthalmologybreakingnews.com/cambiumbio-secures-funding-for-dry-eye-disease-treatment 2024-12-06T13:27:46+03:00 en https://ophthalmologybreakingnews.com/cambiumbio-secures-funding-for-dry-eye-disease-treatment https://ophthalmologybreakingnews.com/files/images/blog_galimedix-therapeutics-begins-phase-1-clinical-trial-for-oral-gal-101.jpg https://ophthalmologybreakingnews.com/galimedix-begins-phase-1-clinical-trial-for-oral-gal-101 2024-12-06T10:20:58+03:00 en https://ophthalmologybreakingnews.com/galimedix-begins-phase-1-clinical-trial-for-oral-gal-101 https://ophthalmologybreakingnews.com/files/images/blog_new-research-reveals-exceptional-sensitivity-of-the-human-visual-system.jpg https://ophthalmologybreakingnews.com/research-reveals-sensitivity-of-human-visual-system 2024-12-27T10:11:57+03:00 en https://ophthalmologybreakingnews.com/research-reveals-sensitivity-of-human-visual-system https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-achieves-key-milestone-in-sol-1-phase-3-trial-for-otx-tki.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-achieves-key-milestone-in-sol1-phase3-trial 2024-12-05T13:34:59+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-achieves-key-milestone-in-sol1-phase3-trial https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-pharmaceuticals-doses-first-patient-in-second-phase-3-lucia-trial-of-duravyu-for-wet-amd.jpg https://ophthalmologybreakingnews.com/eyepoint-doses-first-patient-in-phase-3-trial-of-duravyu 2024-12-05T10:16:19+03:00 en https://ophthalmologybreakingnews.com/eyepoint-doses-first-patient-in-phase-3-trial-of-duravyu https://ophthalmologybreakingnews.com/files/images/blog_nerve-regrowth-breakthrough-could-offer-hope-for-blindness-treatment.jpg https://ophthalmologybreakingnews.com/nerve-regrowth-breakthrough-could-offer-hope-for-blindness-treatment 2024-12-10T08:58:52+03:00 en https://ophthalmologybreakingnews.com/nerve-regrowth-breakthrough-could-offer-hope-for-blindness-treatment https://ophthalmologybreakingnews.com/files/images/blog_arpa-h-awards-125-million-for-eye-transplantation-research.jpg https://ophthalmologybreakingnews.com/arpa-h-awards-125-million-for-eye-transplantation-research 2024-12-04T13:42:25+03:00 en https://ophthalmologybreakingnews.com/arpa-h-awards-125-million-for-eye-transplantation-research https://ophthalmologybreakingnews.com/files/images/blog_2024-recap-top-10-company-acquisitions-in-the-ophthalmic-industry.jpg https://ophthalmologybreakingnews.com/2024-recap-top-10-company-acquisitions 2025-01-10T13:31:35+03:00 en https://ophthalmologybreakingnews.com/2024-recap-top-10-company-acquisitions https://ophthalmologybreakingnews.com/files/images/blog_promising-results-from-polyactivas-pa5108-glaucoma-implant-clinical-trial.jpg https://ophthalmologybreakingnews.com/promising-results-from-polyactivas-pa5108-trial 2025-02-04T10:38:28+03:00 en https://ophthalmologybreakingnews.com/promising-results-from-polyactivas-pa5108-trial https://ophthalmologybreakingnews.com/files/images/blog_nicox-completes-patient-enrollment-for-denali-phase-3-trial-of-ncx-470-in-china.jpg https://ophthalmologybreakingnews.com/nicox-completes-patient-enrollment-for-denali-phase-3-trial-in-china 2024-12-03T15:42:17+03:00 en https://ophthalmologybreakingnews.com/nicox-completes-patient-enrollment-for-denali-phase-3-trial-in-china https://ophthalmologybreakingnews.com/files/images/blog_everything-you-need-to-know-about-epomec-2024.jpg https://ophthalmologybreakingnews.com/everything-you-need-to-know-about-epomec-2024 2024-12-03T10:30:48+03:00 en https://ophthalmologybreakingnews.com/everything-you-need-to-know-about-epomec-2024 https://ophthalmologybreakingnews.com/files/images/blog_research-reveals-hidden-visual-deficits-and-neural-pathway-alterations-in-mild-tbi-patients.jpg https://ophthalmologybreakingnews.com/research-reveals-hidden-visual-deficits-neural-pathway-alterations-in-mild-tbi 2024-12-09T15:42:21+03:00 en https://ophthalmologybreakingnews.com/research-reveals-hidden-visual-deficits-neural-pathway-alterations-in-mild-tbi https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-offers-free-educational-resources-on-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/prevent-blindness-offers-free-educational-resources-on-ga 2024-12-02T10:31:48+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-offers-free-educational-resources-on-ga https://ophthalmologybreakingnews.com/files/images/blog_ai-ready-dataset-released-for-type-2-diabetes-research.jpg https://ophthalmologybreakingnews.com/ai-ready-dataset-released-for-type-2-diabetes-research 2024-11-29T13:33:37+03:00 en https://ophthalmologybreakingnews.com/ai-ready-dataset-released-for-type-2-diabetes-research https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-ons-5010-for-wet-amd-falls-short-of-noninferiority-in-norse-eight-trial.jpg https://ophthalmologybreakingnews.com/ons-5010-for-wet-amd-falls-short-of-noninferiority 2024-11-29T10:15:18+03:00 en https://ophthalmologybreakingnews.com/ons-5010-for-wet-amd-falls-short-of-noninferiority https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-novoxels-tixel-device-for-meibomian-gland-dysfunction-treatment.jpg https://ophthalmologybreakingnews.com/fda-clears-novoxels-tixel-device-for-meibomian-gland-dysfunction-treatment 2025-01-31T14:49:46+03:00 en https://ophthalmologybreakingnews.com/fda-clears-novoxels-tixel-device-for-meibomian-gland-dysfunction-treatment https://ophthalmologybreakingnews.com/files/images/blog_gene-editing-breakthrough-scientists-treat-retinitis-pigmentosa-in-mice.jpg https://ophthalmologybreakingnews.com/scientists-use-crispr-to-treat-retinitis-pigmentosa-in-mice 2024-11-28T13:27:28+03:00 en https://ophthalmologybreakingnews.com/scientists-use-crispr-to-treat-retinitis-pigmentosa-in-mice https://ophthalmologybreakingnews.com/files/images/blog_new-neuronal-circuit-model-offers-insights-into-eye-movement.jpg https://ophthalmologybreakingnews.com/new-neuronal-circuit-model-offers-insights-into-eye-movement 2024-12-09T15:42:49+03:00 en https://ophthalmologybreakingnews.com/new-neuronal-circuit-model-offers-insights-into-eye-movement https://ophthalmologybreakingnews.com/files/images/blog_imprimisrx-awarded-349-million-in-trademark-infringement-case-against-osrx.jpg https://ophthalmologybreakingnews.com/imprimisrx-awarded-349-million-in-trademark-infringement-case-against-osrx 2024-11-27T10:16:28+03:00 en https://ophthalmologybreakingnews.com/imprimisrx-awarded-349-million-in-trademark-infringement-case-against-osrx https://ophthalmologybreakingnews.com/files/images/blog_aoaexcel-endorses-barti-software-as-its-first-eye-care-ehr-system.jpg https://ophthalmologybreakingnews.com/aoaexcel-endorses-barti-software-as-its-first-eye-care-ehr-system 2024-11-26T15:23:05+03:00 en https://ophthalmologybreakingnews.com/aoaexcel-endorses-barti-software-as-its-first-eye-care-ehr-system https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnson-appoints-shawn-millerick-as-president-of-vision-care-americas.jpg https://ophthalmologybreakingnews.com/johnson-johnson-appoints-shawn-millerick-as-president-of-vision-care-americas 2024-11-26T13:23:51+03:00 en https://ophthalmologybreakingnews.com/johnson-johnson-appoints-shawn-millerick-as-president-of-vision-care-americas https://ophthalmologybreakingnews.com/files/images/blog_avirmax-biopharma-doses-first-patient-in-phase-i-iia-clinical-trial-of-abi-110.jpg https://ophthalmologybreakingnews.com/avirmax-doses-first-patient-in-phase-i-iia-clinical-trial-of-abi-110 2024-11-26T10:32:25+03:00 en https://ophthalmologybreakingnews.com/avirmax-doses-first-patient-in-phase-i-iia-clinical-trial-of-abi-110 https://ophthalmologybreakingnews.com/files/images/blog_nhs-introduces-nationwide-oct-scans-to-enhance-diabetic-eye-care.jpg https://ophthalmologybreakingnews.com/nhs-introduces-nationwide-oct-scans-to-enhance-diabetic-eye-care 2024-11-25T15:51:06+03:00 en https://ophthalmologybreakingnews.com/nhs-introduces-nationwide-oct-scans-to-enhance-diabetic-eye-care https://ophthalmologybreakingnews.com/files/images/blog_ocular-pain-and-dry-eye-disease-insights-from-tibetan-plateau-residents-during-covid-19.jpg https://ophthalmologybreakingnews.com/ocular-pain-and-dry-eye-disease-insights-from-tibetan-plateau 2024-11-25T13:28:00+03:00 en https://ophthalmologybreakingnews.com/ocular-pain-and-dry-eye-disease-insights-from-tibetan-plateau https://ophthalmologybreakingnews.com/files/images/blog_chmp-issues-positive-opinion-for-fyb203-a-biosimilar-candidate-to-aflibercept.jpg https://ophthalmologybreakingnews.com/chmp-issues-positive-opinion-for-fyb203 2024-11-25T10:15:04+03:00 en https://ophthalmologybreakingnews.com/chmp-issues-positive-opinion-for-fyb203 https://ophthalmologybreakingnews.com/files/images/blog_usc-researchers-secure-6-million-cirm-grant-to-develop-dry-amd-therapy.jpg https://ophthalmologybreakingnews.com/usc-researchers-secure-6-million-cirm-grant-to-develop-dry-amd-therapy 2024-11-22T13:40:02+03:00 en https://ophthalmologybreakingnews.com/usc-researchers-secure-6-million-cirm-grant-to-develop-dry-amd-therapy https://ophthalmologybreakingnews.com/files/images/blog_adverum-announces-positive-results-from-luna-phase-2-and-optic-long-term-studies-on-gene-therapy-for-wet-amd.jpg https://ophthalmologybreakingnews.com/adverum-announces-positive-results-from-luna-phase-2 2024-11-22T10:20:54+03:00 en https://ophthalmologybreakingnews.com/adverum-announces-positive-results-from-luna-phase-2 https://ophthalmologybreakingnews.com/files/images/blog_spyglass-pharma-completes-enrollment-for-phase-1-2-clinical-trial.jpg https://ophthalmologybreakingnews.com/spyglass-completes-enrollment-for-phase-1-2-clinical-trial 2025-01-23T08:32:05+03:00 en https://ophthalmologybreakingnews.com/spyglass-completes-enrollment-for-phase-1-2-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_emmecell-advances-non-surgical-cell-therapy-for-corneal-edema.jpg https://ophthalmologybreakingnews.com/emmecell-advances-non-surgical-cell-therapy-for-corneal-edema 2024-11-21T15:14:21+03:00 en https://ophthalmologybreakingnews.com/emmecell-advances-non-surgical-cell-therapy-for-corneal-edema https://ophthalmologybreakingnews.com/files/images/blog_melt-pharmaceuticals-announces-positive-phase-3-results-for-melt-300-sedation-solution.jpg https://ophthalmologybreakingnews.com/melt-announces-positive-phase-3-results-for-melt-300 2024-11-21T10:16:15+03:00 en https://ophthalmologybreakingnews.com/melt-announces-positive-phase-3-results-for-melt-300 https://ophthalmologybreakingnews.com/files/images/blog_experts-identify-key-elements-of-cerebral-visual-impairment-cvi-in-children.jpg https://ophthalmologybreakingnews.com/experts-identify-key-elements-of-cvi-in-children 2024-12-11T09:11:21+03:00 en https://ophthalmologybreakingnews.com/experts-identify-key-elements-of-cvi-in-children https://ophthalmologybreakingnews.com/files/images/blog_ocugen-reports-promising-preliminary-results-from-ocu410-trial-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/ocugen-reports-promising-preliminary-results-from-ocu410-trial 2024-11-20T15:15:30+03:00 en https://ophthalmologybreakingnews.com/ocugen-reports-promising-preliminary-results-from-ocu410-trial https://ophthalmologybreakingnews.com/files/images/blog_alkeus-earns-rare-pediatric-disease-and-fast-track-fda-designations-for-gildeuretinol-in-stargardt-disease.jpg https://ophthalmologybreakingnews.com/fda-awards-designations-to-gildeuretinol-for-stargardt 2024-11-20T10:31:13+03:00 en https://ophthalmologybreakingnews.com/fda-awards-designations-to-gildeuretinol-for-stargardt https://ophthalmologybreakingnews.com/files/images/blog_blood-pressure-variability-linked-to-accelerated-vision-loss-in-glaucoma.jpg https://ophthalmologybreakingnews.com/blood-pressure-variability-linked-to-accelerated-vision-loss-in-glaucoma 2024-12-11T09:07:40+03:00 en https://ophthalmologybreakingnews.com/blood-pressure-variability-linked-to-accelerated-vision-loss-in-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_european-commission-approves-opuviz-a-biosimilar-to-eylea-from-samsung-bioepis-and-biogen.jpg https://ophthalmologybreakingnews.com/ec-approves-opuviz-biosimilar-to-eylea-from-samsung-bioepis-and-biogen 2024-11-19T16:10:29+03:00 en https://ophthalmologybreakingnews.com/ec-approves-opuviz-biosimilar-to-eylea-from-samsung-bioepis-and-biogen https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-aldeyras-nda-for-reproxalap-in-dry-eye-disease-partnership-with-abbvie-expands.jpg https://ophthalmologybreakingnews.com/fda-accepts-aldeyras-nda-for-reproxalap-in-dry-eye-disease 2024-11-19T10:12:51+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-aldeyras-nda-for-reproxalap-in-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_seri-partners-with-carl-zeiss-meditec-to-enhance-vision-care-for-singapores-aging-population.jpg https://ophthalmologybreakingnews.com/seri-partners-with-zeiss-to-enhance-vision-care-for-singapores-aging-population 2024-11-18T15:43:13+03:00 en https://ophthalmologybreakingnews.com/seri-partners-with-zeiss-to-enhance-vision-care-for-singapores-aging-population https://ophthalmologybreakingnews.com/files/images/blog_phase-3-trial-of-eyenovias-pediatric-myopia-treatment-falls-short-of-primary-goal.jpg https://ophthalmologybreakingnews.com/phase-3-trial-of-eyenovias-pediatric-myopia-treatment-falls-short-of-primary-goal 2024-11-18T10:10:19+03:00 en https://ophthalmologybreakingnews.com/phase-3-trial-of-eyenovias-pediatric-myopia-treatment-falls-short-of-primary-goal https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-link-between-climate-change-and-eye-conditions.jpg https://ophthalmologybreakingnews.com/study-reveals-link-climate-change-and-eye-conditions 2024-12-11T08:59:21+03:00 en https://ophthalmologybreakingnews.com/study-reveals-link-climate-change-and-eye-conditions https://ophthalmologybreakingnews.com/files/images/blog_sun-pharma-reports-positive-phase-4-data-for-cequa-in-dry-eye-disease-management.jpg https://ophthalmologybreakingnews.com/sun-pharma-reports-positive-phase-4-data-for-cequa-in-dry-eye-disease 2024-11-15T15:38:05+03:00 en https://ophthalmologybreakingnews.com/sun-pharma-reports-positive-phase-4-data-for-cequa-in-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-recycling-programs-collect-over-94-million-units-of-eye-care-waste-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch-lomb-collect-over-94-million-units-of-eye-care-waste-in-us 2024-11-15T10:20:22+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-collect-over-94-million-units-of-eye-care-waste-in-us https://ophthalmologybreakingnews.com/files/images/blog_australian-researchers-identify-101-genetic-regions-linked-to-cataract-risk.jpg https://ophthalmologybreakingnews.com/australian-researchers-identify-101-genetic-regions-linked-to-cataract-risk 2024-12-11T09:09:04+03:00 en https://ophthalmologybreakingnews.com/australian-researchers-identify-101-genetic-regions-linked-to-cataract-risk https://ophthalmologybreakingnews.com/files/images/blog_mediprint-ophthalmics-announces-promising-phase-2b-results-for-drug-eluting-contact-lens-in-glaucoma-management.jpg https://ophthalmologybreakingnews.com/mediprint-announces-promising-phase-2b-results-for-drug-eluting-contact-lens 2024-11-14T15:23:30+03:00 en https://ophthalmologybreakingnews.com/mediprint-announces-promising-phase-2b-results-for-drug-eluting-contact-lens https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-and-nippon-shinyaku-enter-exclusive-license-agreement-for-gene-therapy-atsn-101.jpg https://ophthalmologybreakingnews.com/atsena-nippon-shinyaku-enter-agreement-for-gene-therapy-atsn-101 2024-11-14T10:14:13+03:00 en https://ophthalmologybreakingnews.com/atsena-nippon-shinyaku-enter-agreement-for-gene-therapy-atsn-101 https://ophthalmologybreakingnews.com/files/images/blog_stem-cell-breakthrough-restores-human-vision-in-regenerative-medicine-milestone.jpg https://ophthalmologybreakingnews.com/stem-cell-breakthrough-restores-human-vision-in-regenerative-medicine-milestone 2024-12-10T09:01:57+03:00 en https://ophthalmologybreakingnews.com/stem-cell-breakthrough-restores-human-vision-in-regenerative-medicine-milestone https://ophthalmologybreakingnews.com/files/images/blog_oklahoma-neonatologist-researcher-awarded-23-million-nih-grant-to-advance-retinopathy-of-prematurity-research.jpg https://ophthalmologybreakingnews.com/oklahoma-neonatologist-researcher-awarded-nih-grant 2024-11-13T15:41:51+03:00 en https://ophthalmologybreakingnews.com/oklahoma-neonatologist-researcher-awarded-nih-grant https://ophthalmologybreakingnews.com/files/images/blog_harrow-secures-medicare-part-d-access-for-dry-eye-treatment-vevye.jpg https://ophthalmologybreakingnews.com/harrow-secures-medicare-part-d-access-for-dry-eye-treatment-vevye 2024-11-13T13:20:23+03:00 en https://ophthalmologybreakingnews.com/harrow-secures-medicare-part-d-access-for-dry-eye-treatment-vevye https://ophthalmologybreakingnews.com/files/images/blog_upcoming-15-international-ophthalmology-congress-to-attend-in-2025.jpg https://ophthalmologybreakingnews.com/top-international-ophthalmology-congresses-to-attend-in-2025 2025-08-04T11:39:05+03:00 en https://ophthalmologybreakingnews.com/top-international-ophthalmology-congresses-to-attend-in-2025 https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-precision7-first-one-week-contact-lens-with-activ-flo-technology.jpg https://ophthalmologybreakingnews.com/alcon-launches-precision7-first-one-week-contact-lens 2024-11-12T15:35:57+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-precision7-first-one-week-contact-lens https://ophthalmologybreakingnews.com/files/images/blog_konan-medical-usa-launches-objectivefield-visual-field-analyzer.jpg https://ophthalmologybreakingnews.com/konan-medical-usa-launches-objectivefield-visual-analyzer 2024-11-12T14:53:19+03:00 en https://ophthalmologybreakingnews.com/konan-medical-usa-launches-objectivefield-visual-analyzer https://ophthalmologybreakingnews.com/files/images/blog_noninvasive-choroidal-vessel-analysis-using-deep-learning-a-novel-oct-angiography-technique.jpg https://ophthalmologybreakingnews.com/noninvasive-choroidal-vessel-analysis-using-deep-learning 2025-04-25T10:37:30+03:00 en https://ophthalmologybreakingnews.com/noninvasive-choroidal-vessel-analysis-using-deep-learning https://ophthalmologybreakingnews.com/files/images/blog_de-escalated-adjuvant-chemotherapy-proves-effective-for-high-risk-retinoblastoma.jpg https://ophthalmologybreakingnews.com/de-escalated-adjuvant-chemotherapy-proves-effective-for-high-risk-retinoblastoma 2024-12-09T15:46:53+03:00 en https://ophthalmologybreakingnews.com/de-escalated-adjuvant-chemotherapy-proves-effective-for-high-risk-retinoblastoma https://ophthalmologybreakingnews.com/files/images/blog_neurotech-provides-update-on-bla-for-nt-501-as-treatment-for-macular-telangiectasia-type-2.jpg https://ophthalmologybreakingnews.com/neurotech-provides-update-on-bla-for-nt-501 2024-11-12T14:52:29+03:00 en https://ophthalmologybreakingnews.com/neurotech-provides-update-on-bla-for-nt-501 https://ophthalmologybreakingnews.com/files/images/blog_allovir-and-kalaris-therapeutics-announce-merger-to-advance-retinal-disease-treatments.jpg https://ophthalmologybreakingnews.com/allovir-kalaris-announce-merger-to-advance-retinal-disease-treatments 2025-04-25T10:40:59+03:00 en https://ophthalmologybreakingnews.com/allovir-kalaris-announce-merger-to-advance-retinal-disease-treatments https://ophthalmologybreakingnews.com/files/images/blog_study-links-socioeconomic-deprivation-to-severity-of-rhegmatogenous-retinal-detachment.jpg https://ophthalmologybreakingnews.com/socioeconomic-deprivation-to-severity-of-rhegmatogenous-retinal-detachment 2024-12-09T15:47:36+03:00 en https://ophthalmologybreakingnews.com/socioeconomic-deprivation-to-severity-of-rhegmatogenous-retinal-detachment https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedicals-partner-arctic-vision-signs-commercial-collaboration-with-santen-for-arvn001-in-china.jpg https://ophthalmologybreakingnews.com/arctic-vision-signs-commercial-collaboration-with-santen-for-arvn001-in-china 2024-11-12T14:51:03+03:00 en https://ophthalmologybreakingnews.com/arctic-vision-signs-commercial-collaboration-with-santen-for-arvn001-in-china https://ophthalmologybreakingnews.com/files/images/blog_eye-tracking-study-reveals-retinal-mechanisms-behind-visual-stability.jpg https://ophthalmologybreakingnews.com/eye-tracking-study-reveals-retinal-mechanisms-behind-visual-stability 2024-12-11T09:06:20+03:00 en https://ophthalmologybreakingnews.com/eye-tracking-study-reveals-retinal-mechanisms-behind-visual-stability https://ophthalmologybreakingnews.com/files/images/blog_study-aromatherapy-reduces-postoperative-anxiety-and-pain-in-oculoplastic-surgery-patients.jpg https://ophthalmologybreakingnews.com/aromatherapy-reduces-postoperative-anxiety-in-oculoplastic-surgery 2024-12-09T15:48:05+03:00 en https://ophthalmologybreakingnews.com/aromatherapy-reduces-postoperative-anxiety-in-oculoplastic-surgery https://ophthalmologybreakingnews.com/files/images/blog_formosa-pharmaceuticals-announces-top-line-results-from-phase-3-trial-of-app13007-in-china.jpg https://ophthalmologybreakingnews.com/positive-phase-3-results-for-app13007-in-China 2024-11-12T14:53:06+03:00 en https://ophthalmologybreakingnews.com/positive-phase-3-results-for-app13007-in-China https://ophthalmologybreakingnews.com/files/images/blog_cencora-expands-specialty-care-leadership-with-acquisition-of-retina-consultants-of-america.jpg https://ophthalmologybreakingnews.com/cencora-acquires-retina-consultants-of-america 2025-01-31T14:31:20+03:00 en https://ophthalmologybreakingnews.com/cencora-acquires-retina-consultants-of-america https://ophthalmologybreakingnews.com/files/images/blog_tarsus-pharmaceuticals-appoints-dr-elizabeth-yeu-as-chief-medical-officer.jpg https://ophthalmologybreakingnews.com/tarsus-pharmaceuticals-appoints-dr-elizabeth-yeu-as-chief-medical-officer 2024-11-12T14:54:58+03:00 en https://ophthalmologybreakingnews.com/tarsus-pharmaceuticals-appoints-dr-elizabeth-yeu-as-chief-medical-officer https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-fast-track-designation-to-oral-molecule-flq-101-for-retinopathy-of-prematurity.jpg https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-oral-molecule-flq-101 2024-11-12T14:52:49+03:00 en https://ophthalmologybreakingnews.com/fda-grants-fast-track-designation-to-oral-molecule-flq-101 https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-ind-application-for-hg202-gene-therapy-in-wet-amd.jpg https://ophthalmologybreakingnews.com/fda-clears-ind-application-for-hg202-gene-therapy-in-wet-amd 2024-11-12T14:49:53+03:00 en https://ophthalmologybreakingnews.com/fda-clears-ind-application-for-hg202-gene-therapy-in-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnson-unveils-new-data-on-acuvue-oasys-max-1-day-contact-lenses-at-academy-of-optometry-2024.jpg https://ophthalmologybreakingnews.com/johnson-johnson-unveils-new-data-on-acuvue-oasys-max 2025-04-25T15:39:21+03:00 en https://ophthalmologybreakingnews.com/johnson-johnson-unveils-new-data-on-acuvue-oasys-max https://ophthalmologybreakingnews.com/files/images/blog_lumithera-receives-fda-authorization-for-valeda-treatment-for-dry-amd.jpg https://ophthalmologybreakingnews.com/lumithera-receives-fda-authorization-for-valeda-treatment-for-dry-amd 2024-11-12T14:51:36+03:00 en https://ophthalmologybreakingnews.com/lumithera-receives-fda-authorization-for-valeda-treatment-for-dry-amd https://ophthalmologybreakingnews.com/files/images/blog_increased-cases-of-acute-macular-neuroretinopathy-linked-to-covid-19-pandemic-study-finds.jpg https://ophthalmologybreakingnews.com/increased-cases-of-acute-macular-neuroretinopathy-linked-to-covid-19 2024-12-10T09:03:51+03:00 en https://ophthalmologybreakingnews.com/increased-cases-of-acute-macular-neuroretinopathy-linked-to-covid-19 https://ophthalmologybreakingnews.com/files/images/blog_gensight-biologics-publishes-meta-analysis-on-efficacy-of-treatments-for-leber-hereditary-optic-neuropathy.jpg https://ophthalmologybreakingnews.com/efficacy-of-treatments-for-leber-hereditary-optic-neuropathy 2024-11-12T14:53:53+03:00 en https://ophthalmologybreakingnews.com/efficacy-of-treatments-for-leber-hereditary-optic-neuropathy https://ophthalmologybreakingnews.com/files/images/blog_genentech-announces-phase-4-results-for-vabysmo-in-treating-diabetic-macular-edema-among-underrepresented-populations.jpg https://ophthalmologybreakingnews.com/phase-4-results-for-vabysmo-in-treating-diabetic-macular-edema 2024-11-12T14:51:56+03:00 en https://ophthalmologybreakingnews.com/phase-4-results-for-vabysmo-in-treating-diabetic-macular-edema https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-fluorescent-gel-to-enhance-safety-in-cataract-surgery.jpg https://ophthalmologybreakingnews.com/scientists-develop-fluorescent-gel-to-enhance-safety-in-cataract-surgery 2024-12-09T15:49:16+03:00 en https://ophthalmologybreakingnews.com/scientists-develop-fluorescent-gel-to-enhance-safety-in-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_researchers-secure-64-million-nei-grant-to-advance-treatment-for-blindness-causing-diseases.jpg https://ophthalmologybreakingnews.com/nei-provides-$6.4M-for-new-vision-loss-treatment-innovations 2024-11-01T15:25:32+03:00 en https://ophthalmologybreakingnews.com/nei-provides-$6.4M-for-new-vision-loss-treatment-innovations https://ophthalmologybreakingnews.com/files/images/blog_study-finds-higher-prevalence-of-dry-eye-disease-symptoms-in-south-america.jpg https://ophthalmologybreakingnews.com/higher-prevalence-of-dry-eye-disease-symptoms-in-south-america 2024-12-11T09:14:12+03:00 en https://ophthalmologybreakingnews.com/higher-prevalence-of-dry-eye-disease-symptoms-in-south-america https://ophthalmologybreakingnews.com/files/images/blog_new-research-reveals-how-subtle-eye-movements-optimize-vision.jpg https://ophthalmologybreakingnews.com/research-reveals-how-subtle-eye-movements-optimize-vision 2024-12-09T15:50:08+03:00 en https://ophthalmologybreakingnews.com/research-reveals-how-subtle-eye-movements-optimize-vision https://ophthalmologybreakingnews.com/files/images/blog_gr8-eye-movement-data-highlights-caregiver-misconceptions-and-low-awareness-of-retinal-diseases.jpg https://ophthalmologybreakingnews.com/caregiver-misconceptions-and-low-awareness-of-retinal-diseases 2024-10-30T13:21:50+03:00 en https://ophthalmologybreakingnews.com/caregiver-misconceptions-and-low-awareness-of-retinal-diseases https://ophthalmologybreakingnews.com/files/images/blog_rethinking-dry-eye-diagnosis-in-patients-unresponsive-to-treatment.jpg https://ophthalmologybreakingnews.com/dry-eye-diagnosis-patients-unresponsive 2024-12-09T15:56:36+03:00 en https://ophthalmologybreakingnews.com/dry-eye-diagnosis-patients-unresponsive https://ophthalmologybreakingnews.com/files/images/blog_study-highlights-glaucoma-prevalence-across-us-demographics.jpg https://ophthalmologybreakingnews.com/glaucoma-prevalence-across-us-demographics 2024-12-09T15:56:15+03:00 en https://ophthalmologybreakingnews.com/glaucoma-prevalence-across-us-demographics https://ophthalmologybreakingnews.com/files/images/blog_stanford-study-reveals-ocular-side-effects-linked-to-ovarian-cancer-drug.jpg https://ophthalmologybreakingnews.com/ocular-side-effects-linked-ovarian-drug 2024-12-09T15:55:57+03:00 en https://ophthalmologybreakingnews.com/ocular-side-effects-linked-ovarian-drug https://ophthalmologybreakingnews.com/files/images/blog_cataract-surgery-may-save-your-eyesightmand-your-life-study-suggests.jpg https://ophthalmologybreakingnews.com/cataract-surgery-may-save-life 2024-12-09T15:55:38+03:00 en https://ophthalmologybreakingnews.com/cataract-surgery-may-save-life https://ophthalmologybreakingnews.com/files/images/blog_ai-matches-ophthalmologists-in-diagnosing-corneal-infections-study-reveals.jpg https://ophthalmologybreakingnews.com/ai-matches-ophthalmologists-diagnosing-corneal 2024-12-09T15:55:14+03:00 en https://ophthalmologybreakingnews.com/ai-matches-ophthalmologists-diagnosing-corneal https://ophthalmologybreakingnews.com/files/images/blog_long-term-antiviral-use-key-to-treating-ocular-shingles-research-shows.jpg https://ophthalmologybreakingnews.com/antiviral-use-treating-ocular-shingles 2024-12-09T15:54:54+03:00 en https://ophthalmologybreakingnews.com/antiviral-use-treating-ocular-shingles https://ophthalmologybreakingnews.com/files/images/blog_new-drug-shows-promise-in-protecting-vision-in-dry-amd.jpg https://ophthalmologybreakingnews.com/drug-promise-protecting-dry-amd 2024-12-09T15:54:33+03:00 en https://ophthalmologybreakingnews.com/drug-promise-protecting-dry-amd https://ophthalmologybreakingnews.com/files/images/blog_several-imaging-modalities-effective-in-geographic-atrophy-diagnosis.jpg https://ophthalmologybreakingnews.com/imaging-modalities-effective-geographic-atrophy 2024-12-09T15:54:12+03:00 en https://ophthalmologybreakingnews.com/imaging-modalities-effective-geographic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_aao-2024-light-trial-reveals-slt-outperforms-medications-in-reducing-glaucoma-progression-over-6-years.jpg https://ophthalmologybreakingnews.com/slt-outperforms-medications-reducing-glaucoma 2024-12-09T15:53:50+03:00 en https://ophthalmologybreakingnews.com/slt-outperforms-medications-reducing-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_google-licenses-diabetic-retinopathy-ai-for-free-screenings-in-india-and-thailand.jpg https://ophthalmologybreakingnews.com/google-diabetic-retinopathy-ai-screenings 2024-12-09T15:53:09+03:00 en https://ophthalmologybreakingnews.com/google-diabetic-retinopathy-ai-screenings https://ophthalmologybreakingnews.com/files/images/blog_aao-2024-study-links-dry-eye-to-increased-risk-of-psychiatric-disorders-and-chronic-pain-syndromes.jpg https://ophthalmologybreakingnews.com/study-dry-eye-psychiatric-disorders 2025-02-04T10:42:58+03:00 en https://ophthalmologybreakingnews.com/study-dry-eye-psychiatric-disorders https://ophthalmologybreakingnews.com/files/images/blog_new-drug-targets-identified-for-treating-inherited-retinal-degenerations.jpg https://ophthalmologybreakingnews.com/new-drug-inherited-retinal-degenerations 2024-12-09T15:52:46+03:00 en https://ophthalmologybreakingnews.com/new-drug-inherited-retinal-degenerations https://ophthalmologybreakingnews.com/files/images/blog_after-osa-2024-winners-underline-the-importance-of-recognizing-outstanding-innovations.jpg https://ophthalmologybreakingnews.com/after-osa-2024--winners-underline 2024-12-09T15:52:22+03:00 en https://ophthalmologybreakingnews.com/after-osa-2024--winners-underline https://ophthalmologybreakingnews.com/files/images/blog_steps-to-reduce-the-carbon-footprint-of-intravitreal-injections.jpg https://ophthalmologybreakingnews.com/reduce-carbon-footprint-intravitreal-injections 2024-12-09T15:51:58+03:00 en https://ophthalmologybreakingnews.com/reduce-carbon-footprint-intravitreal-injections https://ophthalmologybreakingnews.com/files/images/blog_adverse-effects-identified-following-faricimab-treatment-for-eye-conditions.jpg https://ophthalmologybreakingnews.com/adverse-effects-identified-following-faricimab 2025-06-04T15:56:42+03:00 en https://ophthalmologybreakingnews.com/adverse-effects-identified-following-faricimab https://ophthalmologybreakingnews.com/files/images/blog_ophthalmic-drug-delivery-summit-to-convene-in-san-francisco.jpg https://ophthalmologybreakingnews.com/ophthalmic-drug-delivery-summit-convene 2024-12-09T15:51:34+03:00 en https://ophthalmologybreakingnews.com/ophthalmic-drug-delivery-summit-convene https://ophthalmologybreakingnews.com/files/images/blog_researchers-test-ai-enhanced-retinal-scanning-to-assess-cardiovascular-risk.jpg https://ophthalmologybreakingnews.com/researchers-test-ai-enhanced-retinal 2024-12-09T15:46:29+03:00 en https://ophthalmologybreakingnews.com/researchers-test-ai-enhanced-retinal https://ophthalmologybreakingnews.com/files/images/blog_human-ipsc-based-study-identifies-key-defects-and-potential-therapies-for-amd-and-related-macular-dystrophies.jpg https://ophthalmologybreakingnews.com/human-ipsc-based-study-identifies 2025-02-04T10:50:32+03:00 en https://ophthalmologybreakingnews.com/human-ipsc-based-study-identifies https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-new-role-of-immune-cells-in-eye-health.jpg https://ophthalmologybreakingnews.com/researchers-discover-new-role 2024-12-27T10:14:06+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-new-role https://ophthalmologybreakingnews.com/files/images/blog_mediwhale-secures-12-million-series-a2-funding-for-ai-powered-retina-scan-technology.jpg https://ophthalmologybreakingnews.com/mediwhale-secures-12-million-dollars-series-a2-funding 2024-10-03T14:15:10+03:00 en https://ophthalmologybreakingnews.com/mediwhale-secures-12-million-dollars-series-a2-funding https://ophthalmologybreakingnews.com/files/images/blog_global-myopia-rates-in-children-and-teens-expected-to-surpass-740-million-by-2050.jpg https://ophthalmologybreakingnews.com/myopia-rates-in-children-and-teens-expected-to-surpass-740-million-by-2050 2024-12-06T15:02:43+03:00 en https://ophthalmologybreakingnews.com/myopia-rates-in-children-and-teens-expected-to-surpass-740-million-by-2050 https://ophthalmologybreakingnews.com/files/images/blog_the-relation-between-eye-pressure-blood-pressure.jpg https://ophthalmologybreakingnews.com/blood-pressure-and-intraocular-pressure-in-glaucoma-risk 2024-10-01T10:44:54+03:00 en https://ophthalmologybreakingnews.com/blood-pressure-and-intraocular-pressure-in-glaucoma-risk https://ophthalmologybreakingnews.com/files/images/blog_gender-gap-in-ophthalmology-authorship-and-peer-review-explored.jpg https://ophthalmologybreakingnews.com/gender-gap-in-ophthalmology-authorship-and-peer-review-explored 2024-10-01T09:41:25+03:00 en https://ophthalmologybreakingnews.com/gender-gap-in-ophthalmology-authorship-and-peer-review-explored https://ophthalmologybreakingnews.com/files/images/blog_lampreys-eye-disease-separating-fact-from-fiction.jpg https://ophthalmologybreakingnews.com/lampreys-eye-disease--separating-fact-from-fiction 2025-01-16T09:16:53+03:00 en https://ophthalmologybreakingnews.com/lampreys-eye-disease--separating-fact-from-fiction https://ophthalmologybreakingnews.com/files/images/blog_nicotines-potential-in-myopia-control-animal-research-findings.jpg https://ophthalmologybreakingnews.com/nicotines-potential-in-myopia-control-animal-research-findings 2025-02-04T14:54:11+03:00 en https://ophthalmologybreakingnews.com/nicotines-potential-in-myopia-control-animal-research-findings https://ophthalmologybreakingnews.com/files/images/blog_enhancing-retinopathy-of-prematurity-rop-risk-profiling-via-placental-vascular-malperfusion-evaluation.jpg https://ophthalmologybreakingnews.com/enhancing-rop-risk-profiling-via-placental-vascular-malperfusion-evaluation 2024-10-01T14:45:54+03:00 en https://ophthalmologybreakingnews.com/enhancing-rop-risk-profiling-via-placental-vascular-malperfusion-evaluation https://ophthalmologybreakingnews.com/files/images/blog_nora-appoints-barbara-barclay-as-executive-director.jpg https://ophthalmologybreakingnews.com/nora-appoints-barbara-barclay-as-executive-director 2024-09-25T13:15:30+03:00 en https://ophthalmologybreakingnews.com/nora-appoints-barbara-barclay-as-executive-director https://ophthalmologybreakingnews.com/files/images/blog_aaof-and-meta-reality-labs-launch-15m-myopia-research-initiative.jpg https://ophthalmologybreakingnews.com/aaof-and-meta-reality-labs-launch-15m-dollar-myopia-research-initiative 2024-09-25T08:42:31+03:00 en https://ophthalmologybreakingnews.com/aaof-and-meta-reality-labs-launch-15m-dollar-myopia-research-initiative https://ophthalmologybreakingnews.com/files/images/blog_color-vision-deficiency-may-affect-diagnosis-of-choroidal-conditions.jpg https://ophthalmologybreakingnews.com/color-vision-deficiency-may-affect-diagnosis-of-choroidal-conditions 2025-02-04T10:46:36+03:00 en https://ophthalmologybreakingnews.com/color-vision-deficiency-may-affect-diagnosis-of-choroidal-conditions https://ophthalmologybreakingnews.com/files/images/blog_new-consensus-report-myopia-should-be-classified-as-a-disease.jpg https://ophthalmologybreakingnews.com/new-consensus-report-myopia-should-be-classified-as-a-disease 2024-10-16T14:03:52+03:00 en https://ophthalmologybreakingnews.com/new-consensus-report-myopia-should-be-classified-as-a-disease https://ophthalmologybreakingnews.com/files/images/blog_chmp-upholds-negative-opinion-on-apellis-pegcetacoplan-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/chmp-upholds-negative-opinion-on-apellis-pegcetacoplan-for-geographic-atrophy 2024-09-23T09:18:23+03:00 en https://ophthalmologybreakingnews.com/chmp-upholds-negative-opinion-on-apellis-pegcetacoplan-for-geographic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_eye-drop-company-faces-fda-scrutiny-again-over-unapproved-products.jpg https://ophthalmologybreakingnews.com/eye-drop-company-faces-fda-scrutiny-again 2024-09-19T15:39:37+03:00 en https://ophthalmologybreakingnews.com/eye-drop-company-faces-fda-scrutiny-again https://ophthalmologybreakingnews.com/files/images/blog_maestror-the-sinusoidal-iol.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-introduced-maestro-the-sinusoidal-iol 2024-11-06T09:23:25+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-introduced-maestro-the-sinusoidal-iol https://ophthalmologybreakingnews.com/files/images/blog_mcg-scientists-receive-15-million-grant-to-target-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/mcg-scientists-receive-grant-to-target-diabetic-retinopathy 2024-09-17T13:32:56+03:00 en https://ophthalmologybreakingnews.com/mcg-scientists-receive-grant-to-target-diabetic-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_prevent-blindness-launches-childrens-vision-health-map.jpg https://ophthalmologybreakingnews.com/prevent-blindness-launches-childrens-vision-health-map 2024-09-12T08:59:56+03:00 en https://ophthalmologybreakingnews.com/prevent-blindness-launches-childrens-vision-health-map https://ophthalmologybreakingnews.com/files/images/blog_trinity-college-researchers-develop-promising-gene-therapy-for-glaucoma-and-amd.jpg https://ophthalmologybreakingnews.com/trinity-college-researchers-develop-promising-gene-therapy-for-glaucoma-and-amd 2024-09-10T11:10:29+03:00 en https://ophthalmologybreakingnews.com/trinity-college-researchers-develop-promising-gene-therapy-for-glaucoma-and-amd https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-announces-winners-of-the-ophthalmology-star-awards-2024-osa-at-escrs-congress.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-announces-winners-of-the-2024-osa-at-escrs 2024-09-23T09:21:43+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-announces-winners-of-the-2024-osa-at-escrs https://ophthalmologybreakingnews.com/files/images/blog_opthea-announces-leadership-changes-as-it-prepares-for-phase-3-data-on-sozinibercept.jpg https://ophthalmologybreakingnews.com/opthea-announces-leadership-changes-as-it-prepares-for-phase-3-data-on-sozinibercept 2024-11-06T09:19:49+03:00 en https://ophthalmologybreakingnews.com/opthea-announces-leadership-changes-as-it-prepares-for-phase-3-data-on-sozinibercept https://ophthalmologybreakingnews.com/files/images/blog_atsena-therapeutics-publishes-12-month-data-on-atsn-101-for-lca1.jpg https://ophthalmologybreakingnews.com/atsena-therapeutics-publishes-12-month-data-on-atsn-101-for-lca1 2024-11-06T09:12:59+03:00 en https://ophthalmologybreakingnews.com/atsena-therapeutics-publishes-12-month-data-on-atsn-101-for-lca1 https://ophthalmologybreakingnews.com/files/images/blog_oculus-introduces-pentacam-cornea-oct-at-escrs-2024.jpg https://ophthalmologybreakingnews.com/oculus-introduces-pentacam-cornea-oct 2024-09-05T09:43:47+03:00 en https://ophthalmologybreakingnews.com/oculus-introduces-pentacam-cornea-oct https://ophthalmologybreakingnews.com/files/images/blog_bluerock-therapeutics-receives-fda-clearance-for-opct-001-ind-application.jpg https://ophthalmologybreakingnews.com/bluerock-therapeutics-receives-fda-clearance-for-opct-001-ind-application 2024-11-06T09:20:12+03:00 en https://ophthalmologybreakingnews.com/bluerock-therapeutics-receives-fda-clearance-for-opct-001-ind-application https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-introduces-metis-ophthalmic-microscope-system.jpg https://ophthalmologybreakingnews.com/haag-streit-introduces-metis-ophthalmic-microscope-system 2025-03-05T13:46:11+03:00 en https://ophthalmologybreakingnews.com/haag-streit-introduces-metis-ophthalmic-microscope-system https://ophthalmologybreakingnews.com/files/images/blog_european-commission-approves-akantior-as-first-treatment-for-acanthamoeba-keratitis.jpg https://ophthalmologybreakingnews.com/european-commission-approves-akantior-as-first-treatment-for-acanthamoeba-keratitis 2025-01-31T15:02:43+03:00 en https://ophthalmologybreakingnews.com/european-commission-approves-akantior-as-first-treatment-for-acanthamoeba-keratitis https://ophthalmologybreakingnews.com/files/images/blog_eye-color-changing-drops-the-dangerous-trend-ophthalmologists-urge-you-to-avoid.jpg https://ophthalmologybreakingnews.com/eye-color-changing-drop-ophthalmologists-urge-you-to-avoid 2024-09-02T10:23:32+03:00 en https://ophthalmologybreakingnews.com/eye-color-changing-drop-ophthalmologists-urge-you-to-avoid https://ophthalmologybreakingnews.com/files/images/blog_covid-19-and-eye-care-an-overview-of-the-impact-and-implications.jpg https://ophthalmologybreakingnews.com/covid-19-and-eye-care-an-overview-of-the-impact-and-implications 2024-10-16T09:50:59+03:00 en https://ophthalmologybreakingnews.com/covid-19-and-eye-care-an-overview-of-the-impact-and-implications https://ophthalmologybreakingnews.com/files/images/blog_chatgpt-40-demonstrates-promise-in-addressing-retinal-disease-queries.jpg https://ophthalmologybreakingnews.com/chatgpt-40-demonstrates-promise-in-addressing-retinal-disease-queries 2024-11-06T09:15:12+03:00 en https://ophthalmologybreakingnews.com/chatgpt-40-demonstrates-promise-in-addressing-retinal-disease-queries https://ophthalmologybreakingnews.com/files/images/blog_bimekizumab-significantly-reduces-uveitis-incidence-in-axspa-patients.jpg https://ophthalmologybreakingnews.com/bimekizumab-significantly-reduces-uveitis-incidence-in-axspa-patients 2024-12-10T09:00:21+03:00 en https://ophthalmologybreakingnews.com/bimekizumab-significantly-reduces-uveitis-incidence-in-axspa-patients https://ophthalmologybreakingnews.com/files/images/blog_escrs-2024-insights-from-ophthalmic-leaders-with-dr-filomena-ribeiro.jpg https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-filomena-ribeiro 2025-02-04T10:49:50+03:00 en https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-filomena-ribeiro https://ophthalmologybreakingnews.com/files/images/blog_visionix-unveils-vx-610-automated-fundus-camera-for-diabetic-retinopathy-screening.jpg https://ophthalmologybreakingnews.com/visionix-unveils-vx-610-fundus-camera-for-diabetic-retinopathy 2024-09-10T09:01:52+03:00 en https://ophthalmologybreakingnews.com/visionix-unveils-vx-610-fundus-camera-for-diabetic-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_the-biggest-challenges-in-ophthalmology-today-survey-insights.jpg https://ophthalmologybreakingnews.com/the-biggest-challenges-in-ophthalmology-today-survey-insights 2024-10-16T14:04:23+03:00 en https://ophthalmologybreakingnews.com/the-biggest-challenges-in-ophthalmology-today-survey-insights https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-receives-fda-rare-pediatric-disease-designation-for-opgx-lca5-gene-therapy.jpg https://ophthalmologybreakingnews.com/opus-genetics-receives-fda-rpd-designation-for-opgx-lca5 2024-08-20T16:28:44+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-receives-fda-rpd-designation-for-opgx-lca5 https://ophthalmologybreakingnews.com/files/images/blog_escrs-2024-insights-from-ophthalmic-leaders-with-dr-h-burkhard-dick.jpg https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-burkhard-dick 2025-02-04T10:47:53+03:00 en https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-burkhard-dick https://ophthalmologybreakingnews.com/files/images/blog_sandoz-receives-fda-approval-for-enzeevut-expanding-ophthalmology-biosimilar-portfolio.jpg https://ophthalmologybreakingnews.com/sandoz-receives-fda-approval-for-enzeevu 2024-08-20T09:02:32+03:00 en https://ophthalmologybreakingnews.com/sandoz-receives-fda-approval-for-enzeevu https://ophthalmologybreakingnews.com/files/images/blog_lensar-receives-eu-certification-for-allyr-adaptive-cataract-treatment-system.jpg https://ophthalmologybreakingnews.com/lensar-receives-eu-certification-for-ally 2024-08-19T10:00:22+03:00 en https://ophthalmologybreakingnews.com/lensar-receives-eu-certification-for-ally https://ophthalmologybreakingnews.com/files/images/blog_long-term-corneal-endothelial-changes-in-post-covid-19-patients-with-ocular-symptoms.jpg https://ophthalmologybreakingnews.com/long-term-changes-in-post-covid19-patients-with-ocular-symptoms 2025-02-04T15:01:49+03:00 en https://ophthalmologybreakingnews.com/long-term-changes-in-post-covid19-patients-with-ocular-symptoms https://ophthalmologybreakingnews.com/files/images/blog_escrs-2024-insights-from-ophthalmic-leaders-with-dr-richard-packard.jpg https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-richard-packard 2025-02-04T10:48:55+03:00 en https://ophthalmologybreakingnews.com/escrs-2024-insights-from-ophthalmic-leaders-with-dr-richard-packard https://ophthalmologybreakingnews.com/files/images/blog_bausch-lombs-teneot-excimer-laser-yields-positive-results-in-clinical-trials.jpg https://ophthalmologybreakingnews.com/bausch-lombs-teneo-excimer-laser-yields-positive-results 2024-08-14T11:38:33+03:00 en https://ophthalmologybreakingnews.com/bausch-lombs-teneo-excimer-laser-yields-positive-results https://ophthalmologybreakingnews.com/files/images/blog_top-5-myths-about-lasik-surgery-debunked_1.jpg https://ophthalmologybreakingnews.com/top-5-myths-about-lasik-surgery-debunked- 2024-08-16T13:43:18+03:00 en https://ophthalmologybreakingnews.com/top-5-myths-about-lasik-surgery-debunked- https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnsons-sight-for-kids-program-reaches-50-million-children-globally.jpg https://ophthalmologybreakingnews.com/johnson-johnsons-sight-for-kids-program-reaches-50-million-children 2024-10-16T09:52:23+03:00 en https://ophthalmologybreakingnews.com/johnson-johnsons-sight-for-kids-program-reaches-50-million-children https://ophthalmologybreakingnews.com/files/images/blog_european-commission-approves-roches-vabysmo-for-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/european-commission-approves-roches-vabysmo-for-rvo 2024-08-20T08:54:47+03:00 en https://ophthalmologybreakingnews.com/european-commission-approves-roches-vabysmo-for-rvo https://ophthalmologybreakingnews.com/files/images/blog_exclusive-preview-whats-in-store-for-escrs-2024-n-workshops-labs-and-more.jpg https://ophthalmologybreakingnews.com/exclusive-whats-in-store-for-escrs-2024-workshops-labs 2024-08-16T09:15:11+03:00 en https://ophthalmologybreakingnews.com/exclusive-whats-in-store-for-escrs-2024-workshops-labs https://ophthalmologybreakingnews.com/files/images/blog_fda-notifies-ocugen-to-begin-expanded-access-program-for-retinitis-pigmentosa-treatment-with-ocu400.jpg https://ophthalmologybreakingnews.com/fda-notifies-ocugen-to-begin-eap-for-retinitis-pigmentosa-treatment 2024-08-16T09:14:27+03:00 en https://ophthalmologybreakingnews.com/fda-notifies-ocugen-to-begin-eap-for-retinitis-pigmentosa-treatment https://ophthalmologybreakingnews.com/files/images/blog_exclusive-unveiling-key-events-at-escrs-2024n-whats-on-the-horizon.jpg https://ophthalmologybreakingnews.com/exclusive-key-events-at-escrs-2024-whats-on-the-horizon 2024-08-16T09:15:20+03:00 en https://ophthalmologybreakingnews.com/exclusive-key-events-at-escrs-2024-whats-on-the-horizon https://ophthalmologybreakingnews.com/files/images/blog_escrs-2024-exclusive-insights-inovationr-day-in-focus.jpg https://ophthalmologybreakingnews.com/escrs-2024-exclusive-insights-inovation-day 2024-12-11T09:05:41+03:00 en https://ophthalmologybreakingnews.com/escrs-2024-exclusive-insights-inovation-day https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-announces-first-patients-enrolled-in-phase-3-wet-amd-study.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-announces-first-patients-enrolled-in-phase-3-wet-amd-study 2024-07-31T15:16:47+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-announces-first-patients-enrolled-in-phase-3-wet-amd-study https://ophthalmologybreakingnews.com/files/images/blog_eyenovia-and-sgn-nanopharma-collaborate-to-develop-treatment-for-chronic-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/eyenovia-and-sgn-collaborate-to-develop-treatment-for-chronic-ded 2024-07-31T10:12:37+03:00 en https://ophthalmologybreakingnews.com/eyenovia-and-sgn-collaborate-to-develop-treatment-for-chronic-ded https://ophthalmologybreakingnews.com/files/images/blog_vialase-laser-receives-ce-mark-approval-for-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/vialase-laser-receives-ce-mark-approval-for-glaucoma-treatment 2024-08-16T09:14:10+03:00 en https://ophthalmologybreakingnews.com/vialase-laser-receives-ce-mark-approval-for-glaucoma-treatment https://ophthalmologybreakingnews.com/files/images/blog_novaliqs-vevizyer-receives-positive-chmp-opinion-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/novaliqs-vevizye-receives-positive-chmp-opinion-for-ded 2024-07-30T13:20:37+03:00 en https://ophthalmologybreakingnews.com/novaliqs-vevizye-receives-positive-chmp-opinion-for-ded https://ophthalmologybreakingnews.com/files/images/blog_elon-musks-blindsight-implant-faces-skepticism-from-university-of-washington-researchers.jpg https://ophthalmologybreakingnews.com/elon-musks-blindsight-implant-faces-skepticism-from-researchers 2024-07-30T10:31:54+03:00 en https://ophthalmologybreakingnews.com/elon-musks-blindsight-implant-faces-skepticism-from-researchers https://ophthalmologybreakingnews.com/files/images/blog_dr-allen-c-ho-appointed-chairman-of-alcon-research-institutes-executive-committee.jpg https://ophthalmologybreakingnews.com/dr-ho-appointed-chairman-of-alcon-research-institutes-executive-committee 2024-07-30T09:55:56+03:00 en https://ophthalmologybreakingnews.com/dr-ho-appointed-chairman-of-alcon-research-institutes-executive-committee https://ophthalmologybreakingnews.com/files/images/blog_nih-researchers-discover-potential-therapeutic-target-for-dry-amd.jpg https://ophthalmologybreakingnews.com/researchers-discover-potential-therapeutic-target-for-dry-amd 2024-07-29T14:50:23+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-potential-therapeutic-target-for-dry-amd https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-increased-risk-of-dr-progression-with-glp1ras-compared-to-sglt2is.jpg https://ophthalmologybreakingnews.com/increased-risk-of-dr-progression-with-glp1ras-compared-to-sglt2is 2024-07-29T13:43:05+03:00 en https://ophthalmologybreakingnews.com/increased-risk-of-dr-progression-with-glp1ras-compared-to-sglt2is https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-link-between-proteins-in-tears-and-pain-after-eye-surgery.jpg https://ophthalmologybreakingnews.com/link-between-proteins-in-tears-and-pain-after-eye-surgery 2024-07-29T13:15:29+03:00 en https://ophthalmologybreakingnews.com/link-between-proteins-in-tears-and-pain-after-eye-surgery https://ophthalmologybreakingnews.com/files/images/blog_new-study-highlights-advances-in-retinoblastoma-treatment-for-children.jpg https://ophthalmologybreakingnews.com/study-highlights-advances-in-retinoblastoma-treatment-for-children 2024-07-26T14:51:14+03:00 en https://ophthalmologybreakingnews.com/study-highlights-advances-in-retinoblastoma-treatment-for-children https://ophthalmologybreakingnews.com/files/images/blog_nicox-completes-recruitment-for-denali-phase-3-trial-of-ncx-470-in-the-us.jpg https://ophthalmologybreakingnews.com/nicox-completes-recruitment-for-denali-phase-3-trial-of-ncx-470-in-the-us 2024-07-26T10:12:01+03:00 en https://ophthalmologybreakingnews.com/nicox-completes-recruitment-for-denali-phase-3-trial-of-ncx-470-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_spryte-medicals-noct-technology-receives-breakthrough-device-designation-from-fda.jpg https://ophthalmologybreakingnews.com/spryte-noct-technology-receives-breakthrough-device-designation 2024-07-26T09:13:16+03:00 en https://ophthalmologybreakingnews.com/spryte-noct-technology-receives-breakthrough-device-designation https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/eyenovia-and-senju-collaborate-on-dry-eye-treatment 2024-07-25T14:55:46+03:00 en https://ophthalmologybreakingnews.com/eyenovia-and-senju-collaborate-on-dry-eye-treatment https://ophthalmologybreakingnews.com/files/images/blog_abbvie-launches-refresh-tears-pf-and-refresh-relieva-pf-xtra.jpg https://ophthalmologybreakingnews.com/abbvie-launches-refresh-tears-pf-and-refresh-relieva-pf-xtra 2024-11-18T14:17:56+03:00 en https://ophthalmologybreakingnews.com/abbvie-launches-refresh-tears-pf-and-refresh-relieva-pf-xtra https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnson-invests-in-refractive-technology-start-up-teclens.jpg https://ophthalmologybreakingnews.com/johnson--johnson-invests-in-start-up-teclens 2024-07-25T11:32:32+03:00 en https://ophthalmologybreakingnews.com/johnson--johnson-invests-in-start-up-teclens https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-acquires-trukera-medical-to-enhance-surgical-capabilities.jpg https://ophthalmologybreakingnews.com/bausch--lomb-acquires-trukera-medical 2024-07-24T16:15:38+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-acquires-trukera-medical https://ophthalmologybreakingnews.com/files/images/blog_oertli-instrumente-receives-fda-clearance-for-faros-anterior-cataract-surgery-system.jpg https://ophthalmologybreakingnews.com/oertli--receives-fda-clearance-for-faros-anterior-surgery-system 2024-07-24T12:44:18+03:00 en https://ophthalmologybreakingnews.com/oertli--receives-fda-clearance-for-faros-anterior-surgery-system https://ophthalmologybreakingnews.com/files/images/blog_osheru-secures-47m-funding-to-advance-ziplyft-device-for-blepharoplasty.jpg https://ophthalmologybreakingnews.com/osheru-secures-$47m-funding-to-advance-ziplyft-device-for-blepharoplasty 2024-07-24T09:50:17+03:00 en https://ophthalmologybreakingnews.com/osheru-secures-$47m-funding-to-advance-ziplyft-device-for-blepharoplasty https://ophthalmologybreakingnews.com/files/images/blog_new-research-explores-uveal-melanoma-metastasis-mechanisms.jpg https://ophthalmologybreakingnews.com/research-explores-uveal-melanoma-metastasis-mechanisms 2024-07-23T14:15:58+03:00 en https://ophthalmologybreakingnews.com/research-explores-uveal-melanoma-metastasis-mechanisms https://ophthalmologybreakingnews.com/files/images/blog_samsara-vision-announces-successful-first-sing-imt-procedure-in-china.jpg https://ophthalmologybreakingnews.com/samsara-announces-successful-first-sing-imt-procedure-in-china 2024-07-23T12:46:02+03:00 en https://ophthalmologybreakingnews.com/samsara-announces-successful-first-sing-imt-procedure-in-china https://ophthalmologybreakingnews.com/files/images/blog_topcon-and-orbis-partner-to-expand-diabetic-retinopathy-screening-in-rwanda.jpg https://ophthalmologybreakingnews.com/topcon-orbis-to-expand-dr-screening-in-rwanda 2024-07-23T12:06:06+03:00 en https://ophthalmologybreakingnews.com/topcon-orbis-to-expand-dr-screening-in-rwanda https://ophthalmologybreakingnews.com/files/images/blog_maternal-asthma-linked-to-increased-risk-of-severe-retinopathy-of-prematurity.jpg https://ophthalmologybreakingnews.com/maternal-asthma-linked-to-increased-risk-of-severe-rop 2025-02-04T15:02:49+03:00 en https://ophthalmologybreakingnews.com/maternal-asthma-linked-to-increased-risk-of-severe-rop https://ophthalmologybreakingnews.com/files/images/blog_trial-results-for-susvimo-demonstrate-sustained-efficacy-in-dme-and-dr.jpg https://ophthalmologybreakingnews.com/trial-results-for-susvimo-demonstrate-sustained-efficacy 2024-07-22T13:39:03+03:00 en https://ophthalmologybreakingnews.com/trial-results-for-susvimo-demonstrate-sustained-efficacy https://ophthalmologybreakingnews.com/files/images/blog_lupin-signs-agreement-with-huons-to-introduce-cyclosporine-ophthalmic-nanoemulsion-in-mexico.jpg https://ophthalmologybreakingnews.com/lupin-signs-agreement-with-huons-to- 2024-10-04T09:31:14+03:00 en https://ophthalmologybreakingnews.com/lupin-signs-agreement-with-huons-to- https://ophthalmologybreakingnews.com/files/images/blog_essilorluxottica-acquires-80-stake-in-heidelberg-engineering.jpg https://ophthalmologybreakingnews.com/essilorluxottica-acquires-80-stake-in-heidelberg-engineering 2025-01-31T13:54:10+03:00 en https://ophthalmologybreakingnews.com/essilorluxottica-acquires-80-stake-in-heidelberg-engineering https://ophthalmologybreakingnews.com/files/images/blog_opthea-launches-medical-advisory-board-with-global-retina-experts.jpg https://ophthalmologybreakingnews.com/opthea-launches-medical-advisory-board-with-global-retina-experts 2024-07-19T11:10:04+03:00 en https://ophthalmologybreakingnews.com/opthea-launches-medical-advisory-board-with-global-retina-experts https://ophthalmologybreakingnews.com/files/images/blog_antioxidant-supplements-show-promise-in-slowing-late-stage-dry-amd-progression.jpg https://ophthalmologybreakingnews.com/antioxidant-supplements-show-promise-in-slowing- 2024-10-04T09:17:37+03:00 en https://ophthalmologybreakingnews.com/antioxidant-supplements-show-promise-in-slowing- https://ophthalmologybreakingnews.com/files/images/blog_nexthera-submits-ind-application-for-nt-101-a-non-invasive-treatment-for-wet-amd.jpg https://ophthalmologybreakingnews.com/nexthera-submits-ind-application-for-nt-101- 2024-07-18T15:47:43+03:00 en https://ophthalmologybreakingnews.com/nexthera-submits-ind-application-for-nt-101- https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-novel-imaging-technique-for-ms-diagnosis.jpg https://ophthalmologybreakingnews.com/researchers-discover-novel-imaging-technique-for-ms-diagnosis- 2024-07-18T13:58:37+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-novel-imaging-technique-for-ms-diagnosis- https://ophthalmologybreakingnews.com/files/images/blog_pulsemedica-secures-12m-to-advance-eye-floater-imaging-and-treatment-technology.jpg https://ophthalmologybreakingnews.com/pulsemedica-secures-$12m-to-advance-eye-floater-imaging-tech 2024-07-18T11:09:43+03:00 en https://ophthalmologybreakingnews.com/pulsemedica-secures-$12m-to-advance-eye-floater-imaging-tech https://ophthalmologybreakingnews.com/files/images/blog_ophthalmologic-manifestations-of-acute-leukemia-are-diverse-and-detectable.jpg https://ophthalmologybreakingnews.com/ophthalmologic-manifestations-of-acute-leukemia-detectable- 2024-07-18T08:56:40+03:00 en https://ophthalmologybreakingnews.com/ophthalmologic-manifestations-of-acute-leukemia-detectable- https://ophthalmologybreakingnews.com/files/images/blog_report-highlights-significant-drug-waste-from-sucd-for-eye-drops.jpg https://ophthalmologybreakingnews.com/report-highlights-significant-drug-waste-from-sucd-for-eye-drops 2024-07-17T16:42:08+03:00 en https://ophthalmologybreakingnews.com/report-highlights-significant-drug-waste-from-sucd-for-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_entod-pharmaceuticals-introduces-novel-eye-drop-preservative-system.jpg https://ophthalmologybreakingnews.com/entod-introduces-novel-eye-drop-preservative-system 2024-07-18T15:42:21+03:00 en https://ophthalmologybreakingnews.com/entod-introduces-novel-eye-drop-preservative-system https://ophthalmologybreakingnews.com/files/images/blog_heidelberg-engineering-receives-fda-clearance-for-enhanced-spectralisr-octa-module.jpg https://ophthalmologybreakingnews.com/fda-clearance-for-enhanced-spectralis-octa-module 2024-07-17T15:31:05+03:00 en https://ophthalmologybreakingnews.com/fda-clearance-for-enhanced-spectralis-octa-module https://ophthalmologybreakingnews.com/files/images/blog_sydnexis-names-perry-j-sternberg-as-chief-executive-officer.jpg https://ophthalmologybreakingnews.com/sydnexis-names-perry-j-sternberg-as-ceo 2024-07-17T10:01:42+03:00 en https://ophthalmologybreakingnews.com/sydnexis-names-perry-j-sternberg-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_merck-completes-acquisition-of-eyebio.jpg https://ophthalmologybreakingnews.com/merck-completes-acquisition-of-eyebio- 2024-07-17T09:11:42+03:00 en https://ophthalmologybreakingnews.com/merck-completes-acquisition-of-eyebio- https://ophthalmologybreakingnews.com/files/images/blog_genentech-to-reintroduce-susvimo-ocular-implant-for-wet-amd.jpg https://ophthalmologybreakingnews.com/genentech-to-reintroduce-susvimo-implant-for-wet-amd- 2024-07-17T00:14:41+03:00 en https://ophthalmologybreakingnews.com/genentech-to-reintroduce-susvimo-implant-for-wet-amd- https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-receives-uk-approval-of-lytenava-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-receives-uk-approval-of-lytenava-for-wet-amd-treatment 2024-07-16T14:42:50+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-receives-uk-approval-of-lytenava-for-wet-amd-treatment https://ophthalmologybreakingnews.com/files/images/blog_okyo-pharma-initiates-phase-2-clinical-trial-for-ok-101-in-neuropathic-corneal-pain.jpg https://ophthalmologybreakingnews.com/phase-2-clinical-trial-for-ok-101-in-neuropathic-corneal-pain 2024-07-19T11:57:41+03:00 en https://ophthalmologybreakingnews.com/phase-2-clinical-trial-for-ok-101-in-neuropathic-corneal-pain https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-high-antibiotic-use-despite-guidelines-for-pink-eye-treatment.jpg https://ophthalmologybreakingnews.com/high-antibiotic-use-despite-guidelines-for-pink-eye-treatment 2024-07-05T12:53:47+03:00 en https://ophthalmologybreakingnews.com/high-antibiotic-use-despite-guidelines-for-pink-eye-treatment https://ophthalmologybreakingnews.com/files/images/blog_fenofibrate-reduces-diabetic-retinopathy-risk-by-27-lens-trial-finds.jpg https://ophthalmologybreakingnews.com/fenofibrate-reduces-diabetic-retinopathy-risk-by-27- 2024-10-04T09:33:41+03:00 en https://ophthalmologybreakingnews.com/fenofibrate-reduces-diabetic-retinopathy-risk-by-27- https://ophthalmologybreakingnews.com/files/images/blog_clinica-baviera-acquires-uk-based-optimax-group-for-e117-million.jpg https://ophthalmologybreakingnews.com/clínica-baviera-acquires-uk-based-optimax-group- 2025-02-04T10:44:22+03:00 en https://ophthalmologybreakingnews.com/clínica-baviera-acquires-uk-based-optimax-group- https://ophthalmologybreakingnews.com/files/images/blog_novo-nordisks-popular-weight-loss-drugs-linked-to-higher-risk-of-naion.jpg https://ophthalmologybreakingnews.com/popular-weight-loss-drugs-linked-to-higher-risk-of-naion 2024-10-04T09:33:11+03:00 en https://ophthalmologybreakingnews.com/popular-weight-loss-drugs-linked-to-higher-risk-of-naion https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-secures-170m-to-advance-ophthalmic-gene-therapy.jpg https://ophthalmologybreakingnews.com/beacon-therapeutics-secures-$170m-to-advance-gene-therapy- 2024-07-04T08:01:44+03:00 en https://ophthalmologybreakingnews.com/beacon-therapeutics-secures-$170m-to-advance-gene-therapy- https://ophthalmologybreakingnews.com/files/images/blog_study-suggests-new-treatment-approach-for-wet-amd.jpg https://ophthalmologybreakingnews.com/study-suggests-new-treatment-approach-for-wet-amd 2024-07-03T16:03:57+03:00 en https://ophthalmologybreakingnews.com/study-suggests-new-treatment-approach-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_cms-j-code-for-glaukos-idose-tr-becomes-active.jpg https://ophthalmologybreakingnews.com/cms-j-code-for-glaukos-idose-tr-becomes-active 2024-07-05T14:00:38+03:00 en https://ophthalmologybreakingnews.com/cms-j-code-for-glaukos-idose-tr-becomes-active https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-formycon-and-klinges-biosimilar-to-eylear.jpg https://ophthalmologybreakingnews.com/fda-approves-formycon-and-klinges-biosimilar-to-eylea 2024-07-04T13:41:06+03:00 en https://ophthalmologybreakingnews.com/fda-approves-formycon-and-klinges-biosimilar-to-eylea https://ophthalmologybreakingnews.com/files/images/blog_nurexone-launches-study-on-exopten-therapy-for-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/nurexone-launches-study-on-exopten-therapy-for-glaucoma 2025-01-29T14:38:43+03:00 en https://ophthalmologybreakingnews.com/nurexone-launches-study-on-exopten-therapy-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_alcon-completes-acquisition-of-belkin-vision.jpg https://ophthalmologybreakingnews.com/alcon-completes-acquisition-of-belkin-vision 2024-07-02T13:36:52+03:00 en https://ophthalmologybreakingnews.com/alcon-completes-acquisition-of-belkin-vision https://ophthalmologybreakingnews.com/files/images/blog_roches-vabysmo-receives-chmp-recommendation-for-rvo-indication.jpg https://ophthalmologybreakingnews.com/roches-vabysmo-receives-chmp-recommendation-for-rvo-indication 2024-07-02T11:19:32+03:00 en https://ophthalmologybreakingnews.com/roches-vabysmo-receives-chmp-recommendation-for-rvo-indication https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-novel-phototherapy-technique-to-treat-ocular-melanoma.jpg https://ophthalmologybreakingnews.com/novel-phototherapy-technique-to-treat-ocular-melanoma 2024-07-03T10:17:24+03:00 en https://ophthalmologybreakingnews.com/novel-phototherapy-technique-to-treat-ocular-melanoma https://ophthalmologybreakingnews.com/files/images/blog_emas-chmp-issues-negative-opinion-on-syfovre-for-ga-apellis-to-pursue-re-examination.jpg https://ophthalmologybreakingnews.com/chmp-issues-negative-opinion-on-syfovre-for-ga 2024-07-01T09:58:22+03:00 en https://ophthalmologybreakingnews.com/chmp-issues-negative-opinion-on-syfovre-for-ga https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-denovo-classification-to-fysxt-ocular-pressure-adjusting-pump.jpg https://ophthalmologybreakingnews.com/fda-grants-denovo-classification-to-ocular-pressure-adjusting-pump- 2025-01-28T09:13:15+03:00 en https://ophthalmologybreakingnews.com/fda-grants-denovo-classification-to-ocular-pressure-adjusting-pump- https://ophthalmologybreakingnews.com/files/images/blog_researchers-awarded-nih-grants-to-advance-vision-restoration-efforts.jpg https://ophthalmologybreakingnews.com/researchers-awarded-nih-grants-to-advance-vision-restoration 2024-06-28T14:27:57+03:00 en https://ophthalmologybreakingnews.com/researchers-awarded-nih-grants-to-advance-vision-restoration https://ophthalmologybreakingnews.com/files/images/blog_selective-antibiotic-prophylaxis-reduces-risk-of-infections-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/selective-antibiotic-prophylaxis-reduces-risk-of-infections 2024-06-28T10:51:09+03:00 en https://ophthalmologybreakingnews.com/selective-antibiotic-prophylaxis-reduces-risk-of-infections https://ophthalmologybreakingnews.com/files/images/blog_thea-pharma-launches-new-website-to-support-ophthalmologists-with-iyuzeh.jpg https://ophthalmologybreakingnews.com/thea-pharma-launches-new-website-for-iyuzeh 2024-06-28T09:15:23+03:00 en https://ophthalmologybreakingnews.com/thea-pharma-launches-new-website-for-iyuzeh https://ophthalmologybreakingnews.com/files/images/blog_researchers-find-a-new-way-to-monitor-eye-microcirculation.jpg https://ophthalmologybreakingnews.com/researchers-find-a-new-way-to-monitor-eye-microcirculation 2024-06-27T10:46:18+03:00 en https://ophthalmologybreakingnews.com/researchers-find-a-new-way-to-monitor-eye-microcirculation https://ophthalmologybreakingnews.com/files/images/blog_new-ai-tool-enhances-efficiency-of-geographic-atrophy-clinical-trials.jpg https://ophthalmologybreakingnews.com/new-ai-tool-enhances-efficiency-of-ga-clinical-trials 2024-06-27T09:17:18+03:00 en https://ophthalmologybreakingnews.com/new-ai-tool-enhances-efficiency-of-ga-clinical-trials https://ophthalmologybreakingnews.com/files/images/blog_who-will-shine-at-the-ophthalmology-star-awards-2024.jpg https://ophthalmologybreakingnews.com/who-will-shine-at-the-ophthalmology-star-awards-2024 2024-06-26T15:42:56+03:00 en https://ophthalmologybreakingnews.com/who-will-shine-at-the-ophthalmology-star-awards-2024 https://ophthalmologybreakingnews.com/files/images/blog_nvision-eye-centers-partners-with-parkhurst-nuvision-to-expand-clinical-trials-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/nvision-eye-centers-partners-with-parkhurst-nuvision 2024-06-26T13:13:55+03:00 en https://ophthalmologybreakingnews.com/nvision-eye-centers-partners-with-parkhurst-nuvision https://ophthalmologybreakingnews.com/files/images/blog_notal-visions-home-based-oct-trial-shows-promising-results-in-managing-wet-amd.jpg https://ophthalmologybreakingnews.com/notal-visions-oct-trial-shows-promising-results-in-wet-amd 2024-06-26T08:00:02+03:00 en https://ophthalmologybreakingnews.com/notal-visions-oct-trial-shows-promising-results-in-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_ani-pharmaceuticals-to-acquire-alimera-sciences-in-381-million-deal.jpg https://ophthalmologybreakingnews.com/ani-pharmaceuticals-to-acquire-alimera-sciences 2024-06-25T16:30:13+03:00 en https://ophthalmologybreakingnews.com/ani-pharmaceuticals-to-acquire-alimera-sciences https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-alcons-unity-vitreoretinal-cataract-system-and-unity-standalone-cataract-system.jpg https://ophthalmologybreakingnews.com/fda-clears-alcons-unity-vitreoretinal-cataract-system 2025-01-31T15:10:05+03:00 en https://ophthalmologybreakingnews.com/fda-clears-alcons-unity-vitreoretinal-cataract-system https://ophthalmologybreakingnews.com/files/images/blog_4dmt-receives-fda-clearance-of-ind-application-for-4d-175-for-ga-treatment.jpg https://ophthalmologybreakingnews.com/4dmt-receives-fda-clearance-of-ind-application-for-ga-treatment- 2024-06-25T13:14:40+03:00 en https://ophthalmologybreakingnews.com/4dmt-receives-fda-clearance-of-ind-application-for-ga-treatment- https://ophthalmologybreakingnews.com/files/images/blog_ikerian-receives-eu-mdr-certificate-for-four-ai-based-medical-devices.jpg https://ophthalmologybreakingnews.com/ikerian-receives-eu-mdr-certificate-for-four-medical-devices 2024-06-25T12:38:10+03:00 en https://ophthalmologybreakingnews.com/ikerian-receives-eu-mdr-certificate-for-four-medical-devices https://ophthalmologybreakingnews.com/files/images/blog_harrow-pharmaceuticals-initiates-triesence-relaunch-strategy.jpg https://ophthalmologybreakingnews.com/harrow-initiates-triesence-relaunch-strategy 2024-06-24T10:11:43+03:00 en https://ophthalmologybreakingnews.com/harrow-initiates-triesence-relaunch-strategy https://ophthalmologybreakingnews.com/files/images/blog_researchers-investigate-impact-of-altered-gravity-on-eye-health-in-space-travel.jpg https://ophthalmologybreakingnews.com/researchers-investigate-impact-of-altered-gravity-on-eye-health 2024-06-24T14:24:36+03:00 en https://ophthalmologybreakingnews.com/researchers-investigate-impact-of-altered-gravity-on-eye-health https://ophthalmologybreakingnews.com/files/images/blog_neurotech-pharmaceuticals-nt-501-granted-priority-review-by-fda-for-macular-telangiectasia-type-2.jpg https://ophthalmologybreakingnews.com/neurotech-nt-501-granted-priority-review-by-fda 2025-01-31T14:17:01+03:00 en https://ophthalmologybreakingnews.com/neurotech-nt-501-granted-priority-review-by-fda https://ophthalmologybreakingnews.com/files/images/blog_aurion-biotechs-aurn001-receives-fda-breakthrough-and-rmat-designations-for-corneal-edema-therapy.jpg https://ophthalmologybreakingnews.com/aurn001-receives-fda-breakthrough-and-rmat-designations 2024-06-21T13:32:41+03:00 en https://ophthalmologybreakingnews.com/aurn001-receives-fda-breakthrough-and-rmat-designations https://ophthalmologybreakingnews.com/files/images/blog_ocugen-initiates-phase-3-clinical-trial-for-ocu400-gene-therapy-for-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/ocugen-initiates-clinical-trial-for-ocu400-for-retinitis-pigmentosa 2025-01-31T14:05:43+03:00 en https://ophthalmologybreakingnews.com/ocugen-initiates-clinical-trial-for-ocu400-for-retinitis-pigmentosa https://ophthalmologybreakingnews.com/files/images/blog_novel-treatment-for-diabetic-retinopathy-shows-promise-in-early-studies.jpg https://ophthalmologybreakingnews.com/novel-treatment-for-diabetic-retinopathy-shows-promise 2024-10-16T09:53:40+03:00 en https://ophthalmologybreakingnews.com/novel-treatment-for-diabetic-retinopathy-shows-promise https://ophthalmologybreakingnews.com/files/images/blog_revopsis-and-kemwell-forge-manufacturing-partnership-for-namd-treatment.jpg https://ophthalmologybreakingnews.com/revopsis-and-kemwell-forge-partnership-for-namd-treatment 2024-06-21T08:18:47+03:00 en https://ophthalmologybreakingnews.com/revopsis-and-kemwell-forge-partnership-for-namd-treatment https://ophthalmologybreakingnews.com/files/images/blog_jjs-nipocalimab-shows-promising-results-in-phase-2-study-for-sjogrens-disease.jpg https://ophthalmologybreakingnews.com/jjs-nipocalimab-shows-promising-results-for-sjogrens 2024-06-20T10:48:32+03:00 en https://ophthalmologybreakingnews.com/jjs-nipocalimab-shows-promising-results-for-sjogrens https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-secures-17m-funding-from-foundation-fighting-blindness-for-two-preclinical-programs.jpg https://ophthalmologybreakingnews.com/opus-genetics-secures-funding-for-two-preclinical-programs 2024-06-24T08:32:15+03:00 en https://ophthalmologybreakingnews.com/opus-genetics-secures-funding-for-two-preclinical-programs https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/device-targets-dry-eye-and-beyond-with-thermal-imaging 2024-06-13T13:16:58+03:00 en https://ophthalmologybreakingnews.com/device-targets-dry-eye-and-beyond-with-thermal-imaging https://ophthalmologybreakingnews.com/files/images/blog_teprotumumab-shows-long-lasting-benefits-for-thyroid-eye-disease-patients.jpg https://ophthalmologybreakingnews.com/teprotumumab-shows-long-lasting-benefits-for-ted-patients 2024-06-13T09:38:56+03:00 en https://ophthalmologybreakingnews.com/teprotumumab-shows-long-lasting-benefits-for-ted-patients https://ophthalmologybreakingnews.com/files/images/blog_beacon-therapeutics-initiates-vista-trial-with-agtc-501-for-x-linked-rp.jpg https://ophthalmologybreakingnews.com/beacon-therapeutics-initiates-vista-trial-with-for-rp 2024-06-13T08:48:44+03:00 en https://ophthalmologybreakingnews.com/beacon-therapeutics-initiates-vista-trial-with-for-rp https://ophthalmologybreakingnews.com/files/images/blog_robot-radiotherapy-could-improve-treatment-for-wet-amd.jpg https://ophthalmologybreakingnews.com/robot-radiotherapy-could-improve-treatment-for-wet-amd 2024-06-12T14:08:41+03:00 en https://ophthalmologybreakingnews.com/robot-radiotherapy-could-improve-treatment-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_oculis-licaminlimab-demonstrates-promising-results-in-phase-2b-relief-trial-for-ded.jpg https://ophthalmologybreakingnews.com/licaminlimab-demonstrates-promising-results-for-ded 2024-06-20T11:15:18+03:00 en https://ophthalmologybreakingnews.com/licaminlimab-demonstrates-promising-results-for-ded https://ophthalmologybreakingnews.com/files/images/blog_melatonin-use-linked-to-reduced-risk-of-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/melatonin-use-linked-to-reduced-risk-of-amd 2024-06-12T09:50:52+03:00 en https://ophthalmologybreakingnews.com/melatonin-use-linked-to-reduced-risk-of-amd https://ophthalmologybreakingnews.com/files/images/blog_australias-second-generation-bionic-eye-shows-promise-in-rp-clinical-trial.jpg https://ophthalmologybreakingnews.com/2nd-generation-bionic-eye-shows-promise-in-rp-clinical-trial 2024-06-11T13:08:40+03:00 en https://ophthalmologybreakingnews.com/2nd-generation-bionic-eye-shows-promise-in-rp-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_skye-bioscience-shifts-focus-after-phase-2-glaucoma-trial-fails.jpg https://ophthalmologybreakingnews.com/skye-shifts-focus-after-phase-2-glaucoma-trial-fails 2024-06-11T09:49:44+03:00 en https://ophthalmologybreakingnews.com/skye-shifts-focus-after-phase-2-glaucoma-trial-fails https://ophthalmologybreakingnews.com/files/images/blog_nidek-receives-ce-mark-for-np-1-np-1c-preloaded-iol-injection-system.jpg https://ophthalmologybreakingnews.com/nidek-receives-ce-mark-preloaded-iol-injection-system 2024-06-11T08:26:34+03:00 en https://ophthalmologybreakingnews.com/nidek-receives-ce-mark-preloaded-iol-injection-system https://ophthalmologybreakingnews.com/files/images/blog_your-complete-guide-to-cataract-surgery-in-2024.jpg https://ophthalmologybreakingnews.com/your-complete-guide-to-cataract-surgery 2024-06-10T15:09:14+03:00 en https://ophthalmologybreakingnews.com/your-complete-guide-to-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_the-revolutionary-phacoemulsification-procedure-an-in-depth-look-at-modern-cataract-surgery.jpg https://ophthalmologybreakingnews.com/the-revolutionary-phacoemulsification-procedure 2024-10-21T09:01:08+03:00 en https://ophthalmologybreakingnews.com/the-revolutionary-phacoemulsification-procedure https://ophthalmologybreakingnews.com/files/images/blog_intracapsular-cataract-extraction-icce-indications-complications-and-management.jpg https://ophthalmologybreakingnews.com/intracapsular-cataract-extraction-icce 2025-01-16T09:42:19+03:00 en https://ophthalmologybreakingnews.com/intracapsular-cataract-extraction-icce https://ophthalmologybreakingnews.com/files/images/blog_explaining-the-procedure-extracapsular-cataract-extraction-ecce.jpg https://ophthalmologybreakingnews.com/extracapsular-cataract-extraction-ecce 2025-01-27T09:20:55+03:00 en https://ophthalmologybreakingnews.com/extracapsular-cataract-extraction-ecce https://ophthalmologybreakingnews.com/files/images/blog_eye-lightr-device-receives-ce-mark-for-dry-amd-and-extended-anterior-segment-pathologies.jpg https://ophthalmologybreakingnews.com/eye-light®-device-receives-ce-mark 2025-01-31T15:07:17+03:00 en https://ophthalmologybreakingnews.com/eye-light®-device-receives-ce-mark https://ophthalmologybreakingnews.com/files/images/blog_melt-pharmaceuticals-initiates-phase-3-program-for-melt-300-opioid-free-sedation.jpg https://ophthalmologybreakingnews.com/melt-pharma-initiates-phase-3-program-for-opioid-free-sedation 2024-06-07T13:53:04+03:00 en https://ophthalmologybreakingnews.com/melt-pharma-initiates-phase-3-program-for-opioid-free-sedation https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-novel-approach-to-combat-age-related-vision-loss.jpg https://ophthalmologybreakingnews.com/researchers-discover-novel-approach-to-combat-vision-loss 2024-10-04T09:31:51+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-novel-approach-to-combat-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_rayner-announces-three-key-appointments-to-management-board.jpg https://ophthalmologybreakingnews.com/rayner-announces-three-key-appointments-to-management-board 2024-06-06T15:45:00+03:00 en https://ophthalmologybreakingnews.com/rayner-announces-three-key-appointments-to-management-board https://ophthalmologybreakingnews.com/files/images/blog_harrow-announces-promising-52-week-data-from-vevye-essence-2-clinical-study.jpg https://ophthalmologybreakingnews.com/harrow-announces-data-from-vevye-essence-2-study 2024-06-06T13:18:30+03:00 en https://ophthalmologybreakingnews.com/harrow-announces-data-from-vevye-essence-2-study https://ophthalmologybreakingnews.com/files/images/blog_reuters-italy-launches-probe-into-pharma-giants-for-market-manipulation.jpg https://ophthalmologybreakingnews.com/italy-launches-probe-into-pharma-giants 2024-06-06T10:59:35+03:00 en https://ophthalmologybreakingnews.com/italy-launches-probe-into-pharma-giants https://ophthalmologybreakingnews.com/files/images/blog_eversight-teams-up-with-lightoptech-to-improve-imaging-modalities-for-eye-tissues.jpg https://ophthalmologybreakingnews.com/eversight-teams-up-with-lightoptech- 2024-06-06T10:08:34+03:00 en https://ophthalmologybreakingnews.com/eversight-teams-up-with-lightoptech- https://ophthalmologybreakingnews.com/files/images/blog_corneagen-launches-ctak-a-novel-solution-for-keratoconus-patients.jpg https://ophthalmologybreakingnews.com/corneagen-launches-ctak-for-keratoconus 2024-06-05T15:48:35+03:00 en https://ophthalmologybreakingnews.com/corneagen-launches-ctak-for-keratoconus https://ophthalmologybreakingnews.com/files/images/blog_biophta-raises-e65m-to-advance-eye-disease-therapies-to-clinical-stage.jpg https://ophthalmologybreakingnews.com/biophta-raises-65m-to-advance-eye-disease-therapies 2024-06-05T14:34:55+03:00 en https://ophthalmologybreakingnews.com/biophta-raises-65m-to-advance-eye-disease-therapies https://ophthalmologybreakingnews.com/files/images/blog_azura-ophthalmics-initiates-phase-3-clinical-trial-for-azr-md-001-in-patients-with-mgd.jpg https://ophthalmologybreakingnews.com/azura-initiates-clinical-trial-for-patients-with-mgd 2024-06-05T10:42:53+03:00 en https://ophthalmologybreakingnews.com/azura-initiates-clinical-trial-for-patients-with-mgd https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-blink-nutritears-for-dry-eye-symptoms.jpg https://ophthalmologybreakingnews.com/bausch-lomb-launches-blink-nutritears-for-dry-eye 2025-01-31T14:14:29+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-launches-blink-nutritears-for-dry-eye https://ophthalmologybreakingnews.com/files/images/blog_nidek-launches-the-rs-1-glauvas-optical-coherence-tomography.jpg https://ophthalmologybreakingnews.com/nidek-launches-rs-1-glauvas-oct 2025-01-27T11:40:33+03:00 en https://ophthalmologybreakingnews.com/nidek-launches-rs-1-glauvas-oct https://ophthalmologybreakingnews.com/files/images/blog_biotissue-unveils-cam360-amniograft-therapy-for-dry-eye-and-ocular-surface-disorders.jpg https://ophthalmologybreakingnews.com/biotissue-cam360-amniograft-therapy-for-dry-eye 2024-06-07T14:52:22+03:00 en https://ophthalmologybreakingnews.com/biotissue-cam360-amniograft-therapy-for-dry-eye https://ophthalmologybreakingnews.com/files/images/blog_lambdavision-secures-funding-to-propel-artificial-retina-development.jpg https://ophthalmologybreakingnews.com/lambdavision-secures-funding-to-propel-artificial-retina 2024-06-03T14:31:26+03:00 en https://ophthalmologybreakingnews.com/lambdavision-secures-funding-to-propel-artificial-retina https://ophthalmologybreakingnews.com/files/images/blog_sightpath-medical-acquires-lasik-services-provider-pennvista.jpg https://ophthalmologybreakingnews.com/sightpath-medical-acquires-pennvista 2024-06-03T11:01:05+03:00 en https://ophthalmologybreakingnews.com/sightpath-medical-acquires-pennvista https://ophthalmologybreakingnews.com/files/images/blog_nordic-pharma-launches-lacrifill-canalicular-gel-to-combat-dry-eye.jpg https://ophthalmologybreakingnews.com/lacrifill-canalicular-gel-to-combat-dry-eye 2024-06-20T10:57:06+03:00 en https://ophthalmologybreakingnews.com/lacrifill-canalicular-gel-to-combat-dry-eye https://ophthalmologybreakingnews.com/files/images/blog_quantel-medical-introduces-pocket-iii-the-lightest-handheld-pachymeter.jpg https://ophthalmologybreakingnews.com/quantel-medical-introduces-pocket-iii- 2024-05-31T13:05:02+03:00 en https://ophthalmologybreakingnews.com/quantel-medical-introduces-pocket-iii- https://ophthalmologybreakingnews.com/files/images/blog_zeiss-unveils-upgraded-cirrus-6000-oct.jpg https://ophthalmologybreakingnews.com/zeiss-unveils-upgraded-cirrus-6000-oct 2024-05-31T10:12:10+03:00 en https://ophthalmologybreakingnews.com/zeiss-unveils-upgraded-cirrus-6000-oct https://ophthalmologybreakingnews.com/files/images/blog_new-eyeglass-lens-technology-offers-relief-for-migraine-patients.jpg https://ophthalmologybreakingnews.com/eyeglass-lens-tech-offers-relief-for-migraine-patients 2024-06-04T10:05:55+03:00 en https://ophthalmologybreakingnews.com/eyeglass-lens-tech-offers-relief-for-migraine-patients https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-aaos-assessment-tool-for-advancing-premium-iol-cataract-surgery.jpg https://ophthalmologybreakingnews.com/fda-approves-assessment-tool-for-iol-cataract-surgery 2024-05-30T15:49:42+03:00 en https://ophthalmologybreakingnews.com/fda-approves-assessment-tool-for-iol-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_entod-pharma-introduces-vitamin-d3-enriched-eye-drops-for-dry-eyes.jpg https://ophthalmologybreakingnews.com/entod-introduces-vitamin-d3-eye-drops-for-dry-eyes 2025-01-31T15:08:46+03:00 en https://ophthalmologybreakingnews.com/entod-introduces-vitamin-d3-eye-drops-for-dry-eyes https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-drug-farms-ind-application-for-df-003-in-rosah-syndrome-patients.jpg https://ophthalmologybreakingnews.com/fda-clears-drug-farms-ind-application-for-df-003 2024-05-30T10:22:10+03:00 en https://ophthalmologybreakingnews.com/fda-clears-drug-farms-ind-application-for-df-003 https://ophthalmologybreakingnews.com/files/images/blog_merck-co-nears-13-billion-acquisition-of-eyebiotech-wsj-reports.jpg https://ophthalmologybreakingnews.com/merck-nears-$13-billion-acquisition-of-eyebiotech 2024-05-29T15:54:33+03:00 en https://ophthalmologybreakingnews.com/merck-nears-$13-billion-acquisition-of-eyebiotech https://ophthalmologybreakingnews.com/files/images/blog_usc-roski-eye-institute-investigates-promising-therapies-for-ted.jpg https://ophthalmologybreakingnews.com/usc-roski-investigates-promising-therapies-for-ted 2024-05-29T15:31:46+03:00 en https://ophthalmologybreakingnews.com/usc-roski-investigates-promising-therapies-for-ted https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-granted-european-authorization-for-lytenava-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-granted-european-authorization-for-lytenava 2024-05-29T08:37:36+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-granted-european-authorization-for-lytenava https://ophthalmologybreakingnews.com/files/images/blog_opthea-announces-completion-of-enrollment-in-phase-3-trials-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/opthea-announces-completion-of-enrollment- 2024-05-28T16:41:42+03:00 en https://ophthalmologybreakingnews.com/opthea-announces-completion-of-enrollment- https://ophthalmologybreakingnews.com/files/images/blog_exonate-expands-leadership-team-with-addition-of-dr-rafiq-hasan.jpg https://ophthalmologybreakingnews.com/exonate-expands-leadership-team-with-dr-rafiq-hasan 2024-05-28T11:49:58+03:00 en https://ophthalmologybreakingnews.com/exonate-expands-leadership-team-with-dr-rafiq-hasan https://ophthalmologybreakingnews.com/files/images/blog_brazilian-study-finds-low-occurrence-of-ocular-metastases-in-retrospective-analysis.jpg https://ophthalmologybreakingnews.com/study-finds-low-occurrence-of-ocular-metastases 2024-10-04T09:40:37+03:00 en https://ophthalmologybreakingnews.com/study-finds-low-occurrence-of-ocular-metastases https://ophthalmologybreakingnews.com/files/images/blog_the-impact-of-screen-time-on-childrens-eye-health-how-much-is-too-much.jpg https://ophthalmologybreakingnews.com/screen-time-on-childrens-eye-health 2024-05-30T14:10:00+03:00 en https://ophthalmologybreakingnews.com/screen-time-on-childrens-eye-health https://ophthalmologybreakingnews.com/files/images/blog_new-type-of-neuron-discovered-to-guide-formation-of-retinal-blood-vessel-lattice.jpg https://ophthalmologybreakingnews.com/neuron-to-guide-formation-of-retinal-blood-vessel-lattice 2024-05-27T10:48:20+03:00 en https://ophthalmologybreakingnews.com/neuron-to-guide-formation-of-retinal-blood-vessel-lattice https://ophthalmologybreakingnews.com/files/images/blog_researchers-investigate-the-effects-of-pegcetacoplan-on-ga-progression.jpg https://ophthalmologybreakingnews.com/the-effects-of-pegcetacoplan-on-ga-progression 2024-05-24T14:09:04+03:00 en https://ophthalmologybreakingnews.com/the-effects-of-pegcetacoplan-on-ga-progression https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-submits-uk-marketing-authorisation-application-for-wet-amd-drug.jpg https://ophthalmologybreakingnews.com/outlook-therapeutics-submits-uk-maa-for-wet-amd-drug 2024-05-24T10:03:25+03:00 en https://ophthalmologybreakingnews.com/outlook-therapeutics-submits-uk-maa-for-wet-amd-drug https://ophthalmologybreakingnews.com/files/images/blog_rezolute-announces-positive-phase-2-results-for-oral-drug-in-dme-patients.jpg https://ophthalmologybreakingnews.com/positive-phase-2-results-for-oral-drug-in-dme-patients 2024-05-23T10:02:22+03:00 en https://ophthalmologybreakingnews.com/positive-phase-2-results-for-oral-drug-in-dme-patients https://ophthalmologybreakingnews.com/files/images/blog_kdb-glider-receives-fda-510k-clearance-for-expanded-indication-in-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/fda-greenlights-kdb-glide-for-glaucoma 2024-05-23T08:43:34+03:00 en https://ophthalmologybreakingnews.com/fda-greenlights-kdb-glide-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_residential-inequity-linked-to-higher-rates-of-vision-difficulty-and-blindness.jpg https://ophthalmologybreakingnews.com/residential-inequity-higher-rates-of-vision-issues 2024-05-22T14:33:12+03:00 en https://ophthalmologybreakingnews.com/residential-inequity-higher-rates-of-vision-issues https://ophthalmologybreakingnews.com/files/images/blog_healthycell-introduces-eye-health-microgel-supplement-for-vision-support.jpg https://ophthalmologybreakingnews.com/healthycell-introduces-eye-health-microgel-supplement 2024-05-22T10:32:39+03:00 en https://ophthalmologybreakingnews.com/healthycell-introduces-eye-health-microgel-supplement https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedical-publishes-guidelines-for-suprachoroidal-space-drug-delivery.jpg https://ophthalmologybreakingnews.com/clearside-biomedical-publishes-guidelines-for-suprachoroidal-space-drug-delivery 2024-05-22T09:54:20+03:00 en https://ophthalmologybreakingnews.com/clearside-biomedical-publishes-guidelines-for-suprachoroidal-space-drug-delivery https://ophthalmologybreakingnews.com/files/images/blog_innovents-nda-for-ted-treatment-granted-priority-review-in-china.jpg https://ophthalmologybreakingnews.com/innovents-nda-for-ted-granted-priority-review-in-china 2024-05-21T15:36:42+03:00 en https://ophthalmologybreakingnews.com/innovents-nda-for-ted-granted-priority-review-in-china https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-biocon-biologics-yesafilit-interchangeable-biosimilar-eylea.jpg https://ophthalmologybreakingnews.com/fda-approves-biocon-biologics-yesafili 2024-05-21T10:16:52+03:00 en https://ophthalmologybreakingnews.com/fda-approves-biocon-biologics-yesafili https://ophthalmologybreakingnews.com/files/images/blog_researchers-pioneer-new-oct-technique-for-scleral-structure-analysis.jpg https://ophthalmologybreakingnews.com/new-oct-technique-for-scleral-structure-analysis 2024-05-21T09:56:57+03:00 en https://ophthalmologybreakingnews.com/new-oct-technique-for-scleral-structure-analysis https://ophthalmologybreakingnews.com/files/images/blog_limiting-certain-light-exposure-can-help-prevent-inherited-retinal-dystrophy.jpg https://ophthalmologybreakingnews.com/limiting-light-exposure-prevent-inherited-retinal-dystrophy 2024-05-20T14:13:56+03:00 en https://ophthalmologybreakingnews.com/limiting-light-exposure-prevent-inherited-retinal-dystrophy https://ophthalmologybreakingnews.com/files/images/blog_novel-resin-technology-could-improve-3d-printing-of-intraocular-devices.jpg https://ophthalmologybreakingnews.com/novel-resin-tech-improve-3d-printing-of-intraocular-devices 2024-05-20T12:22:13+03:00 en https://ophthalmologybreakingnews.com/novel-resin-tech-improve-3d-printing-of-intraocular-devices https://ophthalmologybreakingnews.com/files/images/blog_wayne-state-university-secures-21m-grant-for-diabetes-related-eye-study.jpg https://ophthalmologybreakingnews.com/national-eye-institute-award-diabetes-research 2024-05-17T13:15:45+03:00 en https://ophthalmologybreakingnews.com/national-eye-institute-award-diabetes-research https://ophthalmologybreakingnews.com/files/images/blog_reichert-technologies-introduces-tono-vera-tonometer-with-actiview.jpg https://ophthalmologybreakingnews.com/reichert-introduces-tono-vera-tonometer-with-actiview 2024-05-17T10:46:37+03:00 en https://ophthalmologybreakingnews.com/reichert-introduces-tono-vera-tonometer-with-actiview https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-glenmarks-ophthalmic-solution-for-glaucoma-bioequivalent-to-allergans-combigan.jpg https://ophthalmologybreakingnews.com/fda-approves-glenmarks-ophthalmic-solution-for-glaucoma 2024-05-17T10:08:11+03:00 en https://ophthalmologybreakingnews.com/fda-approves-glenmarks-ophthalmic-solution-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_6-tips-on-how-to-choose-the-right-artificial-tears-for-dry-eyes.jpg https://ophthalmologybreakingnews.com/6-tips-on-how-to-choose-the-right-artificial-tears 2024-05-29T09:13:23+03:00 en https://ophthalmologybreakingnews.com/6-tips-on-how-to-choose-the-right-artificial-tears https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-de-novo-authorization-for-notal-visions-scanly-home-oct-device.jpg https://ophthalmologybreakingnews.com/fda-grants-de-novo-authorization-for-scanly-home-oct 2024-05-17T08:35:40+03:00 en https://ophthalmologybreakingnews.com/fda-grants-de-novo-authorization-for-scanly-home-oct https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-covid-19-virus-can-breach-retinal-barrier.jpg https://ophthalmologybreakingnews.com/covid-19-virus-can-breach-retinal-barrier 2024-05-16T13:42:05+03:00 en https://ophthalmologybreakingnews.com/covid-19-virus-can-breach-retinal-barrier https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-unveils-3d-imaging-option-for-the-imaging-module-910.jpg https://ophthalmologybreakingnews.com/haag-streit-unveils-3d-imaging-option-for-imaging-module-910 2024-05-16T11:03:52+03:00 en https://ophthalmologybreakingnews.com/haag-streit-unveils-3d-imaging-option-for-imaging-module-910 https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-eye-tracking-smart-contact-lenses-with-radio-frequency-tags.jpg https://ophthalmologybreakingnews.com/eye-tracking-smart-contact-lenses-with-radio-frequency-tags 2024-05-16T09:01:21+03:00 en https://ophthalmologybreakingnews.com/eye-tracking-smart-contact-lenses-with-radio-frequency-tags https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-key-risk-factors-for-hydroxychloroquine-retinopathy.jpg https://ophthalmologybreakingnews.com/study-reveals-risk-factors-for-hydroxychloroquine-retinopathy 2024-06-20T11:08:31+03:00 en https://ophthalmologybreakingnews.com/study-reveals-risk-factors-for-hydroxychloroquine-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_beyeonics-vision-installs-first-beyeonics-one-digital-exoscope.jpg https://ophthalmologybreakingnews.com/beyeonics-installs-first-beyeonics-one-digital-exoscope- 2024-05-15T08:36:22+03:00 en https://ophthalmologybreakingnews.com/beyeonics-installs-first-beyeonics-one-digital-exoscope- https://ophthalmologybreakingnews.com/files/images/blog_artiolsr-first-inverted-meniscus-optics-iols-delivering-superior-peripheral-vision.jpg https://ophthalmologybreakingnews.com/first-inverted-meniscus-optics-iols-artiols-by-voptica 2024-12-11T09:16:10+03:00 en https://ophthalmologybreakingnews.com/first-inverted-meniscus-optics-iols-artiols-by-voptica https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-innovative-soft-contact-lens-for-precise-retinal-monitoring.jpg https://ophthalmologybreakingnews.com/soft-contact-lens-for-precise-retinal-monitoring 2024-05-14T13:51:35+03:00 en https://ophthalmologybreakingnews.com/soft-contact-lens-for-precise-retinal-monitoring https://ophthalmologybreakingnews.com/files/images/blog_landmark-research-proposes-ranibizumab-over-laser-for-rop-treatment.jpg https://ophthalmologybreakingnews.com/research-proposes-ranibizumab-over-laser-for-rop-treatment 2024-05-14T10:29:13+03:00 en https://ophthalmologybreakingnews.com/research-proposes-ranibizumab-over-laser-for-rop-treatment https://ophthalmologybreakingnews.com/files/images/blog_arcscans-insightr-100-ophthalmic-ultrasound-imaging-system-receives-approval-in-china.jpg https://ophthalmologybreakingnews.com/arcscans-insight-100-receives-approval-in-china 2024-05-14T09:13:31+03:00 en https://ophthalmologybreakingnews.com/arcscans-insight-100-receives-approval-in-china https://ophthalmologybreakingnews.com/files/images/blog_new-research-unravels-pupil-response-to-glossy-objects.jpg https://ophthalmologybreakingnews.com/research-unravels-pupil-response-to-glossy-objects 2024-05-13T13:28:11+03:00 en https://ophthalmologybreakingnews.com/research-unravels-pupil-response-to-glossy-objects https://ophthalmologybreakingnews.com/files/images/blog_humonix-biosciences-names-karen-torrejon-phd-as-ceo.jpg https://ophthalmologybreakingnews.com/humonix-biosciences-names-karen-torrejon-as-ceo 2024-05-13T10:59:37+03:00 en https://ophthalmologybreakingnews.com/humonix-biosciences-names-karen-torrejon-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_eyecro-announces-promising-clinical-data-for-midrops-technology.jpg https://ophthalmologybreakingnews.com/eyecro-announces-clinical-data-for-midrops-technology- 2024-05-13T09:31:48+03:00 en https://ophthalmologybreakingnews.com/eyecro-announces-clinical-data-for-midrops-technology- https://ophthalmologybreakingnews.com/files/images/blog_breakthrough-smart-contact-lens-measures-eye-pressure-in-all-temperatures.jpg https://ophthalmologybreakingnews.com/smart-contact-lens-measures-eye-pressure-in-all-temperatures 2024-05-10T16:00:49+03:00 en https://ophthalmologybreakingnews.com/smart-contact-lens-measures-eye-pressure-in-all-temperatures https://ophthalmologybreakingnews.com/files/images/blog_topcon-partners-with-microsoft-to-deliver-ai-powered-lhealthcare-from-the-eye.jpg https://ophthalmologybreakingnews.com/topcon-partners-with-microsoft-to-deliver 2024-05-10T13:44:05+03:00 en https://ophthalmologybreakingnews.com/topcon-partners-with-microsoft-to-deliver https://ophthalmologybreakingnews.com/files/images/blog_understanding-retinopathy-of-prematurity-causes-symptoms-and-treatments.jpg https://ophthalmologybreakingnews.com/retinopathy-of-prematurity-causes-symptoms-and-treatments 2024-05-10T11:28:20+03:00 en https://ophthalmologybreakingnews.com/retinopathy-of-prematurity-causes-symptoms-and-treatments https://ophthalmologybreakingnews.com/files/images/blog_oculis-completes-enrollment-of-phase-2-trial-with-ocs-05-for-acute-optic-neuritis.jpg https://ophthalmologybreakingnews.com/oculis-completes-enrollment-of-trial-for-acute-optic-neuritis 2024-05-10T09:29:23+03:00 en https://ophthalmologybreakingnews.com/oculis-completes-enrollment-of-trial-for-acute-optic-neuritis https://ophthalmologybreakingnews.com/files/images/blog_new-contact-lens-uses-lubricant-producing-bacteria-to-combat-dry-eye.jpg https://ophthalmologybreakingnews.com/lens-uses-lubricant-producing-bacteria-to-combat-dry-eye 2024-05-09T16:02:53+03:00 en https://ophthalmologybreakingnews.com/lens-uses-lubricant-producing-bacteria-to-combat-dry-eye https://ophthalmologybreakingnews.com/files/images/blog_innovative-3d-retinal-electrodes-developed-to-restore-vision-in-blind-patients.jpg https://ophthalmologybreakingnews.com/3d-retinal-electrodes-developed-to-restore-vision-in-blind 2024-05-09T09:37:17+03:00 en https://ophthalmologybreakingnews.com/3d-retinal-electrodes-developed-to-restore-vision-in-blind https://ophthalmologybreakingnews.com/files/images/blog_smart-contact-lenses-developed-for-real-time-blood-glucose-monitoring.jpg https://ophthalmologybreakingnews.com/smart-lenses-developed-for-blood-glucose-monitoring 2024-05-09T09:21:41+03:00 en https://ophthalmologybreakingnews.com/smart-lenses-developed-for-blood-glucose-monitoring https://ophthalmologybreakingnews.com/files/images/blog_uv-radiation-at-outdoor-events-linked-to-photokeratitis-study-shows.jpg https://ophthalmologybreakingnews.com/uv-radiation-at-outdoor-events-linked-to-photokeratitis 2024-05-08T14:47:46+03:00 en https://ophthalmologybreakingnews.com/uv-radiation-at-outdoor-events-linked-to-photokeratitis https://ophthalmologybreakingnews.com/files/images/blog_staar-surgical-partners-with-iq-laser-vision-to-expand-evo-icl-use-in-the-us.jpg https://ophthalmologybreakingnews.com/staar-surgical-partners-with-iq-laser-vision 2024-05-08T13:19:55+03:00 en https://ophthalmologybreakingnews.com/staar-surgical-partners-with-iq-laser-vision https://ophthalmologybreakingnews.com/files/images/blog_asclepix-therapeutics-completes-discover-trial-enrollment-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/asclepix-completes-discover-trial-enrollment-for-wet-amd 2024-05-08T11:50:21+03:00 en https://ophthalmologybreakingnews.com/asclepix-completes-discover-trial-enrollment-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_alcon-to-acquire-belkin-vision-for-up-to-325-million.jpg https://ophthalmologybreakingnews.com/alcon-to-acquire-belkin-vision-for-up-to-$325M 2025-02-04T10:45:17+03:00 en https://ophthalmologybreakingnews.com/alcon-to-acquire-belkin-vision-for-up-to-$325M https://ophthalmologybreakingnews.com/files/images/blog_novel-gene-therapy-improves-vision-in-children-with-leber-congenital-amaurosis.jpg https://ophthalmologybreakingnews.com/novel-gene-therapy-improves-vision-in-children-with-lca 2024-05-07T14:43:00+03:00 en https://ophthalmologybreakingnews.com/novel-gene-therapy-improves-vision-in-children-with-lca https://ophthalmologybreakingnews.com/files/images/blog_eye-ultrasound-proves-effective-for-pediatric-brain-shunt-failures.jpg https://ophthalmologybreakingnews.com/eye-ultrasound-effective-for-pediatric-brain-shunt-failures 2024-05-07T13:04:38+03:00 en https://ophthalmologybreakingnews.com/eye-ultrasound-effective-for-pediatric-brain-shunt-failures https://ophthalmologybreakingnews.com/files/images/blog_eyepoints-duravyu-fails-to-achieve-primary-efficacy-endpoint-in-npdr-phase-2-trial.jpg https://ophthalmologybreakingnews.com/eyepoints-duravyu-fails-to-achieve-primary-efficacy-endpoint 2024-05-07T10:36:41+03:00 en https://ophthalmologybreakingnews.com/eyepoints-duravyu-fails-to-achieve-primary-efficacy-endpoint https://ophthalmologybreakingnews.com/files/images/blog_ora-and-singapore-eye-research-institute-partner-to-advance-ophthalmic-research.jpg https://ophthalmologybreakingnews.com/ora-and-seri-partner-to-advance-ophthalmic-research 2024-05-07T10:17:55+03:00 en https://ophthalmologybreakingnews.com/ora-and-seri-partner-to-advance-ophthalmic-research https://ophthalmologybreakingnews.com/files/images/blog_lumibird-introduces-cdiag-next-generation-dry-eye-diagnostic-aid-platform.jpg https://ophthalmologybreakingnews.com/lumibird-introduces-cdiag-next-generation-dry 2024-05-06T13:32:43+03:00 en https://ophthalmologybreakingnews.com/lumibird-introduces-cdiag-next-generation-dry https://ophthalmologybreakingnews.com/files/images/blog_photophobia-in-ophthalmology-causes-and-management-strategies.jpg https://ophthalmologybreakingnews.com/photophobia-in-ophthalmology-causes-and-management 2024-06-24T10:44:41+03:00 en https://ophthalmologybreakingnews.com/photophobia-in-ophthalmology-causes-and-management https://ophthalmologybreakingnews.com/files/images/blog_new-research-reveals-benefits-of-early-patching-for-children-with-lazy-eye.jpg https://ophthalmologybreakingnews.com/research-reveals-benefits-of-early-patching-for-lazy-eye 2024-05-06T10:37:01+03:00 en https://ophthalmologybreakingnews.com/research-reveals-benefits-of-early-patching-for-lazy-eye https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-eluminexs-ind-application-for-trispecific-fusion-antibody-for-dme.jpg https://ophthalmologybreakingnews.com/fda-accepts-eluminexs-ind-application-for-trispecific-fusion 2024-05-06T09:52:52+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-eluminexs-ind-application-for-trispecific-fusion https://ophthalmologybreakingnews.com/files/images/blog_emmetrope-ophthalmics-completes-dosing-in-key-corneal-edema-trial.jpg https://ophthalmologybreakingnews.com/emmetrope-ophthalmics-completes-dosing-in-key-corneal-edema-trial 2024-05-02T14:43:15+03:00 en https://ophthalmologybreakingnews.com/emmetrope-ophthalmics-completes-dosing-in-key-corneal-edema-trial https://ophthalmologybreakingnews.com/files/images/blog_aurion-biotech-completes-enrollment-in-corneal-edema-clinical-trial.jpg https://ophthalmologybreakingnews.com/aurion-biotech-completes-enrollment-in-corneal-edema-clinical-trial 2025-01-31T14:23:35+03:00 en https://ophthalmologybreakingnews.com/aurion-biotech-completes-enrollment-in-corneal-edema-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_retispec-and-topcon-announce-collaboration-on-eye-based-ai-diagnostic-tool.jpg https://ophthalmologybreakingnews.com/retispec-and-topcon-collaborate-on-eye-based-ai-diagnostic-tool- 2024-05-02T10:18:52+03:00 en https://ophthalmologybreakingnews.com/retispec-and-topcon-collaborate-on-eye-based-ai-diagnostic-tool- https://ophthalmologybreakingnews.com/files/images/blog_fda-greenlights-aeye-healths-autonomous-ai-for-portable-diabetic-retinopathy-screening.jpg https://ophthalmologybreakingnews.com/fda-greenlights-aeye-healths-autonomous-ai-for-portable-dr-screening 2024-05-02T09:11:27+03:00 en https://ophthalmologybreakingnews.com/fda-greenlights-aeye-healths-autonomous-ai-for-portable-dr-screening https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-names-ali-tafreshi-as-president-and-ceo.jpg https://ophthalmologybreakingnews.com/topcon-names-ali-tafreshi-as-president-and-ceo- 2025-01-15T14:45:47+03:00 en https://ophthalmologybreakingnews.com/topcon-names-ali-tafreshi-as-president-and-ceo- https://ophthalmologybreakingnews.com/files/images/blog_inflammasome-therapeutics-initiates-clinical-trial-for-geographic-atrophy-treatment.jpg https://ophthalmologybreakingnews.com/inflammasome-therapeutics-initiates-clinical-trial-for-ga-treatment 2024-04-30T10:37:30+03:00 en https://ophthalmologybreakingnews.com/inflammasome-therapeutics-initiates-clinical-trial-for-ga-treatment https://ophthalmologybreakingnews.com/files/images/blog_study-finds-home-vision-tests-inadequate-for-detecting-neovascular-amd.jpg https://ophthalmologybreakingnews.com/home-vision-tests-inadequate-for-detecting-namd 2025-02-04T10:41:35+03:00 en https://ophthalmologybreakingnews.com/home-vision-tests-inadequate-for-detecting-namd https://ophthalmologybreakingnews.com/files/images/blog_alcon-hit-with-34m-penalty-for-patent-infringement-against-sight-sciences.jpg https://ophthalmologybreakingnews.com/alcon-hit-with-penalty-for-patent-infringement-against-sight-sciences 2025-01-28T09:26:54+03:00 en https://ophthalmologybreakingnews.com/alcon-hit-with-penalty-for-patent-infringement-against-sight-sciences https://ophthalmologybreakingnews.com/files/images/blog_eye-tracking-technology-offers-new-hope-for-brain-health-management.jpg https://ophthalmologybreakingnews.com/eye-tracking-tech-offers-new-hope-for-brain-health 2025-01-31T14:40:54+03:00 en https://ophthalmologybreakingnews.com/eye-tracking-tech-offers-new-hope-for-brain-health https://ophthalmologybreakingnews.com/files/images/blog_vision-therapy-what-it-is-and-who-can-benefit-from-it.jpg https://ophthalmologybreakingnews.com/vision-therapy-what-it-is-and-who-can-benefit-from-it 2024-06-24T10:49:20+03:00 en https://ophthalmologybreakingnews.com/vision-therapy-what-it-is-and-who-can-benefit-from-it https://ophthalmologybreakingnews.com/files/images/blog_naegis-pharma-secures-funding-to-advance-ophthalmic-drug-for-eye-diseases.jpg https://ophthalmologybreakingnews.com/naegis-secures-funding-to-advance-ophthalmic-drug- 2024-04-29T10:43:21+03:00 en https://ophthalmologybreakingnews.com/naegis-secures-funding-to-advance-ophthalmic-drug- https://ophthalmologybreakingnews.com/files/images/blog_lvpei-and-core-form-strategic-alliance-to-advance-global-eye-care-and-vision-science.jpg https://ophthalmologybreakingnews.com/lvpei-and-core-to-advance-global-eye-care- 2024-04-29T09:20:22+03:00 en https://ophthalmologybreakingnews.com/lvpei-and-core-to-advance-global-eye-care- https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-announces-promising-results-for-blink-nutritears-in-dry-eye-study.jpg https://ophthalmologybreakingnews.com/bausch-lomb-announces-promising-results-for-blink-nutritears- 2025-01-27T11:48:19+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-announces-promising-results-for-blink-nutritears- https://ophthalmologybreakingnews.com/files/images/blog_revopsis-therapeutics-secures-165m-to-advance-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/revopsis-secures-$165m-to-advance-wet-amd-treatment- 2024-04-26T10:14:16+03:00 en https://ophthalmologybreakingnews.com/revopsis-secures-$165m-to-advance-wet-amd-treatment- https://ophthalmologybreakingnews.com/files/images/blog_new-study-links-visual-impairment-to-increased-suicide-risk.jpg https://ophthalmologybreakingnews.com/study-links-visual-impairment-to-increased-suicide-risk 2024-04-25T13:13:21+03:00 en https://ophthalmologybreakingnews.com/study-links-visual-impairment-to-increased-suicide-risk https://ophthalmologybreakingnews.com/files/images/blog_5-dos-and-5-donts-after-laser-eye-surgery.jpg https://ophthalmologybreakingnews.com/5-dos-and-5-donts-after-laser-eye-surgery 2024-04-25T12:05:43+03:00 en https://ophthalmologybreakingnews.com/5-dos-and-5-donts-after-laser-eye-surgery https://ophthalmologybreakingnews.com/files/images/blog_eye-tests-could-monitor-neurodegeneration-in-parkinsons-disease.jpg https://ophthalmologybreakingnews.com/eye-tests-could-monitor-neurodegeneration-in-parkinsons-disease 2024-04-25T11:13:19+03:00 en https://ophthalmologybreakingnews.com/eye-tests-could-monitor-neurodegeneration-in-parkinsons-disease https://ophthalmologybreakingnews.com/files/images/blog_verana-health-launches-qdata-module-for-thyroid-eye-disease-research.jpg https://ophthalmologybreakingnews.com/verana-health-launches-qdata-module-for-ted-research 2024-04-25T09:53:40+03:00 en https://ophthalmologybreakingnews.com/verana-health-launches-qdata-module-for-ted-research https://ophthalmologybreakingnews.com/files/images/blog_lep-biomedical-secures-pre-seed-funding-to-advance-hyaguard-platform.jpg https://ophthalmologybreakingnews.com/lep-biomedical-secures-funding-to-advance-hyaguard-platform 2024-04-25T09:00:38+03:00 en https://ophthalmologybreakingnews.com/lep-biomedical-secures-funding-to-advance-hyaguard-platform https://ophthalmologybreakingnews.com/files/images/blog_saliogen-therapeutics-selects-sgt-1001-as-development-candidate-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/saliogen-selects-development-candidate-for-stargardt-disease 2024-04-24T13:11:55+03:00 en https://ophthalmologybreakingnews.com/saliogen-selects-development-candidate-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_phoenix-micron-partners-with-artikode-to-enhance-ophthalmic-imaging-with-ai.jpg https://ophthalmologybreakingnews.com/phoenix-micron-partners-with-artikode-for-ai-imaging 2024-04-24T10:44:44+03:00 en https://ophthalmologybreakingnews.com/phoenix-micron-partners-with-artikode-for-ai-imaging https://ophthalmologybreakingnews.com/files/images/blog_ocugen-completes-dosing-in-key-trial-for-geographic-atrophy-treatment.jpg https://ophthalmologybreakingnews.com/ocugen-completes-dosing-in-key-trial-for-ga-treatment 2024-04-24T09:09:19+03:00 en https://ophthalmologybreakingnews.com/ocugen-completes-dosing-in-key-trial-for-ga-treatment https://ophthalmologybreakingnews.com/files/images/blog_ihealthscreen-secures-us-patent-for-ai-based-glaucoma-detection-tool.jpg https://ophthalmologybreakingnews.com/ihealthscreen-secures-us-patent-for-glaucoma-detection-tool 2024-04-19T15:45:16+03:00 en https://ophthalmologybreakingnews.com/ihealthscreen-secures-us-patent-for-glaucoma-detection-tool https://ophthalmologybreakingnews.com/files/images/blog_entod-pharmaceuticals-receives-cdsco-approval-for-presbyopia-drug-in-india.jpg https://ophthalmologybreakingnews.com/entod-receives-cdsco-approval-for-presbyopia-drug- 2025-01-31T15:05:16+03:00 en https://ophthalmologybreakingnews.com/entod-receives-cdsco-approval-for-presbyopia-drug- https://ophthalmologybreakingnews.com/files/images/blog_researchers-identify-potential-genetic-targets-for-strabismus-treatment.jpg https://ophthalmologybreakingnews.com/researchers-identify-genetic-targets-for-strabismus-treatment 2024-04-19T10:33:48+03:00 en https://ophthalmologybreakingnews.com/researchers-identify-genetic-targets-for-strabismus-treatment https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-reports-promising-phase-1-results-for-axpaxli-in-dr-study.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-reports-phase-1-results-for-axpaxli 2024-04-19T08:42:57+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-reports-phase-1-results-for-axpaxli https://ophthalmologybreakingnews.com/files/images/blog_blinking-enhances-visual-signal-strength-new-study-finds.jpg https://ophthalmologybreakingnews.com/blinking-enhances-visual-signal-strength- 2024-04-17T15:31:35+03:00 en https://ophthalmologybreakingnews.com/blinking-enhances-visual-signal-strength- https://ophthalmologybreakingnews.com/files/images/blog_eyesouth-partners-announces-partnership-with-community-eye-care-specialists.jpg https://ophthalmologybreakingnews.com/eyesouth-partners-with-community-eye-care-specialists- 2024-04-17T13:25:00+03:00 en https://ophthalmologybreakingnews.com/eyesouth-partners-with-community-eye-care-specialists- https://ophthalmologybreakingnews.com/files/images/blog_googles-gemini-and-bard-pass-the-ophthalmology-board-test.jpg https://ophthalmologybreakingnews.com/gemini-and-bard-pass-the-ophthalmology-board-test 2024-04-19T09:35:49+03:00 en https://ophthalmologybreakingnews.com/gemini-and-bard-pass-the-ophthalmology-board-test https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-rare-cells-as-possible-missing-link-in-how-we-see-color.jpg https://ophthalmologybreakingnews.com/rare-cells-as-possible-missing-link-in-how-we-see-color 2024-04-17T08:49:35+03:00 en https://ophthalmologybreakingnews.com/rare-cells-as-possible-missing-link-in-how-we-see-color https://ophthalmologybreakingnews.com/files/images/blog_malawi-eye-health-initiative-breaks-barriers-for-equitable-care.jpg https://ophthalmologybreakingnews.com/malawi-eye-health-initiative-breaks-barriers-for-equitable-care 2024-04-16T15:32:17+03:00 en https://ophthalmologybreakingnews.com/malawi-eye-health-initiative-breaks-barriers-for-equitable-care https://ophthalmologybreakingnews.com/files/images/blog_caplin-granted-usfda-approval-for-ketoralac-tromethamine-ophthalmic-solution.jpg https://ophthalmologybreakingnews.com/caplin-granted-usfda-approval-for-ketoralac-tromethamine 2024-04-16T13:28:04+03:00 en https://ophthalmologybreakingnews.com/caplin-granted-usfda-approval-for-ketoralac-tromethamine https://ophthalmologybreakingnews.com/files/images/blog_medevise-consulting-achieves-iso13485-certification.jpg https://ophthalmologybreakingnews.com/medevise-consulting-achieves-iso13485-certification 2024-04-16T10:26:38+03:00 en https://ophthalmologybreakingnews.com/medevise-consulting-achieves-iso13485-certification https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-appoints-pravin-u-dugel-md-president-and-ceo.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-appoints-pravin-dugel-md-president-ceo 2024-04-16T09:01:16+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-appoints-pravin-dugel-md-president-ceo https://ophthalmologybreakingnews.com/files/images/blog_nih-introduces-novel-ai-to-speed-up-retinal-imaging-by-100-times.jpg https://ophthalmologybreakingnews.com/nih-introduces-ai-to-speed-up-retinal-imaging-by-100-times 2024-04-15T13:12:39+03:00 en https://ophthalmologybreakingnews.com/nih-introduces-ai-to-speed-up-retinal-imaging-by-100-times https://ophthalmologybreakingnews.com/files/images/blog_kiora-pharmaceuticals-receives-critical-funding-for-inherited-retinal-disease-trials.jpg https://ophthalmologybreakingnews.com/kiora-receives-funding-for-inherited-retinal-disease-trials 2024-04-15T10:21:03+03:00 en https://ophthalmologybreakingnews.com/kiora-receives-funding-for-inherited-retinal-disease-trials https://ophthalmologybreakingnews.com/files/images/blog_regeneron-faces-lawsuit-for-misreporting-eylea-prices-to-medicare.jpg https://ophthalmologybreakingnews.com/regeneron-faces-lawsuit-for-misreporting-eylea-prices-to-medicare 2024-04-15T09:42:51+03:00 en https://ophthalmologybreakingnews.com/regeneron-faces-lawsuit-for-misreporting-eylea-prices-to-medicare https://ophthalmologybreakingnews.com/files/images/blog_oasis-medical-introduces-new-tapered-plug-for-dry-eye-treatment.jpg https://ophthalmologybreakingnews.com/oasis-medical-introduces-new-tapered-plug-for-dry-eye-treatment 2024-04-11T11:01:47+03:00 en https://ophthalmologybreakingnews.com/oasis-medical-introduces-new-tapered-plug-for-dry-eye-treatment https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-ocugens-phase-3-trial-for-rp-gene-therapy.jpg https://ophthalmologybreakingnews.com/fda-approves-ocugens-phase-3-trial-for-rp-gene-therapy 2025-01-31T13:55:41+03:00 en https://ophthalmologybreakingnews.com/fda-approves-ocugens-phase-3-trial-for-rp-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_-orbis-and-fundamentalvr-launch-innovative-vr-solution-for-cataract-surgery-training.jpg https://ophthalmologybreakingnews.com/innovative-vr-solution-for-cataract-surgery-training 2024-04-08T10:15:38+03:00 en https://ophthalmologybreakingnews.com/innovative-vr-solution-for-cataract-surgery-training https://ophthalmologybreakingnews.com/files/images/blog_theianova-selected-as-finalist-at-eyecelerator-for-keratoconus-therapy-eyes-major-funding-for-keratoconus-therapy.jpg https://ophthalmologybreakingnews.com/theianova-eyes-major-funding-for-keratoconus-therapy 2025-01-28T09:17:28+03:00 en https://ophthalmologybreakingnews.com/theianova-eyes-major-funding-for-keratoconus-therapy https://ophthalmologybreakingnews.com/files/images/blog_lenz-therapeutics-announces-success-in-clarity-phase-3-study-for-presbyopia-treatment.jpg https://ophthalmologybreakingnews.com/lenz-therapeutics-announces-in-clarity-phase-3-study-for-presbyopia 2024-04-05T14:44:54+03:00 en https://ophthalmologybreakingnews.com/lenz-therapeutics-announces-in-clarity-phase-3-study-for-presbyopia https://ophthalmologybreakingnews.com/files/images/blog_vance-thompson-md-becomes-new-predisent-of-ascrs.jpg https://ophthalmologybreakingnews.com/vance-thompson-md-becomes-new-predisent-of-ascrs 2024-04-05T11:27:18+03:00 en https://ophthalmologybreakingnews.com/vance-thompson-md-becomes-new-predisent-of-ascrs https://ophthalmologybreakingnews.com/files/images/blog_carl-zeiss-meditec-completes-acquisition-of-dutch-ophthalmic-research-center.jpg https://ophthalmologybreakingnews.com/zeiss-completes-acquisition-of-dutch-ophthalmic-research-center 2024-04-05T08:46:28+03:00 en https://ophthalmologybreakingnews.com/zeiss-completes-acquisition-of-dutch-ophthalmic-research-center https://ophthalmologybreakingnews.com/files/images/blog_qlaris-bio-advances-qls‑111-into-phase-2-trials-for-ocular-hypertension-and-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/qlaris-bio-advances-phase-2-trials-for-ocular-hypertension-and-glaucoma 2024-04-04T13:33:46+03:00 en https://ophthalmologybreakingnews.com/qlaris-bio-advances-phase-2-trials-for-ocular-hypertension-and-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_glaukos-receives-permanent-j-code-for-idose-tr.jpg https://ophthalmologybreakingnews.com/glaukos-receives-permanent-j-code-for-idose-tr 2025-01-31T13:52:24+03:00 en https://ophthalmologybreakingnews.com/glaukos-receives-permanent-j-code-for-idose-tr https://ophthalmologybreakingnews.com/files/images/blog_west-point-optical-group-and-versea-ophthalmics-sign-exclusive-supply-agreement-for-advanced-ocular-products.jpg https://ophthalmologybreakingnews.com/west-point-and-verséa-ophthalmics-sign-supply-agreement-for-ocular-products 2024-04-04T10:02:51+03:00 en https://ophthalmologybreakingnews.com/west-point-and-verséa-ophthalmics-sign-supply-agreement-for-ocular-products https://ophthalmologybreakingnews.com/files/images/blog_melt-pharmaceuticals-secures-24m-for-advanced-sedation-tablet-development.jpg https://ophthalmologybreakingnews.com/melt-pharmaceuticals-secures-$24m-for-sedation-tablet- 2024-04-03T14:07:01+03:00 en https://ophthalmologybreakingnews.com/melt-pharmaceuticals-secures-$24m-for-sedation-tablet- https://ophthalmologybreakingnews.com/files/images/blog_pantheon-vision-receives-further-funding-to-boost-bioengineered-corneal-implants-development.jpg https://ophthalmologybreakingnews.com/pantheon-receives-funding-to-boost-bioengineered-corneal-implants- 2024-04-03T13:02:46+03:00 en https://ophthalmologybreakingnews.com/pantheon-receives-funding-to-boost-bioengineered-corneal-implants- https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-launches-rop-training-simulator-for-eye-examinations-in-preterm-infants.jpg https://ophthalmologybreakingnews.com/haag-streit-launches-rop-simulator-for-eye-examinations-in-infants 2024-04-08T10:32:14+03:00 en https://ophthalmologybreakingnews.com/haag-streit-launches-rop-simulator-for-eye-examinations-in-infants https://ophthalmologybreakingnews.com/files/images/blog_study-finds-wide-variance-in-visual-speed-among-humans.jpg https://ophthalmologybreakingnews.com/study-finds-wide-variance-in-visual-speed-among-humans 2024-04-02T15:06:49+03:00 en https://ophthalmologybreakingnews.com/study-finds-wide-variance-in-visual-speed-among-humans https://ophthalmologybreakingnews.com/files/images/blog_csi-dry-eye-software-releases-version-50-update.jpg https://ophthalmologybreakingnews.com/csi-dry-eye-software-releases-version-50-update 2024-04-02T10:08:37+03:00 en https://ophthalmologybreakingnews.com/csi-dry-eye-software-releases-version-50-update https://ophthalmologybreakingnews.com/files/images/blog_vialase-secures-40m-in-series-c-funding-to-advance-first-femtosecond-laser-for-glaucoma.jpg https://ophthalmologybreakingnews.com/vialase-secures-funding-to-advance-first-femtosecond-laser-for-glaucoma- 2024-04-02T08:24:55+03:00 en https://ophthalmologybreakingnews.com/vialase-secures-funding-to-advance-first-femtosecond-laser-for-glaucoma- https://ophthalmologybreakingnews.com/files/images/blog_viatris-launches-ryzumvit-phentolamine-ophthalmic-solution-075-in-the-us.jpg https://ophthalmologybreakingnews.com/viatris-launches-ryzumvi™-phentolamine-ophthalmic-solution-075-in-the-us 2024-04-01T15:51:33+03:00 en https://ophthalmologybreakingnews.com/viatris-launches-ryzumvi™-phentolamine-ophthalmic-solution-075-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_ocular-inflammation-types-causes-diagnosis-and-treatment.jpg https://ophthalmologybreakingnews.com/ocular-inflammation--types-causes-diagnosis-and-treatment 2025-02-04T15:14:51+03:00 en https://ophthalmologybreakingnews.com/ocular-inflammation--types-causes-diagnosis-and-treatment https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/alcon-names-terry-kim-as-cmo-and-head-of-global-medical-safety- 2024-04-01T14:08:15+03:00 en https://ophthalmologybreakingnews.com/alcon-names-terry-kim-as-cmo-and-head-of-global-medical-safety- https://ophthalmologybreakingnews.com/files/images/blog_glaucoma-research-foundation-launches-audiobook-for-the-visually-impaired.jpg https://ophthalmologybreakingnews.com/grf-launches-audiobook-for-the-visually-impaired- 2024-04-01T08:48:02+03:00 en https://ophthalmologybreakingnews.com/grf-launches-audiobook-for-the-visually-impaired- https://ophthalmologybreakingnews.com/files/images/blog_aldeyra-therapeutics-sets-sight-on-nda-resubmission-for-ded-drug-reproxalap.jpg https://ophthalmologybreakingnews.com/aldeyra-sets-sight-on-nda-resubmission-for-ded-drug- 2024-03-29T14:04:54+03:00 en https://ophthalmologybreakingnews.com/aldeyra-sets-sight-on-nda-resubmission-for-ded-drug- https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/study-opens-pathways-for-treating-zika-virus-eye-abnormalities 2024-03-29T09:36:07+03:00 en https://ophthalmologybreakingnews.com/study-opens-pathways-for-treating-zika-virus-eye-abnormalities https://ophthalmologybreakingnews.com/files/images/blog_regenxbios-gene-therapy-for-wet-amd-shows-promising-results-in-the-lancet.jpg https://ophthalmologybreakingnews.com/regenxbios-gene-therapy-for-wet-amd-shows-promising-results 2024-03-29T09:32:06+03:00 en https://ophthalmologybreakingnews.com/regenxbios-gene-therapy-for-wet-amd-shows-promising-results https://ophthalmologybreakingnews.com/files/images/blog_first-canadian-participant-dosed-in-aurions-cell-therapy-trial-for-corneal-edema.jpg https://ophthalmologybreakingnews.com/first-patient-dosed-in-aurions-cell-therapy-trial-for-corneal-edema 2024-03-29T08:30:53+03:00 en https://ophthalmologybreakingnews.com/first-patient-dosed-in-aurions-cell-therapy-trial-for-corneal-edema https://ophthalmologybreakingnews.com/files/images/blog_provectus-secures-global-licensing-agreement-for-eye-infection-treatment.jpg https://ophthalmologybreakingnews.com/provectus-secures-licensing-agreement-for-eye-infection-treatment 2024-03-28T16:02:20+03:00 en https://ophthalmologybreakingnews.com/provectus-secures-licensing-agreement-for-eye-infection-treatment https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/the-role-of-3d-printing-today-and-tomorrow 2025-01-31T14:12:39+03:00 en https://ophthalmologybreakingnews.com/the-role-of-3d-printing-today-and-tomorrow https://ophthalmologybreakingnews.com/files/images/blog_dont-miss-out-ascrs-congress-2024-kicks-off-this-april-5-8.jpg https://ophthalmologybreakingnews.com/ascrs-congress-2024-kicks-off-this-april-5-8 2024-03-28T14:12:08+03:00 en https://ophthalmologybreakingnews.com/ascrs-congress-2024-kicks-off-this-april-5-8 https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-announces-positive-results-in-rp-treatment-with-mco-010-gene-therapy.jpg https://ophthalmologybreakingnews.com/nanoscope-announces-results-in-rp-treatment-with-gene-therapy 2024-04-29T11:43:58+03:00 en https://ophthalmologybreakingnews.com/nanoscope-announces-results-in-rp-treatment-with-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_abvc-biopharma-announces-global-licensing-agreement-with-forseecon.jpg https://ophthalmologybreakingnews.com/abvc-biopharma-announces-global-licensing-agreement-with-forseecon- 2024-03-28T11:15:55+03:00 en https://ophthalmologybreakingnews.com/abvc-biopharma-announces-global-licensing-agreement-with-forseecon- https://ophthalmologybreakingnews.com/files/images/blog_opus-genetics-advances-with-novel-lca5-gene-therapy-in-phase-1-2-clinical-trial.jpg https://ophthalmologybreakingnews.com/opus-advances-with-lca5-gene-therapy-in-phase-1-2-clinical-trial 2024-03-27T16:30:42+03:00 en https://ophthalmologybreakingnews.com/opus-advances-with-lca5-gene-therapy-in-phase-1-2-clinical-trial https://ophthalmologybreakingnews.com/files/images/blog_iveric-bio-awarded-permanent-j-code-for-ga-treatment-izervay.jpg https://ophthalmologybreakingnews.com/iveric-bio-awarded-permanent-j-code-for-ga-treatment-izervay 2024-03-27T11:13:57+03:00 en https://ophthalmologybreakingnews.com/iveric-bio-awarded-permanent-j-code-for-ga-treatment-izervay https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-a-protein-that-can-repair-optic-nerve-damage.jpg https://ophthalmologybreakingnews.com/researchers-discover-a-protein-that-can-repair-optic-nerve-damage 2024-10-04T09:21:01+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-a-protein-that-can-repair-optic-nerve-damage https://ophthalmologybreakingnews.com/files/images/blog_rayner-shifts-into-eco-friendly-packaging-to-reduce-carbon-footprint.jpg https://ophthalmologybreakingnews.com/rayner-shifts-into-eco-friendly-packaging-to-reduce-carbon-footprint 2024-03-26T13:29:39+03:00 en https://ophthalmologybreakingnews.com/rayner-shifts-into-eco-friendly-packaging-to-reduce-carbon-footprint https://ophthalmologybreakingnews.com/files/images/blog_researchers-introduce-algae-derived-solution-for-retinal-detachment.jpg https://ophthalmologybreakingnews.com/algae-derived-solution-for-retinal-detachment 2024-03-26T10:24:42+03:00 en https://ophthalmologybreakingnews.com/algae-derived-solution-for-retinal-detachment https://ophthalmologybreakingnews.com/files/images/blog_bluerock-therapeutics-and-foundation-fighting-blindness-collaborate-on-irds-study.jpg https://ophthalmologybreakingnews.com/bluerock-and-foundation-fighting-blindness-collaborate-on-irds-study 2024-03-26T09:28:47+03:00 en https://ophthalmologybreakingnews.com/bluerock-and-foundation-fighting-blindness-collaborate-on-irds-study https://ophthalmologybreakingnews.com/files/images/blog_study-nanodropper-adaptor-matches-traditional-drops-in-iop-control.jpg https://ophthalmologybreakingnews.com/nanodropper-matches-traditional-drops-in-iop-control 2024-03-25T13:09:20+03:00 en https://ophthalmologybreakingnews.com/nanodropper-matches-traditional-drops-in-iop-control https://ophthalmologybreakingnews.com/files/images/blog_the-serious-impact-of-smoking-on-your-eye-health.jpg https://ophthalmologybreakingnews.com/the-impact-of-smoking-on-your-eye-health-explained- 2024-10-22T11:30:15+03:00 en https://ophthalmologybreakingnews.com/the-impact-of-smoking-on-your-eye-health-explained- https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/research-links-eye-imaging-and-ai-to-systemic-disease-diagnosis 2024-03-25T09:29:46+03:00 en https://ophthalmologybreakingnews.com/research-links-eye-imaging-and-ai-to-systemic-disease-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_report-exposes-lack-of-support-for-blind-and-partially-sighted-in-england.jpg https://ophthalmologybreakingnews.com/report-exposes-lack-of-support-for-blind-and--in-england 2024-03-22T15:29:19+03:00 en https://ophthalmologybreakingnews.com/report-exposes-lack-of-support-for-blind-and--in-england https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-healing-contact-lenses-for-quicker-corneal-recovery.jpg https://ophthalmologybreakingnews.com/healing-contact-lenses-for-quicker-corneal-recovery 2024-03-22T13:14:46+03:00 en https://ophthalmologybreakingnews.com/healing-contact-lenses-for-quicker-corneal-recovery https://ophthalmologybreakingnews.com/files/images/blog_new-gene-therapy-aims-to-curtail-retinal-degeneration-in-rp-patients.jpg https://ophthalmologybreakingnews.com/gene-therapy-aims-to-curtail-retinal-degeneration-in-rp 2024-03-22T09:47:15+03:00 en https://ophthalmologybreakingnews.com/gene-therapy-aims-to-curtail-retinal-degeneration-in-rp https://ophthalmologybreakingnews.com/files/images/blog_minocycline-fails-to-halt-progression-of-dry-amd-nei-study.jpg https://ophthalmologybreakingnews.com/minocycline-fails-to-halt-progression-of-dry-amd--nei-study 2024-03-21T15:51:03+03:00 en https://ophthalmologybreakingnews.com/minocycline-fails-to-halt-progression-of-dry-amd--nei-study https://ophthalmologybreakingnews.com/files/images/blog_purdue-engineering-team-to-develop-smart-contacts-with-67m-nih-grant.jpg https://ophthalmologybreakingnews.com/team-to-develop-smart-contacts-with-$67m-nih-grant 2024-03-21T10:00:36+03:00 en https://ophthalmologybreakingnews.com/team-to-develop-smart-contacts-with-$67m-nih-grant https://ophthalmologybreakingnews.com/files/images/blog_nicox-announces-promising-phase-3-results-for-glaucoma-eye-drop.jpg https://ophthalmologybreakingnews.com/nicox-announces-phase-3-results-for-glaucoma-eye-drop 2024-03-21T09:09:08+03:00 en https://ophthalmologybreakingnews.com/nicox-announces-phase-3-results-for-glaucoma-eye-drop https://ophthalmologybreakingnews.com/files/images/blog_eye-health-heroes-10-organizations-making-a-difference.jpg https://ophthalmologybreakingnews.com/eye-health-heroes-10-organizations-making-a-difference 2024-04-20T22:41:47+03:00 en https://ophthalmologybreakingnews.com/eye-health-heroes-10-organizations-making-a-difference https://ophthalmologybreakingnews.com/files/images/blog_innovents-anti-vegf-drug-achieves-primary-endpoint-in-phase-2-trial-for-namd-treatment.jpg https://ophthalmologybreakingnews.com/innovents-drug-achieves-primary-endpoint-for-namd-treatment 2024-03-20T13:17:16+03:00 en https://ophthalmologybreakingnews.com/innovents-drug-achieves-primary-endpoint-for-namd-treatment https://ophthalmologybreakingnews.com/files/images/blog_the-science-of-eye-color-how-it-determines-more-than-just-your-looks.jpg https://ophthalmologybreakingnews.com/eye-color-how-it-determines-more-than-just-your-looks 2024-03-20T10:04:31+03:00 en https://ophthalmologybreakingnews.com/eye-color-how-it-determines-more-than-just-your-looks https://ophthalmologybreakingnews.com/files/images/blog_congress-approves-adjustment-to-medicare-physician-payments.jpg https://ophthalmologybreakingnews.com/congress-approves-adjustment-to-medicare-physician-payments 2024-03-20T09:08:45+03:00 en https://ophthalmologybreakingnews.com/congress-approves-adjustment-to-medicare-physician-payments https://ophthalmologybreakingnews.com/files/images/blog_new-insights-into-diabetic-retinopathy-may-pave-the-way-for-future-treatments.jpg https://ophthalmologybreakingnews.com/new-insights-into-dr-may-pave-the-way-for-future-treatments 2025-02-04T15:09:14+03:00 en https://ophthalmologybreakingnews.com/new-insights-into-dr-may-pave-the-way-for-future-treatments https://ophthalmologybreakingnews.com/files/images/blog_temporary-and-sudden-vision-loss-in-one-eye-what-you-need-to-know.jpg https://ophthalmologybreakingnews.com/temporary-and-sudden-vision-loss-in-one-eye- 2025-01-29T14:43:33+03:00 en https://ophthalmologybreakingnews.com/temporary-and-sudden-vision-loss-in-one-eye- https://ophthalmologybreakingnews.com/files/images/blog_workplace-eye-wellness-month-essential-tips-for-employers-employees.jpg https://ophthalmologybreakingnews.com/workplace-eye-wellness-month-tips-for-employers-employees 2024-03-19T09:37:19+03:00 en https://ophthalmologybreakingnews.com/workplace-eye-wellness-month-tips-for-employers-employees https://ophthalmologybreakingnews.com/files/images/blog_grf-announces-record-25-million-in-grants-for-glaucoma-research.jpg https://ophthalmologybreakingnews.com/grf-announces-record-$25m-for-glaucoma-research 2024-03-18T14:56:53+03:00 en https://ophthalmologybreakingnews.com/grf-announces-record-$25m-for-glaucoma-research https://ophthalmologybreakingnews.com/files/images/blog_oculogenex-to-test-novel-gene-therapy-for-amd-in-space.jpg https://ophthalmologybreakingnews.com/oculogenex-to-test-novel-gene-therapy-for-amd-in-space 2025-01-31T14:38:56+03:00 en https://ophthalmologybreakingnews.com/oculogenex-to-test-novel-gene-therapy-for-amd-in-space https://ophthalmologybreakingnews.com/files/images/blog_ocuterras-nesvategrast-falls-short-in-phase-2-trial-for-diabetic-retinopathy.jpg https://ophthalmologybreakingnews.com/ocuterras-nesvategrast-falls-short-in-phase-2-trial-for-dr 2024-03-18T10:38:59+03:00 en https://ophthalmologybreakingnews.com/ocuterras-nesvategrast-falls-short-in-phase-2-trial-for-dr https://ophthalmologybreakingnews.com/files/images/blog_pandorum-technologies-secures-11-million-for-corneal-blindness-treatment.jpg https://ophthalmologybreakingnews.com/pandorum-secures-$11-million-for-corneal-blindness-treatment 2025-01-28T09:40:37+03:00 en https://ophthalmologybreakingnews.com/pandorum-secures-$11-million-for-corneal-blindness-treatment https://ophthalmologybreakingnews.com/files/images/blog_navigating-health-care-during-ramadan-the-case-for-eye-drops.jpg https://ophthalmologybreakingnews.com/health-care-during-ramadan-the-case-for-eye-drops 2024-03-12T15:05:51+03:00 en https://ophthalmologybreakingnews.com/health-care-during-ramadan-the-case-for-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_mediprint-ophthalmics-completes-drug-eluting-contact-lens-for-glaucoma.jpg https://ophthalmologybreakingnews.com/mediprint-completes-drug-eluting-contact-lens-for-glaucoma 2024-03-12T14:44:19+03:00 en https://ophthalmologybreakingnews.com/mediprint-completes-drug-eluting-contact-lens-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_ravegza-lucentis-biosimilar-granted-marketing-authorization-in-saudi-arabia.jpg https://ophthalmologybreakingnews.com/ravegza-granted-marketing-authorization-in-saudi-arabia 2025-01-16T09:35:57+03:00 en https://ophthalmologybreakingnews.com/ravegza-granted-marketing-authorization-in-saudi-arabia https://ophthalmologybreakingnews.com/files/images/blog_novel-gene-editing-method-shows-promise-in-treating-genetic-eye-disorders.jpg https://ophthalmologybreakingnews.com/gene-editing-method-shows-promise-in-treating-genetic-eye-disorders 2024-03-11T15:24:13+03:00 en https://ophthalmologybreakingnews.com/gene-editing-method-shows-promise-in-treating-genetic-eye-disorders https://ophthalmologybreakingnews.com/files/images/blog_eylea-hd-achieves-key-milestone-in-wet-amd-and-dme-treatment.jpg https://ophthalmologybreakingnews.com/eylea-hd-achieves-key-milestone-in-wet-amd-and-dme-treatment 2025-01-31T14:35:29+03:00 en https://ophthalmologybreakingnews.com/eylea-hd-achieves-key-milestone-in-wet-amd-and-dme-treatment https://ophthalmologybreakingnews.com/files/images/blog_new-study-links-childhood-amblyopia-to-higher-risk-of-adult-health-issues.jpg https://ophthalmologybreakingnews.com/study-links-childhood-amblyopia-to-higher-risk-of-adult-health-issues 2025-01-31T13:49:22+03:00 en https://ophthalmologybreakingnews.com/study-links-childhood-amblyopia-to-higher-risk-of-adult-health-issues https://ophthalmologybreakingnews.com/files/images/blog_revolutionary-ai-detects-blindness-in-premature-babies-with-100-accuracy.jpg https://ophthalmologybreakingnews.com/ai-detects-blindness-in-premature-babies-with-100-accuracy 2024-03-12T15:11:25+03:00 en https://ophthalmologybreakingnews.com/ai-detects-blindness-in-premature-babies-with-100-accuracy https://ophthalmologybreakingnews.com/files/images/blog_sdc-transfers-ophthalmic-biometric-division-to-ora-inc.jpg https://ophthalmologybreakingnews.com/sdc-transfers-ophthalmic-biometric-division-to-ora-inc 2025-01-27T11:39:13+03:00 en https://ophthalmologybreakingnews.com/sdc-transfers-ophthalmic-biometric-division-to-ora-inc https://ophthalmologybreakingnews.com/files/images/blog_acusurgicals-ophthalmology-robot-lucat-completes-worlds-first-retinal-surgery.jpg https://ophthalmologybreakingnews.com/ophthalmology-robot-luca-completes-worlds-first-retinal-surgery- 2025-01-28T09:09:39+03:00 en https://ophthalmologybreakingnews.com/ophthalmology-robot-luca-completes-worlds-first-retinal-surgery- https://ophthalmologybreakingnews.com/files/images/blog_vital-tears-names-joseph-tauber-md-as-chief-medical-officer.jpg https://ophthalmologybreakingnews.com/vital-tears-names-joseph-tauber-md-as-chief-medical-officer 2024-03-07T14:02:10+03:00 en https://ophthalmologybreakingnews.com/vital-tears-names-joseph-tauber-md-as-chief-medical-officer https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/can-people-with-cortical-blindness-have-schizophrenia 2024-03-07T10:37:53+03:00 en https://ophthalmologybreakingnews.com/can-people-with-cortical-blindness-have-schizophrenia https://ophthalmologybreakingnews.com/files/images/blog_telios-pharmas-tl-925-shows-promise-in-dry-eye-disease-treatment.jpg https://ophthalmologybreakingnews.com/telios-tl-925-shows-promise-in-dry-eye-disease-treatment 2025-01-28T09:54:35+03:00 en https://ophthalmologybreakingnews.com/telios-tl-925-shows-promise-in-dry-eye-disease-treatment https://ophthalmologybreakingnews.com/files/images/blog_roche-pharma-india-launches-vabysmo-for-amd-and-dme.jpg https://ophthalmologybreakingnews.com/roche-india-launches-vabysmo-for-amd-and-dme 2025-01-29T14:36:23+03:00 en https://ophthalmologybreakingnews.com/roche-india-launches-vabysmo-for-amd-and-dme https://ophthalmologybreakingnews.com/files/images/blog_neurolens-prescription-lenses-show-promising-results-for-headache-relief.jpg https://ophthalmologybreakingnews.com/neurolenses-show-promising-results-for-headache-relief 2024-03-06T13:33:06+03:00 en https://ophthalmologybreakingnews.com/neurolenses-show-promising-results-for-headache-relief https://ophthalmologybreakingnews.com/files/images/blog_sandoz-finalizes-acquisition-of-biosimilar-cimerli-from-coherus-biosciences.jpg https://ophthalmologybreakingnews.com/sandoz-finalizes-acquisition-of-cimerli-from-coherus- 2024-03-06T08:28:11+03:00 en https://ophthalmologybreakingnews.com/sandoz-finalizes-acquisition-of-cimerli-from-coherus- https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-clobetasol-propionate-eye-drop-for-post-op-inflammation-and-pain.jpg https://ophthalmologybreakingnews.com/fda-approves-treatment-for-inflammation-and-pain 2025-01-31T14:25:31+03:00 en https://ophthalmologybreakingnews.com/fda-approves-treatment-for-inflammation-and-pain https://ophthalmologybreakingnews.com/files/images/blog_the-optical-company-acquires-adelaide-eye-care-practices-in-australia.jpg https://ophthalmologybreakingnews.com/the-optical-company-acquires-adelaide-eye-care-practices 2024-03-05T10:36:47+03:00 en https://ophthalmologybreakingnews.com/the-optical-company-acquires-adelaide-eye-care-practices https://ophthalmologybreakingnews.com/files/images/blog_exonate-announces-promising-results-for-exn407-eye-drops-in-diabetic-eye-disease-trial.jpg https://ophthalmologybreakingnews.com/promising-results-for-exn407-eye-drops-in-diabetic-eye-disease-trial 2025-01-16T09:48:08+03:00 en https://ophthalmologybreakingnews.com/promising-results-for-exn407-eye-drops-in-diabetic-eye-disease-trial https://ophthalmologybreakingnews.com/files/images/blog_amring-pharmaceuticals-changes-corporate-name-to-nordic-pharma.jpg https://ophthalmologybreakingnews.com/amring-changes-corporate-name-to-nordic-pharma- 2024-03-05T08:27:55+03:00 en https://ophthalmologybreakingnews.com/amring-changes-corporate-name-to-nordic-pharma- https://ophthalmologybreakingnews.com/files/images/blog_10-signs-that-you-may-need-glasses-or-a-new-prescription.jpg https://ophthalmologybreakingnews.com/10-signs-that-you-may-need-glasses-or-a-new-prescription 2024-03-04T14:59:33+03:00 en https://ophthalmologybreakingnews.com/10-signs-that-you-may-need-glasses-or-a-new-prescription https://ophthalmologybreakingnews.com/files/images/blog_revolutionary-pediatric-cataract-surgery-restores-vision-for-8-month-old.jpg https://ophthalmologybreakingnews.com/pediatric-cataract-surgery-restores-vision-for-8-month-old- 2024-03-04T10:31:15+03:00 en https://ophthalmologybreakingnews.com/pediatric-cataract-surgery-restores-vision-for-8-month-old- https://ophthalmologybreakingnews.com/files/images/blog_glaukos-idose-tr-for-glaucoma-hits-the-market.jpg https://ophthalmologybreakingnews.com/glaukos-idose-tr-for-glaucoma-hits-the-market- 2024-03-04T09:00:57+03:00 en https://ophthalmologybreakingnews.com/glaukos-idose-tr-for-glaucoma-hits-the-market- https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-eyes-surprising-defense-against-brain-infections.jpg https://ophthalmologybreakingnews.com/study-reveals-eyes-surprising-defense-against-brain-infections 2024-02-29T15:54:19+03:00 en https://ophthalmologybreakingnews.com/study-reveals-eyes-surprising-defense-against-brain-infections https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-faster-cheaper-3d-printing-technique-for-artificial-eyeballs.jpg https://ophthalmologybreakingnews.com/faster-cheaper-3d-printing-technique-for-artificial-eyeballs 2024-02-29T10:47:07+03:00 en https://ophthalmologybreakingnews.com/faster-cheaper-3d-printing-technique-for-artificial-eyeballs https://ophthalmologybreakingnews.com/files/images/blog_pulsesight-therapeutics-introduces-novel-gene-therapies-for-retinal-diseases.jpg https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases 2025-01-28T10:00:46+03:00 en https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases https://ophthalmologybreakingnews.com/files/images/blog_fda-recalls-eye-ointments-sold-at-walmart-and-cvs-over-infection-risk.jpg https://ophthalmologybreakingnews.com/fda-recalls-eye-ointments-over-infection-risk- 2024-02-28T15:21:21+03:00 en https://ophthalmologybreakingnews.com/fda-recalls-eye-ointments-over-infection-risk- https://ophthalmologybreakingnews.com/files/images/blog_n4-pharma-advances-novel-delivery-systems-toward-commercialisation.jpg https://ophthalmologybreakingnews.com/n4-pharma-advances-novel-delivery-systems 2025-01-31T14:37:24+03:00 en https://ophthalmologybreakingnews.com/n4-pharma-advances-novel-delivery-systems https://ophthalmologybreakingnews.com/files/images/blog_cofi-expands-payment-solutions-with-carecredit-collaboration.jpg https://ophthalmologybreakingnews.com/cofi-expands-payment-solutions-with-carecredit-collaboration 2024-02-28T13:33:25+03:00 en https://ophthalmologybreakingnews.com/cofi-expands-payment-solutions-with-carecredit-collaboration https://ophthalmologybreakingnews.com/files/images/blog_corneat-vision-launches-corneat-everpatch-in-the-us.jpg https://ophthalmologybreakingnews.com/corneat-vision-launches-corneat-everpatch-in-the-us 2024-02-28T11:02:01+03:00 en https://ophthalmologybreakingnews.com/corneat-vision-launches-corneat-everpatch-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_vision-impairment-in-seniors-tied-to-increased-mental-health-issues_1.jpg https://ophthalmologybreakingnews.com/vision-impairment-in-seniors-tied-to-increased-mental-health-issues- 2024-10-22T13:13:59+03:00 en https://ophthalmologybreakingnews.com/vision-impairment-in-seniors-tied-to-increased-mental-health-issues- https://ophthalmologybreakingnews.com/files/images/blog_new-research-uncovers-link-between-gut-bacteria-and-inherited-eye-diseases.jpg https://ophthalmologybreakingnews.com/uncovers-link-between-gut-bacteria-and-inherited-eye-diseases 2024-02-27T13:49:06+03:00 en https://ophthalmologybreakingnews.com/uncovers-link-between-gut-bacteria-and-inherited-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_optos-celebrates-25000-device-installations-worldwide-2500-clinical-studies.jpg https://ophthalmologybreakingnews.com/optos-celebrates-device-installations-worldwide-clinical-studies 2024-02-27T10:03:36+03:00 en https://ophthalmologybreakingnews.com/optos-celebrates-device-installations-worldwide-clinical-studies https://ophthalmologybreakingnews.com/files/images/blog_amring-appoints-dr-eric-d-donnenfeld-to-its-us-medical-advisory-board-chair.jpg https://ophthalmologybreakingnews.com/amring-appoints-eric-donnenfeld-to-its-medical-advisory-board-chair 2024-02-27T08:58:12+03:00 en https://ophthalmologybreakingnews.com/amring-appoints-eric-donnenfeld-to-its-medical-advisory-board-chair https://ophthalmologybreakingnews.com/files/images/blog_vegf-therapy-in-namd-linked-to-reduced-mortality-risk.jpg https://ophthalmologybreakingnews.com/vegf-therapy-in-namd-linked-to-reduced-mortality-risk- 2025-02-04T15:11:43+03:00 en https://ophthalmologybreakingnews.com/vegf-therapy-in-namd-linked-to-reduced-mortality-risk- https://ophthalmologybreakingnews.com/files/images/blog_oral-metformin-shows-no-benefit-in-slowing-geographic-atrophy-progression.jpg https://ophthalmologybreakingnews.com/oral-metformin-ineffective-for-ga-progression 2024-06-20T11:03:47+03:00 en https://ophthalmologybreakingnews.com/oral-metformin-ineffective-for-ga-progression https://ophthalmologybreakingnews.com/files/images/blog_ontarios-expansion-of-private-cataract-clinics-faces-billing-complaints.jpg https://ophthalmologybreakingnews.com/ontarios-expansion-of-private-cataract-clinics-faces-billing-complaints 2025-01-27T11:45:28+03:00 en https://ophthalmologybreakingnews.com/ontarios-expansion-of-private-cataract-clinics-faces-billing-complaints https://ophthalmologybreakingnews.com/files/images/blog_swiss-advanced-vision-introduces-new-features-for-its-toric-calculator.jpg https://ophthalmologybreakingnews.com/swiss-advanced-vision-introduces-new-features-for-its-toric-calculator- 2024-02-26T08:27:34+03:00 en https://ophthalmologybreakingnews.com/swiss-advanced-vision-introduces-new-features-for-its-toric-calculator- https://ophthalmologybreakingnews.com/files/images/blog_alcon-to-introduce-updated-marlo-app-at-seco-2024_1.jpg https://ophthalmologybreakingnews.com/alcon-to-introduce-updated-marlo-app-at-seco-2024 2024-10-22T13:27:14+03:00 en https://ophthalmologybreakingnews.com/alcon-to-introduce-updated-marlo-app-at-seco-2024 https://ophthalmologybreakingnews.com/files/images/blog_ai-matches-or-outperforms-ophthalmologists-in-diagnosing-glaucoma-retinal-diseases.jpg https://ophthalmologybreakingnews.com/ai-matches-or-outperforms-ophthalmologists-in-diagnosis 2024-02-23T12:55:20+03:00 en https://ophthalmologybreakingnews.com/ai-matches-or-outperforms-ophthalmologists-in-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_jcyte-moves-forward-with-pivotal-us-trial-for-treatment-of-retinal-diseases.jpg https://ophthalmologybreakingnews.com/jcyte-moves-forward-with-trial-for-treatment-of-retinal-diseases- 2025-01-28T09:24:50+03:00 en https://ophthalmologybreakingnews.com/jcyte-moves-forward-with-trial-for-treatment-of-retinal-diseases- https://ophthalmologybreakingnews.com/files/images/blog_lutein-and-zeaxanthin-improve-eye-health-and-cognitive-functions-in-children.jpg https://ophthalmologybreakingnews.com/lutein-zeaxanthin-improve-eye-health-and-cognitive-functions-in-children- 2025-01-31T14:28:36+03:00 en https://ophthalmologybreakingnews.com/lutein-zeaxanthin-improve-eye-health-and-cognitive-functions-in-children- https://ophthalmologybreakingnews.com/files/images/blog_neurophth-therapeutics-finalizes-enrollment-for-lhon-gene-therapy-trial.jpg https://ophthalmologybreakingnews.com/neurophth-finalizes-enrollment-for-lhon-gene-therapy-trial 2025-02-04T10:53:44+03:00 en https://ophthalmologybreakingnews.com/neurophth-finalizes-enrollment-for-lhon-gene-therapy-trial https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-collaborates-with-great-place-to-workr-certification.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-collaborates-with-great-place-to-work 2024-02-22T10:43:37+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-collaborates-with-great-place-to-work https://ophthalmologybreakingnews.com/files/images/blog_understanding-and-managing-ocular-rosacea-symptoms-treatment-options.jpg https://ophthalmologybreakingnews.com/ocular-rosacea-symptoms-treatment-options 2025-01-27T09:01:24+03:00 en https://ophthalmologybreakingnews.com/ocular-rosacea-symptoms-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_abbvie-names-robert-a-michael-as-chief-executive-officer.jpg https://ophthalmologybreakingnews.com/abbvie-names-robert-michael-as-ceo 2024-02-22T08:55:15+03:00 en https://ophthalmologybreakingnews.com/abbvie-names-robert-michael-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_innovent-biologics-triumphs-in-phase-3-study-of-ted-treatment-in-china.jpg https://ophthalmologybreakingnews.com/innovent-triumphs-in-phase-3-study-of-ted-treatment-in-china- 2024-02-21T16:53:42+03:00 en https://ophthalmologybreakingnews.com/innovent-triumphs-in-phase-3-study-of-ted-treatment-in-china- https://ophthalmologybreakingnews.com/files/images/blog_xpanceo-to-develop-first-laboratory-optic-testing-system-for-smart-contact-lenses.jpg https://ophthalmologybreakingnews.com/xpanceo-to-develop-first-laboratory-optic-testing-system-for-smart-contact-lenses 2025-01-31T14:45:03+03:00 en https://ophthalmologybreakingnews.com/xpanceo-to-develop-first-laboratory-optic-testing-system-for-smart-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_eversight-and-emmecell-biotech-partner-to-pioneer-advances-in-ocular-cell-therapy.jpg https://ophthalmologybreakingnews.com/eversight-and-emmecell-to-pioneer-advances-in-ocular-cell-therapy 2024-02-21T13:53:22+03:00 en https://ophthalmologybreakingnews.com/eversight-and-emmecell-to-pioneer-advances-in-ocular-cell-therapy https://ophthalmologybreakingnews.com/files/images/blog_opthea-welcomes-dr-arshad-m-khanani-as-chief-medical-advisor.jpg https://ophthalmologybreakingnews.com/opthea-welcomes-dr-arshad-m-khanani-as-chief-medical-advisor 2024-02-21T09:29:45+03:00 en https://ophthalmologybreakingnews.com/opthea-welcomes-dr-arshad-m-khanani-as-chief-medical-advisor https://ophthalmologybreakingnews.com/files/images/blog_revolutionary-printable-retinas-could-restore-color-vision.jpg https://ophthalmologybreakingnews.com/revolutionary-printable-retinas-could-restore-color-vision- 2025-01-29T14:33:46+03:00 en https://ophthalmologybreakingnews.com/revolutionary-printable-retinas-could-restore-color-vision- https://ophthalmologybreakingnews.com/files/images/blog_ultimate-guide-to-eyelid-hygiene-preventing-common-eye-conditions.jpg https://ophthalmologybreakingnews.com/ultimate-guide-to-eyelid-hygiene 2024-02-20T13:47:13+03:00 en https://ophthalmologybreakingnews.com/ultimate-guide-to-eyelid-hygiene https://ophthalmologybreakingnews.com/files/images/blog_evmann-holding-sets-sights-on-expanding-ophthalmology-investments-at-escrs.jpg https://ophthalmologybreakingnews.com/evmann-sets-sights-on-expanding-ophthalmology-investments-at-escrs 2024-02-20T13:40:22+03:00 en https://ophthalmologybreakingnews.com/evmann-sets-sights-on-expanding-ophthalmology-investments-at-escrs https://ophthalmologybreakingnews.com/files/images/blog_researcher-receives-300k-award-to-find-innovative-solutions-for-amd.jpg https://ophthalmologybreakingnews.com/researcher-receives-$300k-award-for-amd-Study 2024-02-20T11:00:56+03:00 en https://ophthalmologybreakingnews.com/researcher-receives-$300k-award-for-amd-Study https://ophthalmologybreakingnews.com/files/images/blog_the-abcs-of-hypopyon-causes-symptoms-and-treatments.jpg https://ophthalmologybreakingnews.com/the-abcs-of-hypopyon-causes-symptoms-and-treatments 2025-01-16T09:22:52+03:00 en https://ophthalmologybreakingnews.com/the-abcs-of-hypopyon-causes-symptoms-and-treatments https://ophthalmologybreakingnews.com/files/images/blog_fda-awards-breakthrough-device-status-to-sightglass-visions-myopia-control-lenses.jpg https://ophthalmologybreakingnews.com/fda-awards-breakthrough-device-to-sightglass-myopia-lenses 2025-01-31T14:58:53+03:00 en https://ophthalmologybreakingnews.com/fda-awards-breakthrough-device-to-sightglass-myopia-lenses https://ophthalmologybreakingnews.com/files/images/blog_apotex-secures-exclusive-rights-to-harrows-5-ophthalmic-products-in-canada.jpg https://ophthalmologybreakingnews.com/apotex-secures-rights-to-harrows-5-ophthalmic-products-in-canada- 2025-01-31T13:57:30+03:00 en https://ophthalmologybreakingnews.com/apotex-secures-rights-to-harrows-5-ophthalmic-products-in-canada- https://ophthalmologybreakingnews.com/files/images/blog_study-identifies-key-genes-linked-to-primary-open-angle-glaucoma.jpg https://ophthalmologybreakingnews.com/study-identifies-key-genes-linked-to-primary-open-angle-glaucoma 2024-02-19T11:46:23+03:00 en https://ophthalmologybreakingnews.com/study-identifies-key-genes-linked-to-primary-open-angle-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_demodex-blepharitis-symptoms-causes-and-effective-treatment-options.jpg https://ophthalmologybreakingnews.com/demodex-blepharitis-symptoms-causes-treatment-options 2025-01-16T09:37:37+03:00 en https://ophthalmologybreakingnews.com/demodex-blepharitis-symptoms-causes-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_escrs-winter-meeting-kicks-off-with-exciting-program-lineup.jpg https://ophthalmologybreakingnews.com/escrs-winter-meeting-kicks-off-with-exciting-program-lineup 2024-02-16T16:47:22+03:00 en https://ophthalmologybreakingnews.com/escrs-winter-meeting-kicks-off-with-exciting-program-lineup https://ophthalmologybreakingnews.com/files/images/blog_opthea-completes-patient-enrollment-for-phase-3-trial-on-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/opthea-completes-enrollment-for-phase-3-trial-for-wet-amd- 2024-02-16T14:43:23+03:00 en https://ophthalmologybreakingnews.com/opthea-completes-enrollment-for-phase-3-trial-for-wet-amd- https://ophthalmologybreakingnews.com/files/images/blog_australian-government-awards-35m-to-consortium-for-corneal-blindness-research.jpg https://ophthalmologybreakingnews.com/australian-government-awards-$35m-to-consortium-for-blindness-research 2024-02-16T09:57:18+03:00 en https://ophthalmologybreakingnews.com/australian-government-awards-$35m-to-consortium-for-blindness-research https://ophthalmologybreakingnews.com/files/images/blog_lupin-launches-generic-bromfenac-ophthalmic-solution-in-the-us.jpg https://ophthalmologybreakingnews.com/lupin-launches-bromfenac-ophthalmic-solution-in-the-us 2024-02-19T08:52:18+03:00 en https://ophthalmologybreakingnews.com/lupin-launches-bromfenac-ophthalmic-solution-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_novel-treatment-dramatically-slows-down-progression-of-amd-rp.jpg https://ophthalmologybreakingnews.com/novel-treatment-dramatically-slows-down-progression-of-amd-rp 2024-04-20T22:33:06+03:00 en https://ophthalmologybreakingnews.com/novel-treatment-dramatically-slows-down-progression-of-amd-rp https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-eyenovias-redwood-city-as-commercial-manufacturing-facility.jpg https://ophthalmologybreakingnews.com/fda-approves-eyenovias-redwood-city-as-manufacturing-facility 2024-02-15T13:44:35+03:00 en https://ophthalmologybreakingnews.com/fda-approves-eyenovias-redwood-city-as-manufacturing-facility https://ophthalmologybreakingnews.com/files/images/blog_washu-secures-20m-grant-for-novel-eye-disease-screening-device.jpg https://ophthalmologybreakingnews.com/washu-secures-$20m-for-novel-eye-disease-screening-device 2024-02-15T10:36:06+03:00 en https://ophthalmologybreakingnews.com/washu-secures-$20m-for-novel-eye-disease-screening-device https://ophthalmologybreakingnews.com/files/images/blog_what-causes-chlamydia-eye-infection-and-how-can-you-recognize-it.jpg https://ophthalmologybreakingnews.com/what-causes-chlamydia-eye-infection 2025-01-27T09:05:04+03:00 en https://ophthalmologybreakingnews.com/what-causes-chlamydia-eye-infection https://ophthalmologybreakingnews.com/files/images/blog_ophthalmologists-develop-novel-protocol-to-rapidly-diagnose-eye-stroke.jpg https://ophthalmologybreakingnews.com/ophthalmologists-develop-novel-protocol-to-diagnose-eye-stroke- 2024-02-14T14:03:06+03:00 en https://ophthalmologybreakingnews.com/ophthalmologists-develop-novel-protocol-to-diagnose-eye-stroke- https://ophthalmologybreakingnews.com/files/images/blog_the-role-of-iol-exchange-in-optimizing-visual-clarity.jpg https://ophthalmologybreakingnews.com/the-role-of-iol-exchange-in-optimizing-visual-clarity 2025-01-28T10:03:22+03:00 en https://ophthalmologybreakingnews.com/the-role-of-iol-exchange-in-optimizing-visual-clarity https://ophthalmologybreakingnews.com/files/images/blog_oculus-mainline-instruments-announce-distribution-agreement-in-the-uk-and-ireland.jpg https://ophthalmologybreakingnews.com/oculus-mainline-announce-distribution-agreement-in-uk-and-ireland 2024-02-14T09:51:39+03:00 en https://ophthalmologybreakingnews.com/oculus-mainline-announce-distribution-agreement-in-uk-and-ireland https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/vsy-biotechnology-to-introduce-enova-maestro®-iol-at-escrs 2025-01-28T09:32:05+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-to-introduce-enova-maestro®-iol-at-escrs https://ophthalmologybreakingnews.com/files/images/blog_filamon-receives-24m-grant-from-australian-government-for-wet-amd-therapy.jpg https://ophthalmologybreakingnews.com/filamon-receives-grant-from-australian-government-for-wet-amd 2025-01-31T14:07:25+03:00 en https://ophthalmologybreakingnews.com/filamon-receives-grant-from-australian-government-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_foundation-fighting-blindness-launches-natural-history-study-for-gyrate-atrophy_1.jpg https://ophthalmologybreakingnews.com/foundation-fighting-blindness-launches-study-for-gyrate-atrophy 2024-10-22T11:11:03+03:00 en https://ophthalmologybreakingnews.com/foundation-fighting-blindness-launches-study-for-gyrate-atrophy https://ophthalmologybreakingnews.com/files/images/blog_home-lighting-linked-to-activity-levels-in-older-adults-with-visual-impairment.jpg https://ophthalmologybreakingnews.com/home-lighting-linked-to-activity-levels-in-elderly-with-visual-impairment 2024-02-13T11:19:37+03:00 en https://ophthalmologybreakingnews.com/home-lighting-linked-to-activity-levels-in-elderly-with-visual-impairment https://ophthalmologybreakingnews.com/files/images/blog_what-is-epiphora-and-how-to-manage-it.jpg https://ophthalmologybreakingnews.com/what-is-epiphora-and-how-to-manage-it 2025-01-27T09:06:55+03:00 en https://ophthalmologybreakingnews.com/what-is-epiphora-and-how-to-manage-it https://ophthalmologybreakingnews.com/files/images/blog_eyelid-myokymia.jpg https://ophthalmologybreakingnews.com/eyelid-myokymia-causes-symptoms-management 2025-01-15T15:28:49+03:00 en https://ophthalmologybreakingnews.com/eyelid-myokymia-causes-symptoms-management https://ophthalmologybreakingnews.com/files/images/blog_meridian-medical-launches-ophthalmic-laser-line-in-the-us.jpg https://ophthalmologybreakingnews.com/meridian-medical-launches-ophthalmic-laser-line-in-the-us 2024-02-12T14:01:45+03:00 en https://ophthalmologybreakingnews.com/meridian-medical-launches-ophthalmic-laser-line-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_nicox-inks-exclusive-agreement-with-kowa-for-ncx-470-development-in-japan.jpg https://ophthalmologybreakingnews.com/nicox-inks-agreement-with-kowa-for-ncx-470 2024-02-12T13:39:11+03:00 en https://ophthalmologybreakingnews.com/nicox-inks-agreement-with-kowa-for-ncx-470 https://ophthalmologybreakingnews.com/files/images/blog_china-and-zimbabwe-sign-agreement-for-free-cataract-surgery-program.jpg https://ophthalmologybreakingnews.com/china-zimbabwe-sign-agreement-for-free-cataract-surgeries 2025-01-28T09:29:04+03:00 en https://ophthalmologybreakingnews.com/china-zimbabwe-sign-agreement-for-free-cataract-surgeries https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-ok-101-trial-design-for-okyo-pharmas-neuropathic-corneal-pain-therapy.jpg https://ophthalmologybreakingnews.com/fda-clears-trial-design-for-okyo-neuropathic-corneal-pain-therapy 2024-02-12T09:20:41+03:00 en https://ophthalmologybreakingnews.com/fda-clears-trial-design-for-okyo-neuropathic-corneal-pain-therapy https://ophthalmologybreakingnews.com/files/images/blog_escrs-winter-meeting-in-frankfurt-introduces-exciting-new-features.jpg https://ophthalmologybreakingnews.com/escrs-winter-meeting-introduces-exciting-new-features 2024-02-09T13:45:42+03:00 en https://ophthalmologybreakingnews.com/escrs-winter-meeting-introduces-exciting-new-features https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/innovative-spiral-lens-for-clear-vision-in-varying-light-conditions 2024-02-09T10:34:36+03:00 en https://ophthalmologybreakingnews.com/innovative-spiral-lens-for-clear-vision-in-varying-light-conditions https://ophthalmologybreakingnews.com/files/images/blog_vyjuvek-eyedrop-gene-therapy-restores-vision-in-teen-with-rare-genetic-condition.jpg https://ophthalmologybreakingnews.com/gene-therapy-restores-vision-in-teen-with-rare-genetic-condition 2024-02-15T14:46:00+03:00 en https://ophthalmologybreakingnews.com/gene-therapy-restores-vision-in-teen-with-rare-genetic-condition https://ophthalmologybreakingnews.com/files/images/blog_study-finds-natural-compound-effective-as-contact-lens-disinfectant_1.jpg https://ophthalmologybreakingnews.com/natural-compound-effective-as-contact-lens-disinfectant 2024-10-15T16:15:39+03:00 en https://ophthalmologybreakingnews.com/natural-compound-effective-as-contact-lens-disinfectant https://ophthalmologybreakingnews.com/files/images/blog_shamir-introduces-spark-4w-digital-electro-optic-measurement-system_1.jpg https://ophthalmologybreakingnews.com/shamir-introduces-spark-4w-digital-electro-optic-measurement-system 2024-10-22T13:22:40+03:00 en https://ophthalmologybreakingnews.com/shamir-introduces-spark-4w-digital-electro-optic-measurement-system https://ophthalmologybreakingnews.com/files/images/blog_cdc-investigates-multistate-outbreak-linked-to-artificial-tears_1.jpg https://ophthalmologybreakingnews.com/cdc-investigates-multistate-outbreak-linked-to-artificial-tears 2024-10-22T11:35:04+03:00 en https://ophthalmologybreakingnews.com/cdc-investigates-multistate-outbreak-linked-to-artificial-tears https://ophthalmologybreakingnews.com/files/images/blog_ucl-moorfields-eye-hospital-secures-p5m-to-open-new-research-center.jpg https://ophthalmologybreakingnews.com/moorfields-eye-hospital-secures-£5m-to-open-research-center 2024-02-08T11:05:59+03:00 en https://ophthalmologybreakingnews.com/moorfields-eye-hospital-secures-£5m-to-open-research-center https://ophthalmologybreakingnews.com/files/images/blog_-australian-government-invests-35m-in-manufacturing-facility-for-artificial-corneas.jpg https://ophthalmologybreakingnews.com/-australian-government-invests-$35m-in-artificial-cornea-facility 2024-02-07T15:04:10+03:00 en https://ophthalmologybreakingnews.com/-australian-government-invests-$35m-in-artificial-cornea-facility https://ophthalmologybreakingnews.com/files/images/blog_new-experimental-drug-shows-promise-in-treating-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/new-experimental-drug-shows-promise-in-treating-dme 2024-02-07T13:24:55+03:00 en https://ophthalmologybreakingnews.com/new-experimental-drug-shows-promise-in-treating-dme https://ophthalmologybreakingnews.com/files/images/blog_toku-receives-ce-and-ukca-marks-for-clair-technology.jpg https://ophthalmologybreakingnews.com/toku-receives-ce-and-ukca-marks-for-clair-technology 2024-02-07T10:36:50+03:00 en https://ophthalmologybreakingnews.com/toku-receives-ce-and-ukca-marks-for-clair-technology https://ophthalmologybreakingnews.com/files/images/blog_iridex-secures-european-patent-for-micropulse-technology.jpg https://ophthalmologybreakingnews.com/iridex-secures-european-patent-for-micropulse-tech 2024-02-07T09:32:55+03:00 en https://ophthalmologybreakingnews.com/iridex-secures-european-patent-for-micropulse-tech https://ophthalmologybreakingnews.com/files/images/blog_bayer-and-emirates-society-of-ophthalmology-collaborate-to-transform-eye-care.jpg https://ophthalmologybreakingnews.com/bayer-and-emirates-society-of-ophthalmology-collaborate 2025-01-31T14:02:03+03:00 en https://ophthalmologybreakingnews.com/bayer-and-emirates-society-of-ophthalmology-collaborate https://ophthalmologybreakingnews.com/files/images/blog_4dmt-announces-positive-interim-data-from-phase-2-prism-trial-for-4d-150-in-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/4dmt-announces-positive-interim-data-for-4d-150-in-wet-amd 2024-02-06T13:50:45+03:00 en https://ophthalmologybreakingnews.com/4dmt-announces-positive-interim-data-for-4d-150-in-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_aviceda-initiates-phase-ii-iii-siglec-trial-part-two-for-ga-in-amd-treatment_1.jpg https://ophthalmologybreakingnews.com/aviceda-initiates-phase-ii-iii-trial-part-for-ga-in-amd-treatment 2024-10-22T11:38:08+03:00 en https://ophthalmologybreakingnews.com/aviceda-initiates-phase-ii-iii-trial-part-for-ga-in-amd-treatment https://ophthalmologybreakingnews.com/files/images/blog_novel-drug-offers-hope-in-preventing-diabetic-eye-and-kidney-disease_1.jpg https://ophthalmologybreakingnews.com/drug-offers-hope-in-preventing-diabetic-eye-disease 2024-10-22T11:45:16+03:00 en https://ophthalmologybreakingnews.com/drug-offers-hope-in-preventing-diabetic-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_understanding-itchy-eyelids-causes-relief-and-effective-treatment.jpg https://ophthalmologybreakingnews.com/itchy-eyelids-causes-relief-and-effective-treatment 2024-02-20T11:48:14+03:00 en https://ophthalmologybreakingnews.com/itchy-eyelids-causes-relief-and-effective-treatment https://ophthalmologybreakingnews.com/files/images/blog_macustar-consortium-extends-largest-systematic-study-on-amd.jpg https://ophthalmologybreakingnews.com/macustar-consortium-extends-largest-systematic-study-on-amd 2024-02-20T09:00:20+03:00 en https://ophthalmologybreakingnews.com/macustar-consortium-extends-largest-systematic-study-on-amd https://ophthalmologybreakingnews.com/files/images/blog_kiora-and-thea-partner-to-advance-treatment-for-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/kiora-and-théa-partner-to-advance-treatment-for-irds 2024-02-02T14:17:48+03:00 en https://ophthalmologybreakingnews.com/kiora-and-théa-partner-to-advance-treatment-for-irds https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-warning-on-copycat-eye-drops.jpg https://ophthalmologybreakingnews.com/fda-issues-warning-on-copycat-eye-drops- 2024-02-16T11:29:38+03:00 en https://ophthalmologybreakingnews.com/fda-issues-warning-on-copycat-eye-drops- https://ophthalmologybreakingnews.com/files/images/blog_zeiss-and-topcon-settle-trade-secrets-lawsuit-ensuring-fair-competition.jpg https://ophthalmologybreakingnews.com/zeiss-and-topcon-settle-trade-secrets-lawsuit 2025-01-16T09:26:52+03:00 en https://ophthalmologybreakingnews.com/zeiss-and-topcon-settle-trade-secrets-lawsuit https://ophthalmologybreakingnews.com/files/images/blog_umass-chan-grants-gene-therapy-licenses-to-iveric-bio-for-retinal-diseases.jpg https://ophthalmologybreakingnews.com/umass-chan-grants-gene-therapy-licenses-to-iveric-bio 2024-02-02T08:44:50+03:00 en https://ophthalmologybreakingnews.com/umass-chan-grants-gene-therapy-licenses-to-iveric-bio https://ophthalmologybreakingnews.com/files/images/blog_researcher-warns-against-low-level-red-light-therapy-for-myopia-control.jpg https://ophthalmologybreakingnews.com/low-level-red-light-therapy-for-myopia-control- 2024-02-01T15:20:04+03:00 en https://ophthalmologybreakingnews.com/low-level-red-light-therapy-for-myopia-control- https://ophthalmologybreakingnews.com/files/images/blog_reginald-j-sanders-md-named-as-new-president-of-the-asrs.jpg https://ophthalmologybreakingnews.com/reginald-sanders-named-as-new-president-of-the-asrs 2024-02-01T15:15:44+03:00 en https://ophthalmologybreakingnews.com/reginald-sanders-named-as-new-president-of-the-asrs https://ophthalmologybreakingnews.com/files/images/blog_novel-imaging-method-holds-potential-for-uveitis-monitoring-and-prediction.jpg https://ophthalmologybreakingnews.com/imaging-method-holds-potential-for-uveitis-monitoring 2024-10-16T09:55:38+03:00 en https://ophthalmologybreakingnews.com/imaging-method-holds-potential-for-uveitis-monitoring https://ophthalmologybreakingnews.com/files/images/blog_aao-issues-warning-against-trending-eye-color-changing-surgeries.jpg https://ophthalmologybreakingnews.com/aao-issues-warning-against-eye-color-changing-surgeries 2025-01-28T09:56:18+03:00 en https://ophthalmologybreakingnews.com/aao-issues-warning-against-eye-color-changing-surgeries https://ophthalmologybreakingnews.com/files/images/blog_ascidian-therapeutics-acdn-01-receives-fda-clearance-for-stargardt-disease-treatment.jpg https://ophthalmologybreakingnews.com/ascidian-acdn-01-receives-fda-clearance-for-stargardt-disease 2025-01-29T14:44:52+03:00 en https://ophthalmologybreakingnews.com/ascidian-acdn-01-receives-fda-clearance-for-stargardt-disease https://ophthalmologybreakingnews.com/files/images/blog_mireca-medicines-secures-nearly-1m-award-to-advance-treatment-for-inherited-retinal-diseases.jpg https://ophthalmologybreakingnews.com/mireca-secures-$1m-award-to-advance-treatment-for-irds 2024-01-30T13:22:17+03:00 en https://ophthalmologybreakingnews.com/mireca-secures-$1m-award-to-advance-treatment-for-irds https://ophthalmologybreakingnews.com/files/images/blog_apellis-faces-setback-as-syfovre-receives-negative-opinion-for-ga-in-the-eu.jpg https://ophthalmologybreakingnews.com/apellis-syfovre-receives-negative-opinion-for-ga-in-the-eu 2025-01-16T09:31:28+03:00 en https://ophthalmologybreakingnews.com/apellis-syfovre-receives-negative-opinion-for-ga-in-the-eu https://ophthalmologybreakingnews.com/files/images/blog_ascendis-frazier-life-sciences-launch-new-ophthalmology-company-eyconis.jpg https://ophthalmologybreakingnews.com/ascendis-frazier-life-sciences-launch-new-company-eyconis 2025-01-27T09:28:32+03:00 en https://ophthalmologybreakingnews.com/ascendis-frazier-life-sciences-launch-new-company-eyconis https://ophthalmologybreakingnews.com/files/images/blog_smile-vs-lasik-which-option-is-right-for-you.jpg https://ophthalmologybreakingnews.com/smile-vs-lasik-which-option-is-right-for-you- 2024-01-29T15:41:01+03:00 en https://ophthalmologybreakingnews.com/smile-vs-lasik-which-option-is-right-for-you- https://ophthalmologybreakingnews.com/files/images/blog_eyecare-partners-appoints-chris-throckmorton-as-chief-executive-officer.jpg https://ophthalmologybreakingnews.com/eyecare-partners-appoints-chris-throckmorton-as-ceo 2025-01-31T14:18:24+03:00 en https://ophthalmologybreakingnews.com/eyecare-partners-appoints-chris-throckmorton-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_formosa-and-cristalia-partner-for-exclusive-rights-to-app13007-in-brazil.jpg https://ophthalmologybreakingnews.com/formosa-cristália-partner-for-exclusive-rights-to-app13007-in-brazil 2024-01-29T10:18:09+03:00 en https://ophthalmologybreakingnews.com/formosa-cristália-partner-for-exclusive-rights-to-app13007-in-brazil https://ophthalmologybreakingnews.com/files/images/blog_red-eye-disease-alert-in-mombasa-prevention-and-management-measures.jpg https://ophthalmologybreakingnews.com/red-eye-disease-alert-in-mombasa- 2025-01-16T09:19:36+03:00 en https://ophthalmologybreakingnews.com/red-eye-disease-alert-in-mombasa- https://ophthalmologybreakingnews.com/files/images/blog_breye-initiates-oral-dosing-of-danegaptide-in-phase-1b-2a-clinical-trial-for-dme.jpg https://ophthalmologybreakingnews.com/breye-initiates-dosing-of-danegaptide-clinical-trial-for-dme 2025-01-31T14:08:37+03:00 en https://ophthalmologybreakingnews.com/breye-initiates-dosing-of-danegaptide-clinical-trial-for-dme https://ophthalmologybreakingnews.com/files/images/blog_wco-and-coopervision-collaborate-for-myopia-management-virtual-event-in-latam.jpg https://ophthalmologybreakingnews.com/wco-coopervision-collaborate-for-myopia-management 2024-01-26T10:37:13+03:00 en https://ophthalmologybreakingnews.com/wco-coopervision-collaborate-for-myopia-management https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-secures-fda-nod-for-modified-axpaxli-clinical-trial-in-wet-amd.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-secures-fda-nod-for-modified-axpaxli-trial 2024-01-26T08:36:36+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-secures-fda-nod-for-modified-axpaxli-trial https://ophthalmologybreakingnews.com/files/images/blog_hearing-loss-is-rare-in-tepezza-treatment-for-ted-new-study-finds.jpg https://ophthalmologybreakingnews.com/hearing-loss-is-rare-in-tepezza-treatment-for-ted 2024-01-25T11:42:02+03:00 en https://ophthalmologybreakingnews.com/hearing-loss-is-rare-in-tepezza-treatment-for-ted https://ophthalmologybreakingnews.com/files/images/blog_nanoscope-therapeutics-advances-regulatory-path-for-mco-010-in-retinitis-pigmentosa-treatment.jpg https://ophthalmologybreakingnews.com/nanoscope-advances-regulatory-path-for-mco-010 2025-01-16T09:57:19+03:00 en https://ophthalmologybreakingnews.com/nanoscope-advances-regulatory-path-for-mco-010 https://ophthalmologybreakingnews.com/files/images/blog_pixium-vision-postpones-decision-on-takeover-offer-amid-financial-considerations.jpg https://ophthalmologybreakingnews.com/pixium-vision-postpones-decision-on-takeover-offer 2025-01-28T09:22:20+03:00 en https://ophthalmologybreakingnews.com/pixium-vision-postpones-decision-on-takeover-offer https://ophthalmologybreakingnews.com/files/images/blog_how-long-is-ophthalmology-residency-a-comprehensive-insight.jpg https://ophthalmologybreakingnews.com/how-long-is-ophthalmology-residency 2024-01-24T10:39:45+03:00 en https://ophthalmologybreakingnews.com/how-long-is-ophthalmology-residency https://ophthalmologybreakingnews.com/files/images/blog_outlook-therapeutics-secures-fda-agreement-and-funding-for-ons-5010-development.jpg https://ophthalmologybreakingnews.com/outlook-secures-fda-agreement-and-funding-for-ons-5010 2024-01-24T10:18:03+03:00 en https://ophthalmologybreakingnews.com/outlook-secures-fda-agreement-and-funding-for-ons-5010 https://ophthalmologybreakingnews.com/files/images/blog_lumithera-initiates-global-pbm-trial-for-dry-amd-with-eurolight-registry-study.jpg https://ophthalmologybreakingnews.com/lumithera-initiates-global-pbm-trial-for-dry-amd 2025-01-28T09:34:18+03:00 en https://ophthalmologybreakingnews.com/lumithera-initiates-global-pbm-trial-for-dry-amd https://ophthalmologybreakingnews.com/files/images/blog_sandoz-to-acquire-coherus-ophthalmology-assets-for-170-million.jpg https://ophthalmologybreakingnews.com/sandoz-to-acquire-coherus-ophthalmology-assets 2024-01-25T11:42:19+03:00 en https://ophthalmologybreakingnews.com/sandoz-to-acquire-coherus-ophthalmology-assets https://ophthalmologybreakingnews.com/files/images/blog_digitaloptometrics-launches-real-time-translation-service-to-improve-patient-care.jpg https://ophthalmologybreakingnews.com/digitaloptometrics-launches-real-time-translation-service 2024-01-23T10:29:12+03:00 en https://ophthalmologybreakingnews.com/digitaloptometrics-launches-real-time-translation-service https://ophthalmologybreakingnews.com/files/images/blog_genetic-study-reveals-new-insights-into-glaucoma-in-individuals-of-african-ancestry.jpg https://ophthalmologybreakingnews.com/study-reveals-new-insights-into-glaucoma-in-individuals-of-african-ancestry 2024-01-22T13:36:42+03:00 en https://ophthalmologybreakingnews.com/study-reveals-new-insights-into-glaucoma-in-individuals-of-african-ancestry https://ophthalmologybreakingnews.com/files/images/blog_top-15-international-ophthalmology-congresses-to-attend-in-2024.jpg https://ophthalmologybreakingnews.com/top-international-ophthalmology-congresses-to-attend- 2024-11-13T11:13:32+03:00 en https://ophthalmologybreakingnews.com/top-international-ophthalmology-congresses-to-attend- https://ophthalmologybreakingnews.com/files/images/blog_iuvo-bioscience-acquires-promedica-international.jpg https://ophthalmologybreakingnews.com/iuvo-bioscience-acquires-promedica-international 2024-01-22T11:11:13+03:00 en https://ophthalmologybreakingnews.com/iuvo-bioscience-acquires-promedica-international https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-interview-with-filomena-ribeiro-md-new-president-of-escrs.jpg https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-filomena-ribeiro-md-president-of-escrs 2024-01-18T14:51:16+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-filomena-ribeiro-md-president-of-escrs https://ophthalmologybreakingnews.com/files/images/blog_researchers-receive-2-million-grant-to-pioneer-novel-glaucoma-therapy.jpg https://ophthalmologybreakingnews.com/researchers-receive-$2-million-grant-to-pioneer-novel-glaucoma-therapy 2024-04-29T09:37:52+03:00 en https://ophthalmologybreakingnews.com/researchers-receive-$2-million-grant-to-pioneer-novel-glaucoma-therapy https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-novel-technology-to-treat-ischemic-retinopathy.jpg https://ophthalmologybreakingnews.com/scientists-develop-novel-technology-to-treat-ischemic-retinopathy 2024-02-09T09:05:53+03:00 en https://ophthalmologybreakingnews.com/scientists-develop-novel-technology-to-treat-ischemic-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_rayner-acquires-sophi-developer-of-phacoemulsification-machines.jpg https://ophthalmologybreakingnews.com/rayner-broadens-portfolio-with-acquisition-of-sophi 2025-09-09T15:35:37+03:00 en https://ophthalmologybreakingnews.com/rayner-broadens-portfolio-with-acquisition-of-sophi https://ophthalmologybreakingnews.com/files/images/blog_researchers-from-the-uk-and-turkiye-develop-contact-lens-to-detect-glaucoma.jpg https://ophthalmologybreakingnews.com/researchers-develop-contact-lens-to-detect-glaucoma- 2024-04-29T10:02:15+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-contact-lens-to-detect-glaucoma- https://ophthalmologybreakingnews.com/files/images/blog_nidek-and-orbis-international-join-forces-to-boost-ai-eye-screenings-in-vietnam.jpg https://ophthalmologybreakingnews.com/nidek-and-orbis-to-boost-ai-eye-screenings-in-vietnam 2024-02-16T09:42:36+03:00 en https://ophthalmologybreakingnews.com/nidek-and-orbis-to-boost-ai-eye-screenings-in-vietnam https://ophthalmologybreakingnews.com/files/images/blog_arpa-h-launches-program-to-restore-sight-through-human-eye-transplantation.jpg https://ophthalmologybreakingnews.com/arpa-launches-program-to-restore-sight-through-eye-transplantation 2025-01-31T13:59:18+03:00 en https://ophthalmologybreakingnews.com/arpa-launches-program-to-restore-sight-through-eye-transplantation https://ophthalmologybreakingnews.com/files/images/blog_the-comprehensive-glaucoma-eye-drops-list-you-need.jpg https://ophthalmologybreakingnews.com/comprehensive-glaucoma-eye-drops-list-you-need 2024-04-29T10:16:35+03:00 en https://ophthalmologybreakingnews.com/comprehensive-glaucoma-eye-drops-list-you-need https://ophthalmologybreakingnews.com/files/images/blog_aviceda-therapeutics-initiates-phase-2-trial-for-avd-104-in-dme.jpg https://ophthalmologybreakingnews.com/aviceda-therapeutics-initiates-phase-2-trial-for-avd-104-in-dme 2024-01-16T09:30:39+03:00 en https://ophthalmologybreakingnews.com/aviceda-therapeutics-initiates-phase-2-trial-for-avd-104-in-dme https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-pupil-response-discrepancy-in-patients-with-depression.jpg https://ophthalmologybreakingnews.com/study-reveals-pupil-response-discrepancy-in-patients-with-depression 2024-01-15T14:59:41+03:00 en https://ophthalmologybreakingnews.com/study-reveals-pupil-response-discrepancy-in-patients-with-depression https://ophthalmologybreakingnews.com/files/images/blog_iridex-launches-iridex-532-and-iridex-577-lasers-in-the-us.jpg https://ophthalmologybreakingnews.com/iridex-launches-iridex-532-and-iridex-577-lasers-in-the-us 2024-04-29T10:01:23+03:00 en https://ophthalmologybreakingnews.com/iridex-launches-iridex-532-and-iridex-577-lasers-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_alkeus-pharmaceuticals-reports-promising-data-on-gildeuretinol-for-stargardt-disease.jpg https://ophthalmologybreakingnews.com/alkeus-reports-promising-data-on-gildeuretinol-for-stargardt 2025-01-16T09:45:05+03:00 en https://ophthalmologybreakingnews.com/alkeus-reports-promising-data-on-gildeuretinol-for-stargardt https://ophthalmologybreakingnews.com/files/images/blog_corneal-ectasia-causes-symptoms-and-treatment-options.jpg https://ophthalmologybreakingnews.com/corneal-ectasia-causes-symptoms-and-treatment-options 2025-01-27T09:26:27+03:00 en https://ophthalmologybreakingnews.com/corneal-ectasia-causes-symptoms-and-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_nidek-launches-mirante-scanning-laser-ophthalmoscope-in-the-us_1.jpg https://ophthalmologybreakingnews.com/nidek-launches-mirante-scanning-laser-ophthalmoscope-in-the-us 2024-10-22T13:30:23+03:00 en https://ophthalmologybreakingnews.com/nidek-launches-mirante-scanning-laser-ophthalmoscope-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-zeiss-visumaxr-800-with-smiler-pro-software-for-nearsightedness-surgery.jpg https://ophthalmologybreakingnews.com/fda-approves-zeiss-visumax®-800-with-smile-pro-software 2024-01-12T10:29:27+03:00 en https://ophthalmologybreakingnews.com/fda-approves-zeiss-visumax®-800-with-smile-pro-software https://ophthalmologybreakingnews.com/files/images/blog_chronic-progressive-external-ophthalmoplegia-cpeo.jpg https://ophthalmologybreakingnews.com/chronic-progressive-external-ophthalmoplegia- 2025-01-16T09:33:54+03:00 en https://ophthalmologybreakingnews.com/chronic-progressive-external-ophthalmoplegia- https://ophthalmologybreakingnews.com/files/images/blog_the-dark-side-of-cosmetic-eye-color-change-surgery-risks-and-warnings.jpg https://ophthalmologybreakingnews.com/the-dark-side-of-cosmetic-eye-color-change-surgery 2025-01-16T09:13:23+03:00 en https://ophthalmologybreakingnews.com/the-dark-side-of-cosmetic-eye-color-change-surgery https://ophthalmologybreakingnews.com/files/images/blog_worlds-first-quantum-optics-device-aims-to-prevent-vision-loss-from-amd.jpg https://ophthalmologybreakingnews.com/worlds-first-quantum-optics-device-to-prevent-vision-loss-from-amd 2025-01-31T14:03:28+03:00 en https://ophthalmologybreakingnews.com/worlds-first-quantum-optics-device-to-prevent-vision-loss-from-amd https://ophthalmologybreakingnews.com/files/images/blog_the-role-of-penetrating-keratoplasty-in-corneal-disorder-solutions.jpg https://ophthalmologybreakingnews.com/the-role-of-penetrating-keratoplasty-in-corneal-disorder-solutions- 2024-02-16T13:04:08+03:00 en https://ophthalmologybreakingnews.com/the-role-of-penetrating-keratoplasty-in-corneal-disorder-solutions- https://ophthalmologybreakingnews.com/files/images/blog_eyepoint-pharmaceuticals-initiates-verona-trial-for-eyp-1901-in-dme.jpg https://ophthalmologybreakingnews.com/eyepoint-initiates-verona-trial-for-eyp-1901-in-dme 2024-02-16T09:52:03+03:00 en https://ophthalmologybreakingnews.com/eyepoint-initiates-verona-trial-for-eyp-1901-in-dme https://ophthalmologybreakingnews.com/files/images/blog_mantis-photonics-launches-crowdfunding-campaign-for-eye-screening-technology.jpg https://ophthalmologybreakingnews.com/mantis-photonics-launches-campaign-for-eye-screening-technology 2024-02-16T09:47:26+03:00 en https://ophthalmologybreakingnews.com/mantis-photonics-launches-campaign-for-eye-screening-technology https://ophthalmologybreakingnews.com/files/images/blog_ildong-pharmaceutical-partners-with-hanlim-pharm-to-promote-otc-eye-drops.jpg https://ophthalmologybreakingnews.com/ildong-partners-with-hanlim-pharm-to-promote-otc-eye-drops 2025-01-27T09:12:43+03:00 en https://ophthalmologybreakingnews.com/ildong-partners-with-hanlim-pharm-to-promote-otc-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_university-of-california-irvine-secures-575k-grant-from-research-to-prevent-blindness.jpg https://ophthalmologybreakingnews.com/uci-secures-$575k-grant-from-research-to-prevent-blindness 2024-01-10T08:58:36+03:00 en https://ophthalmologybreakingnews.com/uci-secures-$575k-grant-from-research-to-prevent-blindness https://ophthalmologybreakingnews.com/files/images/blog_gentex-acquires-esight-to-develop-electronic-eyewear-for-the-visually-impaired.jpg https://ophthalmologybreakingnews.com/gentex-acquires-esight-to-develop-electronic-eyewear 2024-01-17T18:42:34+03:00 en https://ophthalmologybreakingnews.com/gentex-acquires-esight-to-develop-electronic-eyewear https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-receives-fda-approval-for-teneo-excimer-laser-platform.jpg https://ophthalmologybreakingnews.com/bausch-lomb-receives-fda-approval-for-teneo-excimer-laser-platform- 2025-01-31T14:46:14+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-receives-fda-approval-for-teneo-excimer-laser-platform- https://ophthalmologybreakingnews.com/files/images/blog_eylea-8-mg-receives-european-commission-approval.jpg https://ophthalmologybreakingnews.com/eylea-8-mg-receives-european-commission-approval- 2025-01-28T09:38:46+03:00 en https://ophthalmologybreakingnews.com/eylea-8-mg-receives-european-commission-approval- https://ophthalmologybreakingnews.com/files/images/blog_alvotechs-biosimilar-avt06-shows-promise-in-eylea-equivalence-study.jpg https://ophthalmologybreakingnews.com/alvotechs-biosimilar-avt06-shows-promise-in-eylea-equivalence-study 2025-01-31T13:50:54+03:00 en https://ophthalmologybreakingnews.com/alvotechs-biosimilar-avt06-shows-promise-in-eylea-equivalence-study https://ophthalmologybreakingnews.com/files/images/blog_alimera-completes-enrollment-for-synchronicity-study-on-yutiq-in-uveitis-treatment.jpg https://ophthalmologybreakingnews.com/alimera-completes-enrollment-for-synchronicity-study-on-yutiq 2024-02-09T10:12:22+03:00 en https://ophthalmologybreakingnews.com/alimera-completes-enrollment-for-synchronicity-study-on-yutiq https://ophthalmologybreakingnews.com/files/images/blog_fda-greenlights-ocuphires-phase-3-trial-for-treatment-of-decreased-visual-acuity-under-mesopic-light-conditions.jpg https://ophthalmologybreakingnews.com/fda-greenlights-ocuphires-phase-3-trial-for-decreased-visual-acuity 2024-01-08T09:46:25+03:00 en https://ophthalmologybreakingnews.com/fda-greenlights-ocuphires-phase-3-trial-for-decreased-visual-acuity https://ophthalmologybreakingnews.com/files/images/blog_lumithera-provides-update-on-fda-review-for-valeda-light-delivery-system.jpg https://ophthalmologybreakingnews.com/lumithera-update-on-fda-review-for-valeda-light-delivery-system 2025-01-31T15:00:21+03:00 en https://ophthalmologybreakingnews.com/lumithera-update-on-fda-review-for-valeda-light-delivery-system https://ophthalmologybreakingnews.com/files/images/blog_fda-announces-revised-draft-guidance-on-quality-considerations-for-ophthalmic-drug-products.jpg https://ophthalmologybreakingnews.com/fda-revised-draft-guidance-on-quality-considerations-for-ophthalmic-drugs 2024-01-05T10:26:40+03:00 en https://ophthalmologybreakingnews.com/fda-revised-draft-guidance-on-quality-considerations-for-ophthalmic-drugs https://ophthalmologybreakingnews.com/files/images/blog_claris-bio-secures-57m-for-corneal-healing-product-candidate.jpg https://ophthalmologybreakingnews.com/claris-bio-secures-$57m-for-corneal-healing-product-candidate 2025-01-27T09:16:54+03:00 en https://ophthalmologybreakingnews.com/claris-bio-secures-$57m-for-corneal-healing-product-candidate https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-interview-with-hillary-a-golden-glaucoma-patient-and-director-at-glaucoma-coach.jpg https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-hillary-a-golden 2024-11-18T15:03:02+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-hillary-a-golden https://ophthalmologybreakingnews.com/files/images/blog_harrow-partners-with-three-healthcare-technology-platforms-to-expand-access-to-vevye.jpg https://ophthalmologybreakingnews.com/harrow-partners-with-healthcare-technology-platforms-for-vevye 2025-01-31T14:42:54+03:00 en https://ophthalmologybreakingnews.com/harrow-partners-with-healthcare-technology-platforms-for-vevye https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-and-glaucoma-research-foundation-launch-faces-of-glaucoma-campaign.jpg https://ophthalmologybreakingnews.com/bausch-lomb-and-glaucoma-research-foundation-launch-campaign 2024-04-29T10:13:31+03:00 en https://ophthalmologybreakingnews.com/bausch-lomb-and-glaucoma-research-foundation-launch-campaign https://ophthalmologybreakingnews.com/files/images/blog_breakthrough-study-reveals-promising-treatment-for-corneal-endothelial-disease.jpg https://ophthalmologybreakingnews.com/study-reveals-promising-treatment-for-corneal-endothelial-disease 2024-01-03T13:25:45+03:00 en https://ophthalmologybreakingnews.com/study-reveals-promising-treatment-for-corneal-endothelial-disease https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-applauds-medicare-contractors-decision-on-migs-lcds.jpg https://ophthalmologybreakingnews.com/sight-sciences-applauds-medicare-contractors-decision-on-migs-lcds 2024-04-29T09:32:10+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-applauds-medicare-contractors-decision-on-migs-lcds https://ophthalmologybreakingnews.com/files/images/blog_akkolens-names-peter-taal-as-chief-executive-officer.jpg https://ophthalmologybreakingnews.com/akkolens-names-peter-taal-as-ceo 2025-01-28T09:15:14+03:00 en https://ophthalmologybreakingnews.com/akkolens-names-peter-taal-as-ceo https://ophthalmologybreakingnews.com/files/images/blog_stuart-therapeutics-initiates-phase-3-trial-for-vezocolmitide-in-ded.jpg https://ophthalmologybreakingnews.com/stuart-therapeutics-initiates-phase-3-trial-for-vezocolmitide-in-ded 2025-02-04T14:58:25+03:00 en https://ophthalmologybreakingnews.com/stuart-therapeutics-initiates-phase-3-trial-for-vezocolmitide-in-ded https://ophthalmologybreakingnews.com/files/images/blog_filomena-ribeiro-md-takes-the-helm-as-president-of-escrs.jpg https://ophthalmologybreakingnews.com/filomena-ribeiro-md-takes-the-helm-as-president-of-escrs 2025-01-29T14:40:55+03:00 en https://ophthalmologybreakingnews.com/filomena-ribeiro-md-takes-the-helm-as-president-of-escrs https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-20-ophthalmic-partnerships-of-the-year.jpg https://ophthalmologybreakingnews.com/2023-recap-top-20-ophthalmic-partnerships-of-the-year 2024-03-19T11:50:05+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-20-ophthalmic-partnerships-of-the-year https://ophthalmologybreakingnews.com/files/images/blog_samsung-bioepis-faces-administrative-penalty-for-clinical-study-violation.jpg https://ophthalmologybreakingnews.com/samsung-bioepis-faces-administrative-penalty-for-clinical-study-violation 2023-12-27T09:56:12+03:00 en https://ophthalmologybreakingnews.com/samsung-bioepis-faces-administrative-penalty-for-clinical-study-violation https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-10-company-acquisitions-in-the-ophthalmic-industry.jpg https://ophthalmologybreakingnews.com/2023-recap-top-10-acquisitions-in-the-ophthalmic-industry 2024-02-12T16:10:42+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-10-acquisitions-in-the-ophthalmic-industry https://ophthalmologybreakingnews.com/files/images/blog_azura-ophthalmics-reports-successful-phase-2-trial-of-azr-md-001-for-contact-lens-discomfort.jpg https://ophthalmologybreakingnews.com/azura-reports-successful-phase-2-trial-of-for-contact-lens-discomfort 2023-12-26T10:23:26+03:00 en https://ophthalmologybreakingnews.com/azura-reports-successful-phase-2-trial-of-for-contact-lens-discomfort https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/4dmt-receives-rmat-designation-for-genetic-medicine-in-wet-amd 2023-12-25T14:56:56+03:00 en https://ophthalmologybreakingnews.com/4dmt-receives-rmat-designation-for-genetic-medicine-in-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_oculis-initiates-phase-3-trial-for-ocs-01-to-treat-inflammation-and-pain-post-cataract-surgery_1.jpg https://ophthalmologybreakingnews.com/oculis-initiates-trial-for-ocs-01-to-treat-inflammation-and-pain 2024-07-01T16:34:18+03:00 en https://ophthalmologybreakingnews.com/oculis-initiates-trial-for-ocs-01-to-treat-inflammation-and-pain https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-15-medical-devices-revolutionizing-ophthalmology.jpg https://ophthalmologybreakingnews.com/2023-recap-top-15-ophthalmic-medical-devices 2024-03-19T10:40:52+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-15-ophthalmic-medical-devices https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/visgenx-extends-collaboration-with-charles-river-for-gene-therapy 2023-12-21T09:17:23+03:00 en https://ophthalmologybreakingnews.com/visgenx-extends-collaboration-with-charles-river-for-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_researchers-identify-a-new-mechanism-crucial-for-cell-survival-in-the-eye-and-brain.jpg https://ophthalmologybreakingnews.com/new-mechanism-crucial-for-cell-survival-in-the-eye-and-brain 2024-01-30T09:39:09+03:00 en https://ophthalmologybreakingnews.com/new-mechanism-crucial-for-cell-survival-in-the-eye-and-brain https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-10-novel-contact-lenses-and-technologies.jpg https://ophthalmologybreakingnews.com/2023-recap-top-10-contact-lenses-and-technologies- 2024-04-29T10:22:39+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-10-contact-lenses-and-technologies- https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-interview-with-gilad-litvin-md-founder-at-corneat-vision.jpg https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-gilad-litvin-at-corneat-vision- 2024-01-08T10:19:04+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-gilad-litvin-at-corneat-vision- https://ophthalmologybreakingnews.com/files/images/blog_glaukos-receives-fda-approval-for-idose-tr-intracameral-implant.jpg https://ophthalmologybreakingnews.com/glaukos-receives-fda-approval-for-idose-tr 2024-02-09T10:53:00+03:00 en https://ophthalmologybreakingnews.com/glaukos-receives-fda-approval-for-idose-tr https://ophthalmologybreakingnews.com/files/images/blog_carl-zeiss-meditec-signs-agreement-to-acquire-dorc.jpg https://ophthalmologybreakingnews.com/carl-zeiss-meditec-signs-agreement-to-acquire-dorc 2024-04-29T09:33:37+03:00 en https://ophthalmologybreakingnews.com/carl-zeiss-meditec-signs-agreement-to-acquire-dorc https://ophthalmologybreakingnews.com/files/images/blog_researchers-unveil-3d-map-of-human-retinal-development-using-lab-grown-models.jpg https://ophthalmologybreakingnews.com/researchers-unveil-3d-map-of-human-retinal-development 2023-12-14T15:40:36+03:00 en https://ophthalmologybreakingnews.com/researchers-unveil-3d-map-of-human-retinal-development https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-12-novel-gene-therapies-for-eye-diseases-and-blindness.jpg https://ophthalmologybreakingnews.com/2023-recap-top-12-gene-therapies-for-eye-diseases-blindness 2024-03-19T11:48:16+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-12-gene-therapies-for-eye-diseases-blindness https://ophthalmologybreakingnews.com/files/images/blog_belkin-vision-receives-fda-clearance-for-eagle-device-for-selective-laser-trabeculoplasty.jpg https://ophthalmologybreakingnews.com/belkin-receives-fda-clearance-for-eagle-device-for-slt 2024-04-29T09:58:52+03:00 en https://ophthalmologybreakingnews.com/belkin-receives-fda-clearance-for-eagle-device-for-slt https://ophthalmologybreakingnews.com/files/images/blog_g-csfs-therapeutic-potential-explored-in-premature-infants-lung-and-eye-health.jpg https://ophthalmologybreakingnews.com/g-csfs-therapeutic-potential-explored-in-premature-infants-eye-health 2023-12-12T10:47:49+03:00 en https://ophthalmologybreakingnews.com/g-csfs-therapeutic-potential-explored-in-premature-infants-eye-health https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-15-breakthroughs-in-ophthalmology-research.jpg https://ophthalmologybreakingnews.com/2023-recap-top-15-breakthroughs-in-ophthalmology-research 2024-12-18T11:24:05+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-15-breakthroughs-in-ophthalmology-research https://ophthalmologybreakingnews.com/files/images/blog_-azalea-vision-announces-first-on-eye-test-of-its-novel-smart-contact-lens-alma.jpg https://ophthalmologybreakingnews.com/vision-announces-first-on-eye-test-of-its-novel-smart-contact-lens 2024-02-16T11:14:32+03:00 en https://ophthalmologybreakingnews.com/vision-announces-first-on-eye-test-of-its-novel-smart-contact-lens https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-top-12-novel-ophthalmic-drugs-that-received-fda-approval_1.jpg https://ophthalmologybreakingnews.com/2023-recap-top-12-ophthalmic-drugs-that-received-fda-approval 2024-12-16T10:20:34+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-12-ophthalmic-drugs-that-received-fda-approval https://ophthalmologybreakingnews.com/files/images/blog_study-shows-faricimabs-success-in-maintaining-bcva-and-extending-injection-intervals-in-namd.jpg https://ophthalmologybreakingnews.com/faricimabs-success-in-treating-namd 2023-12-08T10:04:42+03:00 en https://ophthalmologybreakingnews.com/faricimabs-success-in-treating-namd https://ophthalmologybreakingnews.com/files/images/blog_eye-safe-laser-technology-to-transform-traumatic-brain-injury-diagnosis.jpg https://ophthalmologybreakingnews.com/eye-safe-laser-technology-to-transform-traumatic-brain-injury-diagnosis 2023-12-07T15:09:22+03:00 en https://ophthalmologybreakingnews.com/eye-safe-laser-technology-to-transform-traumatic-brain-injury-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_2023-recap-a-closer-look-at-first-evers-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/2023-recap-top-15-firsts-in-ophthalmology 2024-02-09T09:56:14+03:00 en https://ophthalmologybreakingnews.com/2023-recap-top-15-firsts-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_history-of-cataract-surgery.jpg https://ophthalmologybreakingnews.com/history-of-cataract-surgery 2024-04-29T10:08:18+03:00 en https://ophthalmologybreakingnews.com/history-of-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_persistent-pupillary-membrane-how-does-it-affect-vision.jpg https://ophthalmologybreakingnews.com/persistent-pupillary-membrane 2023-12-05T10:34:32+03:00 en https://ophthalmologybreakingnews.com/persistent-pupillary-membrane https://ophthalmologybreakingnews.com/files/images/blog_goniosynechialysis-surgery-insights-for-glaucoma-management.jpg https://ophthalmologybreakingnews.com/goniosynechialysis-surgery-insights-for-glaucoma-management 2023-12-04T08:52:52+03:00 en https://ophthalmologybreakingnews.com/goniosynechialysis-surgery-insights-for-glaucoma-management https://ophthalmologybreakingnews.com/files/images/blog_infectious-keratitis-causes-treatment-and-prevention-guide.jpg https://ophthalmologybreakingnews.com/infectious-keratitis-causes-treatment-prevention-guide 2024-10-04T08:37:05+03:00 en https://ophthalmologybreakingnews.com/infectious-keratitis-causes-treatment-prevention-guide https://ophthalmologybreakingnews.com/files/images/blog_first-topical-treatment-for-diabetic-retinal-diseases-shows-promise-in-phase-ib-iia-study.jpg https://ophthalmologybreakingnews.com/first-topical-treatment-for-diabetic-retinal-diseases 2024-02-16T09:43:13+03:00 en https://ophthalmologybreakingnews.com/first-topical-treatment-for-diabetic-retinal-diseases https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-showcases-novel-enova-advancedtm-edof-iol-at-epomec-2023.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-showcases-enova-advanced-iol-at-epomec 2023-11-28T10:46:50+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-showcases-enova-advanced-iol-at-epomec https://ophthalmologybreakingnews.com/files/images/blog_the-crucial-role-of-corneal-hysteresis-in-glaucoma-risk-assessment.jpg https://ophthalmologybreakingnews.com/role-of-corneal-hysteresis-in-glaucoma-risk-assessment 2023-11-28T09:34:28+03:00 en https://ophthalmologybreakingnews.com/role-of-corneal-hysteresis-in-glaucoma-risk-assessment https://ophthalmologybreakingnews.com/files/images/blog_fda-requests-further-study-on-aldeyra-therapeutics-reproxalap-for-ded.jpg https://ophthalmologybreakingnews.com/further-study-on-aldeyra-reproxalap-for-ded 2024-02-09T09:13:41+03:00 en https://ophthalmologybreakingnews.com/further-study-on-aldeyra-reproxalap-for-ded https://ophthalmologybreakingnews.com/files/images/blog_blepharoconjunctivitis-a-closer-look-at-its-causes-and-treatment.jpg https://ophthalmologybreakingnews.com/blepharoconjunctivitis-its-causes-and-treatment 2024-02-20T11:48:50+03:00 en https://ophthalmologybreakingnews.com/blepharoconjunctivitis-its-causes-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_researchers-uncover-brains-response-to-new-sensory-input-patterns.jpg https://ophthalmologybreakingnews.com/researchers-uncover-brains-response-to-new-sensory-input-patterns 2024-02-16T13:53:52+03:00 en https://ophthalmologybreakingnews.com/researchers-uncover-brains-response-to-new-sensory-input-patterns https://ophthalmologybreakingnews.com/files/images/blog_emily-chew-md-recognized-as-nih-distinguished-investigator.jpg https://ophthalmologybreakingnews.com/emily-chew-md-recognized-as-nih-distinguished-investigator 2024-02-16T09:49:34+03:00 en https://ophthalmologybreakingnews.com/emily-chew-md-recognized-as-nih-distinguished-investigator https://ophthalmologybreakingnews.com/files/images/blog_oral-drug-blocks-retinal-capillary-stiffening-offering-hope-for-dr-prevention.jpg https://ophthalmologybreakingnews.com/oral-drug-blocks-retinal-capillary-stiffening 2024-02-16T09:45:42+03:00 en https://ophthalmologybreakingnews.com/oral-drug-blocks-retinal-capillary-stiffening https://ophthalmologybreakingnews.com/files/images/blog_2023-eye-drop-recall-list-brand-by-brand-recall-breakdown.jpg https://ophthalmologybreakingnews.com/2023-eye-drop-recall-list-brand-by-brand-recall-breakdown 2024-04-29T11:24:56+03:00 en https://ophthalmologybreakingnews.com/2023-eye-drop-recall-list-brand-by-brand-recall-breakdown https://ophthalmologybreakingnews.com/files/images/blog_schirmers-test-and-its-implications-in-monitoring-and-managing-dry-eyes.jpg https://ophthalmologybreakingnews.com/schirmers-test-and-its-implications 2023-11-30T09:35:50+03:00 en https://ophthalmologybreakingnews.com/schirmers-test-and-its-implications https://ophthalmologybreakingnews.com/files/images/blog_berkeley-scientists-discover-retinal-cells-that-help-stabilize-our-world-view.jpg https://ophthalmologybreakingnews.com/berkeley-scientists-discover-retinal-cells 2023-11-21T16:26:03+03:00 en https://ophthalmologybreakingnews.com/berkeley-scientists-discover-retinal-cells https://ophthalmologybreakingnews.com/files/images/blog_oxurion-files-for-bankruptcy-after-phase-2-clinical-trial-for-dme-drug-fail.jpg https://ophthalmologybreakingnews.com/oxurion-files-for-bankruptcy 2023-11-21T10:20:39+03:00 en https://ophthalmologybreakingnews.com/oxurion-files-for-bankruptcy https://ophthalmologybreakingnews.com/files/images/blog_researchers-unveil-the-role-of-iron-in-ocular-toxoplasmosis.jpg https://ophthalmologybreakingnews.com/researchers-unveil-the-role-of-iron-in-ocular-toxoplasmosis 2023-11-20T14:33:57+03:00 en https://ophthalmologybreakingnews.com/researchers-unveil-the-role-of-iron-in-ocular-toxoplasmosis https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-glaucoma-cell-replacement-therapy-to-reverse-vision-loss.jpg https://ophthalmologybreakingnews.com/researchers-develop-glaucoma-cell-replacement-therapy 2024-04-29T10:15:33+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-glaucoma-cell-replacement-therapy https://ophthalmologybreakingnews.com/files/images/blog_eyebio-secures-130-million-to-accelerate-development-of-restoret.jpg https://ophthalmologybreakingnews.com/eyebio-secures-$130-million-to-accelerate 2023-11-17T10:40:39+03:00 en https://ophthalmologybreakingnews.com/eyebio-secures-$130-million-to-accelerate https://ophthalmologybreakingnews.com/files/images/blog_lenz-therapeutics-and-graphite-bio-announce-merger-agreement.jpg https://ophthalmologybreakingnews.com/lenz-therapeutics-and-graphite-bio-merge 2023-11-16T09:48:41+03:00 en https://ophthalmologybreakingnews.com/lenz-therapeutics-and-graphite-bio-merge https://ophthalmologybreakingnews.com/files/images/blog_ocutrx-technologies-launches-oculenz-ar-xr-headset-for-advanced-amd.jpg https://ophthalmologybreakingnews.com/ocutrx-launches-oculenz-ar-xr-headset 2023-11-16T09:01:40+03:00 en https://ophthalmologybreakingnews.com/ocutrx-launches-oculenz-ar-xr-headset https://ophthalmologybreakingnews.com/files/images/blog_fda-grants-rmat-designation-for-atsenas-gene-therapy-for-lca1.jpg https://ophthalmologybreakingnews.com/fda-grants-rmat-for-atsenas-gene-therapy-for-lca1 2023-11-15T15:47:39+03:00 en https://ophthalmologybreakingnews.com/fda-grants-rmat-for-atsenas-gene-therapy-for-lca1 https://ophthalmologybreakingnews.com/files/images/blog_vitritis-explained-symptoms-diagnosis-and-management.jpg https://ophthalmologybreakingnews.com/vitritis-explained-symptoms-diagnosis 2023-11-30T09:54:15+03:00 en https://ophthalmologybreakingnews.com/vitritis-explained-symptoms-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-warning-to-amazon-over-sale-of-7-unapproved-eye-drops.jpg https://ophthalmologybreakingnews.com/fda-warns-amazon-over-sale-of-7-unapproved-eye-drops 2023-11-15T09:00:36+03:00 en https://ophthalmologybreakingnews.com/fda-warns-amazon-over-sale-of-7-unapproved-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_lupin-and-amman-pharma-sign-licensing-agreement-for-ranibizumab-biosimilar.jpg https://ophthalmologybreakingnews.com/lupin-and-amman-sign-licensing-agreement 2024-02-16T10:59:49+03:00 en https://ophthalmologybreakingnews.com/lupin-and-amman-sign-licensing-agreement https://ophthalmologybreakingnews.com/files/images/blog_autoimmune-retinopathy-insights-into-a-rare-eye-disorder.jpg https://ophthalmologybreakingnews.com/autoimmune-retinopathy 2023-11-30T10:01:24+03:00 en https://ophthalmologybreakingnews.com/autoimmune-retinopathy https://ophthalmologybreakingnews.com/files/images/blog_biocon-biologics-receives-uk-approval-for-yesafilir-biosimilar-aflibercept.jpg https://ophthalmologybreakingnews.com/biocon-receives-uk-approval-for-yesafili® 2024-02-09T09:52:31+03:00 en https://ophthalmologybreakingnews.com/biocon-receives-uk-approval-for-yesafili® https://ophthalmologybreakingnews.com/files/images/blog_bayers-high-dose-eylea-gains-chmp-backing-for-retinal-diseases.jpg https://ophthalmologybreakingnews.com/bayers-high-dose-eylea-gains-chmp 2023-11-13T10:38:05+03:00 en https://ophthalmologybreakingnews.com/bayers-high-dose-eylea-gains-chmp https://ophthalmologybreakingnews.com/files/images/blog_seeing-clearly-again-vitrectomy-surgery-for-floaters.jpg https://ophthalmologybreakingnews.com/vitrectomy-surgery-for-floaters- 2023-11-30T10:05:35+03:00 en https://ophthalmologybreakingnews.com/vitrectomy-surgery-for-floaters- https://ophthalmologybreakingnews.com/files/images/blog_varliciment-a-novel-anti-vegf-agent-for-the-treatment-of-amd-by-vsy-biotechnology-gmbh.jpg https://ophthalmologybreakingnews.com/varliciment-a-novel-anti-vegf-agent-by-vsy-biotechnology 2023-11-10T14:40:37+03:00 en https://ophthalmologybreakingnews.com/varliciment-a-novel-anti-vegf-agent-by-vsy-biotechnology https://ophthalmologybreakingnews.com/files/images/blog_what-does-it-mean-to-have-cotton-wool-spots-on-the-retina.jpg https://ophthalmologybreakingnews.com/cotton-wool-spots-on-the-retina 2023-11-30T10:15:48+03:00 en https://ophthalmologybreakingnews.com/cotton-wool-spots-on-the-retina https://ophthalmologybreakingnews.com/files/images/blog_visionix-usa-forms-strategic-partnership-with-20-20now.jpg https://ophthalmologybreakingnews.com/visionix-usa-forms-strategic-partnership-with-20-20now 2023-11-10T09:58:36+03:00 en https://ophthalmologybreakingnews.com/visionix-usa-forms-strategic-partnership-with-20-20now https://ophthalmologybreakingnews.com/files/images/blog_medical-breakthrough-worlds-first-whole-eye-and-partial-face-transplant.jpg https://ophthalmologybreakingnews.com/worlds-first-whole-eye-and-partial-face-transplant- 2023-11-10T09:02:24+03:00 en https://ophthalmologybreakingnews.com/worlds-first-whole-eye-and-partial-face-transplant- https://ophthalmologybreakingnews.com/files/images/blog_study-novel-algorithm-predicts-amd-progression-with-94-accuracy.jpg https://ophthalmologybreakingnews.com/study-novel-algorithm-predicts-amd-progression 2023-11-09T10:47:37+03:00 en https://ophthalmologybreakingnews.com/study-novel-algorithm-predicts-amd-progression https://ophthalmologybreakingnews.com/files/images/blog_ascrs-appoints-abigail-markward-as-new-executive-director.jpg https://ophthalmologybreakingnews.com/ascrs-appoints-abigail-markward-as-new-executive-director 2023-11-08T13:27:47+03:00 en https://ophthalmologybreakingnews.com/ascrs-appoints-abigail-markward-as-new-executive-director https://ophthalmologybreakingnews.com/files/images/blog_ora-and-blindcan-film-festival-launch-the-blind-canvas-project.jpg https://ophthalmologybreakingnews.com/ora-blindcan-film-festival-launch-the-blind-canvas-project 2023-11-08T08:45:08+03:00 en https://ophthalmologybreakingnews.com/ora-blindcan-film-festival-launch-the-blind-canvas-project https://ophthalmologybreakingnews.com/files/images/blog_ai-can-predict-if-and-when-people-are-at-high-risk-for-glaucoma.jpg https://ophthalmologybreakingnews.com/ai-can-predict-if-and-when-risk-for-glaucoma 2024-04-29T10:19:08+03:00 en https://ophthalmologybreakingnews.com/ai-can-predict-if-and-when-risk-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_pantheon-secures-25m-to-launch-development-of-bioengineered-corneal-implant.jpg https://ophthalmologybreakingnews.com/pantheon-secures-$25m-to-develop-bioengineered 2023-11-03T14:19:59+03:00 en https://ophthalmologybreakingnews.com/pantheon-secures-$25m-to-develop-bioengineered https://ophthalmologybreakingnews.com/files/images/blog_corneal-melt-a-rare-but-vision-threatening-condition.jpg https://ophthalmologybreakingnews.com/corneal-melt--a-rare-but-vision-threatening-condition 2023-11-30T10:22:02+03:00 en https://ophthalmologybreakingnews.com/corneal-melt--a-rare-but-vision-threatening-condition https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-gets-fda-agreement-for-otx-tki-in-wet-amd-trial.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-gets-fda-agreement 2023-11-02T13:29:40+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-gets-fda-agreement https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-interview-with-dr-stanley-windsor-digital-innovation-manager-at-rayner.jpg https://ophthalmologybreakingnews.com/obn-spotlight-interview-with-digital-innovation-manager-at-rayner- 2024-10-04T09:46:27+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-interview-with-digital-innovation-manager-at-rayner- https://ophthalmologybreakingnews.com/files/images/blog_okogen-begins-phase-2b-clinical-trial-for-acute-infectious-conjunctivitis.jpg https://ophthalmologybreakingnews.com/okogen-begins-clinical-trial-for-infectious-conjunctivitis 2023-11-01T13:08:57+03:00 en https://ophthalmologybreakingnews.com/okogen-begins-clinical-trial-for-infectious-conjunctivitis https://ophthalmologybreakingnews.com/files/images/blog_iris-prolapse-a-comprehensive-review-of-causes-diagnosis-and-management.jpg https://ophthalmologybreakingnews.com/iris-prolapse-a-review-of-causes-and-management- 2024-02-09T10:33:00+03:00 en https://ophthalmologybreakingnews.com/iris-prolapse-a-review-of-causes-and-management- https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-onpoint-visions-ide-application-to-initiate-phase-1-trial-of-iopcl-magnifier.jpg https://ophthalmologybreakingnews.com/fda-approves-onpoint-ide-to-initiate-trial-of-iopcl-magnifier 2023-11-01T10:19:25+03:00 en https://ophthalmologybreakingnews.com/fda-approves-onpoint-ide-to-initiate-trial-of-iopcl-magnifier https://ophthalmologybreakingnews.com/files/images/blog_roth-spots-in-the-eye-what-you-need-to-know.jpg https://ophthalmologybreakingnews.com/roth-spots-in-the-eye-what-you-need-to-know 2024-02-16T09:52:44+03:00 en https://ophthalmologybreakingnews.com/roth-spots-in-the-eye-what-you-need-to-know https://ophthalmologybreakingnews.com/files/images/blog_hypertensive-retinopathy-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/hypertensive-retinopathy-causes-symptoms-and-treatment 2024-02-16T09:50:53+03:00 en https://ophthalmologybreakingnews.com/hypertensive-retinopathy-causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_opthea-appoints-fred-guerard-as-ceo-and-peter-lang-as-cfo.jpg https://ophthalmologybreakingnews.com/opthea-appoints-fred-guerard-as-ceo-and-peter-lang-as-cfo 2023-10-30T13:03:43+03:00 en https://ophthalmologybreakingnews.com/opthea-appoints-fred-guerard-as-ceo-and-peter-lang-as-cfo https://ophthalmologybreakingnews.com/files/images/blog_fda-warns-of-26-over-the-counter-eye-drops-from-several-major-brands_1.jpg https://ophthalmologybreakingnews.com/fda-warns-of-26-over-the-counter-eye-drops 2024-10-21T11:44:12+03:00 en https://ophthalmologybreakingnews.com/fda-warns-of-26-over-the-counter-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_corneal-staining-an-in-depth-examination-of-causes-and-effects_1.jpg https://ophthalmologybreakingnews.com/corneal-staining-causes-and-effects 2024-10-21T11:09:15+03:00 en https://ophthalmologybreakingnews.com/corneal-staining-causes-and-effects https://ophthalmologybreakingnews.com/files/images/blog_vigenerons-revert-technology-found-efficient-for-aav-delivery-of-large-genes.jpg https://ophthalmologybreakingnews.com/vigenerons-revert-tech-efficient-for-aav-delivery-of-genes 2023-10-26T10:24:31+03:00 en https://ophthalmologybreakingnews.com/vigenerons-revert-tech-efficient-for-aav-delivery-of-genes https://ophthalmologybreakingnews.com/files/images/blog_white-dot-syndrome-in-focus-types-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/white-dot-syndrome-in-focus--types-symptoms-and-treatment 2023-11-30T10:45:36+03:00 en https://ophthalmologybreakingnews.com/white-dot-syndrome-in-focus--types-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_eyes-irritated-it-could-be-squamous-blepharitis.jpg https://ophthalmologybreakingnews.com/eyes-irritated-it-could-be-squamous-blepharitis- 2024-02-22T15:25:30+03:00 en https://ophthalmologybreakingnews.com/eyes-irritated-it-could-be-squamous-blepharitis- https://ophthalmologybreakingnews.com/files/images/blog_why-is-your-upper-eyelid-swollen-in-the-morning.jpg https://ophthalmologybreakingnews.com/why-is-your-upper-eyelid-swollen-in-the-morning 2023-11-30T10:46:23+03:00 en https://ophthalmologybreakingnews.com/why-is-your-upper-eyelid-swollen-in-the-morning https://ophthalmologybreakingnews.com/files/images/blog_pros-and-cons-of-laser-surgery-for-glaucoma.jpg https://ophthalmologybreakingnews.com/pros-and-cons-of-laser-surgery-for-glaucoma 2024-04-29T10:18:39+03:00 en https://ophthalmologybreakingnews.com/pros-and-cons-of-laser-surgery-for-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_roche-terminates-development-of-diabetic-retinopathy-drug.jpg https://ophthalmologybreakingnews.com/roche-terminates-development-of-diabetic-retinopathy-drug 2024-02-16T09:56:08+03:00 en https://ophthalmologybreakingnews.com/roche-terminates-development-of-diabetic-retinopathy-drug https://ophthalmologybreakingnews.com/files/images/blog_stuart-therapeutics-announces-exclusive-license-agreement-with-glaukos.jpg https://ophthalmologybreakingnews.com/stuart-announces-exclusive-license-agreement-with-glaukos- 2024-02-09T10:15:51+03:00 en https://ophthalmologybreakingnews.com/stuart-announces-exclusive-license-agreement-with-glaukos- https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-strengthens-global-presence-with-launch-of-new-office-in-japan.jpg https://ophthalmologybreakingnews.com/haag-streit-launches-new-office-in-japan 2023-10-20T08:39:55+03:00 en https://ophthalmologybreakingnews.com/haag-streit-launches-new-office-in-japan https://ophthalmologybreakingnews.com/files/images/blog_how-to-protect-your-eyes-from-eclipse-blindness.jpg https://ophthalmologybreakingnews.com/how-to-protect-your-eyes-from-eclipse-blindness 2023-11-30T10:49:24+03:00 en https://ophthalmologybreakingnews.com/how-to-protect-your-eyes-from-eclipse-blindness https://ophthalmologybreakingnews.com/files/images/blog_microscale-eye-implant-could-be-used-to-treat-diabetes-and-other-diseases.jpg https://ophthalmologybreakingnews.com/microscale-eye-implant-to-treat-diabetes- 2023-10-19T09:48:58+03:00 en https://ophthalmologybreakingnews.com/microscale-eye-implant-to-treat-diabetes- https://ophthalmologybreakingnews.com/files/images/blog_obn-spotlight-tv-exclusive-interview-with-prof-dr-oliver-findl_1.jpg https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-prof-dr-oliver-findl- 2024-05-27T16:53:13+03:00 en https://ophthalmologybreakingnews.com/obn-spotlight-tv-interview-with-prof-dr-oliver-findl- https://ophthalmologybreakingnews.com/files/images/blog_baxter-introduces-digital-image-capture-capability-of-panoptic-plus-ophthalmoscope.jpg https://ophthalmologybreakingnews.com/baxter-introduces-digital-image-capture-capability-of-panoptic-plus-ophthalmoscope 2023-10-18T13:25:50+03:00 en https://ophthalmologybreakingnews.com/baxter-introduces-digital-image-capture-capability-of-panoptic-plus-ophthalmoscope https://ophthalmologybreakingnews.com/files/images/blog_the-dolls-eye-reflex-exploring-a-vital-neurological-assessment.jpg https://ophthalmologybreakingnews.com/the-dolls-eye-reflex--exploring-a-vital-neurological-assessment 2023-11-30T10:52:55+03:00 en https://ophthalmologybreakingnews.com/the-dolls-eye-reflex--exploring-a-vital-neurological-assessment https://ophthalmologybreakingnews.com/files/images/blog_xpanceo-raises-40m-to-launch-worlds-first-smart-contact-lenses-with-ar-vision.jpg https://ophthalmologybreakingnews.com/xpanceo-raises-$40m-to-launch-worlds-first-smart-contact-lenses 2023-10-17T13:17:06+03:00 en https://ophthalmologybreakingnews.com/xpanceo-raises-$40m-to-launch-worlds-first-smart-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_retinal-vasculitis-a-closer-look-at-inflammatory-eye-diseases.jpg https://ophthalmologybreakingnews.com/retinal-vasculitis--a-closer-look-at-inflammatory-eye-diseases 2023-11-30T11:31:08+03:00 en https://ophthalmologybreakingnews.com/retinal-vasculitis--a-closer-look-at-inflammatory-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_icter-researchers-introduce-novel-imaging-method-for-early-diagnosis-of-eye-diseases.jpg https://ophthalmologybreakingnews.com/icter-researchers-introduce-novel-imaging-method-for-early-diagnosis 2023-10-16T13:43:10+03:00 en https://ophthalmologybreakingnews.com/icter-researchers-introduce-novel-imaging-method-for-early-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_pupil-size-and-the-brain-exploring-the-science-of-miosis.jpg https://ophthalmologybreakingnews.com/pupil-size-and-the-brain--exploring-the-science-of-miosis 2023-11-30T11:34:18+03:00 en https://ophthalmologybreakingnews.com/pupil-size-and-the-brain--exploring-the-science-of-miosis https://ophthalmologybreakingnews.com/files/images/blog_tilak-healthcare-raises-e10m-funding-to-improve-remote-vision-monitoring-platform.jpg https://ophthalmologybreakingnews.com/tilak-raises-€10m-funding-to-improve-remote-vision-monitoring-platform 2024-02-09T10:47:42+03:00 en https://ophthalmologybreakingnews.com/tilak-raises-€10m-funding-to-improve-remote-vision-monitoring-platform https://ophthalmologybreakingnews.com/files/images/blog_dr-rohit-varma-implants-worlds-first-calibreye-system-into-a-glaucoma-patient.jpg https://ophthalmologybreakingnews.com/worlds-first-calibreye-system-into-a-glaucoma-patient 2024-10-03T14:48:48+03:00 en https://ophthalmologybreakingnews.com/worlds-first-calibreye-system-into-a-glaucoma-patient https://ophthalmologybreakingnews.com/files/images/blog_-pine-pharmaceuticals-announces-urgent-product-recalls-including-avastin.jpg https://ophthalmologybreakingnews.com/-pine-pharmaceuticals-announces-urgent-product-recalls 2024-10-01T12:13:54+03:00 en https://ophthalmologybreakingnews.com/-pine-pharmaceuticals-announces-urgent-product-recalls https://ophthalmologybreakingnews.com/files/images/blog_escrs-2023-recap-leading-biotech-companies-shaping-the-future-of-eye-health.jpg https://ophthalmologybreakingnews.com/leading-biotech-companies-shaping-the-future-of-eye-health 2024-02-16T13:08:25+03:00 en https://ophthalmologybreakingnews.com/leading-biotech-companies-shaping-the-future-of-eye-health https://ophthalmologybreakingnews.com/files/images/blog_understanding-diffuse-lamellar-keratitis-after-lasik-surgery.jpg https://ophthalmologybreakingnews.com/understanding-diffuse-lamellar-keratitis-after-lasik-surgery 2023-10-12T09:08:10+03:00 en https://ophthalmologybreakingnews.com/understanding-diffuse-lamellar-keratitis-after-lasik-surgery https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-initiates-first-pivotal-clinical-trial-in-us-for-wet-amd.jpg https://ophthalmologybreakingnews.com/ocular-therapeutix-initiates-first-pivotal-clinical-trial-in-us-for-wet-amd 2024-04-29T11:38:24+03:00 en https://ophthalmologybreakingnews.com/ocular-therapeutix-initiates-first-pivotal-clinical-trial-in-us-for-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_humonix-biosciences-launches-3d-human-tissue-model.jpg https://ophthalmologybreakingnews.com/humonix-biosciences-launches-3d-human-tissue-model 2024-02-16T09:54:39+03:00 en https://ophthalmologybreakingnews.com/humonix-biosciences-launches-3d-human-tissue-model https://ophthalmologybreakingnews.com/files/images/blog_ocular-toxoplasmosis-causes-treatment-and-prevention.jpg https://ophthalmologybreakingnews.com/ocular-toxoplasmosis--causes-treatment-and-prevention 2023-10-05T08:46:00+03:00 en https://ophthalmologybreakingnews.com/ocular-toxoplasmosis--causes-treatment-and-prevention https://ophthalmologybreakingnews.com/files/images/blog_researchers-introduce-ai-doctor-a-game-changer-in-retinal-disease-diagnosis.jpg https://ophthalmologybreakingnews.com/researchers-introduce-ai-doctor-a-game-changer-in-retinal-disease-diagnosis 2024-02-16T09:43:52+03:00 en https://ophthalmologybreakingnews.com/researchers-introduce-ai-doctor-a-game-changer-in-retinal-disease-diagnosis https://ophthalmologybreakingnews.com/files/images/blog_novel-eye-drop-could-potentially-replace-injections-for-wet-amd-treatment.jpg https://ophthalmologybreakingnews.com/novel-compound-could-potentially-replace-injections-for-wet-amd-treatment- 2024-04-29T11:38:46+03:00 en https://ophthalmologybreakingnews.com/novel-compound-could-potentially-replace-injections-for-wet-amd-treatment- https://ophthalmologybreakingnews.com/files/images/blog_is-light-adjustable-lens-right-for-you-pros-and-cons-to-consider.jpg https://ophthalmologybreakingnews.com/is-light-adjustable-lens-right-for-you-pros-and-cons-to-consider 2023-10-04T09:00:34+03:00 en https://ophthalmologybreakingnews.com/is-light-adjustable-lens-right-for-you-pros-and-cons-to-consider https://ophthalmologybreakingnews.com/files/images/blog_dopavision-completes-enrollment-for-myopiax-1-trial-for-myopiaxr-app.jpg https://ophthalmologybreakingnews.com/dopavision-completes-enrollment-for-myopiax-1-trial 2023-10-03T15:42:02+03:00 en https://ophthalmologybreakingnews.com/dopavision-completes-enrollment-for-myopiax-1-trial https://ophthalmologybreakingnews.com/files/images/blog_idiopathic-multifocal-choroiditis-a-review-of-epidemiology-and-risk-factors.jpg https://ophthalmologybreakingnews.com/idiopathic-multifocal-choroiditis--a-review-of-epidemiology 2023-10-25T08:04:57+03:00 en https://ophthalmologybreakingnews.com/idiopathic-multifocal-choroiditis--a-review-of-epidemiology https://ophthalmologybreakingnews.com/files/images/blog_understanding-corneal-clouding-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/corneal-clouding-causes-symptoms-and-treatment 2023-10-02T15:06:46+03:00 en https://ophthalmologybreakingnews.com/corneal-clouding-causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_novartis-finalizes-sale-of-front-of-eye-assets-to-bausch-lomb-for-25-billion.jpg https://ophthalmologybreakingnews.com/novartis-finalizes-sale-of-front-of-eye-assets-to-bausch--lomb-for-$25-billion 2023-10-02T13:16:33+03:00 en https://ophthalmologybreakingnews.com/novartis-finalizes-sale-of-front-of-eye-assets-to-bausch--lomb-for-$25-billion https://ophthalmologybreakingnews.com/files/images/blog_lumithera-secures-23m-nih-grant-for-dry-amd-trial.jpg https://ophthalmologybreakingnews.com/lumithera-secures-$23m-nih-grant-for-dry-amd-trial 2024-04-29T11:34:23+03:00 en https://ophthalmologybreakingnews.com/lumithera-secures-$23m-nih-grant-for-dry-amd-trial https://ophthalmologybreakingnews.com/files/images/blog_proqr-therapeutics-terminates-agreement-to-divest-ophthalmic-assets-to-thea.jpg https://ophthalmologybreakingnews.com/proqr-therapeutics-terminates-agreement-to-divest-ophthalmic-assets-to-théa 2023-09-28T13:30:56+03:00 en https://ophthalmologybreakingnews.com/proqr-therapeutics-terminates-agreement-to-divest-ophthalmic-assets-to-théa https://ophthalmologybreakingnews.com/files/images/blog_pakistan-closes-over-56000-schools-due-to-conjunctivitis-outbreak.jpg https://ophthalmologybreakingnews.com/pakistan-closes-over-56000-schools-due-to-conjunctivitis-outbreak 2023-09-28T10:48:59+03:00 en https://ophthalmologybreakingnews.com/pakistan-closes-over-56000-schools-due-to-conjunctivitis-outbreak https://ophthalmologybreakingnews.com/files/images/blog_ocuphire-pharma-and-viatris-announce-fda-approval-of-ryzumvi.jpg https://ophthalmologybreakingnews.com/ocuphire-pharma-and-viatris-announce-fda-approval-of-ryzumvi- 2023-09-28T09:33:49+03:00 en https://ophthalmologybreakingnews.com/ocuphire-pharma-and-viatris-announce-fda-approval-of-ryzumvi- https://ophthalmologybreakingnews.com/files/images/blog_behind-the-scenes-10-fascinating-facts-about-ophthalmologists-and-their-work.jpg https://ophthalmologybreakingnews.com/behind-the-scenes--10-fascinating-facts-about-ophthalmologists-and-their-work 2024-02-09T10:31:48+03:00 en https://ophthalmologybreakingnews.com/behind-the-scenes--10-fascinating-facts-about-ophthalmologists-and-their-work https://ophthalmologybreakingnews.com/files/images/blog_thea-pharma-launches-glaucoma-drug-iyuzeh-in-the-us.jpg https://ophthalmologybreakingnews.com/thea-pharma-launches-glaucoma-drug-iyuzeh-in-the-us 2023-09-27T08:17:04+03:00 en https://ophthalmologybreakingnews.com/thea-pharma-launches-glaucoma-drug-iyuzeh-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_ocucell-receives-funding-from-the-georgia-eye-bank.jpg https://ophthalmologybreakingnews.com/ocucell-receives-funding-from-the-georgia-eye-bank 2023-09-26T13:29:18+03:00 en https://ophthalmologybreakingnews.com/ocucell-receives-funding-from-the-georgia-eye-bank https://ophthalmologybreakingnews.com/files/images/blog_can-a-simple-eye-exam-diagnose-autism-in-children.jpg https://ophthalmologybreakingnews.com/can-a-simple-eye-exam-diagnose-autism-in-children- 2023-09-26T13:19:30+03:00 en https://ophthalmologybreakingnews.com/can-a-simple-eye-exam-diagnose-autism-in-children- https://ophthalmologybreakingnews.com/files/images/blog_apellis-receives-permanent-j-code-for-syfovrer.jpg https://ophthalmologybreakingnews.com/apellis-receives-permanent-j-code-for-syfovre® 2024-04-29T11:06:50+03:00 en https://ophthalmologybreakingnews.com/apellis-receives-permanent-j-code-for-syfovre® https://ophthalmologybreakingnews.com/files/images/blog_cortical-blindness-exploring-the-complex-world-of-visual-impairment.jpg https://ophthalmologybreakingnews.com/cortical-blindness--exploring-the-complex-world-of-visual-impairment 2023-09-22T14:55:01+03:00 en https://ophthalmologybreakingnews.com/cortical-blindness--exploring-the-complex-world-of-visual-impairment https://ophthalmologybreakingnews.com/files/images/blog_iveric-bio-partners-with-eric-stonestreet-to-raise-awareness-of-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/iveric-bio-partners-with-eric-stonestreet-to-raise-awareness-of-geographic-atrophy 2024-04-29T11:08:30+03:00 en https://ophthalmologybreakingnews.com/iveric-bio-partners-with-eric-stonestreet-to-raise-awareness-of-geographic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_ocular-herpes-a-closer-look-at-recurrent-eye-infections.jpg https://ophthalmologybreakingnews.com/ocular-herpes--a-closer-look-at-recurrent-eye-infections 2023-09-26T15:40:50+03:00 en https://ophthalmologybreakingnews.com/ocular-herpes--a-closer-look-at-recurrent-eye-infections https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-simulations-to-help-surgeons-see-the-best-iol-options.jpg https://ophthalmologybreakingnews.com/scientists-develop-simulations-to-help-surgeons-see-the-best-iol-options 2024-04-29T11:37:14+03:00 en https://ophthalmologybreakingnews.com/scientists-develop-simulations-to-help-surgeons-see-the-best-iol-options https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-announces-2023-ophthalmology-star-awards-winners.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-announces-2023-ophthalmology-star-awards-winners- 2023-09-21T09:42:04+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-announces-2023-ophthalmology-star-awards-winners- https://ophthalmologybreakingnews.com/files/images/blog_irvine-gass-syndrome-a-comprehensive-guide-to-retinal-swelling.jpg https://ophthalmologybreakingnews.com/irvine-gass-syndrome--a-comprehensive-guide-to-retinal-swelling 2024-02-16T09:56:39+03:00 en https://ophthalmologybreakingnews.com/irvine-gass-syndrome--a-comprehensive-guide-to-retinal-swelling https://ophthalmologybreakingnews.com/files/images/blog_eye-exams-as-a-novel-frontier-in-long-covid-testing.jpg https://ophthalmologybreakingnews.com/eye-exams-as-a-novel-frontier-in-long-covid-testing 2023-09-19T14:59:16+03:00 en https://ophthalmologybreakingnews.com/eye-exams-as-a-novel-frontier-in-long-covid-testing https://ophthalmologybreakingnews.com/files/images/blog_neurophths-candidate-drug-for-adoa-receives-australian-approval.jpg https://ophthalmologybreakingnews.com/neurophths-candidate-drug-for-adoa-receives-australian-approval 2023-09-19T13:12:31+03:00 en https://ophthalmologybreakingnews.com/neurophths-candidate-drug-for-adoa-receives-australian-approval https://ophthalmologybreakingnews.com/files/images/blog_spotlight-on-bulls-eye-maculopathy-what-you-need-to-know.jpg https://ophthalmologybreakingnews.com/spotlight-on-bulls-eye-maculopathy--what-you-need-to-know 2024-04-29T11:07:22+03:00 en https://ophthalmologybreakingnews.com/spotlight-on-bulls-eye-maculopathy--what-you-need-to-know https://ophthalmologybreakingnews.com/files/images/blog_conjunctival-hyperemia-causes-complications-and-solutions.jpg https://ophthalmologybreakingnews.com/conjunctival-hyperemia--causes-complications-and-solutions 2023-09-26T15:41:37+03:00 en https://ophthalmologybreakingnews.com/conjunctival-hyperemia--causes-complications-and-solutions https://ophthalmologybreakingnews.com/files/images/blog_sheikh-shakhbout-medical-city-introduces-novel-medication-for-ted.jpg https://ophthalmologybreakingnews.com/sheikh-shakhbout-medical-city-introduces-novel-medication-for-ted 2023-09-18T15:02:19+03:00 en https://ophthalmologybreakingnews.com/sheikh-shakhbout-medical-city-introduces-novel-medication-for-ted https://ophthalmologybreakingnews.com/files/images/blog_sparingvision-reports-positive-initial-data-for-retinitis-pigmentosa-gene-therapy-trial.jpg https://ophthalmologybreakingnews.com/sparingvision-reports-positive-initial-data-for-retinitis-pigmentosa-trial 2023-09-18T11:24:34+03:00 en https://ophthalmologybreakingnews.com/sparingvision-reports-positive-initial-data-for-retinitis-pigmentosa-trial https://ophthalmologybreakingnews.com/files/images/blog_5-best-eye-drops-for-dry-eyes.jpg https://ophthalmologybreakingnews.com/5-best-eye-drops-for-dry-eyes- 2024-01-01T19:51:47+03:00 en https://ophthalmologybreakingnews.com/5-best-eye-drops-for-dry-eyes- https://ophthalmologybreakingnews.com/files/images/blog_eurostat-cataract-surgeries-drop-by-4-in-eu-during-2021.jpg https://ophthalmologybreakingnews.com/eurostat--cataract-surgeries-drop-by-4-in-eu-during-2021- 2023-09-15T08:54:05+03:00 en https://ophthalmologybreakingnews.com/eurostat--cataract-surgeries-drop-by-4-in-eu-during-2021- https://ophthalmologybreakingnews.com/files/images/blog_researchers-groundbreaking-ai-system-set-to-transform-eye-care.jpg https://ophthalmologybreakingnews.com/researchers-groundbreaking-ai-system-set-to-transform-eye-care- 2023-09-14T15:29:02+03:00 en https://ophthalmologybreakingnews.com/researchers-groundbreaking-ai-system-set-to-transform-eye-care- https://ophthalmologybreakingnews.com/files/images/blog_otsuka-partners-with-shapetx-to-develop-aav-gene-therapies-for-ocular-diseases.jpg https://ophthalmologybreakingnews.com/otsuka-partners-with-shapetx-to-develop-aav-gene-therapies-for-ocular-diseases 2023-09-14T13:52:25+03:00 en https://ophthalmologybreakingnews.com/otsuka-partners-with-shapetx-to-develop-aav-gene-therapies-for-ocular-diseases https://ophthalmologybreakingnews.com/files/images/blog_link-biologics-and-thea-open-innovation-to-develop-ded-treatment.jpg https://ophthalmologybreakingnews.com/link-biologics-and-théa-open-innovation-to-develop-ded-treatment 2023-09-14T13:17:59+03:00 en https://ophthalmologybreakingnews.com/link-biologics-and-théa-open-innovation-to-develop-ded-treatment https://ophthalmologybreakingnews.com/files/images/blog_fda-warns-8-companies-for-marketing-unapproved-eye-products.jpg https://ophthalmologybreakingnews.com/fda-warns-8-companies-for-marketing-unapproved-eye-products 2024-04-29T09:37:25+03:00 en https://ophthalmologybreakingnews.com/fda-warns-8-companies-for-marketing-unapproved-eye-products https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-launches-dry-eye-drug-miebo-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch--lomb-launches-dry-eye-drug-miebo-in-the-us 2023-09-13T09:14:45+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-launches-dry-eye-drug-miebo-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_breakthrough-trial-offers-hope-for-late-amblyopia-treatment.jpg https://ophthalmologybreakingnews.com/breakthrough-trial-offers-hope-for-late-amblyopia-treatment 2024-02-09T09:11:25+03:00 en https://ophthalmologybreakingnews.com/breakthrough-trial-offers-hope-for-late-amblyopia-treatment https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-the-missing-link-in-amd-progression-and-vision-loss.jpg https://ophthalmologybreakingnews.com/the-missing-link-in-amd-progression-and-vision-loss 2024-04-29T11:08:55+03:00 en https://ophthalmologybreakingnews.com/the-missing-link-in-amd-progression-and-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_novartis-to-cease-development-of-ga-gene-therapy.jpg https://ophthalmologybreakingnews.com/novartis-to-cease-development-of-ga-gene-therapy 2024-04-29T11:08:02+03:00 en https://ophthalmologybreakingnews.com/novartis-to-cease-development-of-ga-gene-therapy https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-adverse-connection-between-calcium-channel-blockers-and-glaucoma.jpg https://ophthalmologybreakingnews.com/adverse-connection-between-calcium-channel-blockers-and-glaucoma 2024-04-29T09:30:22+03:00 en https://ophthalmologybreakingnews.com/adverse-connection-between-calcium-channel-blockers-and-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_greener-surgery-and-beyond-highlights-from-day-3-at-escrs-congress.jpg https://ophthalmologybreakingnews.com/greener-surgery-and-beyond--highlights-from-day-3-at-escrs-congress 2023-09-10T10:55:51+03:00 en https://ophthalmologybreakingnews.com/greener-surgery-and-beyond--highlights-from-day-3-at-escrs-congress https://ophthalmologybreakingnews.com/files/images/blog_exciting-insights-and-learning-opportunities-on-day-2-of-the-escrs-congress.jpg https://ophthalmologybreakingnews.com/exciting-insights-and-learning-opportunities-on-day-2-of-the-escrs-congress 2023-09-09T10:47:35+03:00 en https://ophthalmologybreakingnews.com/exciting-insights-and-learning-opportunities-on-day-2-of-the-escrs-congress https://ophthalmologybreakingnews.com/files/images/blog_dacryoadenitis-understanding-lacrimal-gland-inflammation_1.jpg https://ophthalmologybreakingnews.com/dacryoadenitis--understanding-lacrimal-gland-inflammation 2024-10-21T09:28:53+03:00 en https://ophthalmologybreakingnews.com/dacryoadenitis--understanding-lacrimal-gland-inflammation https://ophthalmologybreakingnews.com/files/images/blog_what-you-need-to-know-about-dermoid-cyst-in-the-eye.jpg https://ophthalmologybreakingnews.com/what-you-need-to-know-about-dermoid-cyst-in-the-eye 2023-09-26T15:42:47+03:00 en https://ophthalmologybreakingnews.com/what-you-need-to-know-about-dermoid-cyst-in-the-eye https://ophthalmologybreakingnews.com/files/images/blog_rayner-to-unveil-exciting-updates-to-digital-platforms-at-escrs-2023.jpg https://ophthalmologybreakingnews.com/rayner-to-unveil-exciting-updates-to-digital-platforms-at-escrs-2023 2024-02-09T10:00:28+03:00 en https://ophthalmologybreakingnews.com/rayner-to-unveil-exciting-updates-to-digital-platforms-at-escrs-2023 https://ophthalmologybreakingnews.com/files/images/blog_5-foods-to-avoid-after-cataract-surgery-for-optimal-recovery.jpg https://ophthalmologybreakingnews.com/5-foods-to-avoid-after-cataract-surgery-for-optimal-recovery-- 2024-01-01T19:48:41+03:00 en https://ophthalmologybreakingnews.com/5-foods-to-avoid-after-cataract-surgery-for-optimal-recovery-- https://ophthalmologybreakingnews.com/files/images/blog_myasthenia-gravis-ptosis-a-closer-look-at-the-eye-symptom.jpg https://ophthalmologybreakingnews.com/myasthenia-gravis-ptosis--a-closer-look-at-the-eye-symptom 2023-09-26T15:42:24+03:00 en https://ophthalmologybreakingnews.com/myasthenia-gravis-ptosis--a-closer-look-at-the-eye-symptom https://ophthalmologybreakingnews.com/files/images/blog_ftc-allows-amgen-to-acquire-horizon-therapeutics-for-278b.jpg https://ophthalmologybreakingnews.com/ftc-allows-amgen-to-acquire-horizon-therapeutics-for-$278b 2024-01-23T13:18:04+03:00 en https://ophthalmologybreakingnews.com/ftc-allows-amgen-to-acquire-horizon-therapeutics-for-$278b https://ophthalmologybreakingnews.com/files/images/blog_5-must-see-highlights-at-the-upcoming-escrs-congress-in-vienna.jpg https://ophthalmologybreakingnews.com/5-must-see-highlights-at-the-upcoming-escrs-congress-in-vienna 2024-04-29T10:00:34+03:00 en https://ophthalmologybreakingnews.com/5-must-see-highlights-at-the-upcoming-escrs-congress-in-vienna https://ophthalmologybreakingnews.com/files/images/blog_detailed-eye-atlas-holds-the-key-to-novel-therapies-for-eye-diseases.jpg https://ophthalmologybreakingnews.com/detailed-eye-atlas-holds-the-key-to-novel-therapies-for-eye-diseases 2024-04-29T10:18:07+03:00 en https://ophthalmologybreakingnews.com/detailed-eye-atlas-holds-the-key-to-novel-therapies-for-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_corneal-edema-causes-symptoms-and-treatment-strategies.jpg https://ophthalmologybreakingnews.com/corneal-edema-causes-and-treatment 2024-04-29T10:10:12+03:00 en https://ophthalmologybreakingnews.com/corneal-edema-causes-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-a-nanobody-for-treatment-of-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/researchers-discover-a-nanobody-for-treatment-of-retinitis-pigmentosa- 2024-10-15T15:00:39+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-a-nanobody-for-treatment-of-retinitis-pigmentosa- https://ophthalmologybreakingnews.com/files/images/blog_fda-declines-to-approve-outlook-therapeutics-lytenava-for-wet-amd.jpg https://ophthalmologybreakingnews.com/fda-declines-to-approve-outlook-therapeutics-lytenava-for-wet-amd 2024-04-29T11:39:36+03:00 en https://ophthalmologybreakingnews.com/fda-declines-to-approve-outlook-therapeutics-lytenava-for-wet-amd https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/short-term-use-of-immunosuppressants-for-ocular-inflammation-pose-no-cancer-threat 2023-08-28T15:01:00+03:00 en https://ophthalmologybreakingnews.com/short-term-use-of-immunosuppressants-for-ocular-inflammation-pose-no-cancer-threat https://ophthalmologybreakingnews.com/files/images/blog_a-comprehensive-review-of-peters-anomaly_1.jpg https://ophthalmologybreakingnews.com/a-comprehensive-review-of-peters-anomaly 2024-10-21T11:26:34+03:00 en https://ophthalmologybreakingnews.com/a-comprehensive-review-of-peters-anomaly https://ophthalmologybreakingnews.com/files/images/blog_fatty-acid-supplement-leads-to-improved-vision-function-in-preterm-infants.jpg https://ophthalmologybreakingnews.com/fatty-acid-supplement-leads-to-improved-vision-function-in-preterm-infants 2024-02-09T09:06:56+03:00 en https://ophthalmologybreakingnews.com/fatty-acid-supplement-leads-to-improved-vision-function-in-preterm-infants https://ophthalmologybreakingnews.com/files/images/blog_understanding-capsulorhexis-a-key-step-in-cataract-surgery_1.jpg https://ophthalmologybreakingnews.com/understanding-capsulorhexis--a-key-step-in-cataract-surgery 2024-10-21T09:26:26+03:00 en https://ophthalmologybreakingnews.com/understanding-capsulorhexis--a-key-step-in-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_fda-warns-of-methylsulfonylmethane-eye-drops-due-to-contamination_1.jpg https://ophthalmologybreakingnews.com/fda-warns-of-methylsulfonylmethane-eye-drops-due-to-contamination 2024-10-21T09:47:29+03:00 en https://ophthalmologybreakingnews.com/fda-warns-of-methylsulfonylmethane-eye-drops-due-to-contamination https://ophthalmologybreakingnews.com/files/images/blog_bullous-keratopathy-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/bullous-keratopathy--causes-symptoms-and-treatment 2024-04-29T11:35:22+03:00 en https://ophthalmologybreakingnews.com/bullous-keratopathy--causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_dysthyroid-optic-neuropathy-thyroid-dysfunction-and-ocular-impact_1.jpg https://ophthalmologybreakingnews.com/dysthyroid-optic-neuropathy--thyroid-dysfunction-and-ocular-impact 2024-10-21T10:03:30+03:00 en https://ophthalmologybreakingnews.com/dysthyroid-optic-neuropathy--thyroid-dysfunction-and-ocular-impact https://ophthalmologybreakingnews.com/files/images/blog_exploring-ischemic-optic-neuropathy-and-its-impact-on-vision.jpg https://ophthalmologybreakingnews.com/exploring-ischemic-optic-neuropathy-and-its-impact-on-vision 2023-09-26T15:44:40+03:00 en https://ophthalmologybreakingnews.com/exploring-ischemic-optic-neuropathy-and-its-impact-on-vision https://ophthalmologybreakingnews.com/files/images/blog_radial-keratotomy-a-comprehensive-guide-to-nearsightedness-correction.jpg https://ophthalmologybreakingnews.com/radial-keratotomy--a-comprehensive-guide-to-nearsightedness-correction 2023-09-26T16:38:17+03:00 en https://ophthalmologybreakingnews.com/radial-keratotomy--a-comprehensive-guide-to-nearsightedness-correction https://ophthalmologybreakingnews.com/files/images/blog_sebaceous-gland-carcinoma-ocular-manifestations-and-management.jpg https://ophthalmologybreakingnews.com/sebaceous-gland-carcinoma--ocular-manifestations-and-management 2023-08-21T13:08:38+03:00 en https://ophthalmologybreakingnews.com/sebaceous-gland-carcinoma--ocular-manifestations-and-management https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-regenerons-high-dose-aflibercept-eylea-hd.jpg https://ophthalmologybreakingnews.com/fda-approves-regenerons-high-dose-aflibercept-eylea-hd 2024-04-29T11:39:11+03:00 en https://ophthalmologybreakingnews.com/fda-approves-regenerons-high-dose-aflibercept-eylea-hd https://ophthalmologybreakingnews.com/files/images/blog_enhancing-vision-clarity-the-power-of-yag-laser-capsulotomy.jpg https://ophthalmologybreakingnews.com/enhancing-vision-clarity--the-power-of-yag-laser-capsulotomy 2023-08-16T15:53:20+03:00 en https://ophthalmologybreakingnews.com/enhancing-vision-clarity--the-power-of-yag-laser-capsulotomy https://ophthalmologybreakingnews.com/files/images/blog_lupin-receives-fda-approval-for-bromfenac-ophthalmic-solution-009.jpg https://ophthalmologybreakingnews.com/lupin-receives-fda-approval-for-bromfenac-ophthalmic-solution-009 2023-08-16T15:52:57+03:00 en https://ophthalmologybreakingnews.com/lupin-receives-fda-approval-for-bromfenac-ophthalmic-solution-009 https://ophthalmologybreakingnews.com/files/images/blog_exploring-the-causes-symptoms-and-treatment-of-endophthalmitis.jpg https://ophthalmologybreakingnews.com/exploring-the-causes-symptoms-and-treatment-of-endophthalmitis 2024-04-29T11:33:42+03:00 en https://ophthalmologybreakingnews.com/exploring-the-causes-symptoms-and-treatment-of-endophthalmitis https://ophthalmologybreakingnews.com/files/images/blog_7-tips-on-how-to-reduce-eye-pressure-effectively-and-instantly.jpg https://ophthalmologybreakingnews.com/7-tips-on-how-to-reduce-eye-pressure-effectively-and-instantly 2024-11-20T11:02:28+03:00 en https://ophthalmologybreakingnews.com/7-tips-on-how-to-reduce-eye-pressure-effectively-and-instantly https://ophthalmologybreakingnews.com/files/images/blog_conjunctival-injection-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/conjunctival-injection-causes-symptoms-and-treatment 2023-08-14T15:44:56+03:00 en https://ophthalmologybreakingnews.com/conjunctival-injection-causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_micro-labs-launches-worlds-first-triple-drug-fdc-for-glaucoma.jpg https://ophthalmologybreakingnews.com/micro-labs-launches-worlds-first-triple-drug-fdc-for-glaucoma- 2024-10-15T14:51:15+03:00 en https://ophthalmologybreakingnews.com/micro-labs-launches-worlds-first-triple-drug-fdc-for-glaucoma- https://ophthalmologybreakingnews.com/files/images/blog_conjunctivitis-causes-symptoms-and-effective-management.jpg https://ophthalmologybreakingnews.com/conjunctivitis--causes-symptoms-and-effective-management 2023-08-14T15:52:42+03:00 en https://ophthalmologybreakingnews.com/conjunctivitis--causes-symptoms-and-effective-management https://ophthalmologybreakingnews.com/files/images/blog_t-boone-pickens-foundation-donates-20m-to-johns-hopkins-wilmer-eye-institute.jpg https://ophthalmologybreakingnews.com/t-boone-pickens-foundation-donates-$20m-to-johns-hopkins-wilmer-eye-institute 2024-01-25T09:24:44+03:00 en https://ophthalmologybreakingnews.com/t-boone-pickens-foundation-donates-$20m-to-johns-hopkins-wilmer-eye-institute https://ophthalmologybreakingnews.com/files/images/blog_brain-scan-study-explores-the-biological-roots-of-visual-snow-syndrome.jpg https://ophthalmologybreakingnews.com/brain-scan-study-explores-the-biological-roots-of-visual-snow-syndrome 2024-10-01T15:41:06+03:00 en https://ophthalmologybreakingnews.com/brain-scan-study-explores-the-biological-roots-of-visual-snow-syndrome https://ophthalmologybreakingnews.com/files/images/blog_social-eyest-by-regener-eyesr-transforming-eye-health-through-social-media.jpg https://ophthalmologybreakingnews.com/social-eyes™-by-regener-eyes®--transforming-eye-health-through-social-media 2023-08-10T15:01:56+03:00 en https://ophthalmologybreakingnews.com/social-eyes™-by-regener-eyes®--transforming-eye-health-through-social-media https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-why-albinism-causes-poor-vision.jpg https://ophthalmologybreakingnews.com/new-study-reveals-why-albinism-causes-poor-vision- 2024-02-09T09:12:05+03:00 en https://ophthalmologybreakingnews.com/new-study-reveals-why-albinism-causes-poor-vision- https://ophthalmologybreakingnews.com/files/images/blog_health-canada-recalls-cromolyn-eye-drops-due-to-infection-risks.jpg https://ophthalmologybreakingnews.com/health-canada-recalls-cromolyn-eye-drops-due-to-infection-risks 2024-10-01T15:38:09+03:00 en https://ophthalmologybreakingnews.com/health-canada-recalls-cromolyn-eye-drops-due-to-infection-risks https://ophthalmologybreakingnews.com/files/images/blog_parinaud-oculoglandular-syndrome-a-unique-blend-of-ocular-and-glandular-symptoms.jpg https://ophthalmologybreakingnews.com/parinaud-oculoglandular-syndrome-a-unique-blend-of-ocular-and-glandular-symptoms 2023-10-13T14:55:10+03:00 en https://ophthalmologybreakingnews.com/parinaud-oculoglandular-syndrome-a-unique-blend-of-ocular-and-glandular-symptoms https://ophthalmologybreakingnews.com/files/images/blog_laboratoires-thea-acquires-sepofarsen-and-ultevursen-from-proqr-therapeutics.jpg https://ophthalmologybreakingnews.com/laboratoires-théa-acquires-sepofarsen-and-ultevursen-from-proqr-therapeutics 2024-10-16T14:15:48+03:00 en https://ophthalmologybreakingnews.com/laboratoires-théa-acquires-sepofarsen-and-ultevursen-from-proqr-therapeutics https://ophthalmologybreakingnews.com/files/images/blog_understanding-ectopia-lentis-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/understanding-ectopia-lentis-causes-symptoms-and-treatment 2024-04-29T11:36:44+03:00 en https://ophthalmologybreakingnews.com/understanding-ectopia-lentis-causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_top-10-questions-to-ask-your-ophthalmologist-during-an-eye-exam.jpg https://ophthalmologybreakingnews.com/top-10-questions-to-ask-your-ophthalmologist-during-an-eye-exam 2024-04-29T10:07:45+03:00 en https://ophthalmologybreakingnews.com/top-10-questions-to-ask-your-ophthalmologist-during-an-eye-exam https://ophthalmologybreakingnews.com/files/images/blog_new-app-aims-to-help-people-with-blindness-or-low-vision-to-navigate-nyc-subway.jpg https://ophthalmologybreakingnews.com/new-app-aims-to-help-people-with-blindness-or-low-vision-to-navigate-nyc-subway 2023-08-07T14:24:11+03:00 en https://ophthalmologybreakingnews.com/new-app-aims-to-help-people-with-blindness-or-low-vision-to-navigate-nyc-subway https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-iveric-bios-izervay-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/fda-approves-iveric-bios-izervay-for-geographic-atrophy 2024-04-29T11:05:24+03:00 en https://ophthalmologybreakingnews.com/fda-approves-iveric-bios-izervay-for-geographic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_one-third-of-glaucoma-patients-skip-regular-eye-appointments .jpg https://ophthalmologybreakingnews.com/one-third-of-glaucoma-patients-skip-regular-eye-appointments  2024-04-29T10:21:17+03:00 en https://ophthalmologybreakingnews.com/one-third-of-glaucoma-patients-skip-regular-eye-appointments  https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnologys-in-house-100-glistening-free-iol-material-redefines-the-iol-market.jpg https://ophthalmologybreakingnews.com/vsy-biotechnologys-in-house-100-glistening-free-iol-material-redefines-the-iol-market- 2024-02-16T13:57:30+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnologys-in-house-100-glistening-free-iol-material-redefines-the-iol-market- https://ophthalmologybreakingnews.com/files/images/blog_nih-grants-funding-to-glaucoma-treatment-research-at-st.jpg https://ophthalmologybreakingnews.com/nih-grants-funding-to-glaucoma-treatment-research-at-st 2024-04-29T10:09:17+03:00 en https://ophthalmologybreakingnews.com/nih-grants-funding-to-glaucoma-treatment-research-at-st https://ophthalmologybreakingnews.com/files/images/blog_trabeculectomy-a-comprehensive-guide-to-understanding-the-procedure-and-recovery.jpg https://ophthalmologybreakingnews.com/trabeculectomy-a-comprehensive-guide-to-understanding-the-procedure 2024-04-29T10:08:51+03:00 en https://ophthalmologybreakingnews.com/trabeculectomy-a-comprehensive-guide-to-understanding-the-procedure https://ophthalmologybreakingnews.com/files/images/blog_pseudoexfoliation-syndrome-understanding-causes-diagnosis-and-treatment.jpg https://ophthalmologybreakingnews.com/pseudoexfoliation-syndrome-understanding-causes-diagnosis-and-treatment 2024-04-29T10:15:04+03:00 en https://ophthalmologybreakingnews.com/pseudoexfoliation-syndrome-understanding-causes-diagnosis-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_iridotomy-understanding-the-procedure-benefits-and-recovery.jpg https://ophthalmologybreakingnews.com/iridotomy--understanding-the-procedure-benefits-and-recovery 2024-04-29T10:06:15+03:00 en https://ophthalmologybreakingnews.com/iridotomy--understanding-the-procedure-benefits-and-recovery https://ophthalmologybreakingnews.com/files/images/blog_can-eye-pressure-fluctuate-understanding-intraocular-pressure-variations.jpg https://ophthalmologybreakingnews.com/can-eye-pressure-fluctuate-understanding-intraocular-pressure-variations 2024-02-09T10:17:08+03:00 en https://ophthalmologybreakingnews.com/can-eye-pressure-fluctuate-understanding-intraocular-pressure-variations https://ophthalmologybreakingnews.com/files/images/blog_how-to-manage-eye-irritation-after-cataract-surgery-tips-and-effective-techniques.jpg https://ophthalmologybreakingnews.com/how-to-manage-eye-irritation-after-cataract-surgery--tips-and-effective-techniques 2024-01-01T19:59:24+03:00 en https://ophthalmologybreakingnews.com/how-to-manage-eye-irritation-after-cataract-surgery--tips-and-effective-techniques https://ophthalmologybreakingnews.com/files/images/blog_asclepix-therapeutics-secures-10-million-for-axt107-clinical-study-in-wet-amd.jpg https://ophthalmologybreakingnews.com/asclepix-therapeutics-secures-$10-million-for-axt107-clinical-study-in-wet-amd 2024-04-29T11:39:59+03:00 en https://ophthalmologybreakingnews.com/asclepix-therapeutics-secures-$10-million-for-axt107-clinical-study-in-wet-amd https://ophthalmologybreakingnews.com/files/images/blog_7-essential-tips-to-recognize-and-prevent-eye-flu.jpg https://ophthalmologybreakingnews.com/7-essential-tips-to-recognize-and-prevent-eye-flu 2024-01-01T19:58:50+03:00 en https://ophthalmologybreakingnews.com/7-essential-tips-to-recognize-and-prevent-eye-flu https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-worlds-first-and-only-handheld-corneal-esthesiometer.jpg https://ophthalmologybreakingnews.com/fda-approves-worlds-first-and-only-handheld-corneal-esthesiometer- 2024-09-30T14:59:02+03:00 en https://ophthalmologybreakingnews.com/fda-approves-worlds-first-and-only-handheld-corneal-esthesiometer- https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-tarsus-pharmaceuticals-xdemvy-for-treatment-of-demodex-blepharitis.jpg https://ophthalmologybreakingnews.com/fda-approves-tarsus-pharmaceuticals-xdemvy-for-treatment-of-demodex-blepharitis 2024-02-19T15:30:11+03:00 en https://ophthalmologybreakingnews.com/fda-approves-tarsus-pharmaceuticals-xdemvy-for-treatment-of-demodex-blepharitis https://ophthalmologybreakingnews.com/files/images/blog_waterloo-university-develops-first-drug-to-battle-amd-and-dme.jpg https://ophthalmologybreakingnews.com/waterloo-university-develops-first-drug-to-battle-amd-and-dme 2024-04-29T11:15:39+03:00 en https://ophthalmologybreakingnews.com/waterloo-university-develops-first-drug-to-battle-amd-and-dme https://ophthalmologybreakingnews.com/files/images/blog_fda-includes-hearing-loss-and-impairment-warnings-to-horizons-tepezza-label.jpg https://ophthalmologybreakingnews.com/fda-includes-hearing-loss-and-impairment-warnings-to-horizons-tepezza-label 2024-02-09T10:30:33+03:00 en https://ophthalmologybreakingnews.com/fda-includes-hearing-loss-and-impairment-warnings-to-horizons-tepezza-label https://ophthalmologybreakingnews.com/files/images/blog_9-essential-steps-on-how-to-administer-eye-drops-properly.jpg https://ophthalmologybreakingnews.com/9-essential-steps-on-how-to-administer-eye-drops-properly 2024-04-29T10:00:59+03:00 en https://ophthalmologybreakingnews.com/9-essential-steps-on-how-to-administer-eye-drops-properly https://ophthalmologybreakingnews.com/files/images/blog_caeregen-therapeutics-receives-14m-funding-for-retinal-disease-candidate.jpg https://ophthalmologybreakingnews.com/caeregen-therapeutics-receives-$14m-funding-for-retinal-disease-candidate 2023-07-21T09:13:42+03:00 en https://ophthalmologybreakingnews.com/caeregen-therapeutics-receives-$14m-funding-for-retinal-disease-candidate https://ophthalmologybreakingnews.com/files/images/blog_understanding-ocular-torticollis-causes-and-symptoms.jpg https://ophthalmologybreakingnews.com/understanding-ocular-torticollis-causes-and-symptoms- 2023-09-26T16:16:11+03:00 en https://ophthalmologybreakingnews.com/understanding-ocular-torticollis-causes-and-symptoms- https://ophthalmologybreakingnews.com/files/images/blog_stimulation-of-melanopsin-cells-can-enhance-visual-acuity-study-finds.jpg https://ophthalmologybreakingnews.com/stimulation-of-melanopsin-cells-can-enhance-visual-acuity-study-finds 2023-07-20T16:09:10+03:00 en https://ophthalmologybreakingnews.com/stimulation-of-melanopsin-cells-can-enhance-visual-acuity-study-finds https://ophthalmologybreakingnews.com/files/images/blog_harrow-secures-us-and-canadian-commercial-rights-to-vevye-from-novaliq.jpg https://ophthalmologybreakingnews.com/harrow-secures-us-and-canadian-commercial-rights-to-vevye-from-novaliq 2024-02-09T10:03:35+03:00 en https://ophthalmologybreakingnews.com/harrow-secures-us-and-canadian-commercial-rights-to-vevye-from-novaliq https://ophthalmologybreakingnews.com/files/images/blog_mobile-app-detects-glaucoma-cataracts-and-diabetic-retinopathy-in-seconds.jpg https://ophthalmologybreakingnews.com/mobile-app-detects-glaucoma-cataracts-and-diabetic-retinopathy-in-seconds 2024-04-29T10:09:41+03:00 en https://ophthalmologybreakingnews.com/mobile-app-detects-glaucoma-cataracts-and-diabetic-retinopathy-in-seconds https://ophthalmologybreakingnews.com/files/images/blog_keratoprosthesis-a-comprehensive-guide-to-artificial-cornea-implants.jpg https://ophthalmologybreakingnews.com/keratoprosthesis--a-comprehensive-guide-to-artificial-cornea-implants 2024-04-29T09:39:11+03:00 en https://ophthalmologybreakingnews.com/keratoprosthesis--a-comprehensive-guide-to-artificial-cornea-implants https://ophthalmologybreakingnews.com/files/images/blog_spotlight-on-choroideremia-a-rare-inherited-eye-disorder.jpg https://ophthalmologybreakingnews.com/spotlight-on-choroideremia--a-rare-inherited-eye-disorder- 2023-09-26T16:17:06+03:00 en https://ophthalmologybreakingnews.com/spotlight-on-choroideremia--a-rare-inherited-eye-disorder- https://ophthalmologybreakingnews.com/files/images/blog_six-cases-of-occlusive-retinal-vasculitis-reported-after-apellis-syfovre-injection.jpg https://ophthalmologybreakingnews.com/six-cases-of-occlusive-retinal-vasculitis-reported-after-apellis-syfovre-injection 2023-07-18T08:30:37+03:00 en https://ophthalmologybreakingnews.com/six-cases-of-occlusive-retinal-vasculitis-reported-after-apellis-syfovre-injection https://ophthalmologybreakingnews.com/files/images/blog_top-10-books-every-ophthalmology-resident-should-read.jpg https://ophthalmologybreakingnews.com/top-10-books-every-ophthalmology-resident-should-read 2024-01-01T19:56:40+03:00 en https://ophthalmologybreakingnews.com/top-10-books-every-ophthalmology-resident-should-read https://ophthalmologybreakingnews.com/files/images/blog_anterior-basement-membrane-dystrophy-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/anterior-basement-membrane-dystrophy--causes-symptoms-and-treatment 2023-09-26T16:17:35+03:00 en https://ophthalmologybreakingnews.com/anterior-basement-membrane-dystrophy--causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_study-low-dose-atropine-eye-drops-not-more-effective-than-placebo-for-myopia-progression.jpg https://ophthalmologybreakingnews.com/study--low-dose-atropine-eye-drops-not-more-effective-than-placebo-for-myopia-progression 2024-02-09T13:11:35+03:00 en https://ophthalmologybreakingnews.com/study--low-dose-atropine-eye-drops-not-more-effective-than-placebo-for-myopia-progression https://ophthalmologybreakingnews.com/files/images/blog_could-drops-replace-eye-injections-for-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/could-drops-replace-eye-injections-for-retinal-vein-occlusion 2023-07-14T10:45:16+03:00 en https://ophthalmologybreakingnews.com/could-drops-replace-eye-injections-for-retinal-vein-occlusion https://ophthalmologybreakingnews.com/files/images/blog_tenpoint-therapeutics-secures-70m-to-develop-cell-based-therapies.jpg https://ophthalmologybreakingnews.com/tenpoint-therapeutics-secures-$70m-to-develop-cell-based-therapies 2024-04-29T11:00:22+03:00 en https://ophthalmologybreakingnews.com/tenpoint-therapeutics-secures-$70m-to-develop-cell-based-therapies https://ophthalmologybreakingnews.com/files/images/blog_european-commission-eases-udi-requirements-for-contact-lens-manufacturers.jpg https://ophthalmologybreakingnews.com/european-commission-eases-udi-requirements-for-contact-lens-manufacturers 2023-07-13T09:24:14+03:00 en https://ophthalmologybreakingnews.com/european-commission-eases-udi-requirements-for-contact-lens-manufacturers https://ophthalmologybreakingnews.com/files/images/blog_astellas-inks-940m-ophthalmic-gene-therapy-deal-with-4d-molecular.jpg https://ophthalmologybreakingnews.com/astellas-inks-$940m-ophthalmic-gene-therapy-deal-with-4d-molecular 2024-04-29T11:16:24+03:00 en https://ophthalmologybreakingnews.com/astellas-inks-$940m-ophthalmic-gene-therapy-deal-with-4d-molecular https://ophthalmologybreakingnews.com/files/images/blog_allotex-secures-30-million-funding-for-allogeneic-presbyopia-inlays.jpg https://ophthalmologybreakingnews.com/allotex-secures-$30-million-funding-for-allogeneic-presbyopia-inlays 2024-01-23T10:47:40+03:00 en https://ophthalmologybreakingnews.com/allotex-secures-$30-million-funding-for-allogeneic-presbyopia-inlays https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-novel-eye-drop-that-reaches-the-back-of-the-eye.jpg https://ophthalmologybreakingnews.com/researchers-develop-novel-eye-drop-that-reaches-the-back-of-the-eye 2024-02-16T09:25:31+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-novel-eye-drop-that-reaches-the-back-of-the-eye https://ophthalmologybreakingnews.com/files/images/blog_national-study-aims-to-prevent-child-blindness-from-congenital-cataract_1.jpg https://ophthalmologybreakingnews.com/national-study-aims-to-prevent-child-blindness-from-congenital-cataract 2024-06-24T15:22:05+03:00 en https://ophthalmologybreakingnews.com/national-study-aims-to-prevent-child-blindness-from-congenital-cataract https://ophthalmologybreakingnews.com/files/images/blog_corneal-opacity-symptoms-and-signs-to-watch-out-for.jpg https://ophthalmologybreakingnews.com/corneal-opacity--symptoms-and-signs-to-watch-out-for 2024-04-29T11:27:38+03:00 en https://ophthalmologybreakingnews.com/corneal-opacity--symptoms-and-signs-to-watch-out-for https://ophthalmologybreakingnews.com/files/images/blog_what-causes-dry-eye-syndrome-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/what-causes-dry-eye-syndrome-after-cataract-surgery 2023-07-10T16:35:04+03:00 en https://ophthalmologybreakingnews.com/what-causes-dry-eye-syndrome-after-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_spyglass-pharma-secures-90m-in-series-c-financing-for-glaucoma-treatments.jpg https://ophthalmologybreakingnews.com/spyglass-pharma-secures-$90m-in-series-c-financing-for-glaucoma-treatments 2024-04-29T10:13:55+03:00 en https://ophthalmologybreakingnews.com/spyglass-pharma-secures-$90m-in-series-c-financing-for-glaucoma-treatments https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-improved-diagnosis-for-multiple-sclerosis.jpg https://ophthalmologybreakingnews.com/new-study-reveals-improved-diagnosis-for-multiple-sclerosis 2024-02-09T10:37:15+03:00 en https://ophthalmologybreakingnews.com/new-study-reveals-improved-diagnosis-for-multiple-sclerosis https://ophthalmologybreakingnews.com/files/images/blog_alkem-laboratories-expands-into-ophthalmology-with-new-eye-care-products.jpg https://ophthalmologybreakingnews.com/alkem-laboratories-expands-into-ophthalmology-with-new-eye-care-products 2023-07-12T14:53:01+03:00 en https://ophthalmologybreakingnews.com/alkem-laboratories-expands-into-ophthalmology-with-new-eye-care-products https://ophthalmologybreakingnews.com/files/images/blog_rvl-introduces-elevate-a-prescription-e-commerce-platform_1.jpg https://ophthalmologybreakingnews.com/rvl-introduces-elevate--a-prescription-e-commerce-platform 2024-10-21T10:50:08+03:00 en https://ophthalmologybreakingnews.com/rvl-introduces-elevate--a-prescription-e-commerce-platform https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-acquires-blinkr-eye-drops-for-1065-million.jpg https://ophthalmologybreakingnews.com/bausch--lomb-acquires-blink®-eye-drops-for-$1065-million 2023-07-06T15:34:16+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-acquires-blink®-eye-drops-for-$1065-million https://ophthalmologybreakingnews.com/files/images/blog_hubble-contacts-faces-lawsuit-over-vision-loss-claims.jpg https://ophthalmologybreakingnews.com/hubble-contacts-faces-lawsuit-over-vision-loss-claims 2024-12-10T09:05:30+03:00 en https://ophthalmologybreakingnews.com/hubble-contacts-faces-lawsuit-over-vision-loss-claims https://ophthalmologybreakingnews.com/files/images/blog_exploring-the-power-of-telemedicine-in-ophthalmology_1.jpg https://ophthalmologybreakingnews.com/exploring-the-power-of-telemedicine-in-ophthalmology 2024-06-24T15:27:42+03:00 en https://ophthalmologybreakingnews.com/exploring-the-power-of-telemedicine-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_understanding-conjunctivochalasis-surgery-a-comprehensive-guide.jpg https://ophthalmologybreakingnews.com/understanding-conjunctivochalasis-surgery--a-comprehensive-guide 2023-09-26T16:17:58+03:00 en https://ophthalmologybreakingnews.com/understanding-conjunctivochalasis-surgery--a-comprehensive-guide https://ophthalmologybreakingnews.com/files/images/blog_rising-temperatures-linked-to-serious-vision-impairment-in-older-adults.jpg https://ophthalmologybreakingnews.com/rising-temperatures-linked-to-serious-vision-impairment-in-older-adults 2023-07-03T15:06:58+03:00 en https://ophthalmologybreakingnews.com/rising-temperatures-linked-to-serious-vision-impairment-in-older-adults https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-to-acquire-novartis-eye-drugs-for-up-to-25-billion.jpg https://ophthalmologybreakingnews.com/bausch--lomb-to-acquire-novartis-eye-drugs-for-up-to-$25-billion 2023-10-19T14:53:56+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-to-acquire-novartis-eye-drugs-for-up-to-$25-billion https://ophthalmologybreakingnews.com/files/images/blog_discovering-the-link-between-antidepressants-and-glaucoma.jpg https://ophthalmologybreakingnews.com/discovering-the-link-between-antidepressants-and-glaucoma 2024-04-29T10:13:07+03:00 en https://ophthalmologybreakingnews.com/discovering-the-link-between-antidepressants-and-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_researchers-explore-extraocular-muscles-potential-defense-against-als.jpg https://ophthalmologybreakingnews.com/researchers-explore-extraocular-muscles-potential-defense-against-als 2023-06-23T15:06:33+03:00 en https://ophthalmologybreakingnews.com/researchers-explore-extraocular-muscles-potential-defense-against-als https://ophthalmologybreakingnews.com/files/images/blog_survey-unmasking-the-potential-of-emerging-technologies-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/survey--unmasking-the-potential-of-emerging-technologies-in-ophthalmology 2024-02-09T10:40:55+03:00 en https://ophthalmologybreakingnews.com/survey--unmasking-the-potential-of-emerging-technologies-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_ocular-myasthenia-gravis-insights-into-symptoms-diagnosis-and-treatment.jpg https://ophthalmologybreakingnews.com/ocular-myasthenia-gravis--insights-into-symptoms-diagnosis-and-treatment 2023-09-26T16:19:13+03:00 en https://ophthalmologybreakingnews.com/ocular-myasthenia-gravis--insights-into-symptoms-diagnosis-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_invirsa-completes-77m-series-b-financing.jpg https://ophthalmologybreakingnews.com/invirsa-completes-$77m-series-b-financing 2023-06-22T13:51:31+03:00 en https://ophthalmologybreakingnews.com/invirsa-completes-$77m-series-b-financing https://ophthalmologybreakingnews.com/files/images/blog_eyenuk-secures-fda-clearance-for-additional-camera-in-diabetic-retinopathy-detection_1.jpg https://ophthalmologybreakingnews.com/eyenuk-secures-fda-clearance-for-additional-camera-in-diabetic-retinopathy-detection- 2024-10-21T13:49:38+03:00 en https://ophthalmologybreakingnews.com/eyenuk-secures-fda-clearance-for-additional-camera-in-diabetic-retinopathy-detection- https://ophthalmologybreakingnews.com/files/images/blog_cdsco-probes-alcons-iol-for-drastically-diminishing-patients-sight.jpg https://ophthalmologybreakingnews.com/cdsco-probes-alcons-iol-for-drastically-diminishing-patients-sight 2024-11-18T15:19:38+03:00 en https://ophthalmologybreakingnews.com/cdsco-probes-alcons-iol-for-drastically-diminishing-patients-sight https://ophthalmologybreakingnews.com/files/images/blog_coopervision-initiates-recall-of-biofinity-sphere-contact-lenses-in-specific-lots.jpg https://ophthalmologybreakingnews.com/coopervision-initiates-recall-of-biofinity-sphere-contact-lenses-in-specific-lots 2024-10-16T14:14:36+03:00 en https://ophthalmologybreakingnews.com/coopervision-initiates-recall-of-biofinity-sphere-contact-lenses-in-specific-lots https://ophthalmologybreakingnews.com/files/images/blog_study-uncovers-novel-synaptic-discoveries-in-the-retina.jpg https://ophthalmologybreakingnews.com/study-uncovers-novel-synaptic-discoveries-in-the-retina 2023-06-20T15:04:40+03:00 en https://ophthalmologybreakingnews.com/study-uncovers-novel-synaptic-discoveries-in-the-retina https://ophthalmologybreakingnews.com/files/images/blog_the-high-price-of-vision-loss-australian-study-reveals-52-million-cost-per-person_1.jpg https://ophthalmologybreakingnews.com/the-high-price-of-vision-loss--australian-study-reveals-$52-million-cost-per-person 2024-10-21T10:44:46+03:00 en https://ophthalmologybreakingnews.com/the-high-price-of-vision-loss--australian-study-reveals-$52-million-cost-per-person https://ophthalmologybreakingnews.com/files/images/blog_novel-approach-oral-probiotics-show-promise-in-alleviating-dry-eye-symptoms.jpg https://ophthalmologybreakingnews.com/novel-approach--oral-probiotics-show-promise-in-alleviating-dry-eye-symptoms 2023-06-19T10:19:50+03:00 en https://ophthalmologybreakingnews.com/novel-approach--oral-probiotics-show-promise-in-alleviating-dry-eye-symptoms https://ophthalmologybreakingnews.com/files/images/blog_lab-grown-mini-corneas-offer-new-insights-into-corneal-diseases.jpg https://ophthalmologybreakingnews.com/lab-grown-mini-corneas-offer-new-insights-into-corneal-diseases 2023-06-19T09:42:27+03:00 en https://ophthalmologybreakingnews.com/lab-grown-mini-corneas-offer-new-insights-into-corneal-diseases https://ophthalmologybreakingnews.com/files/images/blog_study-reveals-contact-lenses-can-shed-microplastics-raising-health-concerns.jpg https://ophthalmologybreakingnews.com/study-reveals-contact-lenses-can-shed-microplastics-raising-health-concerns 2024-10-01T15:37:36+03:00 en https://ophthalmologybreakingnews.com/study-reveals-contact-lenses-can-shed-microplastics-raising-health-concerns https://ophthalmologybreakingnews.com/files/images/blog_marinomed-biotech-plans-to-launch-carragelose-eye-drops-in-2024.jpg https://ophthalmologybreakingnews.com/marinomed-biotech-plans-to-launch-carragelose-eye-drops-in-2024 2023-06-15T11:33:05+03:00 en https://ophthalmologybreakingnews.com/marinomed-biotech-plans-to-launch-carragelose-eye-drops-in-2024 https://ophthalmologybreakingnews.com/files/images/blog_intraocular-corticosteroids-proven-as-the-best-treatment-for-uveitic-macular-edema.jpg https://ophthalmologybreakingnews.com/intraocular-corticosteroids-proven-as-the-best-treatment-for-uveitic-macular-edema 2024-04-29T11:05:53+03:00 en https://ophthalmologybreakingnews.com/intraocular-corticosteroids-proven-as-the-best-treatment-for-uveitic-macular-edema https://ophthalmologybreakingnews.com/files/images/blog_calcium-channel-blockers-linked-to-increased-risk-of-glaucoma-study-shows.jpg https://ophthalmologybreakingnews.com/calcium-channel-blockers-linked-to-heightened-risk-of-glaucoma 2024-10-21T13:43:10+03:00 en https://ophthalmologybreakingnews.com/calcium-channel-blockers-linked-to-heightened-risk-of-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-presents-acrivaud-trinova-pro-c-at-the-apacrs-congress.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-presents-acrivaud-trinova-pro-c-at-the-apacrs-congress 2024-02-09T10:04:28+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-presents-acrivaud-trinova-pro-c-at-the-apacrs-congress https://ophthalmologybreakingnews.com/files/images/blog_explained-why-do-some-corneal-transplants-fail.jpg https://ophthalmologybreakingnews.com/explained--why-do-some-corneal-transplants-fail- 2024-04-29T11:28:27+03:00 en https://ophthalmologybreakingnews.com/explained--why-do-some-corneal-transplants-fail- https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/new-nerve-insights-bring-hope-for-healing-specific-types-of-blindness-and-paralysis 2024-04-29T09:32:37+03:00 en https://ophthalmologybreakingnews.com/new-nerve-insights-bring-hope-for-healing-specific-types-of-blindness-and-paralysis https://ophthalmologybreakingnews.com/files/images/blog_pixium-vision-receives-e18-million-research-tax-credit-from-french-government.jpg https://ophthalmologybreakingnews.com/pixium-vision-receives-€18-million-research-tax-credit-from-french-government 2024-04-29T11:11:08+03:00 en https://ophthalmologybreakingnews.com/pixium-vision-receives-€18-million-research-tax-credit-from-french-government https://ophthalmologybreakingnews.com/files/images/blog_top-6-advances-in-cataract-surgery-transforming-vision-restoration.jpg https://ophthalmologybreakingnews.com/top-6-advances-in-cataract-surgery--transforming-vision-restoration 2024-02-09T10:34:16+03:00 en https://ophthalmologybreakingnews.com/top-6-advances-in-cataract-surgery--transforming-vision-restoration https://ophthalmologybreakingnews.com/files/images/blog_cellusion-secures-21-million-funding-to-advance-ips-cell-derived-corneal-endothelial-cell-substitute.jpg https://ophthalmologybreakingnews.com/cellusion-secures-$21-million-funding-to-advance-ips-cell-derived-corneal-endothelial-cell-substitute 2023-06-08T09:50:48+03:00 en https://ophthalmologybreakingnews.com/cellusion-secures-$21-million-funding-to-advance-ips-cell-derived-corneal-endothelial-cell-substitute https://ophthalmologybreakingnews.com/files/images/blog_when-pressure-drops-exploring-the-enigma-of-hypotony-maculopathy.jpg https://ophthalmologybreakingnews.com/when-pressure-drops--exploring-the-enigma-of-hypotony-maculopathy 2023-09-26T16:20:41+03:00 en https://ophthalmologybreakingnews.com/when-pressure-drops--exploring-the-enigma-of-hypotony-maculopathy https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-appoints-hans-jurgen-thier-as-germany-country-manager.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-appoints-hans-jurgen-thier-as-germany-country-manager-- 2023-06-07T11:01:47+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-appoints-hans-jurgen-thier-as-germany-country-manager-- https://ophthalmologybreakingnews.com/files/images/blog_wireless-bottle-cap-monitor-may-improve-eye-drop-adherence-in-glaucoma-treatment.jpg https://ophthalmologybreakingnews.com/wireless-bottle-cap-monitor-may-improve-eye-drop-adherence-in-glaucoma-treatment 2024-04-29T10:07:14+03:00 en https://ophthalmologybreakingnews.com/wireless-bottle-cap-monitor-may-improve-eye-drop-adherence-in-glaucoma-treatment https://ophthalmologybreakingnews.com/files/images/blog_an-asymmetrical-gaze-a-closer-look-at-relative-afferent-pupillary-defect.jpg https://ophthalmologybreakingnews.com/an-asymmetrical-gaze--a-closer-look-at-relative-afferent-pupillary-defect 2023-09-26T16:20:06+03:00 en https://ophthalmologybreakingnews.com/an-asymmetrical-gaze--a-closer-look-at-relative-afferent-pupillary-defect https://ophthalmologybreakingnews.com/files/images/blog_vivavisions-ophthalmic-solution-significantly-reduces-iop-in-phase-ii-study.jpg https://ophthalmologybreakingnews.com/vivavisions-ophthalmic-solution-significantly-reduces-iop-in-phase-ii-study 2023-06-06T09:26:48+03:00 en https://ophthalmologybreakingnews.com/vivavisions-ophthalmic-solution-significantly-reduces-iop-in-phase-ii-study https://ophthalmologybreakingnews.com/files/images/blog_windows-to-the-soul-exploring-the-symbolism-of-eyes-in-art.jpg https://ophthalmologybreakingnews.com/windows-to-the-soul--exploring-the-symbolism-of-eyes-in-art 2024-01-01T19:49:54+03:00 en https://ophthalmologybreakingnews.com/windows-to-the-soul--exploring-the-symbolism-of-eyes-in-art https://ophthalmologybreakingnews.com/files/images/blog_breakthrough-in-ophthalmology-study-reveals-the-dynamic-structure-of-the-human-eye.jpg https://ophthalmologybreakingnews.com/breakthrough-in-ophthalmology--study-reveals-the-dynamic-structure-of-the-human-eye 2024-04-29T11:04:22+03:00 en https://ophthalmologybreakingnews.com/breakthrough-in-ophthalmology--study-reveals-the-dynamic-structure-of-the-human-eye https://ophthalmologybreakingnews.com/files/images/blog_new-smartphone-app-helps-children-with-amblyopia.jpg https://ophthalmologybreakingnews.com/new-smartphone-app-helps-children-with-amblyopia 2023-06-01T10:59:52+03:00 en https://ophthalmologybreakingnews.com/new-smartphone-app-helps-children-with-amblyopia https://ophthalmologybreakingnews.com/files/images/blog_eyes-on-the-sparrow-unfolding-the-mystery-of-birdshot-chorioretinopathy.jpg https://ophthalmologybreakingnews.com/eyes-on-the-sparrow--unfolding-the-mystery-of-birdshot-chorioretinopathy 2023-07-11T10:26:52+03:00 en https://ophthalmologybreakingnews.com/eyes-on-the-sparrow--unfolding-the-mystery-of-birdshot-chorioretinopathy https://ophthalmologybreakingnews.com/files/images/blog_dysphotopsia-visual-phenomena-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/dysphotopsia--visual-phenomena-after-cataract-surgery 2023-10-19T14:34:15+03:00 en https://ophthalmologybreakingnews.com/dysphotopsia--visual-phenomena-after-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_anophthalmia-understanding-a-rare-eye-condition.jpg https://ophthalmologybreakingnews.com/anophthalmia--understanding-a-rare-eye-condition 2023-07-11T09:27:54+03:00 en https://ophthalmologybreakingnews.com/anophthalmia--understanding-a-rare-eye-condition https://ophthalmologybreakingnews.com/files/images/blog_the-evolution-of-eye-care-5-milestones-in-ophthalmology-history.jpg https://ophthalmologybreakingnews.com/the-evolution-of-eye-care--5-milestones-in-ophthalmology-history 2024-02-09T09:22:40+03:00 en https://ophthalmologybreakingnews.com/the-evolution-of-eye-care--5-milestones-in-ophthalmology-history https://ophthalmologybreakingnews.com/files/images/blog_granular-corneal-dystrophy-exploring-a-genetic-condition-affecting-the-cornea.jpg https://ophthalmologybreakingnews.com/granular-corneal-dystrophy--exploring-a-genetic-condition-affecting-the-cornea 2023-09-26T16:22:16+03:00 en https://ophthalmologybreakingnews.com/granular-corneal-dystrophy--exploring-a-genetic-condition-affecting-the-cornea https://ophthalmologybreakingnews.com/files/images/blog_how-antioxidants-stand-guard-for-healthy-eyes.jpg https://ophthalmologybreakingnews.com/how-antioxidants-stand-guard-for-healthy-eyes 2024-02-16T11:00:54+03:00 en https://ophthalmologybreakingnews.com/how-antioxidants-stand-guard-for-healthy-eyes https://ophthalmologybreakingnews.com/files/images/blog_norlase-secures-11m-in-new-funding-for-echo-pattern-laser.jpg https://ophthalmologybreakingnews.com/norlase-secures-$11m-in-new-funding-for-echo-pattern-laser 2024-02-09T10:17:43+03:00 en https://ophthalmologybreakingnews.com/norlase-secures-$11m-in-new-funding-for-echo-pattern-laser https://ophthalmologybreakingnews.com/files/images/blog_conjunctival-nevus-a-benign-growth-on-the-eyes-surface.jpg https://ophthalmologybreakingnews.com/conjunctival-nevus--a-benign-growth-on-the-eyes-surface 2023-05-25T16:46:12+03:00 en https://ophthalmologybreakingnews.com/conjunctival-nevus--a-benign-growth-on-the-eyes-surface https://ophthalmologybreakingnews.com/files/images/blog_what-you-need-to-know-about-the-forever-chemicals-in-your-contact-lenses.jpg https://ophthalmologybreakingnews.com/what-you-need-to-know-about-the-forever-chemicals-in-your-contact-lenses 2023-05-25T15:28:02+03:00 en https://ophthalmologybreakingnews.com/what-you-need-to-know-about-the-forever-chemicals-in-your-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_5-essential-tips-for-choosing-the-right-sunglasses-for-eye-protection.jpg https://ophthalmologybreakingnews.com/5-essential-tips-for-choosing-the-right-sunglasses-for-eye-protection 2024-01-01T19:44:17+03:00 en https://ophthalmologybreakingnews.com/5-essential-tips-for-choosing-the-right-sunglasses-for-eye-protection https://ophthalmologybreakingnews.com/files/images/blog_bulging-eyes-what-causes-exophthalmos-and-how-to-treat-it.jpg https://ophthalmologybreakingnews.com/bulging-eyes--what-causes-exophthalmos-and-how-to-treat-it 2023-09-26T16:23:20+03:00 en https://ophthalmologybreakingnews.com/bulging-eyes--what-causes-exophthalmos-and-how-to-treat-it https://ophthalmologybreakingnews.com/files/images/blog_black-pearl-acquires-ireland-based-maker-of-contact-lenses-n-polydev.jpg https://ophthalmologybreakingnews.com/black-pearl-acquires-ireland-based-maker-of-contact-lenses-–-polydev- 2024-10-01T15:42:39+03:00 en https://ophthalmologybreakingnews.com/black-pearl-acquires-ireland-based-maker-of-contact-lenses-–-polydev- https://ophthalmologybreakingnews.com/files/images/blog_a-step-by-step-guide-to-visual-field-testing-for-residents.jpg https://ophthalmologybreakingnews.com/a-step-by-step-guide-to-visual-field-testing-for-residents- 2024-04-29T10:12:11+03:00 en https://ophthalmologybreakingnews.com/a-step-by-step-guide-to-visual-field-testing-for-residents- https://ophthalmologybreakingnews.com/files/images/blog_blepharoplasty-a-game-changer-for-tired-looking-eyes.jpg https://ophthalmologybreakingnews.com/blepharoplasty--a-game-changer-for-tired-looking-eyes 2023-09-26T16:23:46+03:00 en https://ophthalmologybreakingnews.com/blepharoplasty--a-game-changer-for-tired-looking-eyes https://ophthalmologybreakingnews.com/files/images/blog_contact-lenses-with-forever-chemicals-revealed-alcon-acuvue-coopervision.jpg https://ophthalmologybreakingnews.com/contact-lenses-with-forever-chemicals-revealed--alcon-acuvue-coopervision 2024-09-24T14:17:38+03:00 en https://ophthalmologybreakingnews.com/contact-lenses-with-forever-chemicals-revealed--alcon-acuvue-coopervision https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/bespoke-ai-models-differentiate-healthy-retinas-from-rop-features 2024-02-09T10:45:52+03:00 en https://ophthalmologybreakingnews.com/bespoke-ai-models-differentiate-healthy-retinas-from-rop-features https://ophthalmologybreakingnews.com/files/images/blog_secondhand-smoke-exposure-increases-risk-of-myopia-in-children.jpg https://ophthalmologybreakingnews.com/secondhand-smoke-exposure-increases-risk-of-myopia-in-children 2023-05-22T16:23:14+03:00 en https://ophthalmologybreakingnews.com/secondhand-smoke-exposure-increases-risk-of-myopia-in-children https://ophthalmologybreakingnews.com/files/images/blog_what-is-hyphema-in-the-eye-and-how-to-treat-it.jpg https://ophthalmologybreakingnews.com/what-is-hyphema-in-the-eye-and-how-to-treat-it 2023-05-22T13:33:29+03:00 en https://ophthalmologybreakingnews.com/what-is-hyphema-in-the-eye-and-how-to-treat-it https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-bausch-lomb-and-novaliqs-miebo-for-treatment-of-ded.jpg https://ophthalmologybreakingnews.com/fda-approves-bausch--lomb-and-novaliqs-miebo-for-treatment-of-ded 2023-05-22T08:50:25+03:00 en https://ophthalmologybreakingnews.com/fda-approves-bausch--lomb-and-novaliqs-miebo-for-treatment-of-ded https://ophthalmologybreakingnews.com/files/images/blog_understanding-lebers-hereditary-optic-neuropathy-lhon.jpg https://ophthalmologybreakingnews.com/understanding-lebers-hereditary-optic-neuropathy-lhon 2023-09-26T16:24:13+03:00 en https://ophthalmologybreakingnews.com/understanding-lebers-hereditary-optic-neuropathy-lhon https://ophthalmologybreakingnews.com/files/images/blog_toxic-truth-forever-chemicals-in-contact-lenses-linked-to-cancer.jpg https://ophthalmologybreakingnews.com/toxic-truth--forever-chemicals-in-contact-lenses-linked-to-cancer 2024-10-15T14:49:16+03:00 en https://ophthalmologybreakingnews.com/toxic-truth--forever-chemicals-in-contact-lenses-linked-to-cancer https://ophthalmologybreakingnews.com/files/images/blog_shedding-light-on-optic-neuritis-causes-and-treatments.jpg https://ophthalmologybreakingnews.com/shedding-light-on-optic-neuritis--causes-and-treatments 2023-05-17T13:08:37+03:00 en https://ophthalmologybreakingnews.com/shedding-light-on-optic-neuritis--causes-and-treatments https://ophthalmologybreakingnews.com/files/images/blog_inward-turning-eyelids-a-comprehensive-guide-to-entropion.jpg https://ophthalmologybreakingnews.com/inward-turning-eyelids--a-comprehensive-guide-to-entropion- 2023-05-16T16:31:20+03:00 en https://ophthalmologybreakingnews.com/inward-turning-eyelids--a-comprehensive-guide-to-entropion- https://ophthalmologybreakingnews.com/files/images/blog_omni-surgical-system-greatly-reduces-medication-usage-in-glaucoma-patients.jpg https://ophthalmologybreakingnews.com/omni-surgical-system-greatly-reduces-medication-usage-in-glaucoma-patients 2024-04-29T10:02:40+03:00 en https://ophthalmologybreakingnews.com/omni-surgical-system-greatly-reduces-medication-usage-in-glaucoma-patients https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-gmbh-achieved-strong-growth-in-q1-2023.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-achieved-strong-growth-in-q1-2023 2023-05-16T16:54:44+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-achieved-strong-growth-in-q1-2023 https://ophthalmologybreakingnews.com/files/images/blog_the-eye-pain-you-cant-ignore-a-guide-to-corneal-abrasions.jpg https://ophthalmologybreakingnews.com/the-eye-pain-you-cant-ignore--a-guide-to-corneal-abrasions 2023-05-15T10:54:03+03:00 en https://ophthalmologybreakingnews.com/the-eye-pain-you-cant-ignore--a-guide-to-corneal-abrasions https://ophthalmologybreakingnews.com/files/images/blog_aegis-and-northwell-launch-ai-company-optain-for-detecting-eye-diseases.jpg https://ophthalmologybreakingnews.com/aegis-and-northwell-launch-ai-company-optain-for-detecting-eye-diseases 2024-04-29T11:02:07+03:00 en https://ophthalmologybreakingnews.com/aegis-and-northwell-launch-ai-company-optain-for-detecting-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_what-is-ocular-hypotony-and-how-to-manage-it.jpg https://ophthalmologybreakingnews.com/what-is-ocular-hypotony-and-how-to-manage-it 2023-05-22T16:44:38+03:00 en https://ophthalmologybreakingnews.com/what-is-ocular-hypotony-and-how-to-manage-it https://ophthalmologybreakingnews.com/files/images/blog_10-most-common-vision-problems-in-children-and-how-to-prevent-them.jpg https://ophthalmologybreakingnews.com/10-most-common-vision-problems-in-children-and-how-to-prevent-them 2024-01-01T20:00:07+03:00 en https://ophthalmologybreakingnews.com/10-most-common-vision-problems-in-children-and-how-to-prevent-them https://ophthalmologybreakingnews.com/files/images/blog_inherited-vision-loss-a-closer-look-at-best-disease.jpg https://ophthalmologybreakingnews.com/inherited-vision-loss--a-closer-look-at-best-disease 2023-05-12T13:49:19+03:00 en https://ophthalmologybreakingnews.com/inherited-vision-loss--a-closer-look-at-best-disease https://ophthalmologybreakingnews.com/files/images/blog_the-eye-infection-that-can-steal-your-sight-keratitis-explained.jpg https://ophthalmologybreakingnews.com/the-eye-infection-that-can-steal-your-sight--keratitis-explained 2023-05-17T15:56:57+03:00 en https://ophthalmologybreakingnews.com/the-eye-infection-that-can-steal-your-sight--keratitis-explained https://ophthalmologybreakingnews.com/files/images/blog_exploring-retinal-vascular-occlusion-causes-and-treatments.jpg https://ophthalmologybreakingnews.com/exploring-retinal-vascular-occlusion--causes-and-treatments 2024-04-29T10:17:41+03:00 en https://ophthalmologybreakingnews.com/exploring-retinal-vascular-occlusion--causes-and-treatments https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-application-for-genentechs-vabysmo-for-retinal-vein-occlusion.jpg https://ophthalmologybreakingnews.com/fda-accepts-application-for-genentechs-vabysmo-for-retinal-vein-occlusion- 2024-02-09T10:22:54+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-application-for-genentechs-vabysmo-for-retinal-vein-occlusion- https://ophthalmologybreakingnews.com/files/images/blog_fuchs-dystrophy-a-comprehensive-guide-to-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/fuchs-dystrophy--a-comprehensive-guide-to-symptoms-and-treatment 2023-08-11T09:58:09+03:00 en https://ophthalmologybreakingnews.com/fuchs-dystrophy--a-comprehensive-guide-to-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_researchers-discover-promising-path-to-vision-restoration.jpg https://ophthalmologybreakingnews.com/researchers-discover-promising-path-to-vision-restoration 2023-05-17T17:05:06+03:00 en https://ophthalmologybreakingnews.com/researchers-discover-promising-path-to-vision-restoration https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-eyenovias-mydcombi-first-ophthalmic-spray-for-mydriasis.jpg https://ophthalmologybreakingnews.com/fda-approves-eyenovias-mydcombi-first-ophthalmic-spray-for-mydriasis 2024-02-09T10:52:20+03:00 en https://ophthalmologybreakingnews.com/fda-approves-eyenovias-mydcombi-first-ophthalmic-spray-for-mydriasis https://ophthalmologybreakingnews.com/files/images/blog_researchers-identify-two-new-genes-associated-with-amd.jpg https://ophthalmologybreakingnews.com/researchers-identify-two-new-genes-associated-with-amd- 2024-04-29T11:06:21+03:00 en https://ophthalmologybreakingnews.com/researchers-identify-two-new-genes-associated-with-amd- https://ophthalmologybreakingnews.com/files/images/blog_sip-to-see-better-study-shows-coffee-and-tea-improve-nerve-layer-thickness.jpg https://ophthalmologybreakingnews.com/sip-to-see-better--study-shows-coffee-and-tea-improve-nerve-layer-thickness 2023-05-05T10:09:08+03:00 en https://ophthalmologybreakingnews.com/sip-to-see-better--study-shows-coffee-and-tea-improve-nerve-layer-thickness https://ophthalmologybreakingnews.com/files/images/blog_congenital-eye-diseases-causes-symptoms-and-management.jpg https://ophthalmologybreakingnews.com/congenital-eye-diseases--causes-symptoms-and-management- 2023-09-15T09:27:20+03:00 en https://ophthalmologybreakingnews.com/congenital-eye-diseases--causes-symptoms-and-management- https://ophthalmologybreakingnews.com/files/images/blog_magic-mushrooms-may-have-a-long-lasting-effect-on-color-blindness.jpg https://ophthalmologybreakingnews.com/magic-mushrooms-may-have-a-long-lasting-effect-on-color-blindness 2023-05-04T13:54:23+03:00 en https://ophthalmologybreakingnews.com/magic-mushrooms-may-have-a-long-lasting-effect-on-color-blindness https://ophthalmologybreakingnews.com/files/images/blog_stargardt-disease-understanding-the-basics.jpg https://ophthalmologybreakingnews.com/stargardt-disease--understanding-the-basics 2024-02-09T10:50:50+03:00 en https://ophthalmologybreakingnews.com/stargardt-disease--understanding-the-basics https://ophthalmologybreakingnews.com/files/images/blog_5-things-ophthalmology-residents-should-know-before-going-into-the-field.jpg https://ophthalmologybreakingnews.com/5-things-ophthalmology-residents-should-know-before-going-into-the-field 2024-01-01T19:58:10+03:00 en https://ophthalmologybreakingnews.com/5-things-ophthalmology-residents-should-know-before-going-into-the-field https://ophthalmologybreakingnews.com/files/images/blog_chatgpt-scores-less-than-50-on-ophthalmology-certification-exam.jpg https://ophthalmologybreakingnews.com/chatgpt-scores-less-than-50-on-ophthalmology-certification-exam 2023-05-04T11:43:34+03:00 en https://ophthalmologybreakingnews.com/chatgpt-scores-less-than-50-on-ophthalmology-certification-exam https://ophthalmologybreakingnews.com/files/images/blog_hyperopia-astigmatism-understanding-the-condition.jpg https://ophthalmologybreakingnews.com/hyperopia-farsightedness---understanding-the-condition 2023-08-11T09:59:18+03:00 en https://ophthalmologybreakingnews.com/hyperopia-farsightedness---understanding-the-condition https://ophthalmologybreakingnews.com/files/images/blog_astellas-pharma-acquires-iveric-bio-for-59-billion.jpg https://ophthalmologybreakingnews.com/astellas-pharma-acquires-iveric-bio-for-$59-billion 2024-02-09T10:40:06+03:00 en https://ophthalmologybreakingnews.com/astellas-pharma-acquires-iveric-bio-for-$59-billion https://ophthalmologybreakingnews.com/files/images/blog_espansione-group-launches-second-wave-of-global-clinical-trial-for-dry-amd.jpg https://ophthalmologybreakingnews.com/espansione-group-launches-second-wave-of-global-clinical-trial-for-dry-amd- 2023-04-28T13:09:10+03:00 en https://ophthalmologybreakingnews.com/espansione-group-launches-second-wave-of-global-clinical-trial-for-dry-amd- https://ophthalmologybreakingnews.com/files/images/blog_scientists-develop-low-cost-contact-lenses-for-color-blindness.jpg https://ophthalmologybreakingnews.com/scientists-develop-low-cost-contact-lenses-for-color-blindness 2023-04-28T09:17:47+03:00 en https://ophthalmologybreakingnews.com/scientists-develop-low-cost-contact-lenses-for-color-blindness https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-johnson-johnson-visions-elita-femtosecond-laser.jpg https://ophthalmologybreakingnews.com/fda-clears-johnson--johnson-visions-elita-femtosecond-laser 2023-04-28T08:26:18+03:00 en https://ophthalmologybreakingnews.com/fda-clears-johnson--johnson-visions-elita-femtosecond-laser https://ophthalmologybreakingnews.com/files/images/blog_-5-fascinating-facts-about-how-our-brain-processes-visual-information.jpg https://ophthalmologybreakingnews.com/-5-fascinating-facts-about-how-our-brain-processes-visual-information 2024-01-01T19:56:08+03:00 en https://ophthalmologybreakingnews.com/-5-fascinating-facts-about-how-our-brain-processes-visual-information https://ophthalmologybreakingnews.com/files/images/blog_akorn-pharmaceuticals-recalls-70-plus-drugs-due-to-company-shutdown.jpg https://ophthalmologybreakingnews.com/akorn-pharmaceuticals-recalls-70-plus-drugs-due-to-company-shutdown- 2023-04-27T09:57:40+03:00 en https://ophthalmologybreakingnews.com/akorn-pharmaceuticals-recalls-70-plus-drugs-due-to-company-shutdown- https://ophthalmologybreakingnews.com/files/images/blog_gensight-biologics-halts-lumevoqs-regulatory-process-in-europe.jpg https://ophthalmologybreakingnews.com/gensight-biologics-halts-lumevoqs-regulatory-process-in-europe 2024-10-16T14:16:42+03:00 en https://ophthalmologybreakingnews.com/gensight-biologics-halts-lumevoqs-regulatory-process-in-europe https://ophthalmologybreakingnews.com/files/images/blog_fda-warns-of-unapproved-amniotic-fluid-eye-drops.jpg https://ophthalmologybreakingnews.com/fda-warns-of-unapproved-amniotic-fluid-eye-drops 2023-04-26T13:32:12+03:00 en https://ophthalmologybreakingnews.com/fda-warns-of-unapproved-amniotic-fluid-eye-drops https://ophthalmologybreakingnews.com/files/images/blog_samsaras-implantable-telescope-restores-vision-in-uk-patients-with-late-stage-amd.jpg https://ophthalmologybreakingnews.com/samsaras-implantable-telescope-restores-vision-in-uk-patients-with-late-stage-amd 2024-10-01T12:12:04+03:00 en https://ophthalmologybreakingnews.com/samsaras-implantable-telescope-restores-vision-in-uk-patients-with-late-stage-amd https://ophthalmologybreakingnews.com/files/images/blog_top-5-natural-remedies-for-eye-infections.jpg https://ophthalmologybreakingnews.com/top-5-natural-remedies-for-eye-infections 2024-01-01T19:55:34+03:00 en https://ophthalmologybreakingnews.com/top-5-natural-remedies-for-eye-infections https://ophthalmologybreakingnews.com/files/images/blog_tarsus-names-jeff-farrow-as-chief-financial-officer-and-chief-strategy-officer.jpg https://ophthalmologybreakingnews.com/tarsus-names-jeff-farrow-as-chief-financial-officer-and-chief-strategy-officer 2023-04-25T08:51:04+03:00 en https://ophthalmologybreakingnews.com/tarsus-names-jeff-farrow-as-chief-financial-officer-and-chief-strategy-officer https://ophthalmologybreakingnews.com/files/images/blog_bausch-lombs-stablevisct-cohesive-ovd-totalvisct-viscoelastic-system-now-in-the-us.jpg https://ophthalmologybreakingnews.com/bausch--lombs-stablevisc™-cohesive-ovd--totalvisc™-viscoelastic-system-now-in-the-us 2023-04-24T15:59:49+03:00 en https://ophthalmologybreakingnews.com/bausch--lombs-stablevisc™-cohesive-ovd--totalvisc™-viscoelastic-system-now-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_the-eye-an-in-depth-look-at-its-incredible-anatomy.jpg https://ophthalmologybreakingnews.com/the-eye--an-in-depth-look-at-its-incredible-anatomy 2023-09-14T15:54:45+03:00 en https://ophthalmologybreakingnews.com/the-eye--an-in-depth-look-at-its-incredible-anatomy https://ophthalmologybreakingnews.com/files/images/blog_fda-clears-avicedas-ind-for-treatment-of-geographic-atrophy-from-amd.jpg https://ophthalmologybreakingnews.com/fda-clears-avicedas-ind-for-treatment-of-geographic-atrophy-from-amd 2024-02-09T09:51:19+03:00 en https://ophthalmologybreakingnews.com/fda-clears-avicedas-ind-for-treatment-of-geographic-atrophy-from-amd https://ophthalmologybreakingnews.com/files/images/blog_selective-laser-trabeculoplasty-slt-surgery-a-comprehensive-guide.jpg https://ophthalmologybreakingnews.com/selective-laser-trabeculoplasty-slt-surgery--a-comprehensive-guide 2023-09-26T16:24:54+03:00 en https://ophthalmologybreakingnews.com/selective-laser-trabeculoplasty-slt-surgery--a-comprehensive-guide https://ophthalmologybreakingnews.com/files/images/blog_haag-streit-introduces-new-eyesuite-software.jpg https://ophthalmologybreakingnews.com/haag-streit-introduces-new-eyesuite-software 2023-04-17T12:39:01+03:00 en https://ophthalmologybreakingnews.com/haag-streit-introduces-new-eyesuite-software https://ophthalmologybreakingnews.com/files/images/blog_ocumension-therapeutics-submits-a-new-drug-application-for-zerviate-in-china.jpg https://ophthalmologybreakingnews.com/ocumension-therapeutics-submits-a-new-drug-application-for-zerviate-in-china 2023-04-17T07:35:19+03:00 en https://ophthalmologybreakingnews.com/ocumension-therapeutics-submits-a-new-drug-application-for-zerviate-in-china https://ophthalmologybreakingnews.com/files/images/blog_sickle-cell-retinopathy-understanding-the-condition.jpg https://ophthalmologybreakingnews.com/sickle-cell-retinopathy--understanding-the-condition 2023-09-26T16:25:15+03:00 en https://ophthalmologybreakingnews.com/sickle-cell-retinopathy--understanding-the-condition https://ophthalmologybreakingnews.com/files/images/blog_sightsavers-eye-health-project-transforms-lives-of-thousands-in-tanzania.jpg https://ophthalmologybreakingnews.com/sightsavers-eye-health-project-transforms-lives-of-thousands-in-tanzania- 2023-11-30T13:42:44+03:00 en https://ophthalmologybreakingnews.com/sightsavers-eye-health-project-transforms-lives-of-thousands-in-tanzania- https://ophthalmologybreakingnews.com/files/images/blog_whale-sharks-illuminate-genetic-basis-of-night-blindness-in-humans.jpg https://ophthalmologybreakingnews.com/whale-sharks-illuminate-genetic-basis-of-night-blindness-in-humans 2023-04-26T15:56:47+03:00 en https://ophthalmologybreakingnews.com/whale-sharks-illuminate-genetic-basis-of-night-blindness-in-humans https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnologys-sinusoidal-vision-technology-svtr-secures-us-patent-grant.jpg https://ophthalmologybreakingnews.com/vsy-biotechnologys-sinusoidal-vision-technology-svt®-secures-us-patent-grant 2023-10-19T14:23:57+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnologys-sinusoidal-vision-technology-svt®-secures-us-patent-grant https://ophthalmologybreakingnews.com/files/images/blog_ophthalmologists-express-concerns-about-fdas-inspections-of-otc-eye-products.jpg https://ophthalmologybreakingnews.com/ophthalmologists-express-concerns-about-fdas-inspections-of-otc-eye-products 2024-04-29T11:37:54+03:00 en https://ophthalmologybreakingnews.com/ophthalmologists-express-concerns-about-fdas-inspections-of-otc-eye-products https://ophthalmologybreakingnews.com/files/images/blog_peeq-pro-launches-multipurpose-eyelid-cleansing-device.jpg https://ophthalmologybreakingnews.com/peeq-pro-launches-multipurpose-eyelid-cleansing-device- 2023-04-13T10:48:35+03:00 en https://ophthalmologybreakingnews.com/peeq-pro-launches-multipurpose-eyelid-cleansing-device- https://ophthalmologybreakingnews.com/files/images/blog_phototherapeutic-keratectomy-everything-you-need-to-know.jpg https://ophthalmologybreakingnews.com/phototherapeutic-keratectomy--everything-you-need-to-know 2023-09-26T16:25:38+03:00 en https://ophthalmologybreakingnews.com/phototherapeutic-keratectomy--everything-you-need-to-know https://ophthalmologybreakingnews.com/files/images/blog_horizons-tepezza-improves-proptosis-in-patients-with-chronic-ted.jpg https://ophthalmologybreakingnews.com/horizons-tepezza-improves-proptosis-in-patients-with-chronic-ted 2023-04-12T13:36:27+03:00 en https://ophthalmologybreakingnews.com/horizons-tepezza-improves-proptosis-in-patients-with-chronic-ted https://ophthalmologybreakingnews.com/files/images/blog_corneal-collagen-cross-linking-as-a-game-changer-for-eye-health.jpg https://ophthalmologybreakingnews.com/corneal-collagen-cross-linking-as-a-game-changer-for-eye-health 2024-02-16T13:00:20+03:00 en https://ophthalmologybreakingnews.com/corneal-collagen-cross-linking-as-a-game-changer-for-eye-health https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnson-vision-appoints-new-regional-presidents.jpg https://ophthalmologybreakingnews.com/johnson--johnson-vision-appoints-new-regional-presidents 2023-04-11T08:51:35+03:00 en https://ophthalmologybreakingnews.com/johnson--johnson-vision-appoints-new-regional-presidents https://ophthalmologybreakingnews.com/files/images/blog_5-surprising-ways-your-eye-health-affects-your-overall-health.jpg https://ophthalmologybreakingnews.com/5-surprising-ways-your-eye-health-affects-your-overall-health- 2024-01-01T19:54:36+03:00 en https://ophthalmologybreakingnews.com/5-surprising-ways-your-eye-health-affects-your-overall-health- https://ophthalmologybreakingnews.com/files/images/blog_oral-azithromycin-equivalent-to-six-weeks-of-doxycycline-for-mgd.jpg https://ophthalmologybreakingnews.com/oral-azithromycin-equivalent-to-six-weeks-of-doxycycline-for-mgd 2023-04-25T15:49:26+03:00 en https://ophthalmologybreakingnews.com/oral-azithromycin-equivalent-to-six-weeks-of-doxycycline-for-mgd https://ophthalmologybreakingnews.com/files/images/blog_eversight-introduces-new-dmek-endoglide-for-improved-surgical-precision.jpg https://ophthalmologybreakingnews.com/eversight-introduces-new-dmek-endoglide-for-improved-surgical-precision 2023-04-10T09:25:09+03:00 en https://ophthalmologybreakingnews.com/eversight-introduces-new-dmek-endoglide-for-improved-surgical-precision https://ophthalmologybreakingnews.com/files/images/blog_presbyopia-understanding-age-related-vision-impairment.jpg https://ophthalmologybreakingnews.com/presbyopia--understanding-age-related-vision-impairment- 2024-02-09T09:20:03+03:00 en https://ophthalmologybreakingnews.com/presbyopia--understanding-age-related-vision-impairment- https://ophthalmologybreakingnews.com/files/images/blog_bitemporal-hemianopia-causes-symptoms-and-management.jpg https://ophthalmologybreakingnews.com/bitemporal-hemianopia--causes-symptoms-and-management 2023-09-26T16:27:43+03:00 en https://ophthalmologybreakingnews.com/bitemporal-hemianopia--causes-symptoms-and-management https://ophthalmologybreakingnews.com/files/images/blog_from-diagnosis-to-recovery-navigating-the-journey-of-ocular-syphilis.jpg https://ophthalmologybreakingnews.com/from-diagnosis-to-recovery--navigating-the-journey-of-ocular-syphilis 2023-09-26T16:27:05+03:00 en https://ophthalmologybreakingnews.com/from-diagnosis-to-recovery--navigating-the-journey-of-ocular-syphilis https://ophthalmologybreakingnews.com/files/images/blog_unraveling-the-mystery-of-pigment-dispersion-syndrome.jpg https://ophthalmologybreakingnews.com/unraveling-the-mystery-of-pigment-dispersion-syndrome 2023-09-26T16:28:09+03:00 en https://ophthalmologybreakingnews.com/unraveling-the-mystery-of-pigment-dispersion-syndrome https://ophthalmologybreakingnews.com/files/images/blog_tearrestores-thermal-mask-and-hylawipe-tea-tree-eyelid-wipes-hit-shelves-at-target.jpg https://ophthalmologybreakingnews.com/tearrestores-thermal-mask-and-hylawipe-tea-tree-eyelid-wipes-hit-shelves-at-target 2023-05-08T16:03:36+03:00 en https://ophthalmologybreakingnews.com/tearrestores-thermal-mask-and-hylawipe-tea-tree-eyelid-wipes-hit-shelves-at-target https://ophthalmologybreakingnews.com/files/images/blog_update-on-recalled-eye-drops-bacterial-infection-can-spread-person-to-person.jpg https://ophthalmologybreakingnews.com/update-on-recalled-eye-drops--bacterial-infection-can-spread-person-to-person 2023-05-08T16:22:48+03:00 en https://ophthalmologybreakingnews.com/update-on-recalled-eye-drops--bacterial-infection-can-spread-person-to-person https://ophthalmologybreakingnews.com/files/images/blog_corneal-neovascularization-causes-and-emerging-treatments.jpg https://ophthalmologybreakingnews.com/corneal-neovascularization--causes-and-emerging-treatments 2023-09-26T16:27:21+03:00 en https://ophthalmologybreakingnews.com/corneal-neovascularization--causes-and-emerging-treatments https://ophthalmologybreakingnews.com/files/images/blog_top-10-lifestyle-changes-to-improve-your-eye-health.jpg https://ophthalmologybreakingnews.com/top-10-lifestyle-changes-to-improve-your-eye-health 2024-09-30T15:10:26+03:00 en https://ophthalmologybreakingnews.com/top-10-lifestyle-changes-to-improve-your-eye-health https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/bloomberg--big-pharma-companies-eyeing-apellis-for-acquisition 2024-04-29T11:03:29+03:00 en https://ophthalmologybreakingnews.com/bloomberg--big-pharma-companies-eyeing-apellis-for-acquisition https://ophthalmologybreakingnews.com/files/images/blog_astrazenecas-ultomiris-nears-approval-for-nmosd-treatment-in-eu.jpg https://ophthalmologybreakingnews.com/astrazenecas-ultomiris-nears-approval-for-nmosd-treatment-in-eu 2023-04-04T09:36:55+03:00 en https://ophthalmologybreakingnews.com/astrazenecas-ultomiris-nears-approval-for-nmosd-treatment-in-eu https://ophthalmologybreakingnews.com/files/images/blog_when-the-sun-attacks-understanding-photokeratitis.jpg https://ophthalmologybreakingnews.com/when-the-sun-attacks--understanding-photokeratitis 2023-09-26T16:28:32+03:00 en https://ophthalmologybreakingnews.com/when-the-sun-attacks--understanding-photokeratitis https://ophthalmologybreakingnews.com/files/images/blog_novartis-eye-drug-triggers-rare-retinal-side-effects-in-amd-patients_1.jpg https://ophthalmologybreakingnews.com/novartis-beovu-triggers-rare-retinal-side-effects-in-amd-patients 2024-06-24T15:28:58+03:00 en https://ophthalmologybreakingnews.com/novartis-beovu-triggers-rare-retinal-side-effects-in-amd-patients https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-wins-patent-battle-against-alcon-and-ivantis-in-the-us.jpg https://ophthalmologybreakingnews.com/sight-sciences-wins-patent-battle-against-alcon-and-ivantis-in-the-us 2024-10-16T14:15:03+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-wins-patent-battle-against-alcon-and-ivantis-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_lotilaner-ophthalmic-solution-proven-effective-for-treating-demodex-blepharitis.jpg https://ophthalmologybreakingnews.com/lotilaner-ophthalmic-solution-proven-effective-for-treating-demodex-blepharitis 2024-02-16T11:18:23+03:00 en https://ophthalmologybreakingnews.com/lotilaner-ophthalmic-solution-proven-effective-for-treating-demodex-blepharitis https://ophthalmologybreakingnews.com/files/images/blog_exploring-the-causes-and-treatments-of-anterior-uveitis.jpg https://ophthalmologybreakingnews.com/exploring-the-causes-and-treatments-of-anterior-uveitis 2024-04-29T10:17:05+03:00 en https://ophthalmologybreakingnews.com/exploring-the-causes-and-treatments-of-anterior-uveitis https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-twice-daily-dosing-of-vuity-for-adults-with-presbyopia.jpg https://ophthalmologybreakingnews.com/fda-approves-twice-daily-dosing-of-vuity-for-adults-with-presbyopia 2024-02-09T10:23:32+03:00 en https://ophthalmologybreakingnews.com/fda-approves-twice-daily-dosing-of-vuity-for-adults-with-presbyopia https://ophthalmologybreakingnews.com/files/images/blog_what-is-strabismus-a-comprehensive-guide-for-all.jpg https://ophthalmologybreakingnews.com/what-is-strabismus-a-comprehensive-guide-for-all-- 2023-09-26T16:30:25+03:00 en https://ophthalmologybreakingnews.com/what-is-strabismus-a-comprehensive-guide-for-all-- https://ophthalmologybreakingnews.com/files/images/blog_wco-and-alcon-partner-to-launch-revolutionary-dry-eye-tool.jpg https://ophthalmologybreakingnews.com/wco-and-alcon-partner-to-launch-revolutionary-dry-eye-tool 2023-03-29T09:42:09+03:00 en https://ophthalmologybreakingnews.com/wco-and-alcon-partner-to-launch-revolutionary-dry-eye-tool https://ophthalmologybreakingnews.com/files/images/blog_survey-patient-compliance-identified-as-top-challenge-for-ophthalmologists.jpg https://ophthalmologybreakingnews.com/survey--patient-compliance-identified-as-top-challenge-for-ophthalmologists 2024-02-09T09:24:28+03:00 en https://ophthalmologybreakingnews.com/survey--patient-compliance-identified-as-top-challenge-for-ophthalmologists https://ophthalmologybreakingnews.com/files/images/blog_mydriasis-understanding-pupil-dilation.jpg https://ophthalmologybreakingnews.com/mydriasis--understanding-pupil-dilation 2023-09-26T16:29:59+03:00 en https://ophthalmologybreakingnews.com/mydriasis--understanding-pupil-dilation https://ophthalmologybreakingnews.com/files/images/blog_new-fish-oil-supplement-offers-hope-for-reversing-vision-loss.jpg https://ophthalmologybreakingnews.com/new-fish-oil-supplement-offers-hope-for-reversing-vision-loss- 2023-03-28T09:42:20+03:00 en https://ophthalmologybreakingnews.com/new-fish-oil-supplement-offers-hope-for-reversing-vision-loss- https://ophthalmologybreakingnews.com/files/images/blog_cycloplegia-the-eye-condition-that-affects-your-ability-to-focus-up-close.jpg https://ophthalmologybreakingnews.com/cycloplegia--the-eye-condition-that-affects-your-ability-to-focus-up-close 2023-04-26T14:53:29+03:00 en https://ophthalmologybreakingnews.com/cycloplegia--the-eye-condition-that-affects-your-ability-to-focus-up-close https://ophthalmologybreakingnews.com/files/images/blog_eyes-may-reveal-early-signs-of-alzheimers-disease-study-finds.jpg https://ophthalmologybreakingnews.com/eyes-may-reveal-early-signs-of-alzheimers 2023-03-27T13:40:26+03:00 en https://ophthalmologybreakingnews.com/eyes-may-reveal-early-signs-of-alzheimers https://ophthalmologybreakingnews.com/files/images/blog_areds-2-supplement-and-amd_1.jpg https://ophthalmologybreakingnews.com/areds-2-supplement-and-amd 2024-10-21T11:36:00+03:00 en https://ophthalmologybreakingnews.com/areds-2-supplement-and-amd https://ophthalmologybreakingnews.com/files/images/blog_keratoconjunctivitis-symptoms-causes-and-treatment-options.jpg https://ophthalmologybreakingnews.com/keratoconjunctivitis--symptoms-causes 2023-09-26T16:30:52+03:00 en https://ophthalmologybreakingnews.com/keratoconjunctivitis--symptoms-causes https://ophthalmologybreakingnews.com/files/images/blog_maternal-smoking-linked-to-increased-risk-of-retinoblastoma.jpg https://ophthalmologybreakingnews.com/maternal-smoking-linked-to-increased-risk-of-retinoblastoma 2023-04-26T10:35:53+03:00 en https://ophthalmologybreakingnews.com/maternal-smoking-linked-to-increased-risk-of-retinoblastoma https://ophthalmologybreakingnews.com/files/images/blog_styes-more-than-just-a-bump-on-your-eyelid.jpg https://ophthalmologybreakingnews.com/styes--more-than-just-a-bump-on-your-eyelid 2023-09-15T09:09:36+03:00 en https://ophthalmologybreakingnews.com/styes--more-than-just-a-bump-on-your-eyelid https://ophthalmologybreakingnews.com/files/images/blog_nystagmus-causes-symptoms-and-treatments.jpg https://ophthalmologybreakingnews.com/nystagmus-causes-symptoms-and-treatments- 2023-04-26T14:54:02+03:00 en https://ophthalmologybreakingnews.com/nystagmus-causes-symptoms-and-treatments- https://ophthalmologybreakingnews.com/files/images/blog_aurion-biotech-receives-approval-from-japans-pmda-for-nda.jpg https://ophthalmologybreakingnews.com/aurion-biotech-receives-approval-from-japans-pmda-for-nda 2023-10-19T14:27:42+03:00 en https://ophthalmologybreakingnews.com/aurion-biotech-receives-approval-from-japans-pmda-for-nda https://ophthalmologybreakingnews.com/files/images/blog_linkedin-survey-eye-health-professionals-embrace-complementary-therapies.jpg https://ophthalmologybreakingnews.com/linkedin-survey--eye-health-professionals-embrace-complementary-therapies 2023-04-26T13:27:37+03:00 en https://ophthalmologybreakingnews.com/linkedin-survey--eye-health-professionals-embrace-complementary-therapies https://ophthalmologybreakingnews.com/files/images/blog_a-comprehensive-guide-to-blepharospasm-diagnosis-and-treatment.jpg https://ophthalmologybreakingnews.com/a-comprehensive-guide-to-blepharospasm-diagnosis-and-treatment 2023-09-26T16:31:18+03:00 en https://ophthalmologybreakingnews.com/a-comprehensive-guide-to-blepharospasm-diagnosis-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_what-is-waardenburg-syndrome-all-you-need-to-know.jpg https://ophthalmologybreakingnews.com/what-is-waardenburg-syndrome---all-you-need-to-know 2023-04-26T14:54:49+03:00 en https://ophthalmologybreakingnews.com/what-is-waardenburg-syndrome---all-you-need-to-know https://ophthalmologybreakingnews.com/files/images/blog_singapore-zoo-performs-worlds-first-custom-eye-lens-surgery-on-elderly-penguins.jpg https://ophthalmologybreakingnews.com/singapore-zoo-performs-worlds-first-custom-eye-lens-surgery-on-elderly-penguins 2023-05-08T09:08:03+03:00 en https://ophthalmologybreakingnews.com/singapore-zoo-performs-worlds-first-custom-eye-lens-surgery-on-elderly-penguins https://ophthalmologybreakingnews.com/files/images/blog_top-10-eye-health-apps-and-tools-for-patients.jpg https://ophthalmologybreakingnews.com/top-10-eye-health-apps-and-tools-for-patients 2024-09-24T14:19:46+03:00 en https://ophthalmologybreakingnews.com/top-10-eye-health-apps-and-tools-for-patients https://ophthalmologybreakingnews.com/files/images/blog_astigmatism-an-overview-of-visual-distortion.jpg https://ophthalmologybreakingnews.com/astigmatism--an-overview-of-visual-distortion 2023-04-26T13:32:36+03:00 en https://ophthalmologybreakingnews.com/astigmatism--an-overview-of-visual-distortion https://ophthalmologybreakingnews.com/files/images/blog_lumithera-reports-positive-results-for-dry-amd-treatment-in-us-lightsite-iii-trial.jpg https://ophthalmologybreakingnews.com/lumithera-reports-positive-results-for-dry-amd-treatment-in-us-lightsite-iii-trial 2023-03-20T08:56:01+03:00 en https://ophthalmologybreakingnews.com/lumithera-reports-positive-results-for-dry-amd-treatment-in-us-lightsite-iii-trial https://ophthalmologybreakingnews.com/files/images/blog_the-blurred-horizon-understanding-myopia.jpg https://ophthalmologybreakingnews.com/the-blurred-horizon--understanding-myopia 2023-09-26T16:33:15+03:00 en https://ophthalmologybreakingnews.com/the-blurred-horizon--understanding-myopia https://ophthalmologybreakingnews.com/files/images/blog_study-finds-perfluorohexyloctane-drops-significantly-reduce-dry-eye-symptoms.jpg https://ophthalmologybreakingnews.com/perfluorohexyloctane-drops-significantly-reduce-dry-eye-symptoms 2024-02-06T16:06:41+03:00 en https://ophthalmologybreakingnews.com/perfluorohexyloctane-drops-significantly-reduce-dry-eye-symptoms https://ophthalmologybreakingnews.com/files/images/blog_large-scale-study-provides-new-insights-into-rare-eye-disorders.jpg https://ophthalmologybreakingnews.com/large-scale-study-provides-new-insights-into-rare-eye-disorders 2023-10-19T15:03:52+03:00 en https://ophthalmologybreakingnews.com/large-scale-study-provides-new-insights-into-rare-eye-disorders https://ophthalmologybreakingnews.com/files/images/blog_top-10-ophthalmologists-of-all-time.jpg https://ophthalmologybreakingnews.com/top-10-ophthalmologists-of-all-time 2024-09-24T14:13:29+03:00 en https://ophthalmologybreakingnews.com/top-10-ophthalmologists-of-all-time https://ophthalmologybreakingnews.com/files/images/blog_what-is-heterochromia-in-the-eyes-and-how-to-deal-with-it.jpg https://ophthalmologybreakingnews.com/what-is-heterochromia-in-the-eyes-and-how-to-deal-with-it- 2023-05-25T14:39:35+03:00 en https://ophthalmologybreakingnews.com/what-is-heterochromia-in-the-eyes-and-how-to-deal-with-it- https://ophthalmologybreakingnews.com/files/images/blog_cataracts-causes-symptoms-and-treatment-options.jpg https://ophthalmologybreakingnews.com/cataracts--causes-symptoms-and-treatment-options 2023-09-26T16:32:51+03:00 en https://ophthalmologybreakingnews.com/cataracts--causes-symptoms-and-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_novartis-reportedly-starting-the-sale-of-some-ophthalmology-assets.jpg https://ophthalmologybreakingnews.com/novartis-reportedly-starting-the-sale-of-some-ophthalmology-assets 2023-10-19T14:54:47+03:00 en https://ophthalmologybreakingnews.com/novartis-reportedly-starting-the-sale-of-some-ophthalmology-assets https://ophthalmologybreakingnews.com/files/images/blog_ocular-synechiae-how-to-recognize-the-symptoms-and-seek-treatment.jpg https://ophthalmologybreakingnews.com/ocular-synechiae--how-to-recognize-the-symptoms-and-seek-treatment 2023-07-18T15:11:14+03:00 en https://ophthalmologybreakingnews.com/ocular-synechiae--how-to-recognize-the-symptoms-and-seek-treatment https://ophthalmologybreakingnews.com/files/images/blog_what-is-visual-snow-syndrome-and-how-to-deal-with-it.jpg https://ophthalmologybreakingnews.com/what-is-visual-snow-syndrome-and-how-to-deal-with-it- 2023-04-26T14:56:10+03:00 en https://ophthalmologybreakingnews.com/what-is-visual-snow-syndrome-and-how-to-deal-with-it- https://ophthalmologybreakingnews.com/files/images/blog_researchers-gene-therapy-for-retinitis-pigmentosa-shows-promise-in-early-testing.jpg https://ophthalmologybreakingnews.com/researchers-gene-therapy-for-retinitis-pigmentosa-shows-promise-in-early-testing 2023-03-14T13:20:07+03:00 en https://ophthalmologybreakingnews.com/researchers-gene-therapy-for-retinitis-pigmentosa-shows-promise-in-early-testing https://ophthalmologybreakingnews.com/files/images/blog_visionix-introduces-second-generation-vx-650-multimodal-screener-at-vision-expo-2023.jpg https://ophthalmologybreakingnews.com/visionix-introduces-second-generation-vx-650-multimodal-screener-at-vision-expo-2023 2023-03-14T10:01:04+03:00 en https://ophthalmologybreakingnews.com/visionix-introduces-second-generation-vx-650-multimodal-screener-at-vision-expo-2023 https://ophthalmologybreakingnews.com/files/images/blog_top-10-revolutionary-medical-devices-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/top-10-revolutionary-medical-devices-in-ophthalmology 2024-01-01T19:44:52+03:00 en https://ophthalmologybreakingnews.com/top-10-revolutionary-medical-devices-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_understanding-amblyopia-casues-symptoms-and-treatment.txt https://ophthalmologybreakingnews.com/understanding-amblyopia--casues-symptoms-and-treatment 2023-04-26T14:56:58+03:00 en https://ophthalmologybreakingnews.com/understanding-amblyopia--casues-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_how-to-heal-traumatic-eye-injuries-tips-and-techniques.jpg https://ophthalmologybreakingnews.com/how-to-heal-traumatic-eye-injuries--tips-and-techniques 2023-05-18T12:13:51+03:00 en https://ophthalmologybreakingnews.com/how-to-heal-traumatic-eye-injuries--tips-and-techniques https://ophthalmologybreakingnews.com/files/images/blog_clearing-the-fog-understanding-age-related-macular-degeneration-and-how-to-protect-your-eyesight.jpg https://ophthalmologybreakingnews.com/clearing-the-fog--understanding-age-related-macular-degeneration-and-how-to-protect-your-eyesight 2024-08-20T08:58:49+03:00 en https://ophthalmologybreakingnews.com/clearing-the-fog--understanding-age-related-macular-degeneration-and-how-to-protect-your-eyesight https://ophthalmologybreakingnews.com/files/images/blog_sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system.jpg https://ophthalmologybreakingnews.com/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system 2023-03-10T13:25:24+03:00 en https://ophthalmologybreakingnews.com/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system https://ophthalmologybreakingnews.com/files/images/blog_oertli-instrumente-announces-new-features-for-the-os-4-surgical-platform.jpg https://ophthalmologybreakingnews.com/oertli-instrumente-announces-new-features-for-the-os-4-surgical-platform 2024-02-09T10:35:18+03:00 en https://ophthalmologybreakingnews.com/oertli-instrumente-announces-new-features-for-the-os-4-surgical-platform https://ophthalmologybreakingnews.com/files/images/blog_macular-edema-causes-symptoms-and-treatment-options.jpg https://ophthalmologybreakingnews.com/macular-edema--causes-symptoms-and-treatment-options 2023-09-26T16:33:44+03:00 en https://ophthalmologybreakingnews.com/macular-edema--causes-symptoms-and-treatment-options https://ophthalmologybreakingnews.com/files/images/blog_dermolipoma-a-rare-benign-tumor-of-the-eye.jpg https://ophthalmologybreakingnews.com/dermolipoma--a-rare-benign-tumor-of-the-eye- 2023-05-08T09:05:43+03:00 en https://ophthalmologybreakingnews.com/dermolipoma--a-rare-benign-tumor-of-the-eye- https://ophthalmologybreakingnews.com/files/images/blog_pharmedica-usa-recalls-purely-soothing-15-msm-drops-due-to-non-sterility_1.jpg https://ophthalmologybreakingnews.com/pharmedica-usa-recalls-purely-soothing-15-msm-drops-due-to-non-sterility 2023-05-29T15:59:01+03:00 en https://ophthalmologybreakingnews.com/pharmedica-usa-recalls-purely-soothing-15-msm-drops-due-to-non-sterility https://ophthalmologybreakingnews.com/files/images/blog_top-10-innovations-in-contact-lens-technology.jpg https://ophthalmologybreakingnews.com/top-10-innovations-in-contact-lens-technology 2024-01-01T19:43:43+03:00 en https://ophthalmologybreakingnews.com/top-10-innovations-in-contact-lens-technology https://ophthalmologybreakingnews.com/files/images/blog_selagine-and-grifols-collaborate-on-immunoglobulin-eye-drops-for-ded.jpg https://ophthalmologybreakingnews.com/selagine-and-grifols-collaborate-on-immunoglobulin-eye-drops-for-ded- 2023-03-07T13:12:23+03:00 en https://ophthalmologybreakingnews.com/selagine-and-grifols-collaborate-on-immunoglobulin-eye-drops-for-ded- https://ophthalmologybreakingnews.com/files/images/blog_how-to-recognize-and-manage-symptoms-of-ghost-cell-glaucoma.jpg https://ophthalmologybreakingnews.com/how-to-recognize-and-manage-symptoms-of-ghost-cell-glaucoma 2023-05-08T10:10:42+03:00 en https://ophthalmologybreakingnews.com/how-to-recognize-and-manage-symptoms-of-ghost-cell-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_apotex-corp-voluntarily-recalls-brimonidine-tartrate-ophthalmic-solution.jpg https://ophthalmologybreakingnews.com/apotex-corp-voluntarily-recalls-brimonidine-tartrate-ophthalmic-solution 2023-03-07T08:54:20+03:00 en https://ophthalmologybreakingnews.com/apotex-corp-voluntarily-recalls-brimonidine-tartrate-ophthalmic-solution https://ophthalmologybreakingnews.com/files/images/blog_akorn-files-for-bankruptcy-closes-all-facilities-in-us.jpg https://ophthalmologybreakingnews.com/akorn-files-for-bankruptcy-closes-all-facilities-in-us- 2023-03-06T13:47:05+03:00 en https://ophthalmologybreakingnews.com/akorn-files-for-bankruptcy-closes-all-facilities-in-us- https://ophthalmologybreakingnews.com/files/images/blog_the-silent-thief-of-sight-all-you-need-to-know-about-glaucoma.jpg https://ophthalmologybreakingnews.com/the-silent-thief-of-sight-all-you-need-to-know-about-glaucoma 2024-02-16T11:05:24+03:00 en https://ophthalmologybreakingnews.com/the-silent-thief-of-sight-all-you-need-to-know-about-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_first-patient-enrolled-in-phase-3-clinical-trial-of-brm421-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/first-patient-enrolled-in-phase-3-clinical-trial-of-brm421-for-dry-eye-disease 2024-10-16T14:14:05+03:00 en https://ophthalmologybreakingnews.com/first-patient-enrolled-in-phase-3-clinical-trial-of-brm421-for-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_topcon-healthcare-and-ophtai-announce-partnership-for-artificial-intelligence.jpg https://ophthalmologybreakingnews.com/topcon-healthcare-and-ophtai-announce-partnership-for-artificial-intelligence- 2023-03-03T09:25:36+03:00 en https://ophthalmologybreakingnews.com/topcon-healthcare-and-ophtai-announce-partnership-for-artificial-intelligence- https://ophthalmologybreakingnews.com/files/images/blog_upgrade-your-vision-lasik-enhancement-for-improved-eyesight.jpg https://ophthalmologybreakingnews.com/upgrade-your-vision--lasik-enhancement-for-improved-eyesight 2023-09-26T16:35:46+03:00 en https://ophthalmologybreakingnews.com/upgrade-your-vision--lasik-enhancement-for-improved-eyesight https://ophthalmologybreakingnews.com/files/images/blog_top-10-eye-care-trends-to-watch-in-the-next-decade.jpg https://ophthalmologybreakingnews.com/top-10-eye-care-trends-to-watch-in-the-next-decade 2024-02-09T10:42:37+03:00 en https://ophthalmologybreakingnews.com/top-10-eye-care-trends-to-watch-in-the-next-decade https://ophthalmologybreakingnews.com/files/images/blog_jj-vision-receives-ce-mark-approval-for-the-elita-femtosecond-laser-system.jpg https://ophthalmologybreakingnews.com/jj-vision-receives-ce-mark-approval-for-the-elita-femtosecond-laser-system 2023-03-02T09:39:19+03:00 en https://ophthalmologybreakingnews.com/jj-vision-receives-ce-mark-approval-for-the-elita-femtosecond-laser-system https://ophthalmologybreakingnews.com/files/images/blog_transscleral-cyclophotocoagulation-an-alternative-to-traditional-glaucoma-surgery.jpg https://ophthalmologybreakingnews.com/transscleral-cyclophotocoagulation--an-alternative-to-traditional-glaucoma-surgery 2023-09-26T16:35:19+03:00 en https://ophthalmologybreakingnews.com/transscleral-cyclophotocoagulation--an-alternative-to-traditional-glaucoma-surgery https://ophthalmologybreakingnews.com/files/images/blog_mhra-issues-national-patient-safety-alert-for-nideks-eyecee-preloaded-iols.jpg https://ophthalmologybreakingnews.com/mhra-issues-national-patient-safety-alert-for-nideks-eyecee-preloaded-iols- 2023-08-11T10:03:23+03:00 en https://ophthalmologybreakingnews.com/mhra-issues-national-patient-safety-alert-for-nideks-eyecee-preloaded-iols- https://ophthalmologybreakingnews.com/files/images/blog_linkedin-poll-nearly-half-of-ophthalmologists-willing-to-use-ai-tools-in-patient-care.jpg https://ophthalmologybreakingnews.com/linkedin-poll--nearly-half-of-ophthalmologists-willing-to-use-ai-tools-in-patient-care 2023-05-09T09:37:04+03:00 en https://ophthalmologybreakingnews.com/linkedin-poll--nearly-half-of-ophthalmologists-willing-to-use-ai-tools-in-patient-care https://ophthalmologybreakingnews.com/files/images/blog_anisocoria-when-pupils-dont-play-by-the-same-rules.jpg https://ophthalmologybreakingnews.com/anisocoria--when-pupils-dont-play-by-the-same-rules 2023-09-14T16:00:50+03:00 en https://ophthalmologybreakingnews.com/anisocoria--when-pupils-dont-play-by-the-same-rules https://ophthalmologybreakingnews.com/files/images/blog_study-finds-amsler-grid-test-ineffective-for-diagnosing-neovascular-amd.jpg https://ophthalmologybreakingnews.com/study-finds-amsler-grid-test-ineffective-for-diagnosing-neovascular-amd 2023-02-28T13:43:07+03:00 en https://ophthalmologybreakingnews.com/study-finds-amsler-grid-test-ineffective-for-diagnosing-neovascular-amd https://ophthalmologybreakingnews.com/files/images/blog_dacryocystitis-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/dacryocystitis--causes-symptoms-and-treatment 2023-09-15T09:16:09+03:00 en https://ophthalmologybreakingnews.com/dacryocystitis--causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_the-dangers-of-plaquenil-understanding-retinal-toxicity.jpg https://ophthalmologybreakingnews.com/the-dangers-of-plaquenil--understanding-retinal-toxicity 2023-09-26T16:34:56+03:00 en https://ophthalmologybreakingnews.com/the-dangers-of-plaquenil--understanding-retinal-toxicity https://ophthalmologybreakingnews.com/files/images/blog_vision-correction-market-size-to-exceed-4125-billion-by-2031.jpg https://ophthalmologybreakingnews.com/vision-correction-market-size-to-exceed-$4125-billion-by-2031- 2023-02-27T15:37:34+03:00 en https://ophthalmologybreakingnews.com/vision-correction-market-size-to-exceed-$4125-billion-by-2031- https://ophthalmologybreakingnews.com/files/images/blog_all-about-amniotic-membrane-transplantation.jpg https://ophthalmologybreakingnews.com/all-about-amniotic-membrane-transplantation 2023-09-26T16:36:47+03:00 en https://ophthalmologybreakingnews.com/all-about-amniotic-membrane-transplantation https://ophthalmologybreakingnews.com/files/images/blog_restoring-vision-with-limbal-stem-cell-transplantation.jpg https://ophthalmologybreakingnews.com/restoring-vision-with-limbal-stem-cell-transplantation 2023-05-09T10:51:42+03:00 en https://ophthalmologybreakingnews.com/restoring-vision-with-limbal-stem-cell-transplantation https://ophthalmologybreakingnews.com/files/images/blog_understanding-epithelial-basement-membrane-dystrophy.jpg https://ophthalmologybreakingnews.com/understanding-epithelial-basement-membrane-dystrophy- 2023-09-26T16:37:34+03:00 en https://ophthalmologybreakingnews.com/understanding-epithelial-basement-membrane-dystrophy- https://ophthalmologybreakingnews.com/files/images/blog_uva-researchers-discover-potential-new-way-to-prevent-vision-loss.jpg https://ophthalmologybreakingnews.com/uva-researchers-discover-potential-new-way-to-prevent-vision-loss 2023-02-23T14:00:10+03:00 en https://ophthalmologybreakingnews.com/uva-researchers-discover-potential-new-way-to-prevent-vision-loss https://ophthalmologybreakingnews.com/files/images/blog_fda-extends-warning-on-eye-care-products-to-include-delsam-pharmas-artificial-eye-ointment.jpg https://ophthalmologybreakingnews.com/fda-extends-warning-on-eye-care-products-to-include-delsam-pharmas-artificial-eye-ointment- 2024-10-15T08:58:00+03:00 en https://ophthalmologybreakingnews.com/fda-extends-warning-on-eye-care-products-to-include-delsam-pharmas-artificial-eye-ointment- https://ophthalmologybreakingnews.com/files/images/blog_the-link-between-covid-19-vaccines-and-ocular-inflammation.jpg https://ophthalmologybreakingnews.com/the-link-between-covid-19-vaccines-and-ocular-inflammation- 2025-02-04T15:13:06+03:00 en https://ophthalmologybreakingnews.com/the-link-between-covid-19-vaccines-and-ocular-inflammation- https://ophthalmologybreakingnews.com/files/images/blog_telescopic-contact-lenses-innovative-solutions-for-vision-impairment.jpg https://ophthalmologybreakingnews.com/telescopic-contact-lenses--innovative-solutions-for-vision-impairment 2024-09-24T14:35:30+03:00 en https://ophthalmologybreakingnews.com/telescopic-contact-lenses--innovative-solutions-for-vision-impairment https://ophthalmologybreakingnews.com/files/images/blog_european-parliament-extends-mdr-compliance-timeline-to-2027-2028.jpg https://ophthalmologybreakingnews.com/european-parliament-extends-mdr-compliance-timeline-to-2027-2028- 2023-02-21T13:38:44+03:00 en https://ophthalmologybreakingnews.com/european-parliament-extends-mdr-compliance-timeline-to-2027-2028- https://ophthalmologybreakingnews.com/files/images/blog_global-ophthalmology-market-expected-to-surpass-84-billion-by-2030.jpg https://ophthalmologybreakingnews.com/global-ophthalmology-market-expected-to-surpass-$84-billion-by-2030 2023-05-18T12:09:15+03:00 en https://ophthalmologybreakingnews.com/global-ophthalmology-market-expected-to-surpass-$84-billion-by-2030 https://ophthalmologybreakingnews.com/files/images/blog_alcon-launches-alcon-experience-academy-app-to-expand-on-demand-learning.jpg https://ophthalmologybreakingnews.com/alcon-launches-alcon-experience-academy-app-to-expand-on-demand-learning 2023-09-15T09:24:10+03:00 en https://ophthalmologybreakingnews.com/alcon-launches-alcon-experience-academy-app-to-expand-on-demand-learning https://ophthalmologybreakingnews.com/files/images/blog_open-angle-glaucoma.jpg https://ophthalmologybreakingnews.com/open-angle-glaucoma 2023-09-26T16:37:56+03:00 en https://ophthalmologybreakingnews.com/open-angle-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_ophthalmology-experts-say-ai-for-diagnosis-and-treatment-is-the-next-big-thing.jpg https://ophthalmologybreakingnews.com/ophthalmology-experts-say-ai-for-diagnosis-and-treatment-is-the-next-big-thing 2023-05-09T09:46:56+03:00 en https://ophthalmologybreakingnews.com/ophthalmology-experts-say-ai-for-diagnosis-and-treatment-is-the-next-big-thing https://ophthalmologybreakingnews.com/files/images/blog_man-loses-sight-in-one-eye-after-sleeping-in-lenses.jpg https://ophthalmologybreakingnews.com/man-loses-sight-in-one-eye-after-sleeping-in-lenses 2023-05-09T09:19:58+03:00 en https://ophthalmologybreakingnews.com/man-loses-sight-in-one-eye-after-sleeping-in-lenses https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-apellis-syfovre-as-first-and-only-treatment-for-geographic-atrophy.jpg https://ophthalmologybreakingnews.com/fda-approves-apellis-syfovre-as-first-and-only-treatment-for-geographic-atrophy 2023-03-13T09:08:57+03:00 en https://ophthalmologybreakingnews.com/fda-approves-apellis-syfovre-as-first-and-only-treatment-for-geographic-atrophy https://ophthalmologybreakingnews.com/files/images/blog_what-is-posterior-capsular-opacification.jpg https://ophthalmologybreakingnews.com/what-is-posterior-capsular-opacification 2023-09-26T16:19:41+03:00 en https://ophthalmologybreakingnews.com/what-is-posterior-capsular-opacification https://ophthalmologybreakingnews.com/files/images/blog_frontera-therapeutics-doses-first-patient-in-a-trial-of-ft-002-gene-therapy-for-treatment-of-x-linked-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/frontera-therapeutics-doses-first-patient-in-a-trial-of-ft-002-gene-therapy-for-treatment-of-x-linked-retinitis-pigmentosa 2023-02-17T13:28:58+03:00 en https://ophthalmologybreakingnews.com/frontera-therapeutics-doses-first-patient-in-a-trial-of-ft-002-gene-therapy-for-treatment-of-x-linked-retinitis-pigmentosa https://ophthalmologybreakingnews.com/files/images/blog_how-smartphone-screens-are-affecting-your-vision.jpg https://ophthalmologybreakingnews.com/how-smartphone-screens-are-affecting-your-vision 2023-04-26T13:36:40+03:00 en https://ophthalmologybreakingnews.com/how-smartphone-screens-are-affecting-your-vision https://ophthalmologybreakingnews.com/files/images/blog_the-most-common-eye-allergies-and-treatments.jpg https://ophthalmologybreakingnews.com/the-most-common-eye-allergies-and-treatments 2023-05-05T14:09:46+03:00 en https://ophthalmologybreakingnews.com/the-most-common-eye-allergies-and-treatments https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-navigation-function-for-3d-printed-smart-contact-lens.jpg https://ophthalmologybreakingnews.com/navigation-function-for-3d-printed-smart-contact-lens 2023-03-03T16:19:48+03:00 en https://ophthalmologybreakingnews.com/navigation-function-for-3d-printed-smart-contact-lens https://ophthalmologybreakingnews.com/files/images/blog_fda-issues-warning-letter-to-righteye-for-misbranding-and-adulteration-of-its-vision-system.jpg https://ophthalmologybreakingnews.com/fda-issues-warning-letter-to-righteye-for-misbranding-and-adulteration-of-its-vision-system- 2023-02-15T10:22:24+03:00 en https://ophthalmologybreakingnews.com/fda-issues-warning-letter-to-righteye-for-misbranding-and-adulteration-of-its-vision-system- https://ophthalmologybreakingnews.com/files/images/blog_panuveitis-a-rare-but-serious-eye-inflammation.jpg https://ophthalmologybreakingnews.com/panuveitis--a-rare-but-serious-eye-inflammation 2023-04-26T15:17:31+03:00 en https://ophthalmologybreakingnews.com/panuveitis--a-rare-but-serious-eye-inflammation https://ophthalmologybreakingnews.com/files/images/blog_bruder-becomes-exclusive-licensor-of-the-dry-eye-drink.jpg https://ophthalmologybreakingnews.com/bruder-becomes-exclusive-licensor-of-the-dry-eye-drink 2023-02-14T09:47:46+03:00 en https://ophthalmologybreakingnews.com/bruder-becomes-exclusive-licensor-of-the-dry-eye-drink https://ophthalmologybreakingnews.com/files/images/blog_the-dark-side-of-the-eye-understanding-scleral-melanocytosis.jpg https://ophthalmologybreakingnews.com/the-dark-side-of-the-eye--understanding-scleral-melanocytosis 2023-07-13T15:07:52+03:00 en https://ophthalmologybreakingnews.com/the-dark-side-of-the-eye--understanding-scleral-melanocytosis https://ophthalmologybreakingnews.com/files/images/blog_alcon-resolves-eye-surgery-device-dispute-with-jj-vision-agrees-to-pay-199-million.jpg https://ophthalmologybreakingnews.com/alcon-resolves-eye-surgery-device-dispute-with-jj-vision-agrees-to-pay-$199-million- 2023-02-13T09:02:45+03:00 en https://ophthalmologybreakingnews.com/alcon-resolves-eye-surgery-device-dispute-with-jj-vision-agrees-to-pay-$199-million- https://ophthalmologybreakingnews.com/files/images/blog_emmetropia-the-gold-standard-of-eye-health.jpg https://ophthalmologybreakingnews.com/emmetropia--the-gold-standard-of-eye-health 2023-09-15T10:40:30+03:00 en https://ophthalmologybreakingnews.com/emmetropia--the-gold-standard-of-eye-health https://ophthalmologybreakingnews.com/files/images/blog_complement-therapeutics-enrolls-first-patient-in-i-gain-study-of-people-diagnosed-with-ga.jpg https://ophthalmologybreakingnews.com/complement-therapeutics-enrolls-first-patient-in-i-gain-study-of-people-diagnosed-with-ga 2023-02-10T08:45:05+03:00 en https://ophthalmologybreakingnews.com/complement-therapeutics-enrolls-first-patient-in-i-gain-study-of-people-diagnosed-with-ga https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-regenerons-eylear-injection-as-the-first-pharmacologic-treatment-for-retinopathy-of-prematurity.jpg https://ophthalmologybreakingnews.com/fda-approves-regenerons-eylea®-injection-as-the-first-pharmacologic-treatment-for-retinopathy-of-prematurity- 2023-02-10T07:52:52+03:00 en https://ophthalmologybreakingnews.com/fda-approves-regenerons-eylea®-injection-as-the-first-pharmacologic-treatment-for-retinopathy-of-prematurity- https://ophthalmologybreakingnews.com/files/images/blog_endogena-therapeutics-receives-fda-fast-track-designation-for-treatment-of-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/endogena-therapeutics-receives-fda-fast-track-designation-for-treatment-of-retinitis-pigmentosa 2023-02-08T14:48:26+03:00 en https://ophthalmologybreakingnews.com/endogena-therapeutics-receives-fda-fast-track-designation-for-treatment-of-retinitis-pigmentosa https://ophthalmologybreakingnews.com/files/images/blog_arcus-senilis-understanding-causes-symptoms-and-treatment.jpg https://ophthalmologybreakingnews.com/arcus-senilis--understanding-causes-symptoms-and-treatment 2023-04-26T15:18:19+03:00 en https://ophthalmologybreakingnews.com/arcus-senilis--understanding-causes-symptoms-and-treatment https://ophthalmologybreakingnews.com/files/images/blog_nidek-launches-cube-alpha-ophthalmic-surgical-system.jpg https://ophthalmologybreakingnews.com/nidek-launches-cube-alpha-ophthalmic-surgical-system 2023-02-07T09:53:24+03:00 en https://ophthalmologybreakingnews.com/nidek-launches-cube-alpha-ophthalmic-surgical-system https://ophthalmologybreakingnews.com/files/images/blog_tracey-technologies-announces-new-features-for-itrace-aberrometer.jpg https://ophthalmologybreakingnews.com/tracey-technologies-announces-new-features-for-itrace-aberrometer 2023-05-09T09:49:30+03:00 en https://ophthalmologybreakingnews.com/tracey-technologies-announces-new-features-for-itrace-aberrometer https://ophthalmologybreakingnews.com/files/images/blog_global-pharma-healthcare-issues-nationwide-recall-of-ezricare-artificial-tears.jpg https://ophthalmologybreakingnews.com/global-pharma-healthcare-issues-nationwide-recall-of-ezricare-artificial-tears- 2024-10-15T08:59:23+03:00 en https://ophthalmologybreakingnews.com/global-pharma-healthcare-issues-nationwide-recall-of-ezricare-artificial-tears- https://ophthalmologybreakingnews.com/files/images/blog_nidek-and-hoya-vision-care-establish-global-partnership.jpg https://ophthalmologybreakingnews.com/nidek-and-hoya-vision-care-establish-global-partnership 2023-02-03T09:08:18+03:00 en https://ophthalmologybreakingnews.com/nidek-and-hoya-vision-care-establish-global-partnership https://ophthalmologybreakingnews.com/files/images/blog_symblepharon-the-adhesion-that-impacts-vision_1.jpg https://ophthalmologybreakingnews.com/symblepharon--the-adhesion-that-impacts-vision 2024-07-01T16:32:23+03:00 en https://ophthalmologybreakingnews.com/symblepharon--the-adhesion-that-impacts-vision https://ophthalmologybreakingnews.com/files/images/blog_therapeutic-contact-lenses-market-projected-to-reach-new-heights-by-2033_1.jpg https://ophthalmologybreakingnews.com/therapeutic-contact-lenses-market-projected-to-reach-new-heights-by-2033 2024-10-15T16:18:16+03:00 en https://ophthalmologybreakingnews.com/therapeutic-contact-lenses-market-projected-to-reach-new-heights-by-2033 https://ophthalmologybreakingnews.com/files/images/blog_a-guide-to-understanding-foster-kennedy-syndrome.jpg https://ophthalmologybreakingnews.com/a-guide-to-understanding-foster-kennedy-syndrome 2023-04-26T15:18:37+03:00 en https://ophthalmologybreakingnews.com/a-guide-to-understanding-foster-kennedy-syndrome https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-smart-contact-lens-that-can-diagnose-and-treat-glaucoma.jpg https://ophthalmologybreakingnews.com/researchers-develop-smart-contact-lens-that-can-diagnose-and-treat-glaucoma 2023-02-02T08:48:41+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-smart-contact-lens-that-can-diagnose-and-treat-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_top-10-myths-about-eye-health-and-vision-debunked.jpg https://ophthalmologybreakingnews.com/top-10-myths-about-eye-health-and-vision-debunked- 2024-01-01T19:57:10+03:00 en https://ophthalmologybreakingnews.com/top-10-myths-about-eye-health-and-vision-debunked- https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-and-modulight-announce-fda-approval-of-photodynamic-laser-for-use-with-visudyner.jpg https://ophthalmologybreakingnews.com/bausch--lomb-and-modulight-announce-fda-approval-of-photodynamic-laser-for-use-with-visudyne® 2023-02-01T16:13:59+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-and-modulight-announce-fda-approval-of-photodynamic-laser-for-use-with-visudyne® https://ophthalmologybreakingnews.com/files/images/blog_the-link-between-diabetes-and-intraretinal-microvascular-abnormalities.jpg https://ophthalmologybreakingnews.com/the-link-between-diabetes-and-intraretinal-microvascular-abnormalities 2023-04-26T13:38:09+03:00 en https://ophthalmologybreakingnews.com/the-link-between-diabetes-and-intraretinal-microvascular-abnormalities https://ophthalmologybreakingnews.com/files/images/blog_from-diagnosis-to-management-navigating-chorioretinitis.jpg https://ophthalmologybreakingnews.com/from-diagnosis-to-management--navigating-chorioretinitis 2023-05-09T10:48:45+03:00 en https://ophthalmologybreakingnews.com/from-diagnosis-to-management--navigating-chorioretinitis https://ophthalmologybreakingnews.com/files/images/blog_global-intraocular-lens-market-to-reach-67-billion-by-2032-fmr-report-shows.jpg https://ophthalmologybreakingnews.com/global-intraocular-lens-market-to-reach-$67-billion-by-2032-fmr-report-shows- 2023-01-31T15:43:58+03:00 en https://ophthalmologybreakingnews.com/global-intraocular-lens-market-to-reach-$67-billion-by-2032-fmr-report-shows- https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-contact-lens-to-prevent-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/researchers-develop-contact-lens-to-prevent-dry-eye-disease 2023-05-09T09:06:12+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-contact-lens-to-prevent-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_the-contagious-conjunctivitis-understanding-madras-eye-disease.jpg https://ophthalmologybreakingnews.com/the-contagious-conjunctivitis--understanding-madras-eye-disease 2023-07-17T13:42:27+03:00 en https://ophthalmologybreakingnews.com/the-contagious-conjunctivitis--understanding-madras-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-negative-effect-of-atropine-drops-after-glaucoma-surgery.jpg https://ophthalmologybreakingnews.com/negative-effect-of-atropine-drops-after-glaucoma-surgery 2024-02-06T16:08:00+03:00 en https://ophthalmologybreakingnews.com/negative-effect-of-atropine-drops-after-glaucoma-surgery https://ophthalmologybreakingnews.com/files/images/blog_youtube-star-helps-1000-people-see-again-by-sponsoring-cataract-surgeries.jpg https://ophthalmologybreakingnews.com/youtube-star-helps-1000-people-see-again-by-sponsoring-cataract-surgeries- 2023-04-26T09:51:12+03:00 en https://ophthalmologybreakingnews.com/youtube-star-helps-1000-people-see-again-by-sponsoring-cataract-surgeries- https://ophthalmologybreakingnews.com/files/images/blog_the-human-hand-vs-the-robotic-arm-the-debate-over-cataract-surgery.jpg https://ophthalmologybreakingnews.com/the-human-hand-vs-the-robotic-arm--the-debate-over-cataract-surgery 2023-05-09T08:24:12+03:00 en https://ophthalmologybreakingnews.com/the-human-hand-vs-the-robotic-arm--the-debate-over-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_the-bright-side-of-winter-understanding-snow-blindness.jpg https://ophthalmologybreakingnews.com/the-bright-side-of-winter--understanding-snow-blindness 2023-09-14T15:58:56+03:00 en https://ophthalmologybreakingnews.com/the-bright-side-of-winter--understanding-snow-blindness https://ophthalmologybreakingnews.com/files/images/blog_regeneron-wins-patent-case-against-novartis-for-its-eye-drug-eylea.jpg https://ophthalmologybreakingnews.com/regeneron-wins-patent-case-against-novartis-for-its-eye-drug-eylea- 2023-01-27T13:34:29+03:00 en https://ophthalmologybreakingnews.com/regeneron-wins-patent-case-against-novartis-for-its-eye-drug-eylea- https://ophthalmologybreakingnews.com/files/images/blog_seeing-spots-the-causes-and-symptoms-of-asteroid-hyalosis.jpg https://ophthalmologybreakingnews.com/seeing-spots--the-causes-and-symptoms-of-asteroid-hyalosis 2023-05-09T08:25:00+03:00 en https://ophthalmologybreakingnews.com/seeing-spots--the-causes-and-symptoms-of-asteroid-hyalosis https://ophthalmologybreakingnews.com/files/images/blog_phlyctenular-conjunctivitis-a-guide-to-managing-the-condition.jpg https://ophthalmologybreakingnews.com/phlyctenular-conjunctivitis--a-guide-to-managing-the-condition 2023-04-26T15:19:41+03:00 en https://ophthalmologybreakingnews.com/phlyctenular-conjunctivitis--a-guide-to-managing-the-condition https://ophthalmologybreakingnews.com/files/images/blog_corcoran-consulting-and-conclusn-develop-application-for-ophthalmology-practice-management.jpg https://ophthalmologybreakingnews.com/corcoran-consulting-and-conclusn-develop-application-for-ophthalmology-practice-management 2023-01-26T12:26:10+03:00 en https://ophthalmologybreakingnews.com/corcoran-consulting-and-conclusn-develop-application-for-ophthalmology-practice-management https://ophthalmologybreakingnews.com/files/images/blog_fda-accepts-oxulars-ind-application-for-the-treatment-of-diabetic-macular-edema.jpg https://ophthalmologybreakingnews.com/fda-accepts-oxulars-ind-for-the-treatment-of-diabetic-macular-edema 2024-10-21T09:35:02+03:00 en https://ophthalmologybreakingnews.com/fda-accepts-oxulars-ind-for-the-treatment-of-diabetic-macular-edema https://ophthalmologybreakingnews.com/files/images/blog_ophthalmologists-report-a-fungal-endophthalmitis-outbreak-after-cataract-surgery-in-s-korea.jpg https://ophthalmologybreakingnews.com/ophthalmologists-report-a-fungal-endophthalmitis-outbreak-after-cataract-surgery-in-s-korea- 2023-03-02T15:53:10+03:00 en https://ophthalmologybreakingnews.com/ophthalmologists-report-a-fungal-endophthalmitis-outbreak-after-cataract-surgery-in-s-korea- https://ophthalmologybreakingnews.com/files/images/blog_tfs-healthscience-acquires-appletree-ci-group-expanding-presence-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/tfs-healthscience-acquires-appletree-ci-group-expanding-presence-in-ophthalmology 2023-01-25T11:05:39+03:00 en https://ophthalmologybreakingnews.com/tfs-healthscience-acquires-appletree-ci-group-expanding-presence-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_preventing-blindness-in-newborns-a-look-at-ophthalmia-neonatorum.jpg https://ophthalmologybreakingnews.com/preventing-blindness-in-newborns--a-look-at-ophthalmia-neonatorum 2024-11-13T09:41:52+03:00 en https://ophthalmologybreakingnews.com/preventing-blindness-in-newborns--a-look-at-ophthalmia-neonatorum https://ophthalmologybreakingnews.com/files/images/blog_all-about-choroidal-hemangioma-what-you-need-to-know.jpg https://ophthalmologybreakingnews.com/all-about-choroidal-hemangioma--what-you-need-to-know 2023-05-09T10:54:16+03:00 en https://ophthalmologybreakingnews.com/all-about-choroidal-hemangioma--what-you-need-to-know https://ophthalmologybreakingnews.com/files/images/blog_the-dark-side-of-genetics-the-impact-of-lowe-syndrome.jpg https://ophthalmologybreakingnews.com/the-dark-side-of-genetics--the-impact-of-lowe-syndrome 2023-09-14T16:11:10+03:00 en https://ophthalmologybreakingnews.com/the-dark-side-of-genetics--the-impact-of-lowe-syndrome https://ophthalmologybreakingnews.com/files/images/blog_neuroscientists-discover-a-small-molecule-that-restores-visual-function-after-optic-nerve-injury.jpg https://ophthalmologybreakingnews.com/neuroscientists-discover-a-small-molecule-that-restores-visual-function-after-optic-nerve-injury 2023-03-03T16:16:06+03:00 en https://ophthalmologybreakingnews.com/neuroscientists-discover-a-small-molecule-that-restores-visual-function-after-optic-nerve-injury https://ophthalmologybreakingnews.com/files/images/blog_the-importance-of-selenium-in-maintaining-eye-health-and-vision.jpg https://ophthalmologybreakingnews.com/the-importance-of-selenium-in-maintaining-eye-health-and-vision 2023-04-26T13:40:25+03:00 en https://ophthalmologybreakingnews.com/the-importance-of-selenium-in-maintaining-eye-health-and-vision https://ophthalmologybreakingnews.com/files/images/blog_panophthalmitis-a-sight-threatening-infection.jpg https://ophthalmologybreakingnews.com/panophthalmitis--a-sight-threatening-infection 2023-04-26T13:40:42+03:00 en https://ophthalmologybreakingnews.com/panophthalmitis--a-sight-threatening-infection https://ophthalmologybreakingnews.com/files/images/blog_the-illusion-of-crossed-eyes-understanding-pseudostrabismus.jpg https://ophthalmologybreakingnews.com/the-illusion-of-crossed-eyes--understanding-pseudostrabismus 2023-05-09T09:03:56+03:00 en https://ophthalmologybreakingnews.com/the-illusion-of-crossed-eyes--understanding-pseudostrabismus https://ophthalmologybreakingnews.com/files/images/blog_battling-reimbursement-challenges-the-largest-problem-faced-by-ophthalmologists-today.jpg https://ophthalmologybreakingnews.com/battling-reimbursement-challenges--the-largest-problem-faced-by-ophthalmologists-today 2024-09-24T14:34:27+03:00 en https://ophthalmologybreakingnews.com/battling-reimbursement-challenges--the-largest-problem-faced-by-ophthalmologists-today https://ophthalmologybreakingnews.com/files/images/blog_periorbital-cellulitis-the-role-of-antibiotics-in-treatment.jpg https://ophthalmologybreakingnews.com/periorbital-cellulitis--the-role-of-antibiotics-in-treatment 2023-05-09T08:59:13+03:00 en https://ophthalmologybreakingnews.com/periorbital-cellulitis--the-role-of-antibiotics-in-treatment https://ophthalmologybreakingnews.com/files/images/blog_meibomian-gland-dysfunction-more-than-just-dry-eyes.jpg https://ophthalmologybreakingnews.com/meibomian-gland-dysfunction--more-than-just-dry-eyes 2024-02-20T11:51:57+03:00 en https://ophthalmologybreakingnews.com/meibomian-gland-dysfunction--more-than-just-dry-eyes https://ophthalmologybreakingnews.com/files/images/blog_stada-and-xbrane-receive-british-approval-for-ximlucir-ranibizumab-n-a-biosimilar-referencing-lucentisr.jpg https://ophthalmologybreakingnews.com/stada-and-xbrane-receive-british-approval-for-ximluci®-ranibizumab-–-a-biosimilar-referencing-lucentis® 2023-01-17T16:30:59+03:00 en https://ophthalmologybreakingnews.com/stada-and-xbrane-receive-british-approval-for-ximluci®-ranibizumab-–-a-biosimilar-referencing-lucentis® https://ophthalmologybreakingnews.com/files/images/blog_living-in-the-dark-a-look-into-leber-congenital-amaurosis.jpg https://ophthalmologybreakingnews.com/living-in-the-dark--a-look-into-leber-congenital-amaurosis- 2023-10-19T14:50:47+03:00 en https://ophthalmologybreakingnews.com/living-in-the-dark--a-look-into-leber-congenital-amaurosis- https://ophthalmologybreakingnews.com/files/images/blog_uncovering-the-link-between-xerophthalmia-and-vitamin-a-deficiency.jpg https://ophthalmologybreakingnews.com/uncovering-the-link-between-xerophthalmia-and-vitamin-a-deficiency 2023-05-09T09:41:01+03:00 en https://ophthalmologybreakingnews.com/uncovering-the-link-between-xerophthalmia-and-vitamin-a-deficiency https://ophthalmologybreakingnews.com/files/images/blog_a-rare-disease-that-attacks-the-cornea-thygesons-superficial-punctate-keratitis.jpg https://ophthalmologybreakingnews.com/a-rare-disease-that-attacks-the-cornea--thygesons-superficial-punctate-keratitis 2023-05-09T09:29:14+03:00 en https://ophthalmologybreakingnews.com/a-rare-disease-that-attacks-the-cornea--thygesons-superficial-punctate-keratitis https://ophthalmologybreakingnews.com/files/images/blog_glaukos-idose-tr-implant-demonstrates-favorable-safety-and-tolerability-profile.jpg https://ophthalmologybreakingnews.com/glaukos--idose-tr-implant-demonstrates-favorable-safety-and-tolerability-profile- 2023-01-16T11:40:44+03:00 en https://ophthalmologybreakingnews.com/glaukos--idose-tr-implant-demonstrates-favorable-safety-and-tolerability-profile- https://ophthalmologybreakingnews.com/files/images/blog_a-comprehensive-guide-to-the-tritan-color-blindness.jpg https://ophthalmologybreakingnews.com/a-comprehensive-guide-to-the-tritan-color-blindness 2023-05-09T10:07:51+03:00 en https://ophthalmologybreakingnews.com/a-comprehensive-guide-to-the-tritan-color-blindness https://ophthalmologybreakingnews.com/files/images/blog_sudden-vision-loss-a-medical-emergency.jpg https://ophthalmologybreakingnews.com/sudden-vision-loss--a-medical-emergency 2023-05-09T08:33:21+03:00 en https://ophthalmologybreakingnews.com/sudden-vision-loss--a-medical-emergency https://ophthalmologybreakingnews.com/files/images/blog_researchers-develop-first-criteria-to-diagnose-optic-neuritis.jpg https://ophthalmologybreakingnews.com/researchers-develop-first-criteria-to-diagnose-optic-neuritis 2023-05-18T12:06:51+03:00 en https://ophthalmologybreakingnews.com/researchers-develop-first-criteria-to-diagnose-optic-neuritis https://ophthalmologybreakingnews.com/files/images/blog_balint-syndrome-a-neurological-condition-causing-visual-dysfunction.jpg https://ophthalmologybreakingnews.com/balint-syndrome--a-neurological-condition-causing-visual-dysfunction-- 2023-05-09T10:53:09+03:00 en https://ophthalmologybreakingnews.com/balint-syndrome--a-neurological-condition-causing-visual-dysfunction-- https://ophthalmologybreakingnews.com/files/images/blog_retinoblastoma-a-rare-type-of-eye-cancer-affecting-children.jpg https://ophthalmologybreakingnews.com/retinoblastoma--a-rare-type-of-eye-cancer-affecting-children- 2023-05-09T09:35:54+03:00 en https://ophthalmologybreakingnews.com/retinoblastoma--a-rare-type-of-eye-cancer-affecting-children- https://ophthalmologybreakingnews.com/files/images/blog_market-scope-refractive-market-growth-will-reach-12-billion-driven-by-lens-based-procedures.jpg https://ophthalmologybreakingnews.com/market-scope--refractive-market-growth-will-reach-$12-billion-driven-by-lens-based-procedures 2023-05-09T10:49:57+03:00 en https://ophthalmologybreakingnews.com/market-scope--refractive-market-growth-will-reach-$12-billion-driven-by-lens-based-procedures https://ophthalmologybreakingnews.com/files/images/blog_what-is-binocular-vision-dysfunction-and-how-to-treat-it_1.jpg https://ophthalmologybreakingnews.com/what-is-binocular-vision-dysfunction-and-how-to-treat-it- 2024-10-21T09:39:51+03:00 en https://ophthalmologybreakingnews.com/what-is-binocular-vision-dysfunction-and-how-to-treat-it- https://ophthalmologybreakingnews.com/files/images/blog_eales-disease-causes-symptoms-treatment.jpg https://ophthalmologybreakingnews.com/eales-disease--causes-symptoms-treatment- 2023-09-15T09:25:19+03:00 en https://ophthalmologybreakingnews.com/eales-disease--causes-symptoms-treatment- https://ophthalmologybreakingnews.com/files/images/blog_novartis-ceo-refutes-rumors-for-ophthalmology-unit-sell-off.jpg https://ophthalmologybreakingnews.com/novartis-ceo-refutes-rumors-for-ophthalmology-unit-sell-off- 2023-10-19T14:55:37+03:00 en https://ophthalmologybreakingnews.com/novartis-ceo-refutes-rumors-for-ophthalmology-unit-sell-off- https://ophthalmologybreakingnews.com/files/images/blog_sifi-signs-license-agreement-with-avanzanite-for-acanthamoeba-keratitis-treatment-akantior.jpg https://ophthalmologybreakingnews.com/category/sifi-signs-license-agreement-with-avanzanite-for-acanthamoeba-keratitis-treatment-akantior 2023-01-11T15:37:28+03:00 en https://ophthalmologybreakingnews.com/category/sifi-signs-license-agreement-with-avanzanite-for-acanthamoeba-keratitis-treatment-akantior https://ophthalmologybreakingnews.com/files/images/blog_can-birth-control-affect-eyesight.jpg https://ophthalmologybreakingnews.com/can-birth-control-affect-eyesight- 2023-09-26T13:51:21+03:00 en https://ophthalmologybreakingnews.com/can-birth-control-affect-eyesight- https://ophthalmologybreakingnews.com/files/images/blog_understanding-managing-ocular-migraines_1.jpg https://ophthalmologybreakingnews.com/understanding--managing-ocular-migraines- 2023-05-25T14:56:17+03:00 en https://ophthalmologybreakingnews.com/understanding--managing-ocular-migraines- https://ophthalmologybreakingnews.com/files/images/blog_fci-ophthalmics-launches-ezypor-polyethylene-orbital-implant-in-the-us.jpg https://ophthalmologybreakingnews.com/fci-ophthalmics-launches-ezypor-polyethylene-orbital-implant-in-the-us 2023-09-05T13:45:57+03:00 en https://ophthalmologybreakingnews.com/fci-ophthalmics-launches-ezypor-polyethylene-orbital-implant-in-the-us https://ophthalmologybreakingnews.com/files/images/blog_scleritis-scleritis-a-rare-but-blinding-eye-disease.jpg https://ophthalmologybreakingnews.com/scleritis--scleritis--a-rare-but-blinding-eye-disease-- 2023-04-26T15:21:47+03:00 en https://ophthalmologybreakingnews.com/scleritis--scleritis--a-rare-but-blinding-eye-disease-- https://ophthalmologybreakingnews.com/files/images/blog_chloramphenicol-eye-drops-when-and-how-to-use-it.jpg https://ophthalmologybreakingnews.com/chloramphenicol-eye-drops---when-and-how-to-use-it 2023-04-26T13:43:50+03:00 en https://ophthalmologybreakingnews.com/chloramphenicol-eye-drops---when-and-how-to-use-it https://ophthalmologybreakingnews.com/files/images/blog_viatris-closes-acquisitions-of-oyster-point-and-famy-life-sciences-to-establish-new-eye-care-division.jpg https://ophthalmologybreakingnews.com/viatris-closes-acquisitions-of-oyster-point-and-famy-life-sciences-to-establish-new-eye-care-division 2023-01-12T14:18:13+03:00 en https://ophthalmologybreakingnews.com/viatris-closes-acquisitions-of-oyster-point-and-famy-life-sciences-to-establish-new-eye-care-division https://ophthalmologybreakingnews.com/files/images/blog_what-is-diplopia-disorder-and-how-to-deal-with-it.jpg https://ophthalmologybreakingnews.com/what-is-diplopia-disorder-and-how-to-deal-with-it- 2023-04-26T15:22:04+03:00 en https://ophthalmologybreakingnews.com/what-is-diplopia-disorder-and-how-to-deal-with-it- https://ophthalmologybreakingnews.com/files/images/blog_elios-vision-receives-registration-of-elios-in-the-united-kingdom.jpg https://ophthalmologybreakingnews.com/elios-vision-receives-registration-of-elios-in-the-united-kingdom 2023-01-06T14:41:19+03:00 en https://ophthalmologybreakingnews.com/elios-vision-receives-registration-of-elios-in-the-united-kingdom https://ophthalmologybreakingnews.com/files/images/blog_harrows-fortisite-formulations-are-now-available-for-in-office-use.jpg https://ophthalmologybreakingnews.com/harrows-fortisite-formulations-are-now-available-for-in-office-use- 2023-01-06T09:35:04+03:00 en https://ophthalmologybreakingnews.com/harrows-fortisite-formulations-are-now-available-for-in-office-use- https://ophthalmologybreakingnews.com/files/images/blog_5-simple-ways-to-prevent-vernal-conjunctivitis.jpg https://ophthalmologybreakingnews.com/5-simple-ways-to-prevent-vernal-conjunctivitis 2023-04-26T15:22:20+03:00 en https://ophthalmologybreakingnews.com/5-simple-ways-to-prevent-vernal-conjunctivitis https://ophthalmologybreakingnews.com/files/images/blog_what-is-surfers-eye.jpg https://ophthalmologybreakingnews.com/what-is-surfers-eye 2023-04-26T13:44:08+03:00 en https://ophthalmologybreakingnews.com/what-is-surfers-eye https://ophthalmologybreakingnews.com/files/images/blog_orbital-lymphoma.jpg https://ophthalmologybreakingnews.com/orbital-lymphoma 2023-04-26T15:22:35+03:00 en https://ophthalmologybreakingnews.com/orbital-lymphoma https://ophthalmologybreakingnews.com/files/images/blog_charles-bonnet-syndrome-cbs-children.jpg https://ophthalmologybreakingnews.com/charles-bonnet-syndrome-cbs--children 2023-04-26T11:19:23+03:00 en https://ophthalmologybreakingnews.com/charles-bonnet-syndrome-cbs--children https://ophthalmologybreakingnews.com/files/images/blog_parental-astigmatism-increases-risk-of-child-astigmatism.jpg https://ophthalmologybreakingnews.com/parental-astigmatism-increases-risk-for-child-astigmatism 2024-07-01T16:35:31+03:00 en https://ophthalmologybreakingnews.com/parental-astigmatism-increases-risk-for-child-astigmatism https://ophthalmologybreakingnews.com/files/images/blog_pros-and-cons-of-iol-implantation.jpg https://ophthalmologybreakingnews.com/pros-and-cons-of-iol-implantation- 2023-09-26T13:51:57+03:00 en https://ophthalmologybreakingnews.com/pros-and-cons-of-iol-implantation- https://ophthalmologybreakingnews.com/files/images/blog_contact-lenses-for-color-blindness.jpg https://ophthalmologybreakingnews.com/contact-lenses-for-color-blindness- 2023-04-26T13:44:37+03:00 en https://ophthalmologybreakingnews.com/contact-lenses-for-color-blindness- https://ophthalmologybreakingnews.com/files/images/blog_what-is-suprachoroidal-hemorrhage.jpg https://ophthalmologybreakingnews.com/suprachoroidal-hemorrhage 2024-10-21T13:36:07+03:00 en https://ophthalmologybreakingnews.com/suprachoroidal-hemorrhage https://ophthalmologybreakingnews.com/files/images/blog_top-5-vitamins-for-glaucoma-do-they-really-work.jpg https://ophthalmologybreakingnews.com/top-5-vitamins-for-glaucoma-do-they-really-work 2024-04-29T10:03:48+03:00 en https://ophthalmologybreakingnews.com/top-5-vitamins-for-glaucoma-do-they-really-work https://ophthalmologybreakingnews.com/files/images/blog_retina-group-of-new-england-joins-retina-consultants-of-america.jpg https://ophthalmologybreakingnews.com/retina-group-of-new-england-joins-retina-consultants-of-america 2023-01-02T10:13:12+03:00 en https://ophthalmologybreakingnews.com/retina-group-of-new-england-joins-retina-consultants-of-america https://ophthalmologybreakingnews.com/files/images/blog_what-is-staphyloma.jpg https://ophthalmologybreakingnews.com/staphyloma 2024-06-24T15:33:08+03:00 en https://ophthalmologybreakingnews.com/staphyloma https://ophthalmologybreakingnews.com/files/images/blog_using-anabolic-steroids-can-cause-serious-eye-diseases_1.jpg https://ophthalmologybreakingnews.com/using-anabolic-steroids-can-cause-serious-eye-diseases 2023-09-26T14:08:07+03:00 en https://ophthalmologybreakingnews.com/using-anabolic-steroids-can-cause-serious-eye-diseases https://ophthalmologybreakingnews.com/files/images/blog_pars-planitis-intermediate-uveitis.jpg https://ophthalmologybreakingnews.com/pars-planitis-intermediate-uveitis 2023-04-26T15:23:41+03:00 en https://ophthalmologybreakingnews.com/pars-planitis-intermediate-uveitis https://ophthalmologybreakingnews.com/files/images/blog_optic-atrophy.jpg https://ophthalmologybreakingnews.com/optic-atrophy- 2023-09-15T09:12:57+03:00 en https://ophthalmologybreakingnews.com/optic-atrophy- https://ophthalmologybreakingnews.com/files/images/blog_intumescent-cataract.jpg https://ophthalmologybreakingnews.com/intumescent-cataract 2023-07-11T10:25:57+03:00 en https://ophthalmologybreakingnews.com/intumescent-cataract https://ophthalmologybreakingnews.com/files/images/blog_conjunctivochalasis.jpg https://ophthalmologybreakingnews.com/conjunctivochalasis 2023-07-11T10:34:45+03:00 en https://ophthalmologybreakingnews.com/conjunctivochalasis https://ophthalmologybreakingnews.com/files/images/blog_inflammatory-glaucoma.jpg https://ophthalmologybreakingnews.com/inflammatory-glaucoma 2023-07-11T10:32:48+03:00 en https://ophthalmologybreakingnews.com/inflammatory-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_dark-therapy-found-promising-for-lazy-eye-treatment.jpg https://ophthalmologybreakingnews.com/dark-therapy-found-promising-for-lazy-eye-treatment- 2024-02-06T16:11:06+03:00 en https://ophthalmologybreakingnews.com/dark-therapy-found-promising-for-lazy-eye-treatment- https://ophthalmologybreakingnews.com/files/images/blog_7-tips-on-how-to-train-your-eyes-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/7-tips-on-how-to-train-your-eyes-after-cataract-surgery- 2023-09-26T14:10:18+03:00 en https://ophthalmologybreakingnews.com/7-tips-on-how-to-train-your-eyes-after-cataract-surgery- https://ophthalmologybreakingnews.com/files/images/blog_top-5-ophthalmology-residency-programs-in-the-us-how-to-get-in.jpg https://ophthalmologybreakingnews.com/top-5-ophthalmology-residency-programs-in-the-us--how-to-get-in 2024-01-01T19:49:22+03:00 en https://ophthalmologybreakingnews.com/top-5-ophthalmology-residency-programs-in-the-us--how-to-get-in https://ophthalmologybreakingnews.com/files/images/blog_what-to-do-if-pepper-spray-gets-into-the-eyes.jpg https://ophthalmologybreakingnews.com/pepper-sprayed-eyes 2023-07-13T16:06:39+03:00 en https://ophthalmologybreakingnews.com/pepper-sprayed-eyes https://ophthalmologybreakingnews.com/files/images/blog_toxic-anterior-segment-syndrome-tass-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/toxic-anterior-segment-syndrome-tass-in-ophthalmology 2023-09-15T10:19:36+03:00 en https://ophthalmologybreakingnews.com/toxic-anterior-segment-syndrome-tass-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_irregular-astigmatism.jpg https://ophthalmologybreakingnews.com/irregular-astigmatism- 2023-04-26T15:25:32+03:00 en https://ophthalmologybreakingnews.com/irregular-astigmatism- https://ophthalmologybreakingnews.com/files/images/blog_how-photopsia-occur-and-what-are-the-dangers.jpg https://ophthalmologybreakingnews.com/how-photopsia-occur-and-what-are-the-dangers 2023-07-18T15:06:18+03:00 en https://ophthalmologybreakingnews.com/how-photopsia-occur-and-what-are-the-dangers https://ophthalmologybreakingnews.com/files/images/blog_zonular-cataract.jpg https://ophthalmologybreakingnews.com/zonular-cataract 2023-07-11T10:36:26+03:00 en https://ophthalmologybreakingnews.com/zonular-cataract https://ophthalmologybreakingnews.com/files/images/blog_salzmanns-nodular-degeneration.jpg https://ophthalmologybreakingnews.com/salzmanns-nodular-degeneration 2023-07-11T10:38:03+03:00 en https://ophthalmologybreakingnews.com/salzmanns-nodular-degeneration https://ophthalmologybreakingnews.com/files/images/blog_what-is-mucus-fishing-syndrome.jpg https://ophthalmologybreakingnews.com/what-is-mucus-fishing-syndrome 2023-04-26T13:49:13+03:00 en https://ophthalmologybreakingnews.com/what-is-mucus-fishing-syndrome https://ophthalmologybreakingnews.com/files/images/blog_eugene-de-juan-and-his-contribution-to-the-field-of-ophthalmology.jpg https://ophthalmologybreakingnews.com/eugene-de-juan-and-his-contribution-to-the-field-of-ophthalmology 2023-05-09T09:01:21+03:00 en https://ophthalmologybreakingnews.com/eugene-de-juan-and-his-contribution-to-the-field-of-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_amgen-to-acquire-horizon-therapeutics-in-deal-worth-278-billion.jpg https://ophthalmologybreakingnews.com/amgen-to-acquire-horizon-therapeutics-in-deal-worth-$278-billion 2022-12-13T09:00:01+03:00 en https://ophthalmologybreakingnews.com/amgen-to-acquire-horizon-therapeutics-in-deal-worth-$278-billion https://ophthalmologybreakingnews.com/files/images/blog_giant-papillary-conjunctivitis-gpc.jpg https://ophthalmologybreakingnews.com/giant-papillary-conjunctivitis-gpc 2023-07-11T10:41:25+03:00 en https://ophthalmologybreakingnews.com/giant-papillary-conjunctivitis-gpc https://ophthalmologybreakingnews.com/files/images/blog_what-is-durysta-bimatoprost.jpg https://ophthalmologybreakingnews.com/what-is-durysta-bimatoprost 2023-09-26T16:38:40+03:00 en https://ophthalmologybreakingnews.com/what-is-durysta-bimatoprost https://ophthalmologybreakingnews.com/files/images/blog_alcon-plans-to-cut-2-of-its-global-workforce-to-reduce-costs.jpg https://ophthalmologybreakingnews.com/alcon-plans-to-cut-2-of-its-global-workforce-to-reduce-costs 2024-10-16T14:12:43+03:00 en https://ophthalmologybreakingnews.com/alcon-plans-to-cut-2-of-its-global-workforce-to-reduce-costs https://ophthalmologybreakingnews.com/files/images/blog_retinal-pattern-dystrophies.jpg https://ophthalmologybreakingnews.com/retinal-pattern-dystrophies 2023-07-11T10:30:02+03:00 en https://ophthalmologybreakingnews.com/retinal-pattern-dystrophies https://ophthalmologybreakingnews.com/files/images/blog_what-is-durysta-implant.jpg https://ophthalmologybreakingnews.com/what-is-durysta-implant 2023-04-26T15:27:05+03:00 en https://ophthalmologybreakingnews.com/what-is-durysta-implant https://ophthalmologybreakingnews.com/files/images/blog_how-fake-eyelashes-can-cause-serious-eye-problems.jpg https://ophthalmologybreakingnews.com/how-fake-eyelashes-can-cause-serious-eye-problems- 2023-09-26T13:48:17+03:00 en https://ophthalmologybreakingnews.com/how-fake-eyelashes-can-cause-serious-eye-problems- https://ophthalmologybreakingnews.com/files/images/blog_night-blindness.jpg https://ophthalmologybreakingnews.com/night-blindness- 2023-07-11T10:31:33+03:00 en https://ophthalmologybreakingnews.com/night-blindness- https://ophthalmologybreakingnews.com/files/images/blog_what-is-trachoma.jpg https://ophthalmologybreakingnews.com/what-is-trachoma 2023-04-26T15:27:21+03:00 en https://ophthalmologybreakingnews.com/what-is-trachoma https://ophthalmologybreakingnews.com/files/images/blog_telomeye-pharma-raises-1m-in-post-seed-funding-to-develop-new-eye-therapies.jpg https://ophthalmologybreakingnews.com/telomeye-pharma-raises-$1m-in-post-seed-funding-to-develop-new-eye-therapies 2023-04-25T16:08:28+03:00 en https://ophthalmologybreakingnews.com/telomeye-pharma-raises-$1m-in-post-seed-funding-to-develop-new-eye-therapies https://ophthalmologybreakingnews.com/files/images/blog_what-is-scotoma.jpg https://ophthalmologybreakingnews.com/what-is-scotoma- 2023-07-13T16:23:29+03:00 en https://ophthalmologybreakingnews.com/what-is-scotoma- https://ophthalmologybreakingnews.com/files/images/blog_what-is-color-blindness.jpg https://ophthalmologybreakingnews.com/what-is-color-blindness 2023-04-26T13:53:10+03:00 en https://ophthalmologybreakingnews.com/what-is-color-blindness https://ophthalmologybreakingnews.com/files/images/blog_what-is-pseudophakia.jpg https://ophthalmologybreakingnews.com/what-is-pseudophakia 2023-09-14T15:52:39+03:00 en https://ophthalmologybreakingnews.com/what-is-pseudophakia https://ophthalmologybreakingnews.com/files/images/blog_lens-replacement-surgery-what-to-expect-from-start-to-finish.jpg https://ophthalmologybreakingnews.com/what-is-lens-replacement-surgery 2024-06-10T15:26:14+03:00 en https://ophthalmologybreakingnews.com/what-is-lens-replacement-surgery https://ophthalmologybreakingnews.com/files/images/blog_why-does-my-eye-twitch.jpg https://ophthalmologybreakingnews.com/why-does-my-eye-twitch 2023-09-15T09:19:18+03:00 en https://ophthalmologybreakingnews.com/why-does-my-eye-twitch https://ophthalmologybreakingnews.com/files/images/blog_how-does-eye-color-formation-occur.jpg https://ophthalmologybreakingnews.com/how-does-eye-color-formation-occur 2023-04-26T15:28:29+03:00 en https://ophthalmologybreakingnews.com/how-does-eye-color-formation-occur https://ophthalmologybreakingnews.com/files/images/blog_what-are-custom-contact-lenses.jpg https://ophthalmologybreakingnews.com/what-are-custom-contact-lenses- 2023-09-14T16:08:35+03:00 en https://ophthalmologybreakingnews.com/what-are-custom-contact-lenses- https://ophthalmologybreakingnews.com/files/images/blog_topcon-offers-maestro2-oct-certification-course.jpg https://ophthalmologybreakingnews.com/topcon-offers-maestro2-oct-certification-course 2022-11-02T15:59:31+03:00 en https://ophthalmologybreakingnews.com/topcon-offers-maestro2-oct-certification-course https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/extended-depth-of-focus-iol 2023-09-15T09:29:27+03:00 en https://ophthalmologybreakingnews.com/extended-depth-of-focus-iol https://ophthalmologybreakingnews.com/files/images/blog_the-abcs-of-common-eye-conditions.jpg https://ophthalmologybreakingnews.com/common-eye-conditions 2024-10-04T09:39:49+03:00 en https://ophthalmologybreakingnews.com/common-eye-conditions https://ophthalmologybreakingnews.com/files/images/blog_what-is-lacrimal-lake-treatment.jpg https://ophthalmologybreakingnews.com/what-is-lacrimal-lake-treatment- 2023-05-29T17:00:25+03:00 en https://ophthalmologybreakingnews.com/what-is-lacrimal-lake-treatment- https://ophthalmologybreakingnews.com/files/images/blog_optical-coherence-tomography-oct-n-optimizing-clinical-care.jpg https://ophthalmologybreakingnews.com/optical-coherence-tomography-oct-–-optimizing-clinical-care-- 2023-05-08T09:15:58+03:00 en https://ophthalmologybreakingnews.com/optical-coherence-tomography-oct-–-optimizing-clinical-care-- https://ophthalmologybreakingnews.com/files/images/blog_corneal-swelling-after-cataract-surgery.jpg https://ophthalmologybreakingnews.com/corneal-swelling-after-cataract-surgery 2023-04-26T15:30:59+03:00 en https://ophthalmologybreakingnews.com/corneal-swelling-after-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_ophthalmic-imaging-history.jpg https://ophthalmologybreakingnews.com/ophthalmic-imaging-history 2024-10-07T14:12:46+03:00 en https://ophthalmologybreakingnews.com/ophthalmic-imaging-history https://ophthalmologybreakingnews.com/files/images/blog_reusable-contact-lenses-linked-to-rare-eye-infection-causing-blindness.jpg https://ophthalmologybreakingnews.com/reusable-contact-lenses-linked-to-rare-eye-infection-causing-blindness- 2024-10-04T09:35:05+03:00 en https://ophthalmologybreakingnews.com/reusable-contact-lenses-linked-to-rare-eye-infection-causing-blindness- https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-to-announce-first-clinical-experiences-of-acrivaud-trinova-pro-c-pupil-adaptiver-at-escrs-congress.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-to-announce-first-clinical-experiences-of-acrivaud-trinova-pro-c-pupil-adaptive®-at-escrs-congress- 2023-10-13T12:58:52+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-to-announce-first-clinical-experiences-of-acrivaud-trinova-pro-c-pupil-adaptive®-at-escrs-congress- https://ophthalmologybreakingnews.com/files/images/blog_bausch-lomb-alfa-instruments-announce-distribution-agreement-for-intraocular-dyes.jpg https://ophthalmologybreakingnews.com/bausch--lomb-alfa-instruments-announce-distribution-agreement-for-intraocular-dyes 2024-02-16T13:54:51+03:00 en https://ophthalmologybreakingnews.com/bausch--lomb-alfa-instruments-announce-distribution-agreement-for-intraocular-dyes https://ophthalmologybreakingnews.com/files/images/blog_what-is-ophthalmology_1.jpg https://ophthalmologybreakingnews.com/what-is-ophthalmology 2024-06-24T15:25:22+03:00 en https://ophthalmologybreakingnews.com/what-is-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_potential-health-benefits-of-carotenoid-lutein.jpg https://ophthalmologybreakingnews.com/potential-health-benefits-of-carotenoid-lutein 2023-04-26T10:45:14+03:00 en https://ophthalmologybreakingnews.com/potential-health-benefits-of-carotenoid-lutein https://ophthalmologybreakingnews.com/files/images/blog_gene-therapy-partly-restores-cone-receptors-in-eyes-of-color-blind-children.jpg https://ophthalmologybreakingnews.com/gene-therapy-partly-restores-cone-receptors-in-eyes-of-color-blind-children- 2022-08-24T15:43:26+03:00 en https://ophthalmologybreakingnews.com/gene-therapy-partly-restores-cone-receptors-in-eyes-of-color-blind-children- https://ophthalmologybreakingnews.com/files/images/blog_the-40th-congress-of-the-escrs-milan-16-20-september-2022_1.jpg https://ophthalmologybreakingnews.com/the-40th-congress-of-the-escrs-|-milan-16---20-september-2022 2024-06-24T15:32:03+03:00 en https://ophthalmologybreakingnews.com/the-40th-congress-of-the-escrs-|-milan-16---20-september-2022 https://ophthalmologybreakingnews.com/files/images/blog_effects-of-pregnancy-on-keratoconus.jpg https://ophthalmologybreakingnews.com/effects-of-pregnancy-on-keratoconus 2023-04-26T14:01:22+03:00 en https://ophthalmologybreakingnews.com/effects-of-pregnancy-on-keratoconus https://ophthalmologybreakingnews.com/files/images/blog_alcon-signs-770-million-deal-to-acquire-aerie-pharmaceuticals.jpg https://ophthalmologybreakingnews.com/alcon-signs-$770-million-deal-to-acquire-aerie-pharmaceuticals 2023-03-07T14:46:21+03:00 en https://ophthalmologybreakingnews.com/alcon-signs-$770-million-deal-to-acquire-aerie-pharmaceuticals https://ophthalmologybreakingnews.com/files/images/blog_how-to-deal-with-the-epithelial-herpetic-keratitis.jpg https://ophthalmologybreakingnews.com/how-to-deal-with-the-epithelial-herpetic-keratitis 2023-11-30T12:20:59+03:00 en https://ophthalmologybreakingnews.com/how-to-deal-with-the-epithelial-herpetic-keratitis https://ophthalmologybreakingnews.com/files/images/blog_the-connection-between-lupus-and-macular-degeneration.jpg https://ophthalmologybreakingnews.com/the-connection-between-lupus-and-macular-degeneration 2023-04-26T14:01:39+03:00 en https://ophthalmologybreakingnews.com/the-connection-between-lupus-and-macular-degeneration https://ophthalmologybreakingnews.com/files/images/blog_the-evolution-of-iols.jpg https://ophthalmologybreakingnews.com/the-evolution-of-iols 2023-12-05T13:50:43+03:00 en https://ophthalmologybreakingnews.com/the-evolution-of-iols https://ophthalmologybreakingnews.com/files/images/blog_rayner-recalls-rayone-preloaded-hydrophilic-iols-due-to-package-mislabelling.jpg https://ophthalmologybreakingnews.com/rayner-recalls-rayone-preloaded-hydrophilic-iols-due-to-mislabelling- 2024-12-11T09:03:28+03:00 en https://ophthalmologybreakingnews.com/rayner-recalls-rayone-preloaded-hydrophilic-iols-due-to-mislabelling- https://ophthalmologybreakingnews.com/files/images/blog_how-to-slow-the-myopia-in-children-with-contact-lenses.jpg https://ophthalmologybreakingnews.com/how-to-slow-the-myopia-in-children-with-contact-lenses- 2024-04-29T13:28:19+03:00 en https://ophthalmologybreakingnews.com/how-to-slow-the-myopia-in-children-with-contact-lenses- https://ophthalmologybreakingnews.com/files/images/blog_clearside-biomedical-enters-into-financing-agreement-with-healthcare-royalty-partners-for-up-to-65-million.jpg https://ophthalmologybreakingnews.com/clearside-biomedical-enters-into-financing-agreement-with-healthcare-royalty-partners-for-up-to-$65-million 2023-03-03T15:38:37+03:00 en https://ophthalmologybreakingnews.com/clearside-biomedical-enters-into-financing-agreement-with-healthcare-royalty-partners-for-up-to-$65-million https://ophthalmologybreakingnews.com/files/images/blog_agtc-501-gene-therapy-offers-vision-gains-for-x-linked-rp.jpg https://ophthalmologybreakingnews.com/agtc-501-gene-therapy-offers-vision-gains-for-x-linked-rp 2023-04-26T10:45:54+03:00 en https://ophthalmologybreakingnews.com/agtc-501-gene-therapy-offers-vision-gains-for-x-linked-rp https://ophthalmologybreakingnews.com/files/images/blog_what-is-neuro-ophthalmology.jpg https://ophthalmologybreakingnews.com/what-is-neuro-ophthalmology 2023-04-26T15:35:26+03:00 en https://ophthalmologybreakingnews.com/what-is-neuro-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_dealing-with-achromatopsia.jpg https://ophthalmologybreakingnews.com/dealing-with-achromatopsia- 2023-04-26T15:36:07+03:00 en https://ophthalmologybreakingnews.com/dealing-with-achromatopsia- https://ophthalmologybreakingnews.com/files/images/blog_the-connection-between-blood-pressure-and-glaucoma.jpg https://ophthalmologybreakingnews.com/the-connection-between-blood-pressure-and-glaucoma 2023-04-26T10:46:43+03:00 en https://ophthalmologybreakingnews.com/the-connection-between-blood-pressure-and-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_walmart-teams-up-with-waldo-to-offer-affordable-contact-lenses_1.jpg https://ophthalmologybreakingnews.com/walmart-teams-up-with-waldo-to-offer-affordable-contact-lenses 2024-10-21T13:28:27+03:00 en https://ophthalmologybreakingnews.com/walmart-teams-up-with-waldo-to-offer-affordable-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_oyster-pharmas-tyrvaya-is-now-more-widely-available-to-patients.jpg https://ophthalmologybreakingnews.com/oyster-pharmas-tyrvaya-is-now-more-widely-available-to-patients- 2024-10-16T14:13:40+03:00 en https://ophthalmologybreakingnews.com/oyster-pharmas-tyrvaya-is-now-more-widely-available-to-patients- https://ophthalmologybreakingnews.com/files/images/blog_graves-eye-disease-graves-ophthalmopathy-or-graves-orbitopathy.jpg https://ophthalmologybreakingnews.com/graves-eye-disease-graves-ophthalmopathy-or-graves-orbitopathy 2023-09-15T10:15:47+03:00 en https://ophthalmologybreakingnews.com/graves-eye-disease-graves-ophthalmopathy-or-graves-orbitopathy https://ophthalmologybreakingnews.com/files/images/blog_the-benefits-and-risks-of-low-level-light-therapy-photobiomodulation-in-dry-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/the-benefits-and-risks-of-low-level-light-therapy-photobiomodulation-in-dry-age-related-macular-degeneration 2024-09-30T15:08:44+03:00 en https://ophthalmologybreakingnews.com/the-benefits-and-risks-of-low-level-light-therapy-photobiomodulation-in-dry-age-related-macular-degeneration https://ophthalmologybreakingnews.com/files/images/blog_intraocular-uveal-melanoma-treatment.jpg https://ophthalmologybreakingnews.com/intraocular-uveal-melanoma-treatment- 2024-02-06T15:58:58+03:00 en https://ophthalmologybreakingnews.com/intraocular-uveal-melanoma-treatment- https://ophthalmologybreakingnews.com/files/images/blog_the-recovery-period-after-glaucoma-surgery.jpg https://ophthalmologybreakingnews.com/the-recovery-period-after-glaucoma-surgery- 2023-04-26T15:36:41+03:00 en https://ophthalmologybreakingnews.com/the-recovery-period-after-glaucoma-surgery- https://ophthalmologybreakingnews.com/files/images/blog_all-about-irido-corneal-endothelial-syndrome.jpg https://ophthalmologybreakingnews.com/all-about-irido-corneal-endothelial-syndrome 2023-04-26T14:05:20+03:00 en https://ophthalmologybreakingnews.com/all-about-irido-corneal-endothelial-syndrome https://ophthalmologybreakingnews.com/files/images/blog_preseptal-and-orbital-cellulitis.jpg https://ophthalmologybreakingnews.com/preseptal-and-orbital-cellulitis 2024-06-20T11:00:53+03:00 en https://ophthalmologybreakingnews.com/preseptal-and-orbital-cellulitis https://ophthalmologybreakingnews.com/files/images/blog_correlation-between-keratoconus-and-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/correlation-between-keratoconus-and-dry-eye-disease 2024-02-16T11:12:15+03:00 en https://ophthalmologybreakingnews.com/correlation-between-keratoconus-and-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_dorc-receives-fda-clearance-for-eva-nexus-system_1.jpg https://ophthalmologybreakingnews.com/dorc-receives-fda-clearance-for-eva-nexus-system 2024-06-24T15:20:26+03:00 en https://ophthalmologybreakingnews.com/dorc-receives-fda-clearance-for-eva-nexus-system https://ophthalmologybreakingnews.com/files/images/blog_what-is-x-linked-retinitis-pigmentosa.jpg https://ophthalmologybreakingnews.com/what-is-x-linked-retinitis-pigmentosa 2024-06-20T11:06:29+03:00 en https://ophthalmologybreakingnews.com/what-is-x-linked-retinitis-pigmentosa https://ophthalmologybreakingnews.com/files/images/blog_management-of-mydriasis-in-cataract-iol-surgery.jpg https://ophthalmologybreakingnews.com/management-of-mydriasis-in-cataract---iol-surgery 2023-04-26T11:25:18+03:00 en https://ophthalmologybreakingnews.com/management-of-mydriasis-in-cataract---iol-surgery https://ophthalmologybreakingnews.com/files/images/blog_the-role-of-photodynamic-therapy-in-central-serous-retinopathy.jpg https://ophthalmologybreakingnews.com/the-role-of-photodynamic-therapy-in-central-serous-retinopathy- 2023-04-26T11:25:52+03:00 en https://ophthalmologybreakingnews.com/the-role-of-photodynamic-therapy-in-central-serous-retinopathy- https://ophthalmologybreakingnews.com/files/images/blog_how-to-educate-the-patients-for-pars-plana-vitrectomy-ppv.jpg https://ophthalmologybreakingnews.com/how-to-educate-the-patients-for-pars-plana-vitrectomy-ppv 2023-07-31T13:25:49+03:00 en https://ophthalmologybreakingnews.com/how-to-educate-the-patients-for-pars-plana-vitrectomy-ppv https://ophthalmologybreakingnews.com/files/images/blog_the-best-ovd-producers-survey.jpg https://ophthalmologybreakingnews.com/the-best-ovd-producers-survey- 2024-02-16T13:13:39+03:00 en https://ophthalmologybreakingnews.com/the-best-ovd-producers-survey- https://ophthalmologybreakingnews.com/files/images/blog_how-to-deal-with-usher-syndrome-and-retinal-degeneration.jpg https://ophthalmologybreakingnews.com/how-to-deal-with-usher-syndrome-and-retinal-degeneration 2023-04-26T11:26:23+03:00 en https://ophthalmologybreakingnews.com/how-to-deal-with-usher-syndrome-and-retinal-degeneration https://ophthalmologybreakingnews.com/files/images/blog_rayner-acquires-stake-in-surgical-instrument-belgian-manufacturer-hasa-optix.jpg https://ophthalmologybreakingnews.com/rayner-acquires-stake-in-surgical-instrument-belgian-manufacturer-hasa-optix 2023-01-17T16:24:31+03:00 en https://ophthalmologybreakingnews.com/rayner-acquires-stake-in-surgical-instrument-belgian-manufacturer-hasa-optix https://ophthalmologybreakingnews.com/files/images/blog_cataract-surgery-goniotomy_1.jpg https://ophthalmologybreakingnews.com/cataract-surgery--goniotomy 2023-05-29T15:50:15+03:00 en https://ophthalmologybreakingnews.com/cataract-surgery--goniotomy https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/how-to-repair-iris-trauma 2024-10-01T15:35:10+03:00 en https://ophthalmologybreakingnews.com/how-to-repair-iris-trauma https://ophthalmologybreakingnews.com/files/images/blog_the-link-between-congenital-plasminogen-deficiency-blood-ties.jpg https://ophthalmologybreakingnews.com/the-link-between-congenital-plasminogen-deficiency---blood-ties 2023-04-26T11:29:48+03:00 en https://ophthalmologybreakingnews.com/the-link-between-congenital-plasminogen-deficiency---blood-ties https://ophthalmologybreakingnews.com/files/images/blog_diagnosis-and-treatment-of-corneal-ulcers.jpg https://ophthalmologybreakingnews.com/diagnosis-and-treatment-of-corneal-ulcers 2023-04-26T14:24:42+03:00 en https://ophthalmologybreakingnews.com/diagnosis-and-treatment-of-corneal-ulcers https://ophthalmologybreakingnews.com/files/images/blog_what-is-the-connection-between-too-much-caffeine-blindness-glaucoma_1.jpg https://ophthalmologybreakingnews.com/what-is-the-connection-between-too-much-caffeine--blindness---glaucoma 2024-06-24T15:23:15+03:00 en https://ophthalmologybreakingnews.com/what-is-the-connection-between-too-much-caffeine--blindness---glaucoma https://ophthalmologybreakingnews.com/files/images/blog_an-overview-of-horner-syndrome.jpg https://ophthalmologybreakingnews.com/an-overview-of-horner-syndrome 2024-02-06T16:04:23+03:00 en https://ophthalmologybreakingnews.com/an-overview-of-horner-syndrome https://ophthalmologybreakingnews.com/files/images/blog_the-effects-of-climate-change-on-eye-vision.jpg https://ophthalmologybreakingnews.com/the-effects-of-climate-change-on-eye--vision 2023-05-05T14:44:55+03:00 en https://ophthalmologybreakingnews.com/the-effects-of-climate-change-on-eye--vision https://ophthalmologybreakingnews.com/files/images/blog_glaucomatous-optic-nerve-damage.jpg https://ophthalmologybreakingnews.com/glaucomatous-optic-nerve-damage- 2023-07-31T11:34:22+03:00 en https://ophthalmologybreakingnews.com/glaucomatous-optic-nerve-damage- https://ophthalmologybreakingnews.com/files/images/blog_yamane-technique-intrascleral-iol-nfixation.jpg https://ophthalmologybreakingnews.com/yamane-technique-explained 2024-12-11T09:13:31+03:00 en https://ophthalmologybreakingnews.com/yamane-technique-explained https://ophthalmologybreakingnews.com/files/images/blog_latest-medications-for-dry-eye-disease-treatment.jpg https://ophthalmologybreakingnews.com/latest-medications-for-dry-eye-disease-treatment- 2023-04-26T10:53:44+03:00 en https://ophthalmologybreakingnews.com/latest-medications-for-dry-eye-disease-treatment- https://ophthalmologybreakingnews.com/files/images/blog_omega-3-fatty-acids-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/omega-3-fatty-acids--dry-eye-disease- 2023-04-26T15:41:00+03:00 en https://ophthalmologybreakingnews.com/omega-3-fatty-acids--dry-eye-disease- https://ophthalmologybreakingnews.com/files/images/blog_how-to-diagnose-and-treat-thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/how-to-diagnose-and-treat-thyroid-eye-disease 2023-04-26T15:41:14+03:00 en https://ophthalmologybreakingnews.com/how-to-diagnose-and-treat-thyroid-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_microbial-keratitis-mk_1.jpg https://ophthalmologybreakingnews.com/microbial-keratitis-mk 2024-10-21T13:45:01+03:00 en https://ophthalmologybreakingnews.com/microbial-keratitis-mk https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/cannabis---cbd-oil--ophthalmology- 2023-04-26T15:41:31+03:00 en https://ophthalmologybreakingnews.com/cannabis---cbd-oil--ophthalmology- https://ophthalmologybreakingnews.com/files/images/blog_general-stages-of-amd-management.jpg https://ophthalmologybreakingnews.com/general-stages-of-amd--management 2023-04-26T11:32:08+03:00 en https://ophthalmologybreakingnews.com/general-stages-of-amd--management https://ophthalmologybreakingnews.com/files/images/blog_retina-consultants-of-america-acquires-retina-center-northwest.jpg https://ophthalmologybreakingnews.com/retina-consultants-of-america-acquires-retina-center-northwest 2023-01-25T11:43:47+03:00 en https://ophthalmologybreakingnews.com/retina-consultants-of-america-acquires-retina-center-northwest https://ophthalmologybreakingnews.com/files/images/blog_presbyopia-pharmaceuticals.jpg https://ophthalmologybreakingnews.com/presbyopia--pharmaceuticals 2023-04-26T11:32:25+03:00 en https://ophthalmologybreakingnews.com/presbyopia--pharmaceuticals https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/suprachoroidal-delivery-system- 2023-04-26T11:32:45+03:00 en https://ophthalmologybreakingnews.com/suprachoroidal-delivery-system- https://ophthalmologybreakingnews.com/files/images/blog_the-basics-of-excimer-laser.jpg https://ophthalmologybreakingnews.com/the-basics-of-excimer-laser 2024-04-29T13:27:47+03:00 en https://ophthalmologybreakingnews.com/the-basics-of-excimer-laser https://ophthalmologybreakingnews.com/files/images/blog_vitamin-a-the-ocular-surface_1.jpg https://ophthalmologybreakingnews.com/vitamin-a--the-ocular-surface- 2024-06-24T15:19:31+03:00 en https://ophthalmologybreakingnews.com/vitamin-a--the-ocular-surface- https://ophthalmologybreakingnews.com/files/images/blog_anisometropic-amblyopia-in-children.jpg https://ophthalmologybreakingnews.com/anisometropic-amblyopia-in-children 2023-04-26T11:34:13+03:00 en https://ophthalmologybreakingnews.com/anisometropic-amblyopia-in-children https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-disease-management-the-importance-of-nutrition-and-hygiene.jpg https://ophthalmologybreakingnews.com/dry-eye-disease-management--the-importance-of-nutrition-and-hygiene 2023-04-26T14:14:00+03:00 en https://ophthalmologybreakingnews.com/dry-eye-disease-management--the-importance-of-nutrition-and-hygiene https://ophthalmologybreakingnews.com/files/images/blog_ptosis-surgery.jpg https://ophthalmologybreakingnews.com/ptosis-surgery- 2023-09-15T09:23:07+03:00 en https://ophthalmologybreakingnews.com/ptosis-surgery- https://ophthalmologybreakingnews.com/files/images/blog_herpes-zoster-ophthalmicus.jpg https://ophthalmologybreakingnews.com/herpes-zoster-ophthalmicus 2023-10-13T14:43:22+03:00 en https://ophthalmologybreakingnews.com/herpes-zoster-ophthalmicus https://ophthalmologybreakingnews.com/files/images/blog_complex-corneas-iol-selection-for-already-aberrated-cornea.jpg https://ophthalmologybreakingnews.com/complex-corneas--iol-selection-for-already-aberrated-cornea 2023-04-26T11:35:00+03:00 en https://ophthalmologybreakingnews.com/complex-corneas--iol-selection-for-already-aberrated-cornea https://ophthalmologybreakingnews.com/files/images/blog_steroid-treatment-for-dry-eye-disease.jpg https://ophthalmologybreakingnews.com/steroid-treatment-for-dry-eye-disease 2023-04-26T10:47:16+03:00 en https://ophthalmologybreakingnews.com/steroid-treatment-for-dry-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_one-of-the-founding-fathers-of-modern-ophthalmology-n-dr-william-mackenzie_1.jpg https://ophthalmologybreakingnews.com/one-of-the-founding-fathers-of-modern-ophthalmology-–-dr-william-mackenzie 2024-07-01T16:28:15+03:00 en https://ophthalmologybreakingnews.com/one-of-the-founding-fathers-of-modern-ophthalmology-–-dr-william-mackenzie https://ophthalmologybreakingnews.com/files/images/blog_the-effects-of-statins-on-cataracts.jpg https://ophthalmologybreakingnews.com/the-effects-of-statins-on-cataracts 2024-10-01T15:56:39+03:00 en https://ophthalmologybreakingnews.com/the-effects-of-statins-on-cataracts https://ophthalmologybreakingnews.com/files/images/blog_treating-cataract-patients-with-keratoconus.jpg https://ophthalmologybreakingnews.com/treating-cataract-patients-with-keratoconus 2024-02-16T11:13:53+03:00 en https://ophthalmologybreakingnews.com/treating-cataract-patients-with-keratoconus https://ophthalmologybreakingnews.com/files/images/blog_globaldata-glaucoma-market-to-grow-to-35-billion-by-2030_1.jpg https://ophthalmologybreakingnews.com/globaldata--glaucoma-market-to-grow-to-$35-billion-by-2030 2024-10-21T09:55:34+03:00 en https://ophthalmologybreakingnews.com/globaldata--glaucoma-market-to-grow-to-$35-billion-by-2030 https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-genentechs-vabysmo-the-first-bispecific-antibody-for-the-eye-to-treat-wet-amd-and-dme.jpg https://ophthalmologybreakingnews.com/fda-approves-genentechs-vabysmo-the-first-bispecific-antibody-for-the-eye-to-treat-wet-amd-and-dme 2022-12-23T15:32:41+03:00 en https://ophthalmologybreakingnews.com/fda-approves-genentechs-vabysmo-the-first-bispecific-antibody-for-the-eye-to-treat-wet-amd-and-dme https://ophthalmologybreakingnews.com/files/images/blog_in-light-of-managing-retrobulbar-hemorrhage.jpg https://ophthalmologybreakingnews.com/in-light-of--managing-retrobulbar-hemorrhage 2023-04-26T14:05:04+03:00 en https://ophthalmologybreakingnews.com/in-light-of--managing-retrobulbar-hemorrhage https://ophthalmologybreakingnews.com/files/images/blog_nocturnal-lagophthalmos.jpg https://ophthalmologybreakingnews.com/nocturnal-lagophthalmos 2024-02-06T15:56:49+03:00 en https://ophthalmologybreakingnews.com/nocturnal-lagophthalmos https://ophthalmologybreakingnews.com/files/images/blog_improved-vision-through-a-supplement-from-mexican-marigolds.jpg https://ophthalmologybreakingnews.com/improved-vision-through-a-supplement-from-mexican-marigolds- 2023-04-26T09:57:49+03:00 en https://ophthalmologybreakingnews.com/improved-vision-through-a-supplement-from-mexican-marigolds- https://ophthalmologybreakingnews.com/files/images/blog_avoiding-opioids-in-cataract-surgery.jpg https://ophthalmologybreakingnews.com/avoiding-opioids-in-cataract-surgery 2023-04-26T11:04:40+03:00 en https://ophthalmologybreakingnews.com/avoiding-opioids-in-cataract-surgery https://ophthalmologybreakingnews.com/files/images/blog_glaucomatous-optic-neuropathy-latest-treatments.jpg https://ophthalmologybreakingnews.com/glaucomatous-optic-neuropathy--latest-treatments- 2024-04-29T10:20:14+03:00 en https://ophthalmologybreakingnews.com/glaucomatous-optic-neuropathy--latest-treatments- https://ophthalmologybreakingnews.com/files/images/blog_goji-berries-may-prevent-or-delay-the-development-of-age-related-macular-degeneration.jpg https://ophthalmologybreakingnews.com/goji-berries-may-prevent-or-delay-the-development-of-age-related-macular-degeneration- 2023-11-30T15:08:41+03:00 en https://ophthalmologybreakingnews.com/goji-berries-may-prevent-or-delay-the-development-of-age-related-macular-degeneration- https://ophthalmologybreakingnews.com/files/images/blog_thyroid-eye-disease-ted.jpg https://ophthalmologybreakingnews.com/thyroid-eye-disease-ted 2024-04-29T13:34:49+03:00 en https://ophthalmologybreakingnews.com/thyroid-eye-disease-ted https://ophthalmologybreakingnews.com/files/images/blog_glaucoma-medication-options.jpg https://ophthalmologybreakingnews.com/glaucoma-medication-options 2023-04-26T14:15:13+03:00 en https://ophthalmologybreakingnews.com/glaucoma-medication-options https://ophthalmologybreakingnews.com/files/images/blog_rayner-introduces-its-first-blue-light-filtering-intraocular-lens.jpg https://ophthalmologybreakingnews.com/rayner-introduces-its-first-blue-light-filtering-intraocular-lens 2024-12-11T09:02:02+03:00 en https://ophthalmologybreakingnews.com/rayner-introduces-its-first-blue-light-filtering-intraocular-lens https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-disease-treatment-with-nasal-spray.jpg https://ophthalmologybreakingnews.com/dry-eye-disease-treatment-with-nasal-spray 2023-04-26T11:07:02+03:00 en https://ophthalmologybreakingnews.com/dry-eye-disease-treatment-with-nasal-spray https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnologys-sinusoidal-vision-technology-has-been-officially-patented-in-china_1.jpg https://ophthalmologybreakingnews.com/vsy-biotechnologys-sinusoidal-vision-technology-has-been-officially-patented-in-china 2024-06-24T15:34:18+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnologys-sinusoidal-vision-technology-has-been-officially-patented-in-china https://ophthalmologybreakingnews.com/files/images/blog_how-to-diagnose-papilledema-a-swollen-optic-nerve.jpg https://ophthalmologybreakingnews.com/how-to-diagnose-papilledema-a-swollen-optic-nerve 2023-05-18T12:07:56+03:00 en https://ophthalmologybreakingnews.com/how-to-diagnose-papilledema-a-swollen-optic-nerve https://ophthalmologybreakingnews.com/files/images/blog_primary-open-angle-glaucoma-poag_2.jpg https://ophthalmologybreakingnews.com/primary-open-angle-glaucoma-poag- 2024-06-24T15:18:32+03:00 en https://ophthalmologybreakingnews.com/primary-open-angle-glaucoma-poag- https://ophthalmologybreakingnews.com/files/images/blog_advancements-in-treatment-of-open-angle-glaucoma.jpg https://ophthalmologybreakingnews.com/advancements-in-treatment-of-open-angle-glaucoma 2023-04-26T11:07:48+03:00 en https://ophthalmologybreakingnews.com/advancements-in-treatment-of-open-angle-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_edenlux-launches-campaign-for-otus-personal-eye-trainer-to-prevent-eye-health-issues_1.jpg https://ophthalmologybreakingnews.com/edenlux-launches-campaign-for-otus-personal-eye-trainer-to-prevent-eye-health-issues- 2024-02-09T10:28:29+03:00 en https://ophthalmologybreakingnews.com/edenlux-launches-campaign-for-otus-personal-eye-trainer-to-prevent-eye-health-issues- https://ophthalmologybreakingnews.com/files/images/blog_oculentis-declares-bankruptcy-after-its-intraocular-lenses-result-in-serious-vision-loss.jpg https://ophthalmologybreakingnews.com/oculentis-bv-declares-bankruptcy-after-its-intraocular-lenses-result-in-serious-vision-loss- 2024-10-21T13:40:00+03:00 en https://ophthalmologybreakingnews.com/oculentis-bv-declares-bankruptcy-after-its-intraocular-lenses-result-in-serious-vision-loss- https://ophthalmologybreakingnews.com/files/images/blog_thyroid-eye-disease.jpg https://ophthalmologybreakingnews.com/thyroid-eye-disease 2023-04-26T15:43:40+03:00 en https://ophthalmologybreakingnews.com/thyroid-eye-disease https://ophthalmologybreakingnews.com/files/images/blog_heidelberg-engineering-announces-the-launch-of-spectralis-platform-with-shift-technology.jpg https://ophthalmologybreakingnews.com/heidelberg-engineering-announces-the-launch-of-spectralis-platform-with-shift-technology 2023-01-23T13:37:02+03:00 en https://ophthalmologybreakingnews.com/heidelberg-engineering-announces-the-launch-of-spectralis-platform-with-shift-technology https://ophthalmologybreakingnews.com/files/images/blog_alcon-opens-companys-largest-european-eye-health-education-and-training-center-in-barcelona.jpg https://ophthalmologybreakingnews.com/alcon-opens-companys-largest-european-eye-health-education-and-training-center-in-barcelona 2021-11-08T15:14:16+03:00 en https://ophthalmologybreakingnews.com/alcon-opens-companys-largest-european-eye-health-education-and-training-center-in-barcelona https://ophthalmologybreakingnews.com/files/images/blog_california-approves-expanded-scope-of-practice-legislation-that-california-optometric-association-had-supported_1.jpg https://ophthalmologybreakingnews.com/california-approves-expanded-scope-of-practice-legislation-that-california-optometric-association-had-supported 2024-10-16T14:15:26+03:00 en https://ophthalmologybreakingnews.com/california-approves-expanded-scope-of-practice-legislation-that-california-optometric-association-had-supported https://ophthalmologybreakingnews.com/https://ophthalmologybreakingnews.com/files/logo.png https://ophthalmologybreakingnews.com/the-covid-19-effect-on-uveal-melanoma--advanced-eye-cancers- 2023-04-26T11:38:26+03:00 en https://ophthalmologybreakingnews.com/the-covid-19-effect-on-uveal-melanoma--advanced-eye-cancers- https://ophthalmologybreakingnews.com/files/images/blog_evmann-takes-under-its-umbrella-two-innovative-fast-growing-companies_1.jpg https://ophthalmologybreakingnews.com/evmann-takes-under-its-umbrella-two-innovative-fast-growing-companies 2024-10-21T10:33:34+03:00 en https://ophthalmologybreakingnews.com/evmann-takes-under-its-umbrella-two-innovative-fast-growing-companies https://ophthalmologybreakingnews.com/files/images/blog_crystalens.jpg https://ophthalmologybreakingnews.com/crystalens 2023-09-15T09:20:40+03:00 en https://ophthalmologybreakingnews.com/crystalens https://ophthalmologybreakingnews.com/files/images/blog_postmenopausal-women-dry-eye-disease-estradiol-drops.jpg https://ophthalmologybreakingnews.com/postmenopausal-women---dry-eye-disease--estradiol-drops- 2024-02-22T15:22:23+03:00 en https://ophthalmologybreakingnews.com/postmenopausal-women---dry-eye-disease--estradiol-drops- https://ophthalmologybreakingnews.com/files/images/blog_pars-plana-vitrectomy-ppv-patients-education.jpg https://ophthalmologybreakingnews.com/pars-plana-vitrectomy-ppv--patients-education 2024-09-30T14:55:34+03:00 en https://ophthalmologybreakingnews.com/pars-plana-vitrectomy-ppv--patients-education https://ophthalmologybreakingnews.com/files/images/blog_how-adolf-fercher-paved-the-way-for-optical-coherence-tomography.jpg https://ophthalmologybreakingnews.com/how-adolf-fercher-paved-the-way-for-optical-coherence-tomography 2023-04-26T14:17:59+03:00 en https://ophthalmologybreakingnews.com/how-adolf-fercher-paved-the-way-for-optical-coherence-tomography https://ophthalmologybreakingnews.com/files/images/blog_pneumatic-retinopexy.jpg https://ophthalmologybreakingnews.com/pneumatic-retinopexy 2023-09-15T10:14:38+03:00 en https://ophthalmologybreakingnews.com/pneumatic-retinopexy https://ophthalmologybreakingnews.com/files/images/blog_diabetic-macular-edema-treatment-strategies.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-diabetic-macular-edema-treatment-strategies 2023-04-26T11:10:09+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-diabetic-macular-edema-treatment-strategies https://ophthalmologybreakingnews.com/files/images/blog_fda-approves-cyclosporine-eye-drops-for-vernal-keratoconjunctivitis-in-adults-and-children.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-fda-approves-cyclosporine-eye-drops-for-vernal-keratoconjunctivitis 2023-04-26T10:02:06+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-fda-approves-cyclosporine-eye-drops-for-vernal-keratoconjunctivitis https://ophthalmologybreakingnews.com/files/images/blog_staring-at-a-deep-red-light-three-minutes-a-day-eyesight.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-staring-at-a-deep-red-light-three-minutes-a-day 2023-04-26T11:10:59+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-staring-at-a-deep-red-light-three-minutes-a-day https://ophthalmologybreakingnews.com/files/images/blog_presbyopia-correcting-drops.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-presbyopia-correcting-drops 2023-04-26T15:45:09+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-presbyopia-correcting-drops https://ophthalmologybreakingnews.com/files/images/blog_ultra-widefield-imaging-managing-numerous-retinal-pathologies.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-ultra-widefield-imaging 2023-04-26T15:45:31+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-ultra-widefield-imaging https://ophthalmologybreakingnews.com/files/images/blog_preloaded-iol-injectors-cataract-surgery.jpg https://ophthalmologybreakingnews.com/cataract-surgery-preloaded-iol-injectors 2023-04-26T10:26:13+03:00 en https://ophthalmologybreakingnews.com/cataract-surgery-preloaded-iol-injectors https://ophthalmologybreakingnews.com/files/images/blog_cocoa-increases-the-sharpness-of-vision.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-cocoa-increases-the-sharpness-of-vision 2024-09-30T14:09:11+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-cocoa-increases-the-sharpness-of-vision https://ophthalmologybreakingnews.com/files/images/blog_the-role-of-endoscopy-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-the-role-of-endoscopy-in-ophthalmology 2023-04-26T15:45:48+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-the-role-of-endoscopy-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-disease-ded-meibomian-gland-dysfunction-mgd.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-dry-eye-disease-ded-meibomian-gland-dysfunction-mgd 2024-02-22T15:24:51+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-dry-eye-disease-ded-meibomian-gland-dysfunction-mgd https://ophthalmologybreakingnews.com/files/images/blog_the-link-between-too-much-caffeine-blindness-n-glaucoma.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-the-link-between-too-much-caffeine-blindness-glaucoma 2023-04-26T16:15:07+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-the-link-between-too-much-caffeine-blindness-glaucoma https://ophthalmologybreakingnews.com/files/images/blog_enovar-is-available-now-in-c-haptic-model-n-vsy-biotechnology-gmbh.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-enova-is-available-now-in-c-haptic-model-vsy-biotechnology-gmbh 2024-02-16T11:22:17+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-enova-is-available-now-in-c-haptic-model-vsy-biotechnology-gmbh https://ophthalmologybreakingnews.com/files/images/blog_new-guidelines-by-the-european-glaucoma-society.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-european-glaucoma-society 2023-05-09T08:31:10+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-european-glaucoma-society https://ophthalmologybreakingnews.com/files/images/blog_photobiomodulation-dry-amd-treatment.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-photobiomodulation-dry-amd-treatment 2023-04-26T14:12:23+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-photobiomodulation-dry-amd-treatment https://ophthalmologybreakingnews.com/files/images/blog_johnson-johnson-sues-alcon.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-jjohnsonvision-sues-alcon 2023-01-23T11:02:28+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-jjohnsonvision-sues-alcon https://ophthalmologybreakingnews.com/files/images/blog_updates-on-central-serous-chorioretinopathy.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-central-serous-chorioretinopathy 2023-03-07T15:03:33+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-central-serous-chorioretinopathy https://ophthalmologybreakingnews.com/files/images/blog_ocular-therapeutix-receives-approval-for-resure-sealant.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-ocular-therapeutix-resuresealant 2023-03-09T14:29:28+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-ocular-therapeutix-resuresealant https://ophthalmologybreakingnews.com/files/images/blog_compounded-drugs-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-compounded-drugs-ophthalmology 2023-04-26T11:12:05+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-compounded-drugs-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_horner-syndrome.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-horner-syndrome 2023-07-18T16:07:43+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-horner-syndrome https://ophthalmologybreakingnews.com/files/images/blog_high-tech-contact-lenses-may-replace-smart-phones.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-high-tech-contact-lenses-may-replace-smart-phones 2023-01-20T15:54:34+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-high-tech-contact-lenses-may-replace-smart-phones https://ophthalmologybreakingnews.com/files/images/blog_geographic-atrophy-patients-with-ga.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-geographic-atrophy-patients-with-ga 2024-02-16T11:36:28+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-geographic-atrophy-patients-with-ga https://ophthalmologybreakingnews.com/files/images/blog_recommendations-by-aao-for-standardization-of-images-in-ophthalmology.jpg https://ophthalmologybreakingnews.com/recommendations-by-aao-for-standardization-of-images-in-ophthalmology 2021-04-12T15:42:58+03:00 en https://ophthalmologybreakingnews.com/recommendations-by-aao-for-standardization-of-images-in-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_iris-trauma-repair.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-iris-trauma-repair 2023-05-09T10:50:48+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-iris-trauma-repair https://ophthalmologybreakingnews.com/files/images/blog_the-process-of-unplugging-the-clogged-drain-in-glaucoma-iop.jpg https://ophthalmologybreakingnews.com/the-process-of-unplugging-the-clogged-drain-in-glaucoma-iop 2023-04-26T11:41:19+03:00 en https://ophthalmologybreakingnews.com/the-process-of-unplugging-the-clogged-drain-in-glaucoma-iop https://ophthalmologybreakingnews.com/files/images/blog_rayners-rayone-emv-iol-approved-by-fda.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-rayners-rayone-emv-iol-fdaapproved-ophtalmic 2021-03-29T16:29:19+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-rayners-rayone-emv-iol-fdaapproved-ophtalmic https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-treatment-cyclosporine.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-cyclosporine-dry-eye-relief-ophtalmic 2024-02-16T13:15:21+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-cyclosporine-dry-eye-relief-ophtalmic https://ophthalmologybreakingnews.com/files/images/blog_covid-19-vaccine-ophthalmology.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-covid-19-vaccine-eye-vision 2023-04-26T11:14:13+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-covid-19-vaccine-eye-vision https://ophthalmologybreakingnews.com/files/images/blog_turkey-the-6th-biggest-pharmaceutical-market-in-europe-lets-sifi-in.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-turkey-lets-sifi-in 2021-03-24T12:20:58+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-turkey-lets-sifi-in https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-gmbh-signs-agreement-with-wakamoto-pharmaceutical.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-signs-agreement-with-wakamoto-pharmaceutical-co-ltd-on-intraocular-lens-products 2023-03-09T09:15:28+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-gmbh-signs-agreement-with-wakamoto-pharmaceutical-co-ltd-on-intraocular-lens-products https://ophthalmologybreakingnews.com/files/images/blog_ray-tracing-optimization-n-myopic-lasik-artificial-intelligence.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-raytracingoptimization-myopiclasik-artificial-intelligence 2024-11-20T09:30:13+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-raytracingoptimization-myopiclasik-artificial-intelligence https://ophthalmologybreakingnews.com/files/images/blog_slowing-the-myopia-in-children-with-contact-lenses.jpg https://ophthalmologybreakingnews.com/slowing-the-myopia-in-children-with-contact-lenses 2024-04-29T13:26:32+03:00 en https://ophthalmologybreakingnews.com/slowing-the-myopia-in-children-with-contact-lenses https://ophthalmologybreakingnews.com/files/images/blog_the-pineal-gland-the-eye-of-horus.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-the-pineal-gland-the-eye-of-horus 2024-04-07T21:31:35+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-the-pineal-gland-the-eye-of-horus https://ophthalmologybreakingnews.com/files/images/blog_ophthalmology-in-ancient-egyptian-greek-mythology.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-apollo-thefirst-ophthalmologist 2024-02-22T15:27:01+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-apollo-thefirst-ophthalmologist https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-ocular-allergy.jpg https://ophthalmologybreakingnews.com/dry-eye-ocular-allergy 2023-04-26T14:21:27+03:00 en https://ophthalmologybreakingnews.com/dry-eye-ocular-allergy https://ophthalmologybreakingnews.com/files/images/blog_how-to-get-efficiency-in-glaucoma-testing.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-glaucomatesting 2023-04-26T11:14:45+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-glaucomatesting https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-testing-new-diagnostic-tools.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-dryeyetesting 2024-11-18T15:00:17+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-dryeyetesting https://ophthalmologybreakingnews.com/files/images/blog_the-cataract-journey-role-of-medical-staff-n-patient-care.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-cataractjourney 2023-09-04T16:06:28+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-cataractjourney https://ophthalmologybreakingnews.com/files/images/blog_alcon-announces-launch-of-acrysof-iq-vivity.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-presbyopia-mitigating-lens 2023-09-04T16:23:34+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-presbyopia-mitigating-lens https://ophthalmologybreakingnews.com/files/images/blog_a-next-generation-monofocal-intraocular-lens-from-johnson-johnson-vision.jpg https://ophthalmologybreakingnews.com/a-next-generation-monofocal-intraocular-lens-from-johnson-johnson-vision 2023-03-09T11:17:39+03:00 en https://ophthalmologybreakingnews.com/a-next-generation-monofocal-intraocular-lens-from-johnson-johnson-vision https://ophthalmologybreakingnews.com/files/images/blog_benefits-of-combination-drops-on-glaucoma-management.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-glaucomadrops 2023-03-09T13:22:08+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-glaucomadrops https://ophthalmologybreakingnews.com/files/images/blog_dry-eye-symptoms-differences-between-day-night.jpg https://ophthalmologybreakingnews.com/ophthalmologynews-dryeye 2023-04-26T15:47:49+03:00 en https://ophthalmologybreakingnews.com/ophthalmologynews-dryeye https://ophthalmologybreakingnews.com/files/images/blog_iol-power-calculations-post-myopic-lasik-eyes.jpg https://ophthalmologybreakingnews.com/δophthalmology-iol-power-calculations 2023-09-04T16:10:46+03:00 en https://ophthalmologybreakingnews.com/δophthalmology-iol-power-calculations https://ophthalmologybreakingnews.com/files/images/blog_the-revolution-of-pediatric-ophthalmology.jpg https://ophthalmologybreakingnews.com/ophthalmologyhistorynews 2023-04-26T15:48:23+03:00 en https://ophthalmologybreakingnews.com/ophthalmologyhistorynews https://ophthalmologybreakingnews.com/files/images/blog_smart-contact-lens-with-dynamic-artificial-iris.jpg https://ophthalmologybreakingnews.com/smart-contact-lens-with-dynamic-artificial-iris 2024-04-29T13:34:01+03:00 en https://ophthalmologybreakingnews.com/smart-contact-lens-with-dynamic-artificial-iris https://ophthalmologybreakingnews.com/files/images/blog_enova-new-generation-100-glistening-free-hydrophobic-iol.jpg https://ophthalmologybreakingnews.com/enova-the-first-100-glistening-free-iol 2023-09-14T15:01:23+03:00 en https://ophthalmologybreakingnews.com/enova-the-first-100-glistening-free-iol https://ophthalmologybreakingnews.com/files/images/blog_ophthalmic-market-worth-5328-million-by-2026.jpg https://ophthalmologybreakingnews.com/ophthalmic-sutures-market-worth-532-8-million-by-2026-cagr-6-4-grand-view-research-inc 2023-09-04T16:11:53+03:00 en https://ophthalmologybreakingnews.com/ophthalmic-sutures-market-worth-532-8-million-by-2026-cagr-6-4-grand-view-research-inc https://ophthalmologybreakingnews.com/files/images/blog_how-tinted-lenses-affect-us.jpg https://ophthalmologybreakingnews.com/need-an-emotional-recharge-want-to-feel-refreshed-how-tinted-lenses-affect-us 2023-03-09T11:16:24+03:00 en https://ophthalmologybreakingnews.com/need-an-emotional-recharge-want-to-feel-refreshed-how-tinted-lenses-affect-us https://ophthalmologybreakingnews.com/files/images/blog_worlds-first-and-only-sinusoidal-trifocal-intra-ocular-lens.jpg https://ophthalmologybreakingnews.com/worlds-first-and-only-sinusoidal-trifocal-intra-ocular-lens 2023-01-27T10:26:29+03:00 en https://ophthalmologybreakingnews.com/worlds-first-and-only-sinusoidal-trifocal-intra-ocular-lens https://ophthalmologybreakingnews.com/files/images/blog_jjannounced-new-products-at-the-2019-aao-annual-meeting.jpg https://ophthalmologybreakingnews.com/johnson-johnson-vision-announced-a-series-of-new-products-and-innovations-at-the-2019-aao-annual-meeting-in-san-francisco 2023-03-09T10:01:21+03:00 en https://ophthalmologybreakingnews.com/johnson-johnson-vision-announced-a-series-of-new-products-and-innovations-at-the-2019-aao-annual-meeting-in-san-francisco https://ophthalmologybreakingnews.com/files/images/blog_vsy-biotechnology-picks-the-stars-of-ophthalmology.jpg https://ophthalmologybreakingnews.com/vsy-biotechnology-picks-the-stars-of-ophthalmology 2023-03-09T13:04:41+03:00 en https://ophthalmologybreakingnews.com/vsy-biotechnology-picks-the-stars-of-ophthalmology https://ophthalmologybreakingnews.com/files/images/blog_acquisition-of-mid-labs-and-fritz-ruck.jpg https://ophthalmologybreakingnews.com/hoya-surgical-optics-completes-acquisition-of-mid-labs-and-fritz-ruck 2023-09-05T13:40:00+03:00 en https://ophthalmologybreakingnews.com/hoya-surgical-optics-completes-acquisition-of-mid-labs-and-fritz-ruck https://ophthalmologybreakingnews.com/files/images/blog_halo-and-glare-not-a-problem-anymore.jpg https://ophthalmologybreakingnews.com/halo-and-glare-not-a-problem-anymore 2023-04-26T10:11:47+03:00 en https://ophthalmologybreakingnews.com/halo-and-glare-not-a-problem-anymore https://ophthalmologybreakingnews.com/files/images/blog_bauschlombs-recycling-program.jpg https://ophthalmologybreakingnews.com/bausch-lombs-recycling-program 2023-04-26T10:33:17+03:00 en https://ophthalmologybreakingnews.com/bausch-lombs-recycling-program https://ophthalmologybreakingnews.com/files/images/blog_a-novel-approach-to-trifocal-iols.jpg https://ophthalmologybreakingnews.com/a-novel-approach-to-trifocal-iols-sinusoidal-optic-design 2024-02-16T13:55:20+03:00 en https://ophthalmologybreakingnews.com/a-novel-approach-to-trifocal-iols-sinusoidal-optic-design